archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,1.7309e-08,1.2495,1.1745,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,2.5164e-08,1.1666,0.97399,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.8573e-08,1.0262,0.80439,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,3.019e-11,0.92884,0.92778,1,1
1,GO BLEB ASSEMBLY,2.457e-10,0.9284,0.98452,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,7.7166e-08,0.91228,0.7494,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.1098e-10,0.90122,0.88551,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,9.4499e-11,0.86679,0.79767,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,4.1815e-08,0.8194,0.6878,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,4.6784e-11,0.8146,0.7481,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.3074e-11,0.81216,0.80472,1,1
1,GO RESPONSE TO INTERFERON ALPHA,1.8594e-09,0.79012,0.7871,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,1.0493e-11,0.78394,0.7555,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,4.4302e-11,0.77223,0.70487,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.2682e-10,0.76366,0.78319,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,2.6711e-12,0.76338,0.7978,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,2.3933e-10,0.75639,0.77739,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,9.3752e-12,0.74494,0.69538,1,1
1,GO HEMIDESMOSOME ASSEMBLY,6.2993e-08,0.74258,0.77508,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,5.6451e-10,0.73226,0.71939,1,1
1,GO ETHANOL OXIDATION,3.6162e-06,0.72584,0.55995,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,3.192e-10,0.72173,0.69846,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,2.2117e-10,0.7199,0.7139,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,1.1579e-08,0.71765,0.66051,1,1
1,GO RESPONSE TO INTERFERON BETA,9.3415e-09,0.71686,0.70831,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,4.1815e-08,0.70863,0.6406,1,1
1,GO MEMBRANE RAFT ORGANIZATION,6.895e-08,0.70576,0.65282,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.9926e-08,0.70241,0.71411,1,1
1,GO HYALURONAN CATABOLIC PROCESS,8.0815e-10,0.69878,0.6861,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,3.2894e-09,0.68986,0.60052,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,6.3359e-07,0.68406,0.59589,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,2.6914e-06,0.68302,0.56258,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,8.2864e-09,0.67762,0.57275,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,7.9617e-06,0.67102,0.55579,1,1
1,GO RESPONSE TO TYPE I INTERFERON,3.247e-08,0.66524,0.55906,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.6407e-09,0.66384,0.61447,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.3933e-10,0.64984,0.60038,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,7.2202e-11,0.64783,0.62051,1,1
1,GO NEUTROPHIL HOMEOSTASIS,6.586e-10,0.64225,0.61743,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.2565e-10,0.63037,0.63717,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,4.1815e-08,0.6302,0.53733,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.3769e-07,0.62624,0.52629,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,2.8001e-06,0.62599,0.5403,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,7.0522e-08,0.62313,0.534,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,4.3774e-08,0.62293,0.5889,1,1
1,GO TOLERANCE INDUCTION,1.9558e-07,0.62145,0.53835,1,1
1,GO FIBRINOLYSIS,1.7721e-08,0.62023,0.55365,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.2131e-09,0.6183,0.64621,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,3.357e-07,0.6174,0.54768,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,3.8301e-10,0.61465,0.54395,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.457e-10,0.61352,0.56456,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.5688e-10,0.61157,0.59129,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,2.8573e-11,0.60127,0.5633,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,9.1996e-11,0.59886,0.54326,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,1.5713e-07,0.59606,0.48511,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,3.5427e-10,0.59549,0.6068,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,9.6538e-08,0.59125,0.57173,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,6.0565e-09,0.58975,0.50501,1,1
1,GO MUCUS SECRETION,1.064e-06,0.58914,0.59435,1,1
1,GO CYTOLYSIS,4.9872e-09,0.58763,0.52278,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,2.1595e-09,0.5855,0.50499,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,3.3228e-08,0.5809,0.53927,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,8.2543e-08,0.58045,0.5558,1,1
1,GO RESPONSE TO INTERLEUKIN 18,2.2286e-07,0.57979,0.62395,1,1
1,GO LEUKOCYTE AGGREGATION,1.6782e-07,0.57408,0.51756,1,1
1,GO ZYMOGEN INHIBITION,3.3629e-10,0.57366,0.59046,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,8.9047e-09,0.57252,0.53517,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,3.9822e-07,0.56739,0.52276,1,1
1,GO MYOBLAST MIGRATION,8.2686e-06,0.56696,0.48803,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,1.2886e-07,0.56587,0.55512,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,4.3774e-08,0.56423,0.50895,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,2.0478e-05,0.56382,0.50146,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,7.6792e-10,0.56256,0.57023,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.7442e-10,0.56009,0.48445,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.0546e-09,0.55951,0.52485,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,6.586e-10,0.55292,0.48024,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,5.1691e-12,0.54948,0.53072,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,3.2094e-09,0.54868,0.55331,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.4487e-10,0.54588,0.50378,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,1.0279e-08,0.54408,0.54407,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.3761e-09,0.54266,0.5236,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,1.6001e-09,0.54059,0.52594,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,2.7668e-07,0.54038,0.51386,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,1.2328e-07,0.53993,0.54927,1,1
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,3.094e-05,0.53917,0.40687,1,1
1,GO RESPONSE TO INTERFERON GAMMA,9.9064e-10,0.53897,0.49225,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,4.3774e-08,0.53603,0.57122,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,2.634e-09,0.53566,0.49674,1,1
1,GO EPIBOLY,2.8753e-10,0.535,0.5445,1,1
1,GO T CELL EXTRAVASATION,2.2775e-07,0.53213,0.46185,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,3.4553e-09,0.53213,0.56022,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,2.971e-06,0.53141,0.5042,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,4.1815e-08,0.53022,0.50212,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,5.3617e-10,0.52801,0.51186,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,7.5217e-06,0.5278,0.44811,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,4.0033e-09,0.52755,0.5233,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,1.0422e-09,0.52678,0.5253,1,1
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,1.6158e-05,0.52673,0.45842,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,2.5893e-10,0.5266,0.55015,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,3.4516e-10,0.52352,0.47186,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,1.725e-09,0.52313,0.62896,1,1
1,GO DETECTION OF BIOTIC STIMULUS,1.0527e-08,0.52292,0.50242,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.4586e-08,0.52077,0.54108,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,7.333e-07,0.52068,0.43846,1,1
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0035605,0.5206,0.24879,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,2.0546e-09,0.51983,0.55776,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.1097e-10,0.5198,0.46187,1,1
1,GO LATERAL MESODERM DEVELOPMENT,6.3569e-09,0.51951,0.49407,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,4.2784e-08,0.51904,0.51473,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,2.0546e-09,0.51419,0.52748,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,2.2505e-06,0.51367,0.51785,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.3351e-08,0.51051,0.4692,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,5.4982e-08,0.5099,0.55006,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,8.0898e-09,0.50989,0.57702,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,7.6446e-07,0.50954,0.42315,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.0983e-10,0.5039,0.5216,1,1
1,GO HIPPO SIGNALING,5.5016e-10,0.50385,0.51984,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.9805e-09,0.50379,0.46213,1,1
1,GO TYPE 2 IMMUNE RESPONSE,2.3268e-09,0.50124,0.47293,1,1
1,GO NOTOCHORD DEVELOPMENT,4.4148e-09,0.49933,0.56336,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,2.5695e-09,0.49862,0.44571,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00010673,0.4983,0.39017,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,3.2894e-09,0.49804,0.51033,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,2.0879e-07,0.49745,0.42193,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,1.0791e-07,0.49717,0.52999,1,1
1,GO INTERLEUKIN 2 PRODUCTION,2.9371e-11,0.4971,0.44696,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,3.9035e-08,0.49661,0.48355,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,1.1789e-06,0.49296,0.44148,1,1
1,GO ETHER BIOSYNTHETIC PROCESS,2.538e-07,0.4922,0.48924,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,1.8573e-08,0.49109,0.45862,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,1.0004e-06,0.49082,0.46163,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.0296e-10,0.49048,0.46018,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.3671e-08,0.48946,0.4286,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.4553e-09,0.48802,0.46483,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,8.1361e-07,0.48602,0.5871,1,1
1,GO INTERLEUKIN 1 PRODUCTION,1.5217e-09,0.48546,0.4524,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,5.7536e-08,0.48475,0.47586,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,3.5427e-10,0.48171,0.46082,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,4.7125e-10,0.48021,0.44152,1,1
1,GO PINOCYTOSIS,9.1996e-11,0.47844,0.44162,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,1.9558e-07,0.47707,0.4734,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,5.2359e-09,0.476,0.42524,1,1
1,GO RETINAL METABOLIC PROCESS,1.0756e-05,0.47503,0.43597,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,9.3415e-09,0.47469,0.45729,1,1
1,GO INTERLEUKIN 8 PRODUCTION,5.6451e-10,0.47366,0.44901,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.5922e-10,0.47265,0.43615,1,1
1,GO BIOLOGICAL PHASE,1.8723e-07,0.47082,0.55064,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,2.188e-08,0.46978,0.47619,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,2.3853e-09,0.46768,0.52797,1,1
1,GO T CELL MEDIATED IMMUNITY,1.0161e-09,0.4674,0.42123,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,5.7051e-07,0.46688,0.51879,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.0279e-11,0.46684,0.43526,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,1.0756e-05,0.46677,0.49677,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,6.1583e-08,0.46556,0.56033,1,1
1,GO ZYMOGEN ACTIVATION,1.3769e-07,0.46387,0.45239,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,6.895e-08,0.4616,0.46736,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.4452e-09,0.46157,0.42103,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.6109e-10,0.4608,0.46552,1,1
1,GO MITRAL VALVE DEVELOPMENT,9.086e-06,0.45943,0.39641,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,1.0094e-07,0.45822,0.3613,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,6.7724e-05,0.45807,0.39375,1,1
1,GO ENDODERM FORMATION,5.4967e-09,0.45754,0.46428,1,1
1,GO INTERLEUKIN 13 PRODUCTION,5.9498e-07,0.45699,0.46617,1,1
1,GO ETHANOL METABOLIC PROCESS,9.9803e-06,0.45698,0.4099,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,4.2042e-09,0.45679,0.39765,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,7.6792e-10,0.45679,0.44855,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,5.2359e-09,0.45499,0.46741,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,3.0295e-08,0.45384,0.45448,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.1307e-08,0.4519,0.44107,1,1
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,3.3435e-06,0.45041,0.40752,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,2.8886e-07,0.45019,0.46475,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,6.2565e-10,0.45002,0.43533,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,1.2032e-06,0.44909,0.37785,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,9.028e-08,0.44901,0.39926,1,1
1,GO PEPTIDE CROSS LINKING,1.1789e-06,0.44841,0.38942,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.6362e-08,0.44796,0.43335,1,1
1,GO REGULATION OF FIBRINOLYSIS,1.0004e-06,0.44663,0.3905,1,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,4.0678e-07,0.44624,0.45407,1,1
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00096848,0.44578,0.34418,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.069e-09,0.44418,0.45799,1,1
1,GO INTERLEUKIN 17 PRODUCTION,2.1375e-08,0.44381,0.37848,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.3355e-07,0.44315,0.38614,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,1.7385e-05,0.44291,0.35062,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,2.004e-09,0.44199,0.4315,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,8.2686e-06,0.44172,0.37998,1,1
1,GO DEFENSE RESPONSE TO VIRUS,6.9323e-10,0.44112,0.39223,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,2.004e-09,0.44095,0.43615,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.1819e-07,0.44047,0.43402,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,1.3196e-05,0.44023,0.33324,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,7.5451e-08,0.44,0.426,1,1
1,GO APOPTOTIC CELL CLEARANCE,2.7676e-09,0.43977,0.43274,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.6317e-09,0.43966,0.40984,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,4.2042e-09,0.43795,0.42941,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,3.7195e-09,0.43744,0.40984,1,1
1,GO BONE TRABECULA MORPHOGENESIS,3.628e-05,0.43725,0.42182,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,9.2321e-08,0.4352,0.5006,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,9.8716e-08,0.43445,0.5271,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,7.8976e-09,0.43415,0.45766,1,1
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00059648,0.43342,0.33571,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.7286e-10,0.43133,0.42836,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.3312e-10,0.43116,0.46506,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.8359e-10,0.43049,0.44684,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,1.9926e-08,0.43041,0.41882,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.77e-09,0.43006,0.41249,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,7.2964e-10,0.42956,0.4739,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,4.0033e-09,0.42937,0.46339,1,1
1,GO ENDODERM DEVELOPMENT,5.9116e-09,0.42907,0.40737,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0019819,0.42886,0.32332,1,1
1,GO RESPONSE TO HYDROPEROXIDE,7.5001e-05,0.42861,0.3669,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,1.155e-06,0.42829,0.47073,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,8.4805e-07,0.42633,0.41458,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,5.4982e-08,0.42612,0.3781,1,1
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,5.1304e-06,0.42552,0.3988,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,2.0398e-08,0.42385,0.41161,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,7.2964e-10,0.42244,0.41127,1,1
1,GO REGULATION OF PINOCYTOSIS,4.4787e-08,0.42219,0.36215,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.9064e-09,0.42182,0.36313,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.1316e-06,0.42119,0.35934,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,4.5684e-06,0.42104,0.37627,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,5.9834e-06,0.4208,0.43324,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.5223e-10,0.41987,0.46642,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,2.7452e-06,0.41975,0.38855,1,1
1,GO CHEMOKINE PRODUCTION,1.1086e-06,0.41946,0.2979,1,1
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,2.0776e-06,0.41929,0.35434,1,1
1,GO ENTRY INTO HOST,4.8359e-10,0.41911,0.42055,1,1
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,9.4959e-05,0.41882,0.36918,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,6.9711e-06,0.41813,0.34002,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,1.5713e-07,0.41764,0.37534,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,4.249e-10,0.4172,0.42217,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.3325e-06,0.41692,0.43847,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,7.4873e-07,0.41612,0.39647,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,2.3239e-05,0.4155,0.37454,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,6.8348e-09,0.41539,0.41333,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,1.0212e-06,0.41523,0.41577,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,2.5223e-10,0.41511,0.38188,1,1
1,GO VASCULOGENESIS,9.9064e-10,0.41499,0.4156,1,1
1,GO TROPHOBLAST CELL MIGRATION,4.8198e-07,0.41469,0.40117,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00094089,0.41452,0.46147,1,1
1,GO REGULATION OF CELL KILLING,7.4873e-07,0.41444,0.31853,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,4.2271e-06,0.414,0.43434,1,1
1,GO PLASMINOGEN ACTIVATION,5.1351e-07,0.41373,0.43347,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,3.0302e-06,0.41309,0.41692,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.6877e-06,0.41204,0.37691,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.1034e-07,0.41193,0.43086,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,3.192e-10,0.41107,0.44294,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,7.1819e-07,0.40942,0.42415,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,2.8814e-05,0.40928,0.3338,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,5.7051e-07,0.409,0.45883,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,2.342e-06,0.40842,0.37505,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,1.1282e-07,0.40763,0.52419,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,2.8886e-07,0.40708,0.37334,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.0361e-05,0.40659,0.40502,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,9.2321e-08,0.40603,0.45929,1,1
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,5.6487e-06,0.40598,0.33327,1,1
1,GO RESPONSE TO INTERLEUKIN 15,3.2146e-06,0.40543,0.33148,1,1
1,GO CD40 SIGNALING PATHWAY,2.5066e-09,0.40542,0.41437,1,1
1,GO RESPONSE TO PROTOZOAN,5.3747e-08,0.40503,0.40734,1,1
1,GO PIGMENT ACCUMULATION,2.5756e-08,0.40484,0.42006,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.77e-09,0.40335,0.39119,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,6.757e-10,0.40254,0.43386,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,2.2926e-08,0.40216,0.3754,1,1
1,GO T CELL APOPTOTIC PROCESS,4.0817e-11,0.40198,0.38453,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,4.9872e-09,0.40182,0.40009,1,1
1,GO MONOCYTE CHEMOTAXIS,1.0554e-07,0.40177,0.36116,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,1.064e-06,0.4017,0.3305,1,1
1,GO RESPONSE TO INTERLEUKIN 12,1.3376e-10,0.40164,0.38803,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,3.3435e-06,0.40136,0.38988,1,1
1,GO KERATINOCYTE PROLIFERATION,3.8924e-05,0.40077,0.34739,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.6981e-08,0.40052,0.37254,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.2131e-09,0.40018,0.39439,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.0161e-09,0.40008,0.4411,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,5.6245e-08,0.39999,0.51612,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,5.6085e-05,0.39957,0.38589,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,4.9228e-07,0.3992,0.36714,1,1
1,GO LYMPH VESSEL DEVELOPMENT,2.856e-06,0.39899,0.3777,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,5.1351e-07,0.39897,0.40761,1,1
1,GO DETECTION OF OTHER ORGANISM,8.5867e-06,0.39879,0.43239,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.2733e-08,0.39859,0.41608,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,2.0398e-08,0.39852,0.39611,1,1
1,GO POSITIVE REGULATION OF COAGULATION,1.5037e-07,0.39794,0.35916,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,1.1282e-07,0.39763,0.4436,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,2.0776e-06,0.39698,0.35273,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,6.0565e-09,0.39609,0.36759,1,1
1,GO PROSTANOID METABOLIC PROCESS,7.2129e-08,0.39593,0.40378,1,1
1,GO HEME METABOLIC PROCESS,9.4157e-10,0.39589,0.38724,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.0781e-08,0.39586,0.35653,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,5.6317e-09,0.39543,0.38125,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,1.1794e-07,0.39506,0.36828,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,6.4699e-07,0.39493,0.40426,1,1
1,GO CYTOKINE METABOLIC PROCESS,6.6717e-09,0.39442,0.34901,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,4.3946e-06,0.39436,0.44667,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,8.4415e-08,0.39396,0.318,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,6.0979e-10,0.39375,0.36673,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.188e-08,0.39329,0.34675,1,1
1,GO I KAPPAB PHOSPHORYLATION,7.4854e-10,0.39278,0.36003,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.0527e-08,0.391,0.37118,1,1
1,GO SERTOLI CELL DEVELOPMENT,7.3772e-08,0.39041,0.40957,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.1828e-09,0.39007,0.39067,1,1
1,GO CELLULAR DEFENSE RESPONSE,1.0756e-05,0.38965,0.27499,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0002117,0.38891,0.39419,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,4.31e-06,0.38875,0.38586,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.9805e-09,0.38847,0.42303,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1.5372e-07,0.38789,0.37253,1,1
1,GO VIRAL GENOME REPLICATION,3.7195e-09,0.3878,0.36366,1,1
1,GO REGULATION OF B CELL DIFFERENTIATION,6.1119e-05,0.38739,0.30336,1,1
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0067673,0.38708,0.31937,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,2.971e-06,0.38631,0.30193,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,6.9711e-06,0.3861,0.30558,1,1
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00037835,0.38597,0.41184,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,6.6066e-07,0.38578,0.41442,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,1.8723e-07,0.38521,0.32657,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,1.6654e-06,0.3841,0.34869,1,1
1,GO MONONUCLEAR CELL MIGRATION,1.3351e-08,0.38289,0.34766,1,1
1,GO ELASTIC FIBER ASSEMBLY,0.00010152,0.38234,0.53168,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,7.105e-06,0.38192,0.38605,1,1
1,GO PROTEIN ACTIVATION CASCADE,1.6782e-07,0.38172,0.36867,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,4.5922e-10,0.3812,0.45439,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,5.1304e-06,0.3812,0.36529,1,1
1,GO GERMINAL CENTER FORMATION,5.2344e-05,0.38118,0.3364,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.5027e-08,0.38112,0.34301,1,1
1,GO AMINE CATABOLIC PROCESS,2.2505e-06,0.38089,0.35443,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,2.7e-09,0.38053,0.31924,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,1.471e-07,0.38032,0.41235,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.5217e-09,0.38001,0.35469,1,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,1.475e-06,0.37958,0.39005,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,5.4356e-06,0.3795,0.38571,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.1034e-07,0.37938,0.3675,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,6.3569e-09,0.37886,0.34799,1,1
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00017741,0.3767,0.29171,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00028155,0.3763,0.26354,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,2.0364e-06,0.3756,0.35368,1,1
1,GO EPITHELIAL CELL CELL ADHESION,0.00073415,0.37537,0.36613,1,1
1,GO LIPOPROTEIN LOCALIZATION,1.5576e-05,0.3753,0.31853,1,1
1,GO RESPONSE TO SALT STRESS,3.9035e-08,0.3751,0.33182,1,1
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,2.6914e-06,0.37505,0.39092,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00074504,0.37482,0.25588,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,2.1338e-07,0.37453,0.39876,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00012594,0.37423,0.35782,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.7154e-07,0.3739,0.34727,1,1
1,GO MUSCLE CELL FATE COMMITMENT,2.6914e-06,0.37379,0.32419,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,7.7166e-08,0.37353,0.35522,1,1
1,GO PROSTATE GLAND GROWTH,0.0013069,0.37274,0.39592,1,1
1,GO RESPONSE TO VIRUS,8.2903e-10,0.37212,0.33809,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,1.5372e-07,0.37182,0.31996,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,3.3228e-08,0.37164,0.3561,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,1.9558e-07,0.37092,0.38156,1,1
1,GO DNA DEAMINATION,7.8124e-06,0.37068,0.44051,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.6317e-09,0.37021,0.36851,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,2.0546e-09,0.36988,0.35639,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,3.1479e-07,0.36946,0.35959,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,6.586e-10,0.36911,0.38562,1,1
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,4.2271e-06,0.36898,0.30913,1,1
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.037882,0.36897,0.2726,1,1
1,GO OSTEOBLAST DEVELOPMENT,5.7051e-07,0.36885,0.31904,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,9.2118e-07,0.36873,0.4231,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.2886e-07,0.36846,0.43424,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,1.3039e-08,0.36794,0.39682,1,1
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.5359e-06,0.3678,0.32315,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,8.8282e-08,0.36776,0.42688,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,6.6578e-05,0.36722,0.33811,1,1
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,2.0478e-05,0.36695,0.38348,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.1245e-09,0.36665,0.35176,1,1
1,GO LYMPHANGIOGENESIS,7.8976e-09,0.3663,0.40285,1,1
1,GO AMYLOID BETA CLEARANCE,4.1815e-08,0.3662,0.33728,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,6.895e-08,0.36618,0.33364,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,1.0094e-07,0.36537,0.33118,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,7.1121e-10,0.36468,0.35294,1,1
1,GO CYCLOOXYGENASE PATHWAY,0.0020092,0.3643,0.33488,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,2.2707e-10,0.36415,0.36716,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,3.0156e-07,0.36413,0.32618,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00015838,0.36351,0.26384,1,1
1,GO POSITIVE REGULATION OF CELL KILLING,2.0478e-05,0.36332,0.28719,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,4.1552e-07,0.36324,0.42548,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,2.9514e-07,0.36301,0.47494,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,9.6129e-06,0.36286,0.34696,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,5.3617e-10,0.36285,0.42891,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.7078e-07,0.36274,0.33143,1,1
1,GO INTERFERON BETA PRODUCTION,1.8135e-09,0.36008,0.34468,1,1
1,GO DENDRITIC CELL MIGRATION,4.7488e-06,0.35992,0.34679,1,1
1,GO MACROPHAGE MIGRATION,6.0565e-09,0.35988,0.33118,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,5.1356e-08,0.35971,0.35276,1,1
1,GO REGULATION OF HIPPO SIGNALING,8.1623e-05,0.35944,0.29153,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.00018923,0.35933,0.29954,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,6.8396e-06,0.35927,0.35196,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.0964e-09,0.3591,0.36023,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,2.1595e-09,0.35837,0.37874,1,1
1,GO CERAMIDE CATABOLIC PROCESS,2.6386e-06,0.35837,0.35398,1,1
1,GO TYPE I INTERFERON PRODUCTION,6.0979e-10,0.35829,0.33746,1,1
1,GO REGULATION OF TRANSPOSITION,5.0563e-05,0.35808,0.34636,1,1
1,GO T CELL CYTOKINE PRODUCTION,2.9602e-08,0.35791,0.32202,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,1.8419e-06,0.3578,0.42031,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,1.734e-06,0.35777,0.34708,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.00029976,0.35769,0.31564,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,8.0256e-05,0.35768,0.33379,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,2.0546e-09,0.35733,0.3213,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,3.2784e-06,0.35669,0.38225,1,1
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.9859e-05,0.35653,0.25925,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,4.4787e-08,0.35618,0.3406,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,7.8124e-06,0.35598,0.30079,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,4.3109e-11,0.35597,0.34381,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.7411e-08,0.3559,0.33122,1,1
1,GO FOCAL ADHESION ASSEMBLY,1.0094e-07,0.35548,0.36019,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,1.7687e-09,0.35537,0.31623,1,1
1,GO MACROPHAGE CHEMOTAXIS,2.188e-08,0.3551,0.31578,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,5.0278e-07,0.35425,0.3696,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,9.3752e-12,0.3537,0.3484,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.725e-09,0.35367,0.3727,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,1.6062e-07,0.35366,0.31852,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,1.5688e-10,0.35341,0.35708,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,2.5223e-10,0.35331,0.33253,1,1
1,GO RIG I SIGNALING PATHWAY,6.586e-10,0.35274,0.35567,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,2.3891e-06,0.35259,0.42297,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,2.1338e-07,0.35231,0.32834,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,1.3769e-07,0.35218,0.41424,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.5266e-09,0.35192,0.30535,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,7.3476e-09,0.35186,0.40073,1,1
1,GO STORE OPERATED CALCIUM ENTRY,2.1624e-06,0.35139,0.28697,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.8976e-09,0.35133,0.34762,1,1
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,1.8793e-06,0.35112,0.31371,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,1.0169e-05,0.35095,0.31334,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,1.5576e-05,0.35083,0.33272,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.00054518,0.35071,0.32508,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00065224,0.35043,0.28401,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,4.1026e-05,0.35037,0.34628,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.00038422,0.35022,0.31475,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,2.0398e-08,0.34937,0.36976,1,1
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,2.0478e-05,0.34923,0.31216,1,1
1,GO CHONDROCYTE PROLIFERATION,6.8888e-05,0.34921,0.37164,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,2.6362e-08,0.34917,0.32868,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.0041031,0.34916,0.2381,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,2.6362e-08,0.34893,0.33345,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,5.0278e-07,0.34869,0.4076,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,2.206e-06,0.34835,0.32926,1,1
1,GO ARTERY DEVELOPMENT,1.4741e-05,0.34825,0.27875,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.00033955,0.3482,0.3339,1,1
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0084096,0.34731,0.23091,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,8.4877e-09,0.34634,0.30502,1,1
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.00042777,0.34624,0.36165,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.00043435,0.34606,0.26588,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,1.1828e-09,0.34602,0.3379,1,1
1,GO CELLULAR RESPONSE TO DSRNA,1.5753e-08,0.34602,0.36992,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,6.0979e-10,0.3458,0.36599,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.3039e-08,0.34568,0.34902,1,1
1,GO HYALURONAN METABOLIC PROCESS,7.1819e-07,0.34564,0.30152,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.471e-07,0.34556,0.36731,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.2604e-07,0.34552,0.38844,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,2.5934e-07,0.34525,0.35693,1,1
1,GO REGULATION OF PHAGOCYTOSIS,1.6514e-08,0.34507,0.33733,1,1
1,GO PLATELET AGGREGATION,1.2058e-07,0.34388,0.34147,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,3.1004e-08,0.34318,0.34039,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,1.3419e-09,0.3429,0.36176,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.1361e-07,0.34262,0.29747,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,8.8389e-07,0.34259,0.34599,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,8.0815e-10,0.34221,0.36643,1,1
1,GO RESPONSE TO DSRNA,1.5372e-07,0.34136,0.28644,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.5606e-08,0.34127,0.31213,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,4.3946e-06,0.34068,0.32823,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,2.4586e-08,0.34046,0.32251,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.0527e-08,0.34015,0.31245,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,5.02e-08,0.3399,0.32633,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,1.2733e-08,0.33924,0.29302,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,1.1041e-08,0.33895,0.384,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,7.5266e-09,0.33879,0.32108,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,3.247e-08,0.33875,0.34337,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,8.2686e-06,0.3386,0.36047,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,2.4861e-06,0.33804,0.39014,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,1.6418e-07,0.33762,0.33089,1,1
1,GO RESPONSE TO ANGIOTENSIN,2.1375e-08,0.33751,0.35509,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,1.1806e-05,0.33751,0.28471,1,1
1,GO INTERACTION WITH SYMBIONT,1.1398e-10,0.33745,0.31435,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.0776e-06,0.33684,0.32948,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,3.2784e-06,0.33601,0.40682,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,7.8052e-07,0.336,0.33797,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.0026663,0.33593,0.27339,1,1
1,GO B CELL MEDIATED IMMUNITY,6.4434e-08,0.33591,0.34745,1,1
1,GO GRANULOCYTE MIGRATION,2.7078e-07,0.33564,0.27237,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,3.152e-06,0.33542,0.31725,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,2.4586e-08,0.33541,0.40834,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.5412e-09,0.33536,0.33718,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,6.2046e-07,0.33511,0.38605,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,5.9116e-09,0.33488,0.32868,1,1
1,GO INNATE IMMUNE RESPONSE,4.0033e-09,0.33474,0.31636,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.1375e-05,0.3347,0.2886,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.1165e-05,0.33465,0.35728,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,2.0437e-10,0.33376,0.38064,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,1.5994e-06,0.33333,0.29767,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,2.1234e-05,0.33297,0.29969,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.402e-08,0.33279,0.32604,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,4.719e-07,0.33255,0.33309,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,1.536e-06,0.33227,0.37199,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,2.1234e-05,0.33199,0.34024,1,1
1,GO RESPONSE TO X RAY,2.1064e-09,0.33188,0.40302,1,1
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00025617,0.33168,0.28384,1,1
1,GO T CELL CHEMOTAXIS,2.9602e-08,0.33102,0.31263,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.892e-08,0.33047,0.37222,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,4.3355e-07,0.33014,0.30949,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,5.3747e-08,0.33013,0.27387,1,1
1,GO PODOSOME ASSEMBLY,3.4796e-08,0.32994,0.41436,1,1
1,GO GRANULOCYTE CHEMOTAXIS,1.9563e-06,0.32974,0.25814,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,1.1165e-05,0.32933,0.34247,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,1.9136e-07,0.32916,0.38876,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.8886e-07,0.32903,0.2912,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,2.6386e-06,0.32903,0.27216,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,6.2565e-10,0.32868,0.35775,1,1
1,GO REGULATION OF COAGULATION,1.734e-06,0.32821,0.34044,1,1
1,GO T CELL PROLIFERATION,1.5372e-07,0.32802,0.28366,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,3.8983e-07,0.32772,0.37582,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.7356e-07,0.32763,0.30679,1,1
1,GO TRNA CATABOLIC PROCESS,0.0050904,0.32762,0.25552,1,1
1,GO MYOBLAST PROLIFERATION,0.00076726,0.32759,0.22771,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,6.1583e-08,0.32732,0.33367,1,1
1,GO ALPHA BETA T CELL ACTIVATION,2.9514e-07,0.32727,0.29852,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.5164e-08,0.32695,0.32739,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,2.2286e-07,0.32676,0.29266,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.00040235,0.32658,0.35274,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,4.7963e-08,0.32631,0.28376,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,3.3228e-08,0.32568,0.35658,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.4454e-06,0.32536,0.33906,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,2.0429e-07,0.32533,0.32588,1,1
1,GO NIK NF KAPPAB SIGNALING,4.6112e-12,0.32524,0.35374,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,2.2286e-07,0.32499,0.33781,1,1
1,GO INTERFERON ALPHA PRODUCTION,1.1858e-08,0.32487,0.35082,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.0212e-06,0.32468,0.33575,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.1579e-08,0.32467,0.33144,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,6.8348e-09,0.32467,0.3029,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,3.6877e-06,0.32448,0.29959,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,2.2117e-10,0.32425,0.3258,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,1.1706e-10,0.3236,0.34196,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.2321e-08,0.32341,0.32099,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,7.2129e-08,0.32307,0.32473,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.9136e-07,0.32256,0.377,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.9175e-06,0.32205,0.3366,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,5.1356e-08,0.322,0.33509,1,1
1,GO FIBROBLAST APOPTOTIC PROCESS,6.7105e-06,0.32198,0.30394,1,1
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0098086,0.32157,0.19196,1,1
1,GO BEHAVIORAL RESPONSE TO PAIN,4.9694e-05,0.32132,0.32044,1,1
1,GO VIRAL LIFE CYCLE,1.1706e-10,0.32121,0.32118,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.0295e-08,0.32096,0.29122,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,2.4371e-06,0.32077,0.30438,1,1
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00011406,0.32049,0.24805,1,1
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,4.2487e-05,0.32031,0.31605,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,1.996e-06,0.32017,0.32864,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,2.4305e-07,0.32009,0.307,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,3.5606e-08,0.32005,0.31113,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,2.8369e-09,0.32004,0.31897,1,1
1,GO HYPOTONIC RESPONSE,1.4741e-05,0.31995,0.30337,1,1
1,GO LAMELLIPODIUM MORPHOGENESIS,1.2482e-05,0.31935,0.35256,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,2.0879e-07,0.31867,0.36584,1,1
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.00068191,0.31865,0.28986,1,1
1,GO IMMUNE EFFECTOR PROCESS,6.0565e-09,0.3183,0.29651,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.2759e-09,0.31818,0.30614,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.1356e-08,0.3181,0.29727,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,4.1552e-07,0.31789,0.34571,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,3.4296e-07,0.31785,0.31838,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,4.4807e-06,0.31783,0.3117,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.5037e-07,0.31748,0.37193,1,1
1,GO TRANSPOSITION,8.7316e-05,0.31722,0.2967,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,3.0905e-06,0.317,0.41247,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.9711e-06,0.31554,0.28158,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,5.8698e-06,0.31513,0.35461,1,1
1,GO MYOBLAST FUSION,1.2792e-06,0.31466,0.33787,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,1.0424e-06,0.31464,0.312,1,1
1,GO FIBROBLAST MIGRATION,2.2397e-08,0.31463,0.34075,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,5.5864e-07,0.31454,0.28587,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,3.0295e-08,0.31443,0.30901,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.5412e-09,0.31423,0.2961,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,5.6317e-09,0.31418,0.30484,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,4.7963e-08,0.3137,0.35933,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,3.6435e-08,0.31358,0.30763,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,7.1819e-07,0.31346,0.27707,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,7.5451e-08,0.31345,0.37584,1,1
1,GO SERTOLI CELL DIFFERENTIATION,1.6994e-06,0.31342,0.30988,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,4.0657e-06,0.31337,0.30027,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,1.1041e-08,0.31326,0.38644,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.2397e-08,0.31311,0.29749,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,6.0759e-07,0.31305,0.33893,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.2444e-07,0.31262,0.27902,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00025617,0.31255,0.2653,1,1
1,GO GENITALIA MORPHOGENESIS,0.00030928,0.31228,0.27318,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,1.9136e-07,0.31217,0.287,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,6.1583e-08,0.31205,0.32666,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,1.6062e-07,0.31195,0.30782,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,8.1361e-07,0.31187,0.32844,1,1
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.0016575,0.31156,0.2648,1,1
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,1.0212e-06,0.31133,0.2798,1,1
1,GO INTERLEUKIN 10 PRODUCTION,0.001483,0.31124,0.21726,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00017457,0.31114,0.24814,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,1.0004e-06,0.31113,0.27948,1,1
1,GO RESPONSE TO ESTROGEN,7.1726e-09,0.31095,0.3081,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,3.1479e-07,0.31092,0.32084,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,1.8701e-05,0.31062,0.27803,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,3.6567e-07,0.31042,0.36396,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,7.2414e-06,0.31006,0.36539,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.1165e-05,0.30983,0.23997,1,1
1,GO REGULATION OF MYOBLAST FUSION,1.4454e-06,0.3096,0.3729,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,2.2958e-06,0.30946,0.28726,1,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,8.5858e-05,0.30929,0.29647,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,1.3196e-05,0.30925,0.26809,1,1
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00039018,0.30919,0.28059,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,7.2129e-08,0.30879,0.31628,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00010852,0.30857,0.32329,1,1
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,2.7804e-05,0.30824,0.28767,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,5.9432e-10,0.30818,0.27837,1,1
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.011411,0.30818,0.2632,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,7.8911e-05,0.30793,0.28257,1,1
1,GO ENAMEL MINERALIZATION,0.00017176,0.30791,0.36407,1,1
1,GO ARTERY MORPHOGENESIS,0.0005133,0.30764,0.23674,1,1
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.0023637,0.30752,0.20699,1,1
1,GO TRACHEA DEVELOPMENT,3.3806e-05,0.30734,0.30291,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,7.6657e-06,0.30719,0.29914,1,1
1,GO REGULATION OF RESPONSE TO TUMOR CELL,7.1274e-05,0.30718,0.2693,1,1
1,GO MEMBRANE INVAGINATION,1.8318e-07,0.30697,0.29803,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,3.2859e-07,0.30653,0.34129,1,1
1,GO ARGININE METABOLIC PROCESS,2.0364e-06,0.30653,0.30636,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,1.7922e-07,0.30649,0.28048,1,1
1,GO CELLULAR RESPONSE TO VIRUS,2.8369e-09,0.30625,0.31186,1,1
1,GO PROTEIN DEGLYCOSYLATION,1.1316e-06,0.30615,0.32715,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,2.5695e-09,0.30609,0.36599,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,4.0678e-07,0.30577,0.32793,1,1
1,GO REGULATION OF DNA METHYLATION,0.0071051,0.30566,0.17894,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,2.4371e-06,0.30561,0.27809,1,1
1,GO ACTIN FILAMENT SEVERING,3.5022e-05,0.30559,0.3861,1,1
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.0016347,0.30551,0.18531,1,1
1,GO REGULATION OF PROTEIN MATURATION,5.2253e-10,0.30532,0.31585,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,2.9078e-09,0.30529,0.27516,1,1
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00011596,0.30521,0.21438,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,9.1793e-10,0.30483,0.31091,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,1.475e-06,0.3048,0.32077,1,1
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0015038,0.30473,0.24468,1,1
1,GO NAD BIOSYNTHETIC PROCESS,0.00060545,0.30446,0.2386,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.7534e-07,0.30441,0.33731,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0066039,0.30429,0.22873,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,1.0958e-05,0.30413,0.27596,1,1
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00021857,0.30397,0.24505,1,1
1,GO POSITIVE REGULATION OF WOUND HEALING,3.758e-05,0.30369,0.27749,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,1.6986e-10,0.30368,0.31719,1,1
1,GO EMBRYO IMPLANTATION,1.0094e-07,0.30352,0.31929,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,8.8389e-07,0.30344,0.27076,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.0554e-07,0.30339,0.29426,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,5.2445e-07,0.30327,0.33024,1,1
1,GO NECROTIC CELL DEATH,5.2445e-07,0.30326,0.27512,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.538e-07,0.30303,0.32972,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,3.3435e-06,0.303,0.3301,1,1
1,GO NEUROBLAST DIVISION,0.0045438,0.30291,0.21333,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.2027e-05,0.30283,0.24211,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.0033799,0.30279,0.35314,1,1
1,GO BARBED END ACTIN FILAMENT CAPPING,8.0256e-05,0.30257,0.30896,1,1
1,GO MACROPHAGE DIFFERENTIATION,2.1338e-07,0.30245,0.31172,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,2.7312e-05,0.30239,0.30283,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.00069207,0.30238,0.24191,1,1
1,GO REGULATION OF STEROL TRANSPORT,2.1807e-07,0.30211,0.32267,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,4.1552e-07,0.30135,0.34422,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,2.8262e-08,0.30124,0.29647,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,1.8419e-06,0.30119,0.27666,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,2.2505e-06,0.30118,0.33506,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,2.9332e-05,0.30112,0.32994,1,1
1,GO RESPONSE TO CYTOKINE,2.634e-09,0.30109,0.28276,1,1
1,GO PSEUDOPODIUM ORGANIZATION,0.0060595,0.30101,0.26408,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,2.1543e-10,0.30079,0.29144,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.6362e-08,0.29923,0.28637,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,5.4967e-09,0.29923,0.31457,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,1.1858e-08,0.29885,0.31492,1,1
1,GO SEQUESTERING OF METAL ION,2.1196e-06,0.29878,0.29729,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.4528e-05,0.29868,0.26829,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.2784e-08,0.29847,0.28782,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,4.719e-07,0.29809,0.32125,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.1595e-09,0.29807,0.33671,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,1.3948e-05,0.2977,0.34207,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,3.0296e-10,0.29747,0.2891,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,3.3806e-05,0.29742,0.34063,1,1
1,GO REGULATION OF GASTRULATION,2.8369e-09,0.29723,0.3208,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,1.9465e-08,0.2967,0.32326,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,5.7582e-06,0.29668,0.32396,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,2.1807e-07,0.29661,0.28981,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.969e-07,0.29641,0.28897,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,2.6981e-08,0.29601,0.30888,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,4.2784e-08,0.29592,0.30375,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,4.9872e-09,0.29574,0.26904,1,1
1,GO AORTA DEVELOPMENT,0.00032408,0.29566,0.2467,1,1
1,GO RESPONSE TO INTERLEUKIN 1,3.1896e-11,0.29536,0.30517,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,8.4415e-08,0.29513,0.29629,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,4.3946e-06,0.29484,0.31218,1,1
1,GO NATURAL KILLER CELL ACTIVATION,9.5677e-09,0.29482,0.30918,1,1
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,7.7586e-05,0.29471,0.25015,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,3.8924e-05,0.29462,0.28558,1,1
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.032607,0.29457,0.24563,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.0781e-08,0.29448,0.29069,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.2733e-08,0.29439,0.30877,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,2.0879e-07,0.29432,0.3061,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.6654e-06,0.2943,0.37637,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0044864,0.294,0.30395,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.3761e-09,0.29391,0.32947,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00014599,0.29379,0.24679,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,4.3355e-07,0.29368,0.29362,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,2.65e-07,0.29349,0.34074,1,1
1,GO COPPER ION HOMEOSTASIS,9.4407e-08,0.29339,0.31333,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,5.8698e-06,0.29319,0.30912,1,1
1,GO COLLAGEN CATABOLIC PROCESS,2.7078e-07,0.29302,0.32682,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,1.7693e-06,0.293,0.34437,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.6001e-09,0.29266,0.32241,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,1.1034e-07,0.29214,0.33852,1,1
1,GO VAGINA DEVELOPMENT,1.2281e-06,0.29211,0.34666,1,1
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00087508,0.29185,0.27614,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,1.2434e-08,0.29172,0.26417,1,1
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0001862,0.29171,0.25155,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,6.0991e-06,0.29169,0.29467,1,1
1,GO INTERACTION WITH HOST,3.2764e-10,0.2916,0.32026,1,1
1,GO LAMELLIPODIUM ORGANIZATION,8.0712e-08,0.29157,0.27285,1,1
1,GO T CELL MIGRATION,4.6202e-07,0.29141,0.30143,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,2.8001e-06,0.2909,0.31163,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.6407e-09,0.29087,0.30345,1,1
1,GO LIVER REGENERATION,2.188e-08,0.29076,0.30577,1,1
1,GO CELL SUBSTRATE ADHESION,1.8318e-07,0.29055,0.31879,1,1
1,GO RECEPTOR CATABOLIC PROCESS,3.4003e-08,0.29042,0.34922,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,1.9136e-07,0.29038,0.2859,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,7.0337e-07,0.2903,0.32463,1,1
1,GO PHAGOCYTOSIS,1.2143e-08,0.29027,0.31047,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.6514e-08,0.29011,0.29555,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.8262e-08,0.29007,0.2892,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.155e-06,0.29007,0.32107,1,1
1,GO OSTEOCLAST DEVELOPMENT,9.5999e-07,0.29004,0.3488,1,1
1,GO REGULATION OF CELL FATE SPECIFICATION,0.011411,0.28971,0.21793,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,3.0295e-08,0.28927,0.33245,1,1
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,3.7605e-06,0.28914,0.26233,1,1
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.0007901,0.28852,0.19788,1,1
1,GO VIRAL RNA GENOME REPLICATION,7.1819e-07,0.28808,0.28273,1,1
1,GO RETINOL METABOLIC PROCESS,5.8698e-06,0.28789,0.26134,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,5.5864e-07,0.28766,0.30371,1,1
1,GO PRIMARY MIRNA PROCESSING,4.8198e-07,0.28732,0.32295,1,1
1,GO AORTIC VALVE DEVELOPMENT,6.7724e-05,0.28709,0.31615,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,3.758e-05,0.287,0.28634,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,9.795e-06,0.28679,0.22295,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,1.6129e-08,0.28673,0.32016,1,1
1,GO P38MAPK CASCADE,5.4701e-07,0.2867,0.28104,1,1
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00091404,0.28655,0.23797,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,2.7676e-09,0.28648,0.26023,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,1.1086e-06,0.28639,0.29749,1,1
1,GO T CELL ACTIVATION,9.6538e-08,0.28543,0.27292,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0012705,0.28539,0.23949,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.7804e-05,0.28479,0.31754,1,1
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0029645,0.28409,0.24305,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,6.1583e-08,0.28367,0.31569,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,3.8161e-07,0.28335,0.28115,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,1.2143e-08,0.28333,0.26691,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.4796e-08,0.28328,0.30332,1,1
1,GO RESPIRATORY BURST,0.0024609,0.28321,0.18708,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00032408,0.28318,0.19608,1,1
1,GO REPLACEMENT OSSIFICATION,9.9844e-05,0.2831,0.29307,1,1
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,3.7356e-07,0.28295,0.27234,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,1.0004e-06,0.28278,0.2734,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,5.9056e-05,0.28204,0.26007,1,1
1,GO SALIVARY GLAND DEVELOPMENT,6.9711e-06,0.28201,0.3757,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,6.8348e-09,0.28146,0.3071,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00015083,0.28131,0.33124,1,1
1,GO MUSCLE CELL MIGRATION,6.8396e-06,0.28112,0.26171,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,8.2864e-09,0.28086,0.28323,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,3.5461e-06,0.28071,0.25493,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00010497,0.28062,0.32586,1,1
1,GO CELL MATRIX ADHESION,6.0759e-07,0.28061,0.29679,1,1
1,GO WOUND HEALING,2.3274e-07,0.28059,0.27995,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,2.5868e-06,0.2804,0.28745,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,2.5756e-08,0.28039,0.2854,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,1.1086e-06,0.28029,0.3051,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00013899,0.28021,0.3019,1,1
1,GO MACROPHAGE PROLIFERATION,0.00072342,0.28019,0.28853,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,4.6202e-07,0.27998,0.31783,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,4.7501e-09,0.27984,0.32816,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,5.6245e-08,0.27963,0.35254,1,1
1,GO BILE ACID AND BILE SALT TRANSPORT,0.00095459,0.27958,0.21164,1,1
1,GO OXYGEN TRANSPORT,0.052083,0.27957,0.15376,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,9.086e-06,0.27852,0.24928,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,0.00020835,0.27852,0.39051,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,2.1807e-07,0.27805,0.27036,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,8.0898e-09,0.2779,0.2783,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,5.8049e-05,0.27716,0.25292,1,1
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,4.9228e-07,0.27704,0.25767,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,6.0979e-10,0.27679,0.3242,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,2.7452e-06,0.27632,0.27873,1,1
1,GO TONGUE DEVELOPMENT,0.00049802,0.27593,0.25731,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,9.7998e-07,0.27574,0.37831,1,1
1,GO VITAMIN D METABOLIC PROCESS,0.001118,0.2756,0.22642,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,2.1196e-06,0.27526,0.27861,1,1
1,GO COAGULATION,1.155e-06,0.27522,0.24444,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,4.4787e-08,0.27521,0.29211,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,4.0678e-07,0.27505,0.28144,1,1
1,GO SPROUTING ANGIOGENESIS,5.7536e-08,0.27495,0.31279,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,9.3415e-09,0.27457,0.3063,1,1
1,GO RESPONSE TO UV B,0.00084997,0.27456,0.2559,1,1
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00030449,0.27451,0.26732,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,6.6066e-07,0.2742,0.30837,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.00029511,0.27405,0.25687,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,7.0017e-09,0.27393,0.27293,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,9.6538e-08,0.27393,0.30405,1,1
1,GO FIBROBLAST ACTIVATION,3.2146e-06,0.27363,0.31393,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,4.5558e-05,0.27243,0.21682,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,3.4296e-07,0.27221,0.2692,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,9.8716e-08,0.27202,0.25843,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0001803,0.27198,0.22561,1,1
1,GO LEUKOCYTE PROLIFERATION,7.333e-07,0.27184,0.25933,1,1
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00024819,0.27181,0.32426,1,1
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00022565,0.27178,0.29746,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,3.628e-05,0.27176,0.27819,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,9.3415e-09,0.27159,0.25166,1,1
1,GO PROTEIN DEMANNOSYLATION,6.3249e-05,0.27159,0.25713,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,1.4163e-06,0.27152,0.27545,1,1
1,GO PROTEASOME ASSEMBLY,1.9393e-05,0.27148,0.20833,1,1
1,GO TISSUE REGENERATION,5.8262e-07,0.27144,0.26241,1,1
1,GO FOREGUT MORPHOGENESIS,9.0235e-07,0.27143,0.33191,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.001422,0.27124,0.2405,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,4.719e-07,0.27095,0.2537,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00094089,0.27086,0.19101,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,3.5646e-05,0.27057,0.25377,1,1
1,GO COMPLEMENT ACTIVATION,4.1456e-06,0.27053,0.32907,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00024045,0.27046,0.22752,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,3.2146e-06,0.27019,0.32987,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00026024,0.27011,0.2576,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,6.3249e-05,0.27009,0.25021,1,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00034485,0.26994,0.23824,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,7.892e-08,0.26989,0.27951,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00023294,0.26984,0.23696,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.00010673,0.26939,0.26582,1,1
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.00022927,0.2693,0.25162,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.0036e-08,0.26922,0.29619,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.6162e-06,0.26882,0.2671,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,6.5906e-08,0.26879,0.28184,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,5.0278e-07,0.26877,0.34447,1,1
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.00023667,0.26871,0.30069,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,4.6359e-05,0.26853,0.25798,1,1
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.00094089,0.26836,0.20733,1,1
1,GO GLAND MORPHOGENESIS,5.7582e-06,0.26823,0.32352,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,1.6457e-05,0.26792,0.33616,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,5.1356e-08,0.26773,0.27185,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0010865,0.26758,0.32249,1,1
1,GO CYTOKINE PRODUCTION,1.5027e-08,0.26751,0.27935,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00019541,0.26749,0.26032,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,2.4586e-08,0.26747,0.26922,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,5.4701e-07,0.26719,0.29486,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,1.5372e-07,0.26717,0.26681,1,1
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00080175,0.26702,0.33848,1,1
1,GO CELL REDOX HOMEOSTASIS,2.1338e-07,0.26634,0.23241,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,4.8839e-05,0.26629,0.30594,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,3.5461e-06,0.26628,0.2562,1,1
1,GO REGULATION OF WOUND HEALING,4.2271e-06,0.26628,0.27648,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,2.3274e-07,0.26618,0.28463,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00033432,0.26602,0.19293,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,3.9035e-08,0.26594,0.27726,1,1
1,GO KERATINOCYTE DIFFERENTIATION,0.00057029,0.26593,0.23707,1,1
1,GO NEUTROPHIL MIGRATION,8.1138e-06,0.26582,0.23051,1,1
1,GO REGULATION OF BONE DEVELOPMENT,2.1196e-06,0.26577,0.2856,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,2.3784e-07,0.26564,0.2611,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,7.71e-09,0.26555,0.26537,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00024045,0.26527,0.3193,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.0522e-08,0.26518,0.28191,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.6129e-08,0.26504,0.28103,1,1
1,GO FOAM CELL DIFFERENTIATION,8.3013e-05,0.26497,0.26645,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.8416e-06,0.26471,0.22049,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,1.5576e-05,0.26464,0.27823,1,1
1,GO VESICLE CARGO LOADING,1.9926e-08,0.26458,0.2976,1,1
1,GO BLOOD VESSEL REMODELING,0.00016901,0.26445,0.25065,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,9.9844e-05,0.26443,0.29169,1,1
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,2.5884e-05,0.26437,0.23011,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,2.856e-06,0.26429,0.26399,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00030928,0.26425,0.18714,1,1
1,GO SOMATIC STEM CELL DIVISION,0.05357,0.26402,0.22308,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.4434e-08,0.26387,0.2828,1,1
1,GO ERK1 AND ERK2 CASCADE,5.0278e-07,0.26376,0.23428,1,1
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.040981,0.26358,0.31099,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,6.4699e-07,0.26338,0.24543,1,1
1,GO PIGMENT GRANULE ORGANIZATION,4.4787e-08,0.2633,0.32097,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,1.0169e-05,0.26301,0.26746,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,1.0756e-05,0.26287,0.25492,1,1
1,GO REGULATION OF T CELL ACTIVATION,2.4305e-07,0.26275,0.26103,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,2.2958e-06,0.26255,0.23072,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00026024,0.26249,0.24673,1,1
1,GO STEM CELL DIVISION,6.3249e-05,0.26236,0.25658,1,1
1,GO BONE GROWTH,3.094e-05,0.26213,0.32185,1,1
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0096941,0.26212,0.23202,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,9.819e-05,0.26203,0.30654,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,1.4207e-05,0.26192,0.25992,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,7.5217e-06,0.26186,0.27844,1,1
1,GO CELLULAR OXIDANT DETOXIFICATION,9.7998e-07,0.26181,0.21577,1,1
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.016386,0.26154,0.19008,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,1.8142e-08,0.2615,0.26008,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00014839,0.26144,0.3052,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,3.0395e-05,0.2609,0.22828,1,1
1,GO ERBB2 SIGNALING PATHWAY,1.5037e-07,0.26089,0.28103,1,1
1,GO STEROL TRANSPORT,1.2253e-05,0.26087,0.2283,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2792e-06,0.26069,0.26873,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,1.9393e-05,0.26056,0.2212,1,1
1,GO SEQUESTERING OF TRIGLYCERIDE,2.4091e-05,0.26052,0.27623,1,1
1,GO MUSCLE FILAMENT SLIDING,8.3013e-05,0.26047,0.20898,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.5604e-09,0.26042,0.29816,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.1858e-08,0.26039,0.27101,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,3.3435e-06,0.26024,0.2679,1,1
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,4.2271e-06,0.25986,0.25218,1,1
1,GO PORE COMPLEX ASSEMBLY,1.0791e-07,0.25983,0.26388,1,1
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0023637,0.25979,0.23723,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,6.7461e-07,0.25973,0.28893,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,2.0364e-06,0.25967,0.27133,1,1
1,GO MICROVILLUS ASSEMBLY,0.0018006,0.25951,0.20679,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.5293e-05,0.25923,0.25385,1,1
1,GO REPLICATIVE SENESCENCE,0.00072342,0.25904,0.22038,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.00029052,0.25902,0.2894,1,1
1,GO GLOMERULUS DEVELOPMENT,9.819e-05,0.25887,0.30914,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00019229,0.25882,0.19166,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,3.0302e-06,0.25873,0.27815,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.188e-08,0.25853,0.31292,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,2.7078e-07,0.25849,0.25378,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,2.7614e-08,0.25841,0.2767,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.4773e-06,0.25833,0.23867,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.475e-06,0.25831,0.25313,1,1
1,GO RESPONSE TO BACTERIUM,3.9941e-08,0.25794,0.26775,1,1
1,GO PLATELET DEGRANULATION,3.8347e-06,0.25783,0.30011,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,1.7693e-06,0.25779,0.2364,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,9.0235e-07,0.25778,0.29362,1,1
1,GO REGULATION OF CELL ADHESION,5.7582e-06,0.25733,0.23321,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,1.3948e-05,0.25727,0.27043,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.2397e-08,0.25712,0.25811,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.2886e-07,0.25689,0.25235,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.3355e-07,0.25634,0.24556,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,1.4207e-05,0.25625,0.24287,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,3.9872e-06,0.25621,0.23432,1,1
1,GO RESPONSE TO DEXAMETHASONE,8.1623e-05,0.25604,0.21148,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,3.5038e-07,0.25601,0.273,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,1.5014e-05,0.25565,0.22878,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,2.6386e-06,0.25529,0.27977,1,1
1,GO KERATINOCYTE MIGRATION,1.0361e-05,0.25526,0.23457,1,1
1,GO COPPER ION TRANSPORT,1.0861e-06,0.2552,0.281,1,1
1,GO REGULATION OF IMMUNE RESPONSE,2.7614e-08,0.25519,0.25724,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,9.4407e-08,0.25503,0.25826,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,1.8318e-07,0.25454,0.26625,1,1
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.001235,0.25375,0.23864,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,4.4787e-08,0.25347,0.23141,1,1
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.0081133,0.25337,0.24616,1,1
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00024819,0.25337,0.20492,1,1
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.0044298,0.25325,0.31685,1,1
1,GO MATURATION OF SSU RRNA,5.4184e-05,0.25298,0.23217,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,3.4773e-06,0.25283,0.22653,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,1.9563e-06,0.25266,0.32775,1,1
1,GO CELL ACTIVATION,4.3774e-08,0.25266,0.24352,1,1
1,GO MATURATION OF 5 8S RRNA,0.00034485,0.2526,0.19143,1,1
1,GO BRONCHUS DEVELOPMENT,0.021053,0.25227,0.20846,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,1.3056e-06,0.25216,0.30977,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,2.8814e-05,0.25196,0.2315,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.000286,0.25183,0.21656,1,1
1,GO ERBB SIGNALING PATHWAY,8.3066e-07,0.25175,0.22741,1,1
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,4.5558e-05,0.25169,0.22469,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,1.8701e-05,0.25137,0.25305,1,1
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,9.1829e-05,0.25134,0.23308,1,1
1,GO RESPONSE TO MANGANESE ION,1.536e-06,0.25121,0.23868,1,1
1,GO CHOLESTEROL EFFLUX,3.4409e-05,0.25114,0.22412,1,1
1,GO CORNIFICATION,0.03902,0.25106,0.18342,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00010673,0.25087,0.22765,1,1
1,GO RESPONSE TO IONIZING RADIATION,8.6937e-09,0.25075,0.25021,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,9.1829e-05,0.25074,0.25434,1,1
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,1.8032e-05,0.25065,0.28231,1,1
1,GO GASTRULATION,4.3774e-08,0.25063,0.2782,1,1
1,GO MYOBLAST DIFFERENTIATION,8.6328e-08,0.25039,0.28247,1,1
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.001776,0.25032,0.20282,1,1
1,GO RESPONSE TO INTERLEUKIN 7,1.7071e-05,0.2503,0.22685,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.1086e-06,0.25021,0.26698,1,1
1,GO ASYMMETRIC CELL DIVISION,2.1621e-05,0.25021,0.25269,1,1
1,GO CELLULAR RESPONSE TO X RAY,9.4341e-06,0.24961,0.32899,1,1
1,GO OSTEOCLAST DIFFERENTIATION,4.8198e-07,0.24955,0.23869,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0016806,0.24928,0.30001,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00026858,0.24902,0.23911,1,1
1,GO GLIAL CELL ACTIVATION,2.7804e-05,0.24868,0.24183,1,1
1,GO BONE DEVELOPMENT,8.5867e-06,0.24859,0.23016,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,1.6994e-06,0.24842,0.22744,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,2.913e-06,0.2483,0.25807,1,1
1,GO VIRAL TRANSLATION,1.8032e-05,0.24829,0.2505,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,2.5164e-08,0.24806,0.25147,1,1
1,GO NEUTROPHIL CHEMOTAXIS,0.00014129,0.24794,0.2054,1,1
1,GO RESPONSE TO GAMMA RADIATION,1.6782e-07,0.24788,0.25239,1,1
1,GO REGULATION OF LIPASE ACTIVITY,1.6418e-07,0.24779,0.25076,1,1
1,GO PHOSPHOLIPID HOMEOSTASIS,0.0005056,0.2477,0.23527,1,1
1,GO LYMPHOCYTE ACTIVATION,1.3468e-07,0.24765,0.24254,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,3.8246e-05,0.24756,0.30356,1,1
1,GO TERPENOID METABOLIC PROCESS,0.00015583,0.24749,0.18993,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,2.9332e-05,0.24735,0.23023,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0002443,0.24728,0.24775,1,1
1,GO ERYTHROCYTE DEVELOPMENT,8.2686e-06,0.24727,0.22231,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,2.7078e-07,0.24707,0.26955,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00070238,0.24683,0.19392,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION,1.536e-06,0.24679,0.24874,1,1
1,GO INTERFERON GAMMA PRODUCTION,3.9822e-07,0.24666,0.28049,1,1
1,GO VASCULATURE DEVELOPMENT,1.5372e-07,0.24663,0.26938,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,5.4982e-08,0.24641,0.25659,1,1
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00044103,0.24638,0.23353,1,1
1,GO TISSUE MIGRATION,7.333e-07,0.24598,0.2811,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,1.6407e-09,0.24576,0.2972,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.6352e-05,0.24556,0.22045,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00020835,0.24549,0.22699,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,1.734e-06,0.2453,0.26611,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,1.2281e-06,0.24521,0.2571,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,8.8389e-07,0.24518,0.24326,1,1
1,GO SECRETION BY TISSUE,0.00021511,0.24512,0.21304,1,1
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.001422,0.24441,0.19923,1,1
1,GO TUMOR NECROSIS FACTOR SECRETION,1.3693e-05,0.24433,0.21511,1,1
1,GO REGULATION OF STEM CELL DIVISION,0.017506,0.24425,0.1535,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,7.9617e-06,0.24413,0.25076,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00023294,0.24411,0.27627,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,8.8389e-07,0.2441,0.22884,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,2.0398e-08,0.24408,0.27928,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.00062378,0.24396,0.22679,1,1
1,GO ACTIVATED T CELL PROLIFERATION,8.7316e-05,0.24395,0.20642,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.0011836,0.24392,0.24331,1,1
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.00019857,0.24338,0.26013,1,1
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,5.5412e-06,0.24325,0.27411,1,1
1,GO TRABECULA FORMATION,0.00070238,0.24288,0.29796,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00083767,0.24286,0.20823,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,1.1858e-08,0.24278,0.25418,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0012527,0.24269,0.20904,1,1
1,GO LINOLEIC ACID METABOLIC PROCESS,0.024428,0.24263,0.17076,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,7.8976e-09,0.24254,0.2735,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,2.2958e-06,0.24253,0.2234,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,2.5884e-05,0.24233,0.26215,1,1
1,GO LUNG MORPHOGENESIS,1.8363e-05,0.24221,0.30837,1,1
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.0020646,0.24213,0.29355,1,1
1,GO T HELPER CELL LINEAGE COMMITMENT,0.0005618,0.24171,0.19399,1,1
1,GO SYNCYTIUM FORMATION,3.5038e-07,0.24152,0.31047,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,6.7461e-07,0.2414,0.28182,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,1.9044e-05,0.24125,0.23383,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,8.6937e-09,0.2407,0.2337,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,2.2926e-08,0.24054,0.25206,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,6.7461e-07,0.24051,0.29869,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.3747e-08,0.2405,0.27541,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,6.2046e-07,0.2405,0.24634,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,1.536e-06,0.24023,0.27298,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0014624,0.24014,0.14745,1,1
1,GO PSEUDOURIDINE SYNTHESIS,0.00055343,0.23993,0.1898,1,1
1,GO FIBROBLAST PROLIFERATION,1.2281e-06,0.23989,0.27561,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.6457e-05,0.23957,0.24218,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,6.3359e-07,0.23953,0.26915,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.3803e-06,0.23945,0.29111,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,1.3325e-06,0.23942,0.24136,1,1
1,GO REGULATION OF CELL FATE COMMITMENT,0.0014022,0.23941,0.22407,1,1
1,GO REGULATION OF CELL SHAPE,1.6321e-06,0.23934,0.25014,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,6.8348e-09,0.23923,0.2415,1,1
1,GO PERICARDIUM DEVELOPMENT,0.00030928,0.23916,0.25035,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00012186,0.23916,0.22407,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,5.0323e-06,0.23913,0.30698,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,5.0563e-05,0.23889,0.30542,1,1
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,4.5558e-05,0.23876,0.24023,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.2253e-05,0.23872,0.22246,1,1
1,GO ASTROCYTE DEVELOPMENT,6.0991e-06,0.23857,0.26218,1,1
1,GO ISOPRENOID METABOLIC PROCESS,4.5558e-05,0.23849,0.1865,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,2.8001e-06,0.23822,0.21954,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,4.4285e-07,0.23815,0.25991,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,3.6567e-07,0.2381,0.25847,1,1
1,GO TRNA METHYLATION,6.3249e-05,0.23808,0.19925,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,1.6418e-07,0.23803,0.27958,1,1
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.053071,0.23801,0.097771,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00022565,0.23785,0.26776,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,1.6457e-05,0.23782,0.27536,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,7.969e-07,0.23758,0.25261,1,1
1,GO REGULATION OF CELL ACTIVATION,3.4296e-07,0.23752,0.24403,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,4.31e-06,0.23751,0.20617,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00039622,0.23746,0.20095,1,1
1,GO B CELL HOMEOSTASIS,0.00034485,0.2374,0.22681,1,1
1,GO RESPONSE TO RETINOIC ACID,2.342e-06,0.23739,0.24993,1,1
1,GO AMELOGENESIS,0.0020929,0.23717,0.22774,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,7.5217e-06,0.23713,0.25944,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,2.2505e-06,0.23711,0.21416,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.7078e-07,0.23693,0.26589,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,3.0302e-06,0.23691,0.264,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0054872,0.23676,0.3001,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.3228e-08,0.23662,0.25124,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,7.6283e-05,0.23644,0.20199,1,1
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.001118,0.23606,0.1936,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,9.4341e-06,0.23605,0.22064,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,6.545e-05,0.23591,0.24163,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.4796e-08,0.23568,0.24532,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,3.4773e-06,0.23527,0.3012,1,1
1,GO REGULATION OF MAST CELL ACTIVATION,0.0019285,0.23503,0.21788,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,2.9514e-07,0.23466,0.24563,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,4.7172e-05,0.23462,0.2098,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,1.6129e-08,0.23459,0.2578,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00080175,0.23439,0.2735,1,1
1,GO PROTEIN HYDROXYLATION,0.001118,0.23437,0.25915,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,1.4163e-06,0.23425,0.25739,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00013899,0.23424,0.21302,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00032408,0.23423,0.26634,1,1
1,GO LEUKOTRIENE METABOLIC PROCESS,0.018693,0.23373,0.16296,1,1
1,GO DEFENSE RESPONSE,9.6538e-08,0.23369,0.24015,1,1
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.00040235,0.23362,0.22966,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.1165e-05,0.23351,0.28519,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.00040857,0.23346,0.23516,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00033432,0.23319,0.21182,1,1
1,GO PIGMENT METABOLIC PROCESS,7.333e-07,0.23308,0.20357,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,5.6245e-08,0.23306,0.23535,1,1
1,GO RESPONSE TO VITAMIN,0.00084997,0.23256,0.18889,1,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00010152,0.23255,0.25547,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,1.6782e-07,0.23242,0.24205,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,3.4098e-06,0.23237,0.24032,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.0005211,0.23232,0.21644,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,4.1552e-07,0.23217,0.25215,1,1
1,GO ENDOTHELIAL CELL MIGRATION,1.8053e-06,0.23205,0.28499,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,1.2954e-05,0.23187,0.22964,1,1
1,GO AORTA MORPHOGENESIS,0.026838,0.23172,0.17439,1,1
1,GO LEUKOCYTE CHEMOTAXIS,9.3381e-05,0.23147,0.20385,1,1
1,GO PROTEIN NITROSYLATION,0.0075485,0.23101,0.16362,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00016098,0.23099,0.22298,1,1
1,GO MATURATION OF LSU RRNA,0.00016098,0.23085,0.2333,1,1
1,GO HISTONE H4 DEACETYLATION,0.00073415,0.23076,0.21384,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,2.2416e-05,0.23075,0.22945,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,3.5794e-07,0.23058,0.27944,1,1
1,GO EPIDERMAL CELL DIFFERENTIATION,0.0071918,0.23047,0.17421,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,2.7078e-07,0.23032,0.27243,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,1.0361e-05,0.23014,0.2751,1,1
1,GO CELLULAR EXTRAVASATION,2.971e-06,0.22967,0.24489,1,1
1,GO REGULATION OF LIPID KINASE ACTIVITY,1.3442e-05,0.22956,0.21655,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,3.4773e-06,0.22925,0.23062,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.7166e-08,0.22924,0.23915,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0085105,0.22924,0.16014,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,3.2859e-07,0.22912,0.2559,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,1.6761e-05,0.22907,0.23054,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,3.8246e-05,0.22893,0.27253,1,1
1,GO REGULATION OF HEMOPOIESIS,4.7501e-09,0.22889,0.25055,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,2.3239e-05,0.22888,0.25926,1,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.00012804,0.22887,0.20276,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.000662,0.22855,0.18522,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,9.1205e-09,0.22855,0.2553,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,1.5217e-09,0.22852,0.23771,1,1
1,GO CERAMIDE TRANSPORT,8.0256e-05,0.22851,0.28065,1,1
1,GO PLACENTA DEVELOPMENT,7.5217e-06,0.22847,0.20433,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00010323,0.22832,0.29638,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,5.1351e-07,0.22816,0.209,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,4.6359e-05,0.22795,0.20073,1,1
1,GO RESPONSE TO UV C,2.7804e-05,0.22795,0.27372,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,4.7488e-06,0.22789,0.22987,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,9.0235e-07,0.22767,0.25487,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,8.5867e-06,0.22753,0.25876,1,1
1,GO AUTOPHAGY OF NUCLEUS,7.5217e-06,0.22727,0.23786,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,7.4873e-07,0.22646,0.22842,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,3.152e-06,0.22612,0.28283,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,2.2958e-06,0.22597,0.2042,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,1.4207e-05,0.22586,0.24802,1,1
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0002117,0.22551,0.23615,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.0071051,0.2255,0.22228,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,1.7071e-05,0.22547,0.19427,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.2886e-07,0.22545,0.2757,1,1
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.019735,0.22523,0.14692,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00013451,0.22521,0.26014,1,1
1,GO RRNA MODIFICATION,9.9844e-05,0.22512,0.17212,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,2.5424e-05,0.2251,0.19049,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.002702,0.22507,0.19132,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,2.1338e-07,0.22505,0.23243,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,5.7051e-07,0.22452,0.21336,1,1
1,GO PLATELET ACTIVATION,3.3214e-05,0.22444,0.22712,1,1
1,GO SYMBIOTIC PROCESS,5.5078e-11,0.22435,0.23301,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,4.0657e-06,0.22427,0.22866,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.011411,0.22409,0.19078,1,1
1,GO DETOXIFICATION,4.4771e-05,0.22397,0.18796,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00095459,0.22393,0.21447,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,6.2169e-06,0.22336,0.22688,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,4.5822e-08,0.22329,0.20504,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00013899,0.2231,0.27197,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0050904,0.22309,0.22285,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,2.6352e-05,0.22303,0.25856,1,1
1,GO PROTEIN ADP RIBOSYLATION,1.0361e-05,0.22297,0.23831,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,4.9228e-07,0.22275,0.27418,1,1
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00067188,0.22261,0.18012,1,1
1,GO TOXIN TRANSPORT,4.31e-06,0.2226,0.21001,1,1
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0093576,0.22259,0.16147,1,1
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00073415,0.22257,0.23213,1,1
1,GO RNA 5 END PROCESSING,8.3013e-05,0.22249,0.20857,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,2.206e-06,0.22243,0.24558,1,1
1,GO SELECTIVE AUTOPHAGY,1.7721e-08,0.22243,0.23542,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00083767,0.2224,0.20851,1,1
1,GO PLATELET MORPHOGENESIS,7.105e-06,0.22239,0.28568,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,2.7312e-05,0.22234,0.26221,1,1
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,4.3997e-05,0.22229,0.21201,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.5293e-05,0.22214,0.25059,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0012005,0.22185,0.25647,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,2.0853e-05,0.22184,0.23235,1,1
1,GO LAMELLIPODIUM ASSEMBLY,1.155e-06,0.2218,0.22898,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.00029976,0.22145,0.19716,1,1
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0046018,0.22136,0.22562,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.439e-07,0.22098,0.20559,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0074579,0.22078,0.21492,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,6.5837e-06,0.22072,0.24912,1,1
1,GO ETHANOL CATABOLIC PROCESS,0.029754,0.22055,0.23004,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00023294,0.22025,0.24159,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,2.3661e-05,0.22021,0.21844,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,8.5867e-06,0.22014,0.26294,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,7.0072e-05,0.22008,0.25383,1,1
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00038422,0.22006,0.18704,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0001862,0.21985,0.23512,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,7.6657e-06,0.21934,0.27255,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.3671e-08,0.21907,0.24565,1,1
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00069207,0.21902,0.21157,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.2286e-07,0.21882,0.26216,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,1.5027e-08,0.21881,0.24671,1,1
1,GO RESPONSE TO WOUNDING,1.1086e-06,0.21866,0.23901,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00030928,0.21859,0.27744,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.00040857,0.21849,0.24312,1,1
1,GO LIPID STORAGE,2.2958e-06,0.21839,0.22642,1,1
1,GO CELL CHEMOTAXIS,1.1165e-05,0.21839,0.22275,1,1
1,GO STRESS FIBER ASSEMBLY,8.7502e-06,0.21836,0.2454,1,1
1,GO HISTONE H2B UBIQUITINATION,2.4371e-06,0.21829,0.22045,1,1
1,GO REGULATION OF B CELL ACTIVATION,2.011e-05,0.21823,0.22421,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,1.475e-06,0.21818,0.24139,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,7.5001e-05,0.21773,0.24607,1,1
1,GO CHONDROCYTE DIFFERENTIATION,2.1234e-05,0.21744,0.23425,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.3774e-08,0.21719,0.20801,1,1
1,GO IMMUNOGLOBULIN SECRETION,0.00082553,0.21719,0.20012,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.4091e-05,0.21715,0.26403,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.0424e-06,0.2171,0.22219,1,1
1,GO IRON ION HOMEOSTASIS,8.6328e-08,0.21693,0.23194,1,1
1,GO T CELL DIFFERENTIATION,4.4807e-06,0.21691,0.23009,1,1
1,GO RESPONSE TO CORTICOSTEROID,2.1234e-05,0.21686,0.20368,1,1
1,GO REGULATION OF DEFENSE RESPONSE,5.2538e-08,0.21673,0.23578,1,1
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00029052,0.21659,0.22946,1,1
1,GO MYELOID LEUKOCYTE MIGRATION,3.3214e-05,0.21651,0.21005,1,1
1,GO ASTROCYTE ACTIVATION,2.6352e-05,0.21613,0.21666,1,1
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.0010865,0.21606,0.19998,1,1
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.0030038,0.21603,0.15413,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,7.2497e-05,0.21602,0.23672,1,1
1,GO MULTI ORGANISM LOCALIZATION,3.9941e-08,0.21598,0.23284,1,1
1,GO ERYTHROCYTE MATURATION,0.0003557,0.21586,0.25087,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0016347,0.21585,0.27064,1,1
1,GO INFLAMMATORY RESPONSE,1.1789e-06,0.21581,0.23273,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,8.7316e-05,0.21576,0.19839,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00040235,0.21559,0.2176,1,1
1,GO BLASTODERM SEGMENTATION,0.014332,0.21559,0.18593,1,1
1,GO AUTOPHAGOSOME MATURATION,1.5372e-07,0.21552,0.2254,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,3.3214e-05,0.21549,0.27857,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00049053,0.21539,0.18545,1,1
1,GO ANIMAL ORGAN REGENERATION,1.439e-07,0.21519,0.25713,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.00028155,0.21506,0.19604,1,1
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.001235,0.21464,0.19609,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,6.8885e-07,0.21453,0.24532,1,1
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,3.5794e-07,0.21446,0.23055,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0016575,0.21445,0.16429,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,8.9166e-06,0.2144,0.24318,1,1
1,GO MYELOID CELL HOMEOSTASIS,9.028e-08,0.21432,0.22664,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,6.5906e-08,0.21431,0.24103,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,6.0205e-08,0.21422,0.22896,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,3.7356e-07,0.21408,0.22953,1,1
1,GO MALE GENITALIA DEVELOPMENT,0.0032078,0.21392,0.18301,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,1.0756e-05,0.21389,0.31483,1,1
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.00021511,0.21345,0.21452,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.024428,0.21337,0.20239,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.00013673,0.21335,0.23049,1,1
1,GO MUSCLE CELL PROLIFERATION,1.439e-07,0.21317,0.26175,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,2.9514e-07,0.21304,0.21448,1,1
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00029511,0.21288,0.21257,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00055343,0.21285,0.2036,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,9.2118e-07,0.21268,0.24065,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,2.6362e-08,0.21259,0.24082,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.0005133,0.21258,0.2,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.006444,0.21234,0.16198,1,1
1,GO MESODERM MORPHOGENESIS,1.3056e-06,0.21229,0.22541,1,1
1,GO PENTOSE METABOLIC PROCESS,0.00029511,0.21202,0.24046,1,1
1,GO LIVER MORPHOGENESIS,0.001483,0.21193,0.19783,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.2482e-05,0.21183,0.21926,1,1
1,GO TOOTH MINERALIZATION,0.0019819,0.2115,0.24814,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,3.7605e-06,0.21142,0.21745,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,7.0072e-05,0.21119,0.18345,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00027716,0.21106,0.17811,1,1
1,GO LEUKOCYTE DIFFERENTIATION,5.7051e-07,0.21089,0.23445,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,7.8052e-07,0.21084,0.2001,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,3.0811e-07,0.21084,0.23472,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,4.5684e-06,0.21081,0.27729,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00031907,0.21061,0.19598,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.0278e-07,0.21032,0.21389,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,9.2585e-06,0.21028,0.22803,1,1
1,GO B CELL ACTIVATION,4.6578e-06,0.21008,0.21999,1,1
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.047827,0.20964,0.15862,1,1
1,GO PROTEIN KINASE A SIGNALING,6.6578e-05,0.2095,0.17847,1,1
1,GO AXIS ELONGATION,0.00082553,0.20949,0.26999,1,1
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0052854,0.20949,0.26712,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,1.0527e-08,0.20949,0.21603,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0023637,0.20921,0.15201,1,1
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0012527,0.20917,0.22332,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.012798,0.20907,0.14319,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.4454e-06,0.20903,0.21796,1,1
1,GO NEURAL TUBE PATTERNING,0.0018006,0.20888,0.19021,1,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00018323,0.20862,0.19684,1,1
1,GO FACE DEVELOPMENT,8.4424e-05,0.20861,0.23798,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00022208,0.20841,0.20721,1,1
1,GO MANGANESE ION TRANSPORT,0.00028155,0.20813,0.18838,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,9.086e-06,0.20809,0.2336,1,1
1,GO CELLULAR RESPONSE TO LIPID,7.969e-07,0.20801,0.20229,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0093576,0.20795,0.1634,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0046018,0.20792,0.15289,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,9.9803e-06,0.20777,0.2342,1,1
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.025743,0.20765,0.22932,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.3761e-09,0.20763,0.22457,1,1
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0023009,0.2076,0.23012,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.0012527,0.20678,0.14667,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0019023,0.20664,0.19101,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,8.0256e-05,0.2066,0.27194,1,1
1,GO VIRION ASSEMBLY,8.8389e-07,0.20658,0.17951,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,2.9332e-05,0.20651,0.27047,1,1
1,GO GLYCOSIDE METABOLIC PROCESS,0.012945,0.20638,0.15999,1,1
1,GO ODONTOGENESIS,0.00092737,0.20633,0.20096,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.00030449,0.2063,0.18417,1,1
1,GO LYMPHOCYTE MIGRATION,3.4098e-06,0.20626,0.23538,1,1
1,GO LIPID IMPORT INTO CELL,0.00045468,0.20618,0.20001,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00016901,0.20607,0.21144,1,1
1,GO CYTOKINETIC PROCESS,1.4163e-06,0.20571,0.22256,1,1
1,GO MYELOID CELL DIFFERENTIATION,7.7166e-08,0.20571,0.22518,1,1
1,GO REGULATION OF LIPID STORAGE,1.9563e-06,0.20561,0.2334,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,8.8389e-07,0.20508,0.20702,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00033432,0.20498,0.21778,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,2.4972e-05,0.20493,0.20765,1,1
1,GO REGENERATION,3.0156e-07,0.20487,0.21451,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.1479e-07,0.20472,0.21756,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.011949,0.20471,0.15476,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00059648,0.20457,0.16634,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,3.3806e-05,0.20398,0.26342,1,1
1,GO LEUKOCYTE MIGRATION,3.6924e-05,0.20386,0.21101,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.003607,0.20376,0.26403,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,1.1375e-05,0.2037,0.25442,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0040509,0.20363,0.22331,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00048316,0.20355,0.23903,1,1
1,GO GAS TRANSPORT,0.0027747,0.20349,0.22324,1,1
1,GO VIRAL RELEASE FROM HOST CELL,1.9465e-08,0.20346,0.23342,1,1
1,GO REGULATION OF PROTEOLYSIS,2.4305e-07,0.20345,0.1948,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.5372e-07,0.20334,0.21897,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,8.5867e-06,0.20327,0.21038,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,7.3803e-06,0.20326,0.2977,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,2.1621e-05,0.20321,0.20028,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.3174e-07,0.20289,0.24836,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,1.9749e-05,0.2026,0.1954,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,1.2792e-06,0.20227,0.23556,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,1.5576e-05,0.20225,0.23921,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00019229,0.20206,0.21352,1,1
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0005789,0.20203,0.17507,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,4.4148e-09,0.20191,0.21648,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,1.2716e-05,0.20188,0.28779,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,1.0791e-07,0.20186,0.22998,1,1
1,GO PEPTIDE CATABOLIC PROCESS,3.0905e-06,0.20181,0.25554,1,1
1,GO HISTONE H3 K4 TRIMETHYLATION,0.0072795,0.20168,0.15937,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.0062108,0.20161,0.18284,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,4.2487e-05,0.20152,0.20408,1,1
1,GO RESPONSE TO TESTOSTERONE,5.0323e-06,0.20125,0.22398,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,5.7051e-07,0.20118,0.21948,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,2.8271e-07,0.20101,0.21535,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,8.2864e-09,0.20086,0.21912,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.00070238,0.20079,0.17643,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,3.0302e-06,0.2007,0.19759,1,1
1,GO LIPID OXIDATION,5.7059e-05,0.20059,0.17329,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,3.3435e-06,0.20045,0.19417,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,3.7605e-06,0.20038,0.23338,1,1
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0005618,0.19973,0.18308,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,3.4098e-06,0.19965,0.22543,1,1
1,GO CELLULAR PIGMENTATION,6.0759e-07,0.19938,0.22315,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,6.3249e-05,0.19937,0.21933,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,3.7356e-07,0.19927,0.19964,1,1
1,GO FATTY ACID BETA OXIDATION,0.00011986,0.19902,0.17135,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,3.3435e-06,0.19902,0.22108,1,1
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00023667,0.19883,0.19705,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.00049802,0.19873,0.20118,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00016901,0.19864,0.26201,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00096848,0.19848,0.18038,1,1
1,GO EPIDERMIS DEVELOPMENT,0.0028118,0.19843,0.17279,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0070192,0.19834,0.18912,1,1
1,GO RESPONSE TO VITAMIN A,0.00084997,0.19819,0.18861,1,1
1,GO MITOCHONDRIAL RNA PROCESSING,0.03429,0.19797,0.13285,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,1.5994e-06,0.19779,0.19086,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0007901,0.19763,0.17202,1,1
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.0005133,0.19761,0.2228,1,1
1,GO LYMPHOCYTE DIFFERENTIATION,2.2958e-06,0.19757,0.22862,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,3.3214e-05,0.19746,0.20458,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,2.3274e-07,0.19745,0.20004,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,9.6129e-06,0.19738,0.17863,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,3.5461e-06,0.19709,0.18699,1,1
1,GO SKIN DEVELOPMENT,0.001776,0.19698,0.19055,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,1.5576e-05,0.19685,0.207,1,1
1,GO NUCLEAR PORE ORGANIZATION,2.8814e-05,0.19649,0.22625,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,1.3325e-06,0.1964,0.2604,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.00012594,0.19635,0.19293,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,7.6657e-06,0.19628,0.1957,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,7.8911e-05,0.19621,0.17933,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,7.6657e-06,0.19617,0.19119,1,1
1,GO HETEROTYPIC CELL CELL ADHESION,0.017506,0.1961,0.14611,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.439e-07,0.19592,0.24032,1,1
1,GO TONGUE MORPHOGENESIS,0.015159,0.19587,0.20251,1,1
1,GO VIRAL GENE EXPRESSION,0.00015083,0.1958,0.17179,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,1.4677e-08,0.19575,0.19713,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,2.2824e-05,0.19567,0.18374,1,1
1,GO CELL CELL RECOGNITION,4.6356e-09,0.19557,0.21583,1,1
1,GO NCRNA PROCESSING,3.5022e-05,0.19555,0.179,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,1.1535e-07,0.19552,0.20049,1,1
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0010865,0.19528,0.2242,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.0019023,0.19522,0.16242,1,1
1,GO ACUTE PHASE RESPONSE,0.00014839,0.19481,0.19636,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0065235,0.1947,0.17095,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00033432,0.1947,0.2217,1,1
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,2.3661e-05,0.19464,0.30692,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.9989e-07,0.19445,0.20166,1,1
1,GO RESPONSE TO ANTIBIOTIC,1.0424e-06,0.19445,0.2155,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,5.7582e-06,0.19444,0.19111,1,1
1,GO REGULATION OF RUFFLE ASSEMBLY,0.0047798,0.19441,0.13494,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0020929,0.19413,0.20789,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,9.8716e-08,0.19409,0.20588,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,1.9175e-06,0.19398,0.19544,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,1.3671e-08,0.19386,0.20748,1,1
1,GO TRNA PROCESSING,0.00030449,0.19369,0.13771,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00071283,0.19367,0.1782,1,1
1,GO GTP METABOLIC PROCESS,4.7172e-05,0.19347,0.21431,1,1
1,GO BODY FLUID SECRETION,5.1304e-06,0.1933,0.18884,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,6.5837e-06,0.19322,0.24735,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00013673,0.1931,0.1766,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0039992,0.19303,0.23073,1,1
1,GO MRNA TRANSCRIPTION,4.0657e-06,0.19303,0.26495,1,1
1,GO RNA METHYLATION,9.819e-05,0.1928,0.16974,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00022565,0.19268,0.21098,1,1
1,GO NADP METABOLIC PROCESS,0.0021798,0.19243,0.166,1,1
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.007921,0.19229,0.15338,1,1
1,GO POSITIVE CHEMOTAXIS,0.00159,0.19226,0.1956,1,1
1,GO RNA DESTABILIZATION,7.105e-06,0.19218,0.21299,1,1
1,GO RECEPTOR RECYCLING,0.00010673,0.19191,0.1743,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.3693e-05,0.19183,0.18036,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00023667,0.19179,0.22968,1,1
1,GO HUMORAL IMMUNE RESPONSE,0.00040235,0.19173,0.18826,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0012177,0.1917,0.1644,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00026438,0.19162,0.23717,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,9.404e-07,0.19155,0.17601,1,1
1,GO REGULATION OF PROTEIN SUMOYLATION,1.8053e-06,0.19153,0.18785,1,1
1,GO REGULATION OF T CELL MIGRATION,0.00026024,0.19132,0.19733,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00015331,0.19131,0.1558,1,1
1,GO PROTEIN KINASE B SIGNALING,2.1234e-05,0.1913,0.18371,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,2.5934e-07,0.1913,0.17686,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.0013633,0.19116,0.15603,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,4.7172e-05,0.19103,0.21064,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.3806e-05,0.191,0.18242,1,1
1,GO GLIAL CELL MIGRATION,0.0080166,0.19063,0.14905,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,2.6914e-06,0.19055,0.19156,1,1
1,GO LYMPHOCYTE COSTIMULATION,2.9332e-05,0.19054,0.22726,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00040235,0.19022,0.21629,1,1
1,GO VESICLE TARGETING,7.6657e-06,0.19016,0.17857,1,1
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.001955,0.19014,0.17065,1,1
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.020385,0.19007,0.1121,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,5.0563e-05,0.18993,0.21003,1,1
1,GO REGULATION OF CELL AGING,8.7502e-06,0.18991,0.18449,1,1
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.014013,0.18963,0.11917,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00072342,0.18954,0.17021,1,1
1,GO CYTOKINE SECRETION,0.0020929,0.18932,0.14771,1,1
1,GO RESPONSE TO CHEMOKINE,5.2445e-07,0.18926,0.21606,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.00095459,0.18924,0.28887,1,1
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.022928,0.18919,0.13122,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.032938,0.189,0.16176,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00014839,0.18892,0.20251,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.003654,0.18871,0.19136,1,1
1,GO MYOTUBE DIFFERENTIATION,0.0010865,0.18866,0.15688,1,1
1,GO INTRACELLULAR STEROL TRANSPORT,0.00054518,0.18824,0.22666,1,1
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.015159,0.18816,0.18076,1,1
1,GO COPII COATED VESICLE CARGO LOADING,4.31e-06,0.18813,0.21207,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.9514e-07,0.18812,0.16248,1,1
1,GO REGULATION OF AMYLOID BETA FORMATION,0.00095459,0.18799,0.20131,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0024941,0.18791,0.15418,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00030449,0.18773,0.20213,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,7.6446e-07,0.18768,0.22573,1,1
1,GO RRNA METABOLIC PROCESS,0.00010323,0.18766,0.17579,1,1
1,GO CARTILAGE DEVELOPMENT,2.3661e-05,0.1876,0.21066,1,1
1,GO TRNA MODIFICATION,0.00052901,0.18723,0.14645,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,8.4415e-08,0.18715,0.17994,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0011668,0.18707,0.21436,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00014129,0.18668,0.20955,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,3.5461e-06,0.18658,0.19289,1,1
1,GO TUBE MORPHOGENESIS,5.7582e-06,0.18635,0.21219,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0035605,0.18625,0.15201,1,1
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00053704,0.18617,0.1854,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.00046165,0.18617,0.27679,1,1
1,GO RIBOSOME BIOGENESIS,7.0072e-05,0.18614,0.18527,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,8.4805e-07,0.1861,0.19311,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00049053,0.18596,0.21192,1,1
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0059852,0.18564,0.18151,1,1
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00011033,0.18554,0.19384,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00031414,0.18552,0.19652,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,2.0478e-05,0.18542,0.16293,1,1
1,GO RNA DECAPPING,1.2716e-05,0.18521,0.18821,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,5.2344e-05,0.18505,0.29429,1,1
1,GO NEURAL TUBE DEVELOPMENT,7.5001e-05,0.185,0.19346,1,1
1,GO ERAD PATHWAY,1.2253e-05,0.18484,0.17158,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00019857,0.18482,0.19899,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00030928,0.18439,0.20603,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,5.6085e-05,0.18434,0.18427,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00028155,0.18433,0.20024,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00011596,0.18423,0.22869,1,1
1,GO HISTONE PHOSPHORYLATION,4.9694e-05,0.18409,0.15513,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.004156,0.18402,0.1216,1,1
1,GO FATTY ACID TRANSPORT,0.00010152,0.18386,0.15375,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,1.8032e-05,0.18375,0.16517,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0012177,0.18373,0.16489,1,1
1,GO AMYLOID BETA METABOLIC PROCESS,0.00033432,0.18367,0.19516,1,1
1,GO REGULATION OF GENE SILENCING,3.357e-07,0.18362,0.18704,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,4.0657e-06,0.18356,0.19108,1,1
1,GO MYELOID CELL DEVELOPMENT,0.00012594,0.18352,0.19963,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,7.7586e-05,0.18332,0.19559,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00011033,0.18308,0.19366,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,4.4807e-06,0.18307,0.24086,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.0070192,0.18303,0.15176,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.0037016,0.18279,0.27122,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,4.7172e-05,0.18265,0.19409,1,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,1.4472e-05,0.18259,0.23285,1,1
1,GO REGULATION OF BODY FLUID LEVELS,7.1274e-05,0.18254,0.17864,1,1
1,GO RESPONSE TO PROGESTERONE,0.0013069,0.18204,0.20088,1,1
1,GO RESPONSE TO ISCHEMIA,0.00013016,0.18201,0.18629,1,1
1,GO HEART VALVE DEVELOPMENT,0.0047798,0.18169,0.19181,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,2.971e-06,0.18162,0.17926,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0032928,0.18161,0.17331,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,9.2585e-06,0.18136,0.18862,1,1
1,GO ACTIN FILAMENT ORGANIZATION,3.8246e-05,0.18132,0.17155,1,1
1,GO AMYLOID BETA FORMATION,0.00058763,0.1813,0.1888,1,1
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00013451,0.18118,0.15861,1,1
1,GO RNA MODIFICATION,4.3236e-05,0.18107,0.16551,1,1
1,GO RESPONSE TO VITAMIN D,0.045155,0.18098,0.11548,1,1
1,GO BONE CELL DEVELOPMENT,0.003166,0.18077,0.2016,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,7.8124e-06,0.18069,0.1757,1,1
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00018923,0.18029,0.21335,1,1
1,GO NCRNA CATABOLIC PROCESS,0.0030038,0.18024,0.14237,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.05063,0.18009,0.11487,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00084997,0.18007,0.16816,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,2.6914e-06,0.17924,0.21068,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,1.4207e-05,0.17921,0.1692,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.00010497,0.17915,0.19428,1,1
1,GO NEURAL TUBE FORMATION,7.7586e-05,0.17913,0.19508,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00012388,0.1787,0.1592,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0044864,0.1786,0.20044,1,1
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.022446,0.17857,0.13056,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,4.9694e-05,0.17856,0.21222,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.3039e-08,0.1785,0.18414,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.0011668,0.17825,0.29788,1,1
1,GO NCRNA METABOLIC PROCESS,7.2497e-05,0.17818,0.15758,1,1
1,GO TRNA METABOLIC PROCESS,0.00036686,0.17811,0.1337,1,1
1,GO RESPONSE TO GROWTH HORMONE,0.0012177,0.17796,0.22852,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0014022,0.17775,0.18756,1,1
1,GO TRABECULA MORPHOGENESIS,0.0028492,0.17766,0.20567,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0021215,0.17756,0.15691,1,1
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.001118,0.1775,0.15134,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.028264,0.17729,0.12677,1,1
1,GO RESPONSE TO FATTY ACID,0.029754,0.17727,0.10812,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0022095,0.17724,0.19525,1,1
1,GO PIGMENT GRANULE LOCALIZATION,0.0037985,0.17684,0.14843,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,3.8347e-06,0.1766,0.21899,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.6994e-06,0.17643,0.21576,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00013451,0.17638,0.16089,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.00040235,0.17635,0.16429,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.00016098,0.17607,0.1951,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,1.9136e-07,0.17602,0.18091,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,1.5994e-06,0.17572,0.19356,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0023321,0.17569,0.16286,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,2.913e-06,0.17563,0.18847,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.00039018,0.17555,0.20073,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.020605,0.17546,0.15844,1,1
1,GO REGULATION OF LIPID LOCALIZATION,6.9711e-06,0.1753,0.1906,1,1
1,GO GOLGI VESICLE BUDDING,1.0557e-05,0.17523,0.16454,1,1
1,GO PLASMA MEMBRANE FUSION,0.062114,0.1752,0.15291,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00014129,0.1749,0.16331,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0014624,0.17489,0.14969,1,1
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.013243,0.1747,0.21337,1,1
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00037257,0.17462,0.16298,1,1
1,GO REGULATION OF GASTRIC ACID SECRETION,0.012653,0.17446,0.19268,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,9.795e-06,0.17442,0.20364,1,1
1,GO REGULATION OF TELOMERASE ACTIVITY,0.00037257,0.17411,0.16011,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00042128,0.17399,0.19356,1,1
1,GO RENAL VESICLE DEVELOPMENT,0.013546,0.17398,0.15,1,1
1,GO TRACHEA MORPHOGENESIS,0.00016629,0.17368,0.25281,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,2.3891e-06,0.17349,0.20425,1,1
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.015501,0.17349,0.11469,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00069207,0.17344,0.2605,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,3.0302e-06,0.17331,0.22118,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,7.7586e-05,0.17321,0.16354,1,1
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0011503,0.17321,0.20889,1,1
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.00021511,0.173,0.16787,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00013232,0.1728,0.18003,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0043184,0.17263,0.17861,1,1
1,GO MESENCHYME MORPHOGENESIS,0.0069343,0.17208,0.19349,1,1
1,GO REGULATION OF HEART GROWTH,0.00039622,0.17207,0.17163,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0024941,0.17198,0.17423,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00012186,0.17172,0.16773,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00033432,0.17167,0.17057,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,4.4807e-06,0.17164,0.21279,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.7154e-07,0.17124,0.21272,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,8.8282e-08,0.17119,0.19092,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,2.2824e-05,0.17103,0.19088,1,1
1,GO LATERAL VENTRICLE DEVELOPMENT,0.0037985,0.1709,0.21212,1,1
1,GO RRNA METHYLATION,0.00024819,0.17073,0.16888,1,1
1,GO NEPHRON TUBULE FORMATION,0.0083098,0.17071,0.23206,1,1
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.03068,0.17068,0.1334,1,1
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.0039481,0.17008,0.17721,1,1
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0045438,0.17001,0.13947,1,1
1,GO RESPONSE TO OSMOTIC STRESS,2.3891e-06,0.16991,0.19165,1,1
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,4.1751e-05,0.16979,0.15274,1,1
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0046018,0.16978,0.13179,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,9.2118e-07,0.16973,0.16534,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00045468,0.16971,0.21695,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00033432,0.16969,0.1744,1,1
1,GO REGULATION OF VASCULOGENESIS,0.02915,0.16969,0.19655,1,1
1,GO REGULATION OF ORGAN GROWTH,1.3599e-06,0.16963,0.21776,1,1
1,GO GLYCINE METABOLIC PROCESS,0.056652,0.1696,0.09657,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00039622,0.16959,0.16582,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0104,0.1695,0.17585,1,1
1,GO ACTIN FILAMENT BASED PROCESS,0.00026024,0.16944,0.14806,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,2.2015e-05,0.16934,0.18193,1,1
1,GO DNA LIGATION,0.0021215,0.16929,0.15864,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,1.064e-06,0.16921,0.20535,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,3.0395e-05,0.16917,0.19929,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,9.0235e-07,0.16906,0.18474,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,9.028e-08,0.16889,0.19269,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,2.538e-07,0.16889,0.1711,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,4.4807e-06,0.16889,0.18218,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00012388,0.16837,0.20085,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0068504,0.16822,0.10884,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00015838,0.1682,0.16877,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.00064263,0.16811,0.10586,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.00011406,0.16789,0.19382,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.0039481,0.16782,0.19866,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,1.4741e-05,0.16765,0.185,1,1
1,GO BLASTOCYST FORMATION,1.6654e-06,0.16736,0.17978,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,4.1751e-05,0.16728,0.16135,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.0054872,0.16726,0.15791,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,4.3946e-06,0.16723,0.18011,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.004156,0.16719,0.16719,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.00016629,0.16714,0.16502,1,1
1,GO TRNA 5 END PROCESSING,0.00067188,0.16711,0.18039,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.00044781,0.1671,0.16697,1,1
1,GO GENITALIA DEVELOPMENT,0.00075607,0.16709,0.14656,1,1
1,GO RESPONSE TO LIPID,1.8363e-05,0.16701,0.17097,1,1
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00045468,0.16698,0.18166,1,1
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0054192,0.16697,0.14544,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.00012594,0.16679,0.15288,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.3806e-05,0.1667,0.18377,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,6.8396e-06,0.16639,0.17034,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0019819,0.16636,0.19479,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,1.5994e-06,0.16629,0.16719,1,1
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0049019,0.16627,0.14198,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.00030928,0.16621,0.16787,1,1
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00031907,0.16618,0.19473,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,2.9332e-05,0.16575,0.15072,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0031247,0.16554,0.18952,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,9.03e-05,0.16553,0.15793,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.0557e-05,0.16532,0.18001,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.4528e-05,0.16516,0.17325,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0014022,0.16504,0.16605,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00011986,0.16495,0.16634,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,8.5858e-05,0.16489,0.21903,1,1
1,GO CELL AGING,1.8053e-06,0.16488,0.1749,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,6.337e-06,0.16473,0.19825,1,1
1,GO MESODERM DEVELOPMENT,3.4773e-06,0.16472,0.17618,1,1
1,GO RESPONSE TO OXYGEN LEVELS,4.0657e-06,0.16466,0.15967,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0010408,0.16445,0.21295,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,3.3806e-05,0.16433,0.16195,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.9069e-08,0.16433,0.18908,1,1
1,GO PROTEIN PROCESSING,2.011e-05,0.16419,0.17916,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00084997,0.16343,0.1716,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.00159,0.16327,0.14001,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,8.8796e-05,0.16327,0.18649,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.0019285,0.16321,0.14169,1,1
1,GO NEURAL CREST CELL MIGRATION,0.01585,0.16289,0.14839,1,1
1,GO TISSUE MORPHOGENESIS,2.9859e-05,0.16273,0.16309,1,1
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.012945,0.1626,0.16064,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,1.9044e-05,0.16257,0.14052,1,1
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.00030928,0.16255,0.13706,1,1
1,GO TRANSCYTOSIS,0.004156,0.1625,0.1703,1,1
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.000286,0.16247,0.16618,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00016361,0.1624,0.16672,1,1
1,GO EPITHELIAL CELL DEVELOPMENT,0.0020646,0.16215,0.16207,1,1
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.010645,0.16196,0.14856,1,1
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0033361,0.16178,0.15776,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,6.3249e-05,0.16168,0.17461,1,1
1,GO BIOLOGICAL ADHESION,0.0010259,0.16147,0.15264,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.00042128,0.16122,0.12231,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00013451,0.16107,0.21275,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.0054192,0.16099,0.13296,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0030839,0.16097,0.14792,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.028556,0.16094,0.10755,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.00032408,0.16094,0.12219,1,1
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0032501,0.16078,0.15287,1,1
1,GO EXOCYTOSIS,0.00049053,0.16078,0.13813,1,1
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.0045438,0.16071,0.15459,1,1
1,GO RESPONSE TO STEROID HORMONE,6.545e-05,0.1607,0.16563,1,1
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00036124,0.16048,0.15104,1,1
1,GO REGULATION OF FATTY ACID OXIDATION,0.0137,0.16044,0.13425,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0034692,0.16023,0.10804,1,1
1,GO MITOTIC CYTOKINESIS,9.819e-05,0.16018,0.15156,1,1
1,GO LIPID MODIFICATION,0.00024819,0.15995,0.13595,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00011986,0.15986,0.19137,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,5.2445e-07,0.15981,0.14417,1,1
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00070238,0.15977,0.17472,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,5.2303e-06,0.15964,0.17527,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.0030839,0.1596,0.18395,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.00011033,0.15946,0.17101,1,1
1,GO FLUID TRANSPORT,0.00063314,0.15944,0.18248,1,1
1,GO CHROMATIN DISASSEMBLY,0.064418,0.15892,0.08736,1,1
1,GO STEM CELL DIFFERENTIATION,1.6321e-06,0.1588,0.177,1,1
1,GO LIPID HOMEOSTASIS,0.00044103,0.15841,0.14726,1,1
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.00013016,0.15834,0.1778,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.00063314,0.15833,0.20506,1,1
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.011544,0.15832,0.19956,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00044781,0.15826,0.18617,1,1
1,GO CELLULAR RESPONSE TO UV,5.6487e-06,0.15812,0.17815,1,1
1,GO REGULATION OF MRNA BINDING,0.0024941,0.158,0.16617,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0032928,0.15795,0.16005,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.0076401,0.15794,0.12327,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0023637,0.15793,0.12186,1,1
1,GO MAINTENANCE OF CELL NUMBER,0.00057029,0.1577,0.1636,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0029645,0.15769,0.12639,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,3.4098e-06,0.15754,0.1641,1,1
1,GO MEMBRANE DISASSEMBLY,0.016205,0.15748,0.14194,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.066192,0.15747,0.093305,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,1.9044e-05,0.15725,0.15809,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,6.0991e-06,0.15718,0.15614,1,1
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.00083767,0.15716,0.17306,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,1.1316e-06,0.15674,0.18197,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00059648,0.15651,0.14334,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,2.3661e-05,0.15632,0.15951,1,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0021505,0.15622,0.22656,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,3.9613e-05,0.15621,0.15752,1,1
1,GO REGULATION OF RESPONSE TO STRESS,3.0811e-07,0.1559,0.16929,1,1
1,GO PIGMENT CELL DIFFERENTIATION,0.011411,0.15588,0.13272,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0096941,0.15577,0.17537,1,1
1,GO GOLGI TO ENDOSOME TRANSPORT,0.0013069,0.15571,0.17832,1,1
1,GO AMINO ACID ACTIVATION,0.011151,0.15554,0.11623,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.00043435,0.15551,0.16827,1,1
1,GO REGULATION OF LIPID TRANSPORT,7.3739e-05,0.15547,0.17677,1,1
1,GO REGULATION OF CHEMOTAXIS,0.00046872,0.15534,0.15987,1,1
1,GO NUCLEOSIDE SALVAGE,0.0053519,0.15531,0.17184,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.9361e-06,0.15529,0.15786,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.4528e-05,0.15525,0.16182,1,1
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00029052,0.15516,0.16077,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,0.0020367,0.15486,0.12007,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,9.03e-05,0.15481,0.16693,1,1
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.043025,0.1546,0.1654,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00015331,0.15441,0.16685,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.034636,0.15435,0.14042,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,5.1446e-05,0.15422,0.14368,1,1
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.5217e-06,0.15414,0.1895,1,1
1,GO GOLGI RIBBON FORMATION,0.00054518,0.15388,0.19323,1,1
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,7.7586e-05,0.15374,0.1916,1,1
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.031953,0.15369,0.11894,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.0014624,0.15349,0.20061,1,1
1,GO LEFT RIGHT PATTERN FORMATION,0.0041031,0.15345,0.19152,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.5359e-06,0.15332,0.14757,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.00080175,0.15331,0.18106,1,1
1,GO PLASMA MEMBRANE TUBULATION,0.00091404,0.15315,0.19772,1,1
1,GO RNA INTERFERENCE,0.0062877,0.15295,0.12677,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.001955,0.1529,0.18067,1,1
1,GO OSTEOBLAST DIFFERENTIATION,1.6457e-05,0.15286,0.21101,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0039481,0.15274,0.13233,1,1
1,GO RESPONSE TO NUTRIENT,0.00041488,0.15265,0.163,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,8.4805e-07,0.1526,0.17549,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.035336,0.15255,0.13098,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.0013255,0.15232,0.15057,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0011836,0.1523,0.2704,1,1
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0013443,0.15229,0.15286,1,1
1,GO CARNITINE SHUTTLE,0.0025617,0.15228,0.16854,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,5.4184e-05,0.15224,0.14668,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.00071283,0.15222,0.18248,1,1
1,GO REGULATION OF LIPID METABOLIC PROCESS,8.4424e-05,0.15202,0.1543,1,1
1,GO POSITIVE REGULATION OF JNK CASCADE,0.001704,0.15196,0.13907,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.020828,0.15194,0.12048,1,1
1,GO TUBE FORMATION,0.00049802,0.15193,0.15922,1,1
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.0017517,0.15159,0.15701,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0020367,0.15155,0.1505,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0026663,0.1515,0.14886,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00059648,0.15123,0.14396,1,1
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.00044781,0.151,0.1541,1,1
1,GO RNA CATABOLIC PROCESS,1.3599e-06,0.15071,0.15551,1,1
1,GO MESENCHYME DEVELOPMENT,0.00031414,0.15062,0.16701,1,1
1,GO REGULATION OF CELL DEATH,7.6657e-06,0.15062,0.14587,1,1
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.00013673,0.15058,0.20264,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0010408,0.15057,0.11232,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,1.6321e-06,0.1505,0.16439,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,1.0958e-05,0.1505,0.17637,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0095807,0.15016,0.1632,1,1
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0024281,0.15014,0.16132,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0089251,0.14971,0.12903,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,2.0879e-07,0.14965,0.15984,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,1.1034e-07,0.14952,0.16414,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,7.105e-06,0.14931,0.22949,1,1
1,GO VIRAL BUDDING,0.00073415,0.14915,0.13804,1,1
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00012388,0.14908,0.18783,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0093576,0.14876,0.16659,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,9.1829e-05,0.14873,0.12673,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,2.0853e-05,0.14868,0.18188,1,1
1,GO SPLEEN DEVELOPMENT,0.014494,0.14849,0.11052,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0013826,0.14841,0.13168,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.6761e-05,0.14835,0.16124,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,2.8001e-06,0.14832,0.15627,1,1
1,GO ENDOCRINE PROCESS,0.00029052,0.1483,0.17137,1,1
1,GO FATTY ACID METABOLIC PROCESS,4.3997e-05,0.14825,0.14873,1,1
1,GO RNA SURVEILLANCE,0.0070192,0.14793,0.10942,1,1
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.064418,0.14788,0.11579,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0039992,0.14786,0.16056,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.0035146,0.1476,0.13839,1,1
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.00049802,0.14756,0.17283,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0032501,0.14755,0.18702,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00045468,0.14751,0.14197,1,1
1,GO CELLULAR RESPONSE TO KETONE,0.0057669,0.14745,0.12282,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00076726,0.14706,0.16563,1,1
1,GO REGULATION OF URINE VOLUME,1.7385e-05,0.14706,0.21667,1,1
1,GO HISTONE DEACETYLATION,0.0010408,0.14689,0.11574,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00049053,0.14665,0.18809,1,1
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0038977,0.14662,0.19016,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.4296e-07,0.14659,0.1408,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.00049802,0.14658,0.13912,1,1
1,GO REGULATION OF PROTEIN BINDING,0.00013016,0.14658,0.14573,1,1
1,GO MAMMARY GLAND DEVELOPMENT,0.0084096,0.14656,0.13296,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,6.0079e-05,0.14635,0.15023,1,1
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.00023667,0.14608,0.14922,1,1
1,GO PROTEIN POLYUBIQUITINATION,1.3056e-06,0.14606,0.15061,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,6.6578e-05,0.14604,0.18727,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0067673,0.14583,0.1437,1,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.00015583,0.1458,0.26058,1,1
1,GO CELLULAR RESPONSE TO ALCOHOL,0.0028118,0.14579,0.15543,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00035024,0.14577,0.16437,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.019312,0.14564,0.22165,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.012227,0.14558,0.11219,1,1
1,GO CARDIAC CHAMBER DEVELOPMENT,0.0084096,0.14557,0.13326,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.0011836,0.14554,0.14185,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0044864,0.1455,0.15462,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00024819,0.1454,0.15672,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,2.2416e-05,0.14535,0.15595,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0023957,0.1453,0.18021,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.0011341,0.14514,0.14567,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.014172,0.14514,0.17428,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,1.6994e-06,0.14509,0.17038,1,1
1,GO NEPHRON DEVELOPMENT,0.001955,0.14509,0.17662,1,1
1,GO UV PROTECTION,0.046921,0.14492,0.15018,1,1
1,GO MALE SEX DIFFERENTIATION,0.0010408,0.14481,0.14777,1,1
1,GO OSSIFICATION,0.00032916,0.14463,0.16591,1,1
1,GO VACUOLE ORGANIZATION,3.9613e-05,0.14463,0.15315,1,1
1,GO ACTIVATION OF JNKK ACTIVITY,0.0022396,0.14451,0.1826,1,1
1,GO REGULATION OF OSSIFICATION,0.00099681,0.14444,0.17213,1,1
1,GO EPITHELIAL TUBE FORMATION,0.00057029,0.14444,0.16226,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.00059648,0.14439,0.14808,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,8.7316e-05,0.14404,0.16677,1,1
1,GO HISTONE MONOUBIQUITINATION,0.0137,0.14404,0.093632,1,1
1,GO MITOCHONDRIAL TRANSCRIPTION,0.038637,0.14397,0.089756,1,1
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0033799,0.14359,0.15277,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.0005133,0.14352,0.13509,1,1
1,GO COPII COATED VESICLE BUDDING,9.086e-06,0.14345,0.1644,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0054192,0.14336,0.13855,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,6.1119e-05,0.14336,0.17871,1,1
1,GO PROTEIN SUMOYLATION,0.00011033,0.1433,0.13088,1,1
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.014658,0.14328,0.11517,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.0001179,0.14321,0.15733,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.0013255,0.14319,0.16268,1,1
1,GO EMBRYONIC HEMOPOIESIS,0.043444,0.14301,0.12922,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.00082553,0.14293,0.15185,1,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.032278,0.14293,0.15045,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,1.1588e-05,0.14284,0.15893,1,1
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0028492,0.14284,0.12295,1,1
1,GO CELL MOTILITY,0.00092737,0.14281,0.13492,1,1
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.012367,0.14259,0.17343,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,9.086e-06,0.14254,0.18286,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.00087508,0.14248,0.19167,1,1
1,GO RESPONSE TO UV,7.3803e-06,0.14247,0.16753,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0012177,0.14221,0.11864,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,9.03e-05,0.14215,0.15568,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.9393e-05,0.14194,0.12912,1,1
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.014494,0.14192,0.11281,1,1
1,GO MITOCHONDRIAL GENE EXPRESSION,0.0051547,0.14184,0.1059,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.010645,0.14172,0.15429,1,1
1,GO RIBOSOME ASSEMBLY,0.0037985,0.14164,0.14729,1,1
1,GO ER NUCLEUS SIGNALING PATHWAY,0.015329,0.14157,0.11442,1,1
1,GO PROTEIN O LINKED GLYCOSYLATION,0.009139,0.14157,0.12173,1,1
1,GO JNK CASCADE,0.0007786,0.14153,0.12968,1,1
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.028852,0.14152,0.12603,1,1
1,GO REGULATION OF JUN KINASE ACTIVITY,0.0039992,0.14139,0.13712,1,1
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0012005,0.1413,0.15279,1,1
1,GO PROTEIN IMPORT,3.4773e-06,0.14118,0.15128,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0014022,0.1411,0.15515,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.021973,0.14107,0.15658,1,1
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0054872,0.14105,0.15212,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,5.4184e-05,0.14098,0.15496,1,1
1,GO TUBE DEVELOPMENT,7.7586e-05,0.14093,0.17595,1,1
1,GO SARCOMERE ORGANIZATION,0.017315,0.14087,0.13191,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.004964,0.14079,0.10893,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0090315,0.14079,0.16719,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0019285,0.14056,0.13343,1,1
1,GO PROTEIN MATURATION,3.0395e-05,0.14039,0.13927,1,1
1,GO NUCLEAR MIGRATION,0.064418,0.14029,0.12295,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,1.3056e-06,0.14005,0.12759,1,1
1,GO SPERM EGG RECOGNITION,0.00026858,0.14005,0.12922,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0005618,0.14004,0.13204,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.00019541,0.13999,0.15151,1,1
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0018006,0.13991,0.14564,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,4.9694e-05,0.13991,0.1245,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,1.1789e-06,0.13975,0.1703,1,1
1,GO FAT CELL DIFFERENTIATION,0.00044103,0.13971,0.15647,1,1
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0011503,0.13936,0.16675,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.05063,0.13935,0.091152,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.0022095,0.13929,0.15557,1,1
1,GO LIPID LOCALIZATION,0.00049802,0.13925,0.13802,1,1
1,GO ENDOCYTIC RECYCLING,0.0043737,0.1391,0.13054,1,1
1,GO APICAL JUNCTION ASSEMBLY,0.011949,0.13904,0.15372,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,1.7534e-07,0.13881,0.1501,1,1
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0061347,0.13856,0.17582,1,1
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.00044781,0.13835,0.14565,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0095807,0.13815,0.13505,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.00064263,0.13808,0.11972,1,1
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.012087,0.13802,0.10203,1,1
1,GO RESPONSE TO STEROL,0.0074579,0.13786,0.15451,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.01251,0.13781,0.093407,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,3.9613e-05,0.13774,0.14362,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,5.4184e-05,0.13758,0.14693,1,1
1,GO RUFFLE ORGANIZATION,7.6283e-05,0.13756,0.16232,1,1
1,GO MIDBODY ABSCISSION,0.00061456,0.13731,0.18569,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.0010259,0.13729,0.18052,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,1.5014e-05,0.13719,0.11652,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,8.3013e-05,0.13716,0.15443,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.00042128,0.13713,0.13969,1,1
1,GO AGING,1.3442e-05,0.13712,0.14496,1,1
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0033799,0.13711,0.18616,1,1
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.0083098,0.13701,0.13346,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0027381,0.13699,0.17035,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,2.4972e-05,0.13699,0.1665,1,1
1,GO ENDOSOME ORGANIZATION,2.8814e-05,0.13691,0.15472,1,1
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.014658,0.13664,0.06473,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.019312,0.13655,0.11389,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.003166,0.13645,0.17593,1,1
1,GO TRNA TRANSPORT,0.0005211,0.13634,0.14121,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,4.5684e-06,0.13629,0.13559,1,1
1,GO VACUOLAR ACIDIFICATION,0.003166,0.13627,0.13012,1,1
1,GO IMPORT INTO NUCLEUS,1.4207e-05,0.13626,0.14808,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00018923,0.13621,0.1769,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,3.2146e-06,0.13606,0.14341,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.00095459,0.13584,0.13145,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,3.5022e-05,0.13582,0.14857,1,1
1,GO NUCLEAR EXPORT,2.2824e-05,0.13575,0.14224,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.063258,0.13572,0.18626,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,2.4861e-06,0.13566,0.16485,1,1
1,GO GOLGI VESICLE TRANSPORT,1.0004e-06,0.13537,0.15358,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00094089,0.13528,0.18452,1,1
1,GO MAINTENANCE OF LOCATION,2.5424e-05,0.13526,0.15132,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00042777,0.13523,0.12242,1,1
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.011949,0.13519,0.11993,1,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.017315,0.13511,0.13751,1,1
1,GO ORGANELLE INHERITANCE,0.0075485,0.13505,0.096881,1,1
1,GO DRUG CATABOLIC PROCESS,0.040187,0.13498,0.12188,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0041031,0.13497,0.11592,1,1
1,GO MUSCLE ADAPTATION,0.0054192,0.13474,0.12421,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.0052197,0.13462,0.11591,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,2.2015e-05,0.13458,0.16449,1,1
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.022686,0.13441,0.12476,1,1
1,GO NODAL SIGNALING PATHWAY,0.0094686,0.1344,0.11435,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,9.9803e-06,0.13432,0.15796,1,1
1,GO RNA LOCALIZATION,7.5001e-05,0.1343,0.13921,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0001862,0.13407,0.1382,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.011678,0.13403,0.11378,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0012005,0.1339,0.16088,1,1
1,GO RESPONSE TO KETONE,0.0010865,0.13388,0.13531,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,8.1623e-05,0.13378,0.13444,1,1
1,GO RESPONSE TO GROWTH FACTOR,0.0013255,0.13333,0.13076,1,1
1,GO PROTEIN AUTOPHOSPHORYLATION,0.00022565,0.13311,0.15192,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00015583,0.13289,0.13213,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,6.9711e-06,0.13261,0.146,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00036686,0.13256,0.18116,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,8.6579e-07,0.13247,0.12485,1,1
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00090088,0.13226,0.13886,1,1
1,GO MRNA TRANSPORT,9.819e-05,0.13222,0.13389,1,1
1,GO XENOBIOTIC TRANSPORT,0.0030436,0.13203,0.15573,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.029754,0.13174,0.11489,1,1
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.058787,0.13169,0.1586,1,1
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.055609,0.13155,0.10269,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,0.0002443,0.13143,0.12524,1,1
1,GO FOLIC ACID METABOLIC PROCESS,0.020828,0.13123,0.11277,1,1
1,GO VIRAL LATENCY,0.051595,0.13114,0.069907,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,2.9332e-05,0.13107,0.15104,1,1
1,GO RNA POLYADENYLATION,0.0059852,0.13097,0.10992,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.00019541,0.13097,0.13119,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.030368,0.13093,0.13648,1,1
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,9.6562e-05,0.13093,0.13894,1,1
1,GO ORGAN GROWTH,0.00016361,0.13078,0.18105,1,1
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.022928,0.13057,0.1261,1,1
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.0011021,0.13057,0.12563,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0031247,0.13035,0.13611,1,1
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.001071,0.12984,0.15255,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,8.1138e-06,0.12973,0.17252,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,4.3946e-06,0.12959,0.14751,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,2.4861e-06,0.12958,0.16084,1,1
1,GO LYSOSOMAL TRANSPORT,0.00038422,0.12956,0.1506,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0044298,0.12953,0.10879,1,1
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00032408,0.12941,0.16643,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,3.6924e-05,0.12922,0.15203,1,1
1,GO MITOTIC CELL CYCLE ARREST,0.013093,0.12922,0.13953,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,6.545e-05,0.12917,0.14368,1,1
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0049019,0.12911,0.13197,1,1
1,GO ANION HOMEOSTASIS,0.0022095,0.12898,0.14931,1,1
1,GO HEART MORPHOGENESIS,0.0021215,0.12893,0.14298,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,1.8363e-05,0.12879,0.12494,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.009139,0.12875,0.11636,1,1
1,GO PEPTIDYL METHIONINE MODIFICATION,0.0137,0.12831,0.13153,1,1
1,GO VACUOLAR TRANSPORT,0.00024045,0.12817,0.13575,1,1
1,GO MITOTIC RECOMBINATION,0.052575,0.12803,0.10214,1,1
1,GO PROTEIN STABILIZATION,0.00015331,0.12798,0.12778,1,1
1,GO P BODY ASSEMBLY,0.01251,0.12798,0.098926,1,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.018693,0.12795,0.099865,1,1
1,GO RESPONSE TO HEAT,4.4771e-05,0.1278,0.15003,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,6.9711e-06,0.12774,0.12269,1,1
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.021053,0.12772,0.10371,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.0037016,0.12727,0.15861,1,1
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,2.5884e-05,0.12721,0.12571,1,1
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.037509,0.12718,0.091377,1,1
1,GO REGULATION OF CATABOLIC PROCESS,6.6066e-07,0.1271,0.13818,1,1
1,GO PROTEOLYSIS,7.6657e-06,0.12703,0.13293,1,1
1,GO PEPTIDE METABOLIC PROCESS,6.0991e-06,0.12696,0.12468,1,1
1,GO PIGMENTATION,0.019104,0.12693,0.10011,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0030038,0.12678,0.10125,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.017894,0.12672,0.1024,1,1
1,GO BLASTOCYST GROWTH,0.0005133,0.12668,0.19104,1,1
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.045591,0.12616,0.10257,1,1
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.05063,0.12609,0.10027,1,1
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.012367,0.12607,0.14383,1,1
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.012798,0.12606,0.15015,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.00016629,0.12604,0.14644,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0042095,0.12602,0.10752,1,1
1,GO CELLULAR RESPONSE TO FATTY ACID,0.024687,0.12595,0.12673,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.0017277,0.1259,0.11065,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00016098,0.12588,0.15803,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0012527,0.12577,0.1295,1,1
1,GO APOPTOTIC PROCESS,4.1026e-05,0.12575,0.12697,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0037985,0.12574,0.12385,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.045591,0.1256,0.064426,1,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0001803,0.12548,0.13669,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.043866,0.12538,0.10338,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0023009,0.12533,0.10066,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.0057669,0.12512,0.087522,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00073415,0.12507,0.12809,1,1
1,GO CELLULAR RESPONSE TO RADIATION,4.2271e-06,0.12499,0.15332,1,1
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0061347,0.12487,0.13288,1,1
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.043025,0.12464,0.094404,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0037498,0.12456,0.13128,1,1
1,GO ANIMAL ORGAN FORMATION,0.016027,0.12451,0.12616,1,1
1,GO MITOCHONDRIAL TRANSLATION,0.0084096,0.12425,0.10428,1,1
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0022095,0.12404,0.11469,1,1
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00024045,0.12403,0.13367,1,1
1,GO CELLULAR RESPONSE TO ATP,0.0037498,0.12396,0.11204,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00067188,0.12387,0.1034,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00035024,0.12386,0.12967,1,1
1,GO LIPID CATABOLIC PROCESS,0.00040235,0.12386,0.12645,1,1
1,GO RESPONSE TO NITRIC OXIDE,0.015329,0.12384,0.090347,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,5.8698e-06,0.12381,0.13227,1,1
1,GO DNA METHYLATION OR DEMETHYLATION,0.0058389,0.12372,0.096952,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0022095,0.12343,0.12193,1,1
1,GO RNA 3 END PROCESSING,0.00087508,0.12326,0.10571,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0023957,0.12311,0.11608,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.001568,0.1229,0.13555,1,1
1,GO DE NOVO PROTEIN FOLDING,0.03429,0.12282,0.097142,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0033361,0.1228,0.11463,1,1
1,GO NCRNA 3 END PROCESSING,0.0078263,0.12273,0.12734,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,7.8124e-06,0.12256,0.13185,1,1
1,GO NUCLEUS LOCALIZATION,0.036772,0.12252,0.12878,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,4.8839e-05,0.1225,0.13227,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00049802,0.12247,0.14285,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.00063314,0.12236,0.16729,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0010113,0.12229,0.17305,1,1
1,GO OUTFLOW TRACT MORPHOGENESIS,0.013856,0.12221,0.17385,1,1
1,GO ESTROGEN METABOLIC PROCESS,0.001483,0.12207,0.14864,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0015249,0.12206,0.097672,1,1
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.029754,0.12124,0.13417,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0037016,0.12121,0.11216,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00013899,0.12117,0.11053,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0039481,0.12093,0.10498,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.00031907,0.12063,0.11191,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.00018323,0.12056,0.12307,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00068191,0.12054,0.12486,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,6.7105e-06,0.12047,0.11518,1,1
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0013443,0.12045,0.13564,1,1
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.059879,0.12044,0.069132,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,6.6578e-05,0.12034,0.15505,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00016629,0.12011,0.14519,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,7.105e-06,0.12007,0.12734,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00030449,0.11999,0.13135,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0033361,0.11998,0.14445,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0022095,0.11997,0.12968,1,1
1,GO REGULATION OF RNA BINDING,0.0027747,0.11988,0.13244,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,2.6352e-05,0.11969,0.13178,1,1
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0037498,0.11954,0.11371,1,1
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.039406,0.11945,0.11447,1,1
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0044864,0.11945,0.11684,1,1
1,GO SNRNA PROCESSING,0.0047798,0.11945,0.17775,1,1
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.0022095,0.11918,0.12596,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.012653,0.11903,0.13058,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00010852,0.11903,0.1397,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,6.1119e-05,0.119,0.132,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0001179,0.11895,0.12942,1,1
1,GO CARDIOCYTE DIFFERENTIATION,0.011949,0.11886,0.1243,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00029976,0.11875,0.12956,1,1
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0011503,0.11875,0.12972,1,1
1,GO RESPONSE TO DRUG,0.00075607,0.11874,0.12943,1,1
1,GO HYPEROSMOTIC RESPONSE,0.004156,0.11867,0.136,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,0.00016361,0.11855,0.10476,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.00031414,0.11845,0.10027,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.001955,0.11836,0.10788,1,1
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0023637,0.11833,0.14148,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0013255,0.11833,0.1396,1,1
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0007786,0.11804,0.12486,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0023957,0.11801,0.12088,1,1
1,GO SNRNA METABOLIC PROCESS,0.0047198,0.11797,0.14175,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,3.8246e-05,0.11797,0.12003,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00092737,0.11783,0.11239,1,1
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0030436,0.1178,0.16072,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0060595,0.11761,0.13637,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.048746,0.11756,0.076842,1,1
1,GO CELL CELL SIGNALING BY WNT,0.0020367,0.11747,0.11644,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00021857,0.11745,0.13313,1,1
1,GO PROTEIN CATABOLIC PROCESS,1.1375e-05,0.11732,0.12346,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0005789,0.11717,0.1303,1,1
1,GO CELL JUNCTION DISASSEMBLY,0.0056958,0.11716,0.18283,1,1
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.060432,0.11715,0.070161,1,1
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.034984,0.11715,0.081866,1,1
1,GO ACTIVATION OF GTPASE ACTIVITY,0.0089251,0.11704,0.11516,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0010408,0.11682,0.10891,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,2.1621e-05,0.11673,0.13592,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.015159,0.11666,0.1003,1,1
1,GO REGULATION OF PROTEIN STABILITY,2.6352e-05,0.11662,0.1281,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00073415,0.11641,0.14379,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,3.2859e-07,0.11576,0.13369,1,1
1,GO LIPID METABOLIC PROCESS,0.0005056,0.11567,0.11852,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,8.4262e-06,0.11562,0.12863,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0014022,0.11554,0.10064,1,1
1,GO DNA MODIFICATION,0.0039992,0.11494,0.094496,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,7.2414e-06,0.1149,0.11862,1,1
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0028118,0.11461,0.10792,1,1
1,GO TRANSLATIONAL INITIATION,0.0072795,0.11456,0.12139,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.0026663,0.11443,0.12031,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0012177,0.11413,0.12628,1,1
1,GO DNA DEALKYLATION,0.0042095,0.114,0.15172,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0078263,0.11392,0.09195,1,1
1,GO RESPONSE TO PEPTIDE,0.0011503,0.11381,0.11039,1,1
1,GO MRNA CLEAVAGE,0.0012005,0.11381,0.10192,1,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.037509,0.11378,0.11548,1,1
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0014022,0.11369,0.13895,1,1
1,GO CELLULAR LIPID METABOLIC PROCESS,0.00040857,0.11356,0.12362,1,1
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.015501,0.1134,0.12762,1,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0098086,0.11317,0.1797,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0029645,0.11287,0.092533,1,1
1,GO PEROXISOME ORGANIZATION,0.0005618,0.11282,0.12952,1,1
1,GO TELOMERE ORGANIZATION,0.00026024,0.11241,0.10529,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.02128,0.11235,0.13533,1,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0053519,0.11226,0.15967,1,1
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.0087156,0.11216,0.12846,1,1
1,GO NUCLEAR TRANSPORT,2.1621e-05,0.11209,0.12462,1,1
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.011813,0.11199,0.18054,1,1
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0094686,0.11172,0.15474,1,1
1,GO DNA METHYLATION,0.014823,0.11156,0.088335,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0034692,0.11131,0.1629,1,1
1,GO PEROXISOMAL TRANSPORT,0.00091404,0.11124,0.13323,1,1
1,GO CELL CYCLE PHASE TRANSITION,8.3013e-05,0.11083,0.098507,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,8.5858e-05,0.11062,0.10186,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0030839,0.11047,0.12916,1,1
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.026013,0.11043,0.098437,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00010152,0.11028,0.12098,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.014172,0.11005,0.084936,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00030449,0.11005,0.1224,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.00070238,0.10991,0.12351,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.00043435,0.10985,0.11504,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00059648,0.10973,0.12127,1,1
1,GO SULFATION,0.012653,0.10948,0.1661,1,1
1,GO REGULATION OF AUTOPHAGY,0.00016361,0.1094,0.11632,1,1
1,GO HISTONE UBIQUITINATION,0.028852,0.10932,0.070629,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.042197,0.10913,0.10118,1,1
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.01995,0.10907,0.12955,1,1
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.0018508,0.10901,0.14987,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.0080166,0.10901,0.14178,1,1
1,GO GLYCEROLIPID METABOLIC PROCESS,0.00061456,0.10871,0.11831,1,1
1,GO DNA BIOSYNTHETIC PROCESS,2.9332e-05,0.10863,0.11143,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.013093,0.10811,0.066475,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.023173,0.10809,0.12157,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,5.9056e-05,0.10751,0.10234,1,1
1,GO PROTEIN AUTOUBIQUITINATION,0.014823,0.10743,0.081704,1,1
1,GO WHITE FAT CELL DIFFERENTIATION,0.062684,0.10741,0.09295,1,1
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.021973,0.10739,0.12419,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0049019,0.10731,0.11878,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,3.6162e-06,0.10708,0.13275,1,1
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0045438,0.10703,0.10644,1,1
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.016027,0.10677,0.097755,1,1
1,GO REGULATION OF MUSCLE ADAPTATION,0.044722,0.10675,0.094375,1,1
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.0019819,0.1065,0.11883,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0028118,0.1064,0.12035,1,1
1,GO RUFFLE ASSEMBLY,0.0071051,0.10634,0.11822,1,1
1,GO ENDOSOMAL TRANSPORT,0.00012186,0.1063,0.11996,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.00042777,0.106,0.12874,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0029645,0.10598,0.1033,1,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.048285,0.10578,0.084662,1,1
1,GO MYOFIBRIL ASSEMBLY,0.055609,0.10565,0.11,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.0019023,0.10556,0.1056,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.0025617,0.10521,0.10253,1,1
1,GO RESPONSE TO ESTRADIOL,0.0048405,0.10504,0.11542,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.3256e-05,0.1048,0.13678,1,1
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0030839,0.10443,0.12439,1,1
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.0027381,0.10408,0.10591,1,1
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.062684,0.10389,0.080573,1,1
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.024947,0.10385,0.095069,1,1
1,GO MITOPHAGY,0.0013069,0.10383,0.14815,1,1
1,GO TRANSLESION SYNTHESIS,0.002631,0.1038,0.097992,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0027747,0.10374,0.10996,1,1
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0035605,0.10337,0.11801,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0020646,0.10337,0.12222,1,1
1,GO SPINDLE LOCALIZATION,0.015501,0.10332,0.088127,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0012886,0.1033,0.10341,1,1
1,GO POSTREPLICATION REPAIR,0.001483,0.10326,0.093142,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.00026024,0.1031,0.13231,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00018323,0.103,0.1172,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.00040857,0.10258,0.11947,1,1
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.043866,0.10254,0.085442,1,1
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.0030038,0.10219,0.11913,1,1
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.00058763,0.10206,0.12236,1,1
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00035024,0.10182,0.12092,1,1
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.024687,0.10158,0.098361,1,1
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00022208,0.10153,0.12367,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,8.7316e-05,0.10152,0.11324,1,1
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0016806,0.10144,0.11235,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,6.6578e-05,0.10144,0.10157,1,1
1,GO RESPONSE TO ALCOHOL,0.036772,0.10133,0.086445,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.00058763,0.10127,0.1115,1,1
1,GO CYTOKINESIS,0.018091,0.10118,0.073123,1,1
1,GO PROTEIN NEDDYLATION,0.027401,0.10112,0.087924,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.022209,0.10109,0.093245,1,1
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0023009,0.10086,0.11749,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.015674,0.10079,0.079552,1,1
1,GO RNA PROCESSING,0.00040857,0.10063,0.11529,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0019285,0.10028,0.10538,1,1
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.016027,0.10018,0.089213,1,1
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00091404,0.10016,0.12939,1,1
1,GO GENE SILENCING,6.6578e-05,0.099895,0.12084,1,1
1,GO L GLUTAMATE IMPORT,0.059331,0.099767,0.10079,1,1
1,GO RESPONSE TO HORMONE,0.00098255,0.099649,0.11922,1,1
1,GO SIGNAL PEPTIDE PROCESSING,0.060988,0.099527,0.1107,1,1
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.001704,0.099439,0.095066,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.01995,0.098799,0.12409,1,1
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.00014129,0.098549,0.10524,1,1
1,GO MRNA 3 END PROCESSING,0.0052854,0.098548,0.094161,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00047589,0.098523,0.10984,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00012594,0.098202,0.10932,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0029256,0.097998,0.10563,1,1
1,GO CENTRIOLE ASSEMBLY,0.029754,0.097982,0.081256,1,1
1,GO GOLGI ORGANIZATION,0.0012886,0.097961,0.12333,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,9.1829e-05,0.097873,0.10407,1,1
1,GO HEART DEVELOPMENT,0.00084997,0.097772,0.13781,1,1
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.022686,0.097734,0.10703,1,1
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.051595,0.097699,0.075847,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.0016806,0.097531,0.10355,1,1
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0039992,0.097109,0.11086,1,1
1,GO LACTATION,0.014658,0.097054,0.12483,1,1
1,GO LIPID PHOSPHORYLATION,0.038258,0.096974,0.093621,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.001071,0.096922,0.10024,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,2.4528e-05,0.096696,0.12901,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0017517,0.096655,0.10343,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.004156,0.096361,0.10745,1,1
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0033361,0.096107,0.098899,1,1
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.020166,0.096048,0.10847,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0015463,0.095981,0.10695,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0016347,0.095976,0.11934,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.0005789,0.095749,0.13573,1,1
1,GO REGULATION OF BINDING,0.00044103,0.095538,0.11486,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.022446,0.095475,0.11151,1,1
1,GO REGULATION OF GTPASE ACTIVITY,0.014013,0.095455,0.10339,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.0018764,0.095133,0.12428,1,1
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0023637,0.09513,0.11825,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.0054872,0.095101,0.10936,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.006444,0.095091,0.11504,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0068504,0.094809,0.096285,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0005211,0.094756,0.10236,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.0070192,0.094613,0.10267,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.0022701,0.094508,0.08275,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,4.1751e-05,0.094471,0.12368,1,1
1,GO TRANSLATIONAL TERMINATION,0.0077327,0.094428,0.11588,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0070192,0.094061,0.14894,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,9.4959e-05,0.093944,0.12398,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0029645,0.093844,0.091693,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.013093,0.093435,0.15311,1,1
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.019735,0.093376,0.099862,1,1
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.017894,0.093273,0.098263,1,1
1,GO OXIDATION REDUCTION PROCESS,0.00054518,0.093264,0.10133,1,1
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.031953,0.093015,0.086719,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00099681,0.092937,0.12638,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.054582,0.092803,0.093869,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0021505,0.092787,0.11294,1,1
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.021509,0.092666,0.10323,1,1
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00022927,0.092596,0.1154,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0012005,0.092555,0.093096,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00042777,0.092489,0.10448,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.0013255,0.092444,0.095873,1,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.016938,0.09236,0.082467,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.028556,0.091969,0.091603,1,1
1,GO CELL DIVISION,0.0059852,0.091883,0.076349,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0012886,0.091353,0.087705,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.0022396,0.091314,0.10024,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.065596,0.091307,0.076394,1,1
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.061549,0.091169,0.081983,1,1
1,GO CELLULAR SENESCENCE,0.0005056,0.091116,0.12925,1,1
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.0098086,0.0909,0.094653,1,1
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.026286,0.09047,0.089527,1,1
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.01128,0.09023,0.11832,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.018091,0.090158,0.081793,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.0041031,0.090036,0.15102,1,1
1,GO MACROAUTOPHAGY,2.1621e-05,0.089792,0.12902,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.002702,0.08943,0.098019,1,1
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0038478,0.089114,0.090294,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0025617,0.088946,0.094876,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,2.8305e-05,0.088918,0.11226,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0023321,0.088905,0.10665,1,1
1,GO MUSCLE CELL DIFFERENTIATION,0.01849,0.088808,0.096845,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,8.7316e-05,0.088036,0.11563,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.016205,0.087956,0.075162,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00031907,0.087937,0.099299,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.00040857,0.087791,0.084315,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0010259,0.087733,0.10235,1,1
1,GO MRNA METABOLIC PROCESS,0.00047589,0.086735,0.10083,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0022701,0.086668,0.094444,1,1
1,GO RNA STABILIZATION,0.037882,0.086609,0.075291,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0028872,0.086543,0.094716,1,1
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.017894,0.086318,0.09502,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.011544,0.0863,0.065874,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0104,0.086253,0.079657,1,1
1,GO REGULATION OF MYELINATION,0.044722,0.086202,0.098243,1,1
1,GO AMP METABOLIC PROCESS,0.031311,0.086079,0.14709,1,1
1,GO RESPONSE TO ACTIVITY,0.060988,0.085887,0.077125,1,1
1,GO HORMONE METABOLIC PROCESS,0.020166,0.085535,0.08899,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.015159,0.085527,0.085213,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.013394,0.085064,0.13256,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.003166,0.084833,0.093701,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.001483,0.084577,0.1021,1,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0075485,0.084511,0.083257,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.0046018,0.084332,0.072014,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.00040857,0.083922,0.10911,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.012367,0.083911,0.08571,1,1
1,GO CELL VOLUME HOMEOSTASIS,0.011022,0.083892,0.11595,1,1
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.0023009,0.083664,0.13289,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.010645,0.083647,0.06294,1,1
1,GO NUCLEUS ORGANIZATION,0.0074579,0.083646,0.085052,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0028492,0.083415,0.090388,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.0048405,0.083194,0.10384,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.00022208,0.082597,0.092277,1,1
1,GO TRANSITION METAL ION TRANSPORT,0.0030839,0.082107,0.090485,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.002631,0.081941,0.08792,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.030994,0.081845,0.048,1,1
1,GO REGULATION OF HISTONE UBIQUITINATION,0.019735,0.08171,0.090526,1,1
1,GO DNA GEOMETRIC CHANGE,0.0046018,0.080748,0.089587,1,1
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.010645,0.08066,0.087099,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.021509,0.080612,0.10696,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.00040857,0.080334,0.081943,1,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.016568,0.079935,0.095628,1,1
1,GO CALCINEURIN MEDIATED SIGNALING,0.051111,0.079859,0.095976,1,1
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.012227,0.079822,0.094779,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0059116,0.079611,0.076922,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00010497,0.079419,0.093756,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0078263,0.079389,0.11575,1,1
1,GO MUSCLE TISSUE DEVELOPMENT,0.058247,0.078647,0.076681,1,1
1,GO PROTEIN TETRAMERIZATION,0.0067673,0.078559,0.092903,1,1
1,GO HISTONE H3 ACETYLATION,0.049681,0.078469,0.063683,1,1
1,GO CELL CYCLE ARREST,0.033271,0.078416,0.062188,1,1
1,GO REGULATION OF DNA REPAIR,0.032607,0.078094,0.056069,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.011411,0.0779,0.11407,1,1
1,GO CYTOSKELETON ORGANIZATION,0.019312,0.077839,0.082003,1,1
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.0020646,0.077684,0.097982,1,1
1,GO DNA RECOMBINATION,0.0056255,0.077623,0.078333,1,1
1,GO ORGANELLE DISASSEMBLY,0.0054872,0.077233,0.085276,1,1
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.046921,0.077143,0.047691,1,1
1,GO SPECIFICATION OF SYMMETRY,0.036048,0.076598,0.073943,1,1
1,GO MIRNA METABOLIC PROCESS,0.0055559,0.076223,0.12374,1,1
1,GO VITAMIN METABOLIC PROCESS,0.018091,0.075731,0.091799,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0057669,0.075577,0.083352,1,1
1,GO RESPONSE TO INSULIN,0.023419,0.07545,0.085484,1,1
1,GO MITOTIC CELL CYCLE,0.00072342,0.075397,0.082525,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.0015249,0.073859,0.084902,1,1
1,GO REGULATION OF ERAD PATHWAY,0.0059852,0.073524,0.11931,1,1
1,GO CELL CYCLE CHECKPOINT,0.012227,0.072966,0.06334,1,1
1,GO REGULATION OF ATP METABOLIC PROCESS,0.033948,0.072536,0.07233,1,1
1,GO DNA INTEGRITY CHECKPOINT,0.012227,0.072427,0.076694,1,1
1,GO REGULATION OF CELL DIVISION,0.017506,0.072339,0.086039,1,1
1,GO DNA METABOLIC PROCESS,0.00099681,0.072012,0.070647,1,1
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.041789,0.071333,0.10323,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.023173,0.071238,0.11069,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0027747,0.07081,0.095733,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.033948,0.070148,0.072354,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0012527,0.069774,0.090229,1,1
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.024687,0.069363,0.064929,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.020605,0.069237,0.062023,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0087156,0.068555,0.078265,1,1
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.036772,0.067205,0.067646,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00055343,0.067152,0.088234,1,1
1,GO REGULATION OF CELL CYCLE,0.002702,0.066792,0.068495,1,1
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.042609,0.066724,0.10256,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.0104,0.066335,0.06776,1,1
1,GO RESPONSE TO RADIATION,0.0055559,0.066263,0.077451,1,1
1,GO CELL CYCLE PROCESS,0.0024281,0.065915,0.067187,1,1
1,GO SNRNA TRANSCRIPTION,0.026561,0.065267,0.070935,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0018508,0.065131,0.068345,1,1
1,GO NEGATIVE REGULATION OF BINDING,0.0022396,0.064875,0.10129,1,1
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.01016,0.064809,0.077254,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.046474,0.064603,0.058414,1,1
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.031631,0.064022,0.087355,1,1
1,GO CYTOSOLIC TRANSPORT,0.021053,0.06389,0.083915,1,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.048285,0.063573,0.063461,1,1
1,GO RESPONSE TO ACID CHEMICAL,0.055609,0.06253,0.086754,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.019312,0.062212,0.064367,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.037139,0.061398,0.06896,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.010522,0.061389,0.13988,1,1
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0032078,0.061213,0.088536,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0062877,0.060598,0.082626,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0025277,0.060499,0.070927,1,1
1,GO CHROMOSOME SEGREGATION,0.056128,0.059797,0.03352,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.0043184,0.058578,0.068776,1,1
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.031953,0.058406,0.081105,1,1
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.051595,0.058315,0.072809,1,1
1,GO NCRNA TRANSCRIPTION,0.046921,0.058281,0.064957,1,1
1,GO PROTEIN TARGETING,0.0070192,0.058085,0.075027,1,1
1,GO NEGATIVE REGULATION OF GROWTH,0.036772,0.057731,0.085025,1,1
1,GO MACROMOLECULE DEACYLATION,0.039795,0.056905,0.065743,1,1
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.027973,0.056768,0.069891,1,1
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.058787,0.05657,0.079853,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0022396,0.056044,0.10773,1,1
1,GO CELL CYCLE,0.0026663,0.056011,0.064253,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.019523,0.055859,0.08506,1,1
1,GO REGULATION OF DNA REPLICATION,0.033271,0.053228,0.069049,1,1
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.058787,0.053069,0.066222,1,1
1,GO INTRACELLULAR TRANSPORT,0.0039992,0.052593,0.069202,1,1
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.033271,0.05184,0.074073,1,1
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.052575,0.051753,0.064607,1,1
1,GO PROTEIN FOLDING,0.022928,0.051702,0.1012,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.042609,0.05159,0.046488,1,1
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.022686,0.051389,0.064512,1,1
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.02128,0.051252,0.063213,1,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.05357,0.050566,0.066343,1,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.056652,0.048019,0.051201,1,1
1,GO BLASTOCYST DEVELOPMENT,0.053071,0.04787,0.053526,1,1
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.043444,0.047078,0.059979,1,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.024173,0.044684,0.056678,1,1
1,GO DNA REPAIR,0.01585,0.044362,0.053629,1,1
1,GO DNA CONFORMATION CHANGE,0.059331,0.043945,0.041745,1,1
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.05357,0.04249,0.04664,1,1
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,8.9047e-09,0.90042,0.79773,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.1479e-07,0.74415,0.6509,1,1
2,GO SYNAPSE MATURATION,2.0478e-05,0.58504,0.45558,1,1
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,5.8698e-06,0.57401,0.58923,1,1
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,4.2271e-06,0.55009,0.46604,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,4.0657e-06,0.52201,0.46141,1,1
2,GO RESPONSE TO L GLUTAMATE,6.5125e-09,0.51224,0.47959,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,9.086e-06,0.51064,0.45901,1,1
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,6.3359e-07,0.50738,0.47308,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,1.2534e-06,0.5047,0.45256,1,1
2,GO REGULATION OF SYNAPSE MATURATION,0.00018323,0.503,0.3842,1,1
2,GO NEURON CELLULAR HOMEOSTASIS,1.1307e-08,0.48601,0.45743,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00010152,0.44349,0.37891,1,1
2,GO SECRETORY GRANULE LOCALIZATION,0.00014362,0.44291,0.35717,1,1
2,GO GLYCINE TRANSPORT,0.00043435,0.43133,0.38545,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,4.6202e-07,0.43075,0.36147,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,6.3249e-05,0.42938,0.46768,1,1
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00014599,0.42905,0.39061,1,1
2,GO DENSE CORE GRANULE TRANSPORT,0.00159,0.42061,0.33397,1,1
2,GO SYNAPTIC VESICLE MATURATION,5.2344e-05,0.41423,0.38759,1,1
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,2.9514e-07,0.41307,0.41768,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,3.2784e-06,0.4125,0.35792,1,1
2,GO POSTSYNAPSE ASSEMBLY,4.4771e-05,0.40969,0.40671,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,3.2784e-06,0.4041,0.35624,1,1
2,GO IMP METABOLIC PROCESS,1.536e-06,0.40254,0.44859,1,1
2,GO CYTOPLASMIC TRANSLATION,9.404e-07,0.39893,0.36419,1,1
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,6.4699e-07,0.39179,0.39216,1,1
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,6.5837e-06,0.39043,0.34689,1,1
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,4.9694e-05,0.38939,0.35656,1,1
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00032916,0.38668,0.37126,1,1
2,GO MATURATION OF LSU RRNA,8.8389e-07,0.38652,0.3909,1,1
2,GO MYOBLAST PROLIFERATION,1.4677e-08,0.38507,0.37598,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,7.0072e-05,0.38447,0.38879,1,1
2,GO CORPUS CALLOSUM DEVELOPMENT,1.7721e-08,0.38257,0.43305,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,6.5837e-06,0.382,0.4027,1,1
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,3.1312e-09,0.38153,0.34965,1,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.00010152,0.37492,0.32822,1,1
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.00013673,0.37439,0.37997,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,1.5576e-05,0.37289,0.33802,1,1
2,GO BRANCHING MORPHOGENESIS OF A NERVE,1.5865e-05,0.37014,0.45107,1,1
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00049802,0.36926,0.34942,1,1
2,GO SYNAPTIC MEMBRANE ADHESION,0.011678,0.36883,0.25188,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00010152,0.3683,0.31353,1,1
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,5.8698e-06,0.36054,0.35801,1,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,2.4371e-06,0.36025,0.3741,1,1
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,1.5604e-09,0.35748,0.36145,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.0156e-07,0.357,0.41156,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00052901,0.35389,0.28467,1,1
2,GO CARDIAC VENTRICLE FORMATION,0.0037016,0.35385,0.26704,1,1
2,GO TELENCEPHALON GLIAL CELL MIGRATION,2.5884e-05,0.3517,0.31226,1,1
2,GO SUCKLING BEHAVIOR,6.2169e-06,0.35022,0.36201,1,1
2,GO UV PROTECTION,6.2046e-07,0.34963,0.36518,1,1
2,GO HOMOCYSTEINE METABOLIC PROCESS,1.5014e-05,0.34861,0.41655,1,1
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.1807e-07,0.3472,0.38489,1,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,5.7582e-06,0.34417,0.37054,1,1
2,GO RESPONSE TO ELECTRICAL STIMULUS,1.7071e-05,0.34133,0.26315,1,1
2,GO TRANSLATIONAL INITIATION,1.3693e-05,0.34035,0.30956,1,1
2,GO ANATOMICAL STRUCTURE REGRESSION,0.0046604,0.33834,0.25579,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00074504,0.33772,0.26812,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00019857,0.33749,0.33197,1,1
2,GO REGULATION OF MRNA BINDING,1.475e-06,0.33313,0.3257,1,1
2,GO L GLUTAMATE IMPORT,2.1621e-05,0.32968,0.26087,1,1
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.00014599,0.32966,0.30042,1,1
2,GO CARDIAC CHAMBER FORMATION,0.0023957,0.32914,0.26457,1,1
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0010113,0.32663,0.30546,1,1
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0016347,0.32585,0.24286,1,1
2,GO PROTEIN LOCALIZATION TO AXON,0.0010259,0.32399,0.38703,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00022208,0.32325,0.3364,1,1
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,2.3274e-07,0.31936,0.3624,1,1
2,GO OXYGEN TRANSPORT,0.026013,0.31879,0.27238,1,1
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.2416e-05,0.31605,0.28998,1,1
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.0781e-08,0.31254,0.30374,1,1
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.0031247,0.31033,0.27142,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,2.0853e-05,0.3099,0.33351,1,1
2,GO RIBOSOME ASSEMBLY,2.7452e-06,0.30751,0.3562,1,1
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.017894,0.30386,0.25557,1,1
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00058763,0.3037,0.29673,1,1
2,GO DENTATE GYRUS DEVELOPMENT,1.7071e-05,0.30211,0.40353,1,1
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.00018323,0.30103,0.30966,1,1
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,1.3693e-05,0.30047,0.29085,1,1
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,4.3236e-05,0.30003,0.29706,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,1.8053e-06,0.29988,0.34385,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,1.3878e-06,0.29983,0.28476,1,1
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,2.5884e-05,0.29927,0.2681,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,4.1456e-06,0.29537,0.32714,1,1
2,GO EMBRYONIC BRAIN DEVELOPMENT,1.4454e-06,0.29326,0.27473,1,1
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.00013232,0.29283,0.2533,1,1
2,GO PHAGOCYTOSIS RECOGNITION,2.7312e-05,0.29263,0.27376,1,1
2,GO NEUROTRANSMITTER REUPTAKE,8.3013e-05,0.29252,0.25848,1,1
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.2926e-08,0.292,0.35576,1,1
2,GO TELOMERASE RNA LOCALIZATION,1.155e-06,0.29126,0.32136,1,1
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,6.8888e-05,0.29093,0.2579,1,1
2,GO AMP METABOLIC PROCESS,0.00021857,0.29058,0.26157,1,1
2,GO GLYCINE METABOLIC PROCESS,0.0052854,0.29027,0.20555,1,1
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0015463,0.28941,0.2459,1,1
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,8.2686e-06,0.28934,0.29276,1,1
2,GO GAS TRANSPORT,0.0062877,0.28887,0.24888,1,1
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.001442,0.28879,0.3108,1,1
2,GO PREPULSE INHIBITION,0.026561,0.28798,0.22147,1,1
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.00022565,0.28778,0.29675,1,1
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,2.4091e-05,0.28572,0.33657,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,3.2631e-05,0.28525,0.26551,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,2.5884e-05,0.28516,0.2968,1,1
2,GO MATURATION OF SSU RRNA,1.2954e-05,0.28439,0.31422,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,1.4741e-05,0.28375,0.29096,1,1
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,6.2175e-05,0.2827,0.26684,1,1
2,GO NEGATIVE CHEMOTAXIS,1.9044e-05,0.28218,0.30862,1,1
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,6.4341e-05,0.28197,0.25306,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,1.3693e-05,0.28089,0.31188,1,1
2,GO ADULT HEART DEVELOPMENT,5.2344e-05,0.28044,0.33287,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00014129,0.28,0.25565,1,1
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0070192,0.27885,0.26189,1,1
2,GO REGULATION OF VESICLE FUSION,0.00012388,0.27883,0.28155,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,2.1621e-05,0.27879,0.28461,1,1
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00013451,0.27794,0.28753,1,1
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0040509,0.27701,0.21806,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0003557,0.27689,0.22841,1,1
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00012388,0.27599,0.28174,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,8.0256e-05,0.27578,0.32418,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0012705,0.27335,0.24383,1,1
2,GO PENTOSE METABOLIC PROCESS,0.00010152,0.27329,0.22305,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,1.2281e-06,0.27233,0.35748,1,1
2,GO PROTEIN TARGETING TO MEMBRANE,2.2416e-05,0.26911,0.23776,1,1
2,GO AROMATIC AMINO ACID TRANSPORT,0.0033799,0.26878,0.35226,1,1
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0001803,0.26716,0.32401,1,1
2,GO MATURATION OF 5 8S RRNA,5.3256e-05,0.2665,0.27335,1,1
2,GO FACIAL NERVE MORPHOGENESIS,0.063836,0.26625,0.17744,1,1
2,GO VIRAL TRANSLATION,4.4807e-06,0.26596,0.30568,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,1.1806e-05,0.26199,0.34223,1,1
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,6.9711e-06,0.26194,0.24633,1,1
2,GO DIVALENT METAL ION EXPORT,5.9056e-05,0.26156,0.32734,1,1
2,GO REGULATION OF RNA BINDING,4.7488e-06,0.25714,0.26105,1,1
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.9803e-06,0.25613,0.20491,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.00011406,0.25471,0.32893,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00011406,0.25243,0.23107,1,1
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.012087,0.25196,0.1945,1,1
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,3.628e-05,0.24874,0.28593,1,1
2,GO PROTEIN TRIMERIZATION,4.1751e-05,0.2486,0.25112,1,1
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0011668,0.24804,0.17493,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,1.7385e-05,0.248,0.3188,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,6.4592e-06,0.24729,0.30479,1,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.6761e-05,0.2459,0.23607,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0069343,0.24568,0.19953,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0001803,0.24492,0.26205,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00040857,0.24373,0.23948,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0030839,0.24365,0.3036,1,1
2,GO ADAPTATION OF SIGNALING PATHWAY,0.00012186,0.24364,0.24908,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,4.2487e-05,0.24246,0.23771,1,1
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0013633,0.24235,0.26231,1,1
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001862,0.24011,0.23921,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00026858,0.23994,0.2434,1,1
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,8.7316e-05,0.23969,0.26576,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0012005,0.23964,0.20913,1,1
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0037016,0.23951,0.19797,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00032916,0.23846,0.17685,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,9.9844e-05,0.23769,0.26937,1,1
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.0098086,0.23758,0.18745,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.00049802,0.23732,0.2311,1,1
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00016098,0.23656,0.25068,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.00014599,0.23642,0.19933,1,1
2,GO CELL PROLIFERATION IN HINDBRAIN,0.0066851,0.2349,0.18619,1,1
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0033799,0.23419,0.22961,1,1
2,GO REGULATION OF NEURON MIGRATION,0.016752,0.23402,0.15912,1,1
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0025617,0.23311,0.21024,1,1
2,GO GTP METABOLIC PROCESS,1.5865e-05,0.23303,0.25118,1,1
2,GO REGULATION OF LYASE ACTIVITY,2.6386e-06,0.23241,0.24274,1,1
2,GO CELL PROLIFERATION IN FOREBRAIN,0.0070192,0.23227,0.19754,1,1
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0098086,0.22957,0.2459,1,1
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,9.9844e-05,0.22898,0.24981,1,1
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.00026024,0.22891,0.2047,1,1
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,3.2631e-05,0.22889,0.19397,1,1
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00082553,0.2283,0.23384,1,1
2,GO SIALYLATION,0.0018764,0.22827,0.31919,1,1
2,GO NEURON REMODELING,0.00099681,0.22782,0.21028,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,3.628e-05,0.22717,0.23483,1,1
2,GO NEURON PROJECTION ORGANIZATION,0.00016098,0.22659,0.21767,1,1
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.001071,0.22651,0.18815,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.02128,0.22552,0.19788,1,1
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0085105,0.2249,0.15102,1,1
2,GO MITOCHONDRIAL RNA PROCESSING,0.003166,0.22484,0.25964,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.0005211,0.22264,0.25862,1,1
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.013546,0.22192,0.17286,1,1
2,GO NEUROTRANSMITTER UPTAKE,0.00016361,0.22189,0.21441,1,1
2,GO L SERINE METABOLIC PROCESS,0.017699,0.2218,0.20975,1,1
2,GO HEART VALVE FORMATION,0.0037016,0.2214,0.22137,1,1
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00018923,0.2213,0.19082,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.0023009,0.22075,0.19578,1,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.027686,0.22019,0.17844,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00015583,0.21937,0.22321,1,1
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.0024609,0.21889,0.24739,1,1
2,GO ARGININE METABOLIC PROCESS,0.00075607,0.21847,0.25736,1,1
2,GO REGULATION OF TRANSLATIONAL ELONGATION,1.4207e-05,0.21821,0.20213,1,1
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,9.086e-06,0.2179,0.24969,1,1
2,GO REGULATION OF CYCLASE ACTIVITY,1.0557e-05,0.2178,0.23035,1,1
2,GO PEPTIDYL ARGININE METHYLATION,4.0314e-05,0.21778,0.22681,1,1
2,GO NAD METABOLIC PROCESS,2.1621e-05,0.21731,0.25861,1,1
2,GO TRNA MODIFICATION,1.2482e-05,0.2169,0.22901,1,1
2,GO GLUTAMATE SECRETION,0.0005789,0.21602,0.22028,1,1
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0015463,0.21554,0.31646,1,1
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0080166,0.21531,0.18125,1,1
2,GO PROTEIN OXIDATION,0.024687,0.21501,0.15555,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00010497,0.21459,0.28275,1,1
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00065224,0.21459,0.21768,1,1
2,GO VIRAL GENE EXPRESSION,0.00027284,0.21417,0.22421,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.00073415,0.21342,0.2168,1,1
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0053519,0.21277,0.1807,1,1
2,GO INNERVATION,0.036409,0.21203,0.20682,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00065224,0.21178,0.25064,1,1
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.016938,0.21143,0.22547,1,1
2,GO TRANSLATIONAL ELONGATION,6.7105e-06,0.21132,0.22018,1,1
2,GO SNORNA 3 END PROCESSING,0.00010497,0.21006,0.29692,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,7.2497e-05,0.20999,0.20405,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.017506,0.20985,0.13464,1,1
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,2.4837e-07,0.20969,0.22388,1,1
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0062877,0.20839,0.16833,1,1
2,GO ACYLGLYCEROL HOMEOSTASIS,0.011678,0.20784,0.15984,1,1
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.010895,0.207,0.21576,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0022396,0.2068,0.23321,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.018693,0.2064,0.14678,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00020178,0.20597,0.21259,1,1
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0020646,0.20575,0.19903,1,1
2,GO CHEMOSENSORY BEHAVIOR,0.00081356,0.2057,0.1754,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,3.1494e-05,0.20554,0.24621,1,1
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.015674,0.20483,0.18318,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0020929,0.20442,0.15952,1,1
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0042636,0.20442,0.20935,1,1
2,GO SYNAPTIC VESICLE PRIMING,0.0089251,0.20345,0.19905,1,1
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.001235,0.20295,0.37701,1,1
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,2.5359e-06,0.20293,0.24734,1,1
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.024428,0.20285,0.16069,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.011678,0.20243,0.18368,1,1
2,GO CGMP METABOLIC PROCESS,0.0013633,0.20087,0.26875,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0034692,0.19956,0.16117,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0047198,0.19904,0.24007,1,1
2,GO RNA SURVEILLANCE,0.0024609,0.19891,0.15915,1,1
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0037016,0.19862,0.16396,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00086244,0.19832,0.20114,1,1
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,1.6158e-05,0.19815,0.23183,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,7.2497e-05,0.19807,0.1862,1,1
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00020178,0.19801,0.22131,1,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0039481,0.19774,0.16393,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.019104,0.19764,0.16923,1,1
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.017894,0.19667,0.198,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,6.7724e-05,0.19623,0.26214,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,2.206e-06,0.19608,0.18591,1,1
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.012227,0.1955,0.1593,1,1
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0078263,0.19518,0.18449,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0098086,0.19505,0.1401,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,3.9613e-05,0.19489,0.20315,1,1
2,GO NOREPINEPHRINE TRANSPORT,0.0013069,0.1946,0.18615,1,1
2,GO TRANSLATIONAL TERMINATION,0.00017176,0.19387,0.20645,1,1
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00023294,0.19338,0.18836,1,1
2,GO NEUROBLAST DIVISION,0.017894,0.19229,0.23398,1,1
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0094686,0.19214,0.17518,1,1
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.00046165,0.19187,0.20319,1,1
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,3.4409e-05,0.1909,0.17132,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.00030449,0.19016,0.17062,1,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.012087,0.19003,0.19063,1,1
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,6.6578e-05,0.18989,0.26411,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00032408,0.18927,0.23177,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.00098255,0.18921,0.14376,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,1.8701e-05,0.18911,0.23262,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.0014022,0.18887,0.16692,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.5865e-05,0.18861,0.19056,1,1
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0017277,0.18847,0.18105,1,1
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,4.1026e-05,0.18812,0.18603,1,1
2,GO MITOCHONDRIAL TRANSLATION,0.000286,0.18796,0.20936,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,6.337e-06,0.18787,0.20308,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,2.8305e-05,0.18696,0.2083,1,1
2,GO RIBOSOME BIOGENESIS,4.2487e-05,0.18663,0.26364,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0019023,0.18637,0.16543,1,1
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0032928,0.18564,0.17966,1,1
2,GO SYNAPSE ORGANIZATION,0.0052854,0.18526,0.13892,1,1
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0015249,0.18518,0.17549,1,1
2,GO CGMP MEDIATED SIGNALING,0.0010259,0.18494,0.17521,1,1
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0047798,0.18485,0.17457,1,1
2,GO REGULATION OF GONAD DEVELOPMENT,0.0028872,0.18433,0.18319,1,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,2.1621e-05,0.18398,0.1796,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00044781,0.18396,0.22082,1,1
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0030436,0.18282,0.14816,1,1
2,GO SHORT TERM MEMORY,0.0020929,0.18224,0.32308,1,1
2,GO NEURON RECOGNITION,0.0052854,0.18111,0.18995,1,1
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.001071,0.18073,0.23911,1,1
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.028264,0.18066,0.15634,1,1
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.024173,0.18039,0.13941,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001776,0.18002,0.16134,1,1
2,GO LONG TERM SYNAPTIC DEPRESSION,0.01251,0.17986,0.16195,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.001442,0.17887,0.17342,1,1
2,GO CELL JUNCTION DISASSEMBLY,0.00024045,0.17882,0.2133,1,1
2,GO AEROBIC RESPIRATION,0.00022565,0.17857,0.15721,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0056958,0.17785,0.16269,1,1
2,GO SNORNA METABOLIC PROCESS,0.00021857,0.17754,0.28823,1,1
2,GO AMINO ACID IMPORT,0.002631,0.17753,0.20013,1,1
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0027381,0.17733,0.15467,1,1
2,GO RRNA MODIFICATION,0.001422,0.17577,0.22967,1,1
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.0020092,0.17322,0.18797,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00087508,0.17283,0.16845,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0020646,0.17238,0.23007,1,1
2,GO STRESS GRANULE ASSEMBLY,0.001568,0.17225,0.15311,1,1
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.047827,0.17218,0.12866,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.00025215,0.1715,0.16168,1,1
2,GO MITOCHONDRION LOCALIZATION,0.00086244,0.17142,0.1538,1,1
2,GO MRNA MODIFICATION,6.8888e-05,0.17139,0.24291,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.0011836,0.1713,0.1736,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,4.3997e-05,0.17059,0.17291,1,1
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,5.3256e-05,0.17,0.19665,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0034692,0.16981,0.16935,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00024045,0.16971,0.24406,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0038478,0.16949,0.17198,1,1
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.052083,0.16905,0.13206,1,1
2,GO MESODERMAL CELL FATE SPECIFICATION,0.066192,0.16892,0.13413,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.0018256,0.1686,0.18011,1,1
2,GO RRNA TRANSCRIPTION,2.2416e-05,0.16848,0.2083,1,1
2,GO POSITIVE REGULATION OF MRNA PROCESSING,6.7724e-05,0.1682,0.14583,1,1
2,GO FOLIC ACID METABOLIC PROCESS,0.0041031,0.16814,0.18869,1,1
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.00058763,0.16799,0.15834,1,1
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0002117,0.16793,0.18452,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0010259,0.16668,0.19472,1,1
2,GO WALKING BEHAVIOR,1.7071e-05,0.16663,0.25021,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.00052901,0.16611,0.14583,1,1
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0031247,0.16479,0.15617,1,1
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.012653,0.16456,0.13919,1,1
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,3.628e-05,0.16378,0.17565,1,1
2,GO REGULATION OF SPINDLE CHECKPOINT,0.0019819,0.16368,0.12402,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.00015838,0.16285,0.15181,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,0.00033432,0.16242,0.21104,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00013232,0.16213,0.15412,1,1
2,GO RRNA METABOLIC PROCESS,5.1446e-05,0.16205,0.24199,1,1
2,GO NUCLEOBASE METABOLIC PROCESS,3.2057e-05,0.1616,0.23312,1,1
2,GO POSTSYNAPSE ORGANIZATION,0.001483,0.16158,0.17584,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.0012705,0.16143,0.17759,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00017741,0.16141,0.17912,1,1
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0073682,0.1611,0.1508,1,1
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0033361,0.16042,0.18164,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.058787,0.15871,0.12185,1,1
2,GO ACIDIC AMINO ACID TRANSPORT,0.00064263,0.15852,0.16509,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0030038,0.15851,0.18027,1,1
2,GO DENDRITIC TRANSPORT,0.0045438,0.15769,0.19942,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0015249,0.15766,0.18509,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.00016361,0.15742,0.13058,1,1
2,GO L AMINO ACID TRANSPORT,0.00014129,0.15739,0.22486,1,1
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.019312,0.15605,0.12578,1,1
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00044103,0.15566,0.15215,1,1
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0012005,0.15536,0.14043,1,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,3.8924e-05,0.1548,0.14781,1,1
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0050904,0.15474,0.14471,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,0.00011218,0.15471,0.13844,1,1
2,GO CRISTAE FORMATION,0.0021798,0.15445,0.20283,1,1
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.003607,0.15437,0.1571,1,1
2,GO GLUCOSE CATABOLIC PROCESS,0.0052854,0.15364,0.18941,1,1
2,GO REGULATION OF MRNA POLYADENYLATION,0.0012177,0.15317,0.13069,1,1
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.0081133,0.15113,0.1581,1,1
2,GO RELAXATION OF MUSCLE,0.0050269,0.15081,0.15193,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,9.9844e-05,0.15036,0.19652,1,1
2,GO NADH METABOLIC PROCESS,0.00017457,0.14946,0.22397,1,1
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0029256,0.1494,0.16002,1,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.001422,0.14903,0.13656,1,1
2,GO RESPIRATORY SYSTEM PROCESS,0.00052901,0.14847,0.20819,1,1
2,GO MEMBRANE REPOLARIZATION,0.00098255,0.1481,0.1606,1,1
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.0048405,0.14783,0.15521,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00072342,0.14742,0.15044,1,1
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0059852,0.14724,0.12832,1,1
2,GO NUCLEOTIDE SALVAGE,0.009139,0.14715,0.23376,1,1
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00070238,0.1466,0.15264,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.012367,0.14638,0.14496,1,1
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.049681,0.14498,0.15044,1,1
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0066851,0.14474,0.15134,1,1
2,GO IRON COORDINATION ENTITY TRANSPORT,0.0071051,0.14471,0.15089,1,1
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.022209,0.1438,0.17565,1,1
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0052854,0.14355,0.18362,1,1
2,GO ONE CARBON METABOLIC PROCESS,0.0055559,0.14147,0.13433,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.038258,0.14111,0.11766,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0048405,0.14066,0.12362,1,1
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0089251,0.1403,0.13075,1,1
2,GO NCRNA PROCESSING,0.00010852,0.14002,0.20955,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00015331,0.13921,0.22722,1,1
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.0032928,0.13848,0.16877,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0037985,0.13796,0.14359,1,1
2,GO MITOCHONDRION DISTRIBUTION,0.0065235,0.13796,0.15282,1,1
2,GO CELLULAR RESPIRATION,0.0005133,0.1376,0.13859,1,1
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00068191,0.13746,0.16535,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.051111,0.13727,0.15844,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.051111,0.13724,0.1409,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.00070238,0.13707,0.16014,1,1
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.0063654,0.13671,0.18647,1,1
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.025743,0.1361,0.12258,1,1
2,GO RNA POLYADENYLATION,0.0017277,0.13557,0.1224,1,1
2,GO URONIC ACID METABOLIC PROCESS,0.015501,0.13534,0.099266,1,1
2,GO AMIDE BIOSYNTHETIC PROCESS,0.00018923,0.13531,0.13708,1,1
2,GO NEURON PROJECTION EXTENSION,0.0080166,0.13512,0.12698,1,1
2,GO RNA CATABOLIC PROCESS,0.00071283,0.13442,0.13328,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.00014599,0.13428,0.12807,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,8.3013e-05,0.13374,0.17173,1,1
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.023419,0.13365,0.11582,1,1
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.013394,0.13347,0.11711,1,1
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.022209,0.13318,0.13328,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00091404,0.13279,0.15509,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.036409,0.1326,0.15436,1,1
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.0023637,0.13241,0.15822,1,1
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.052575,0.13181,0.115,1,1
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.014332,0.13158,0.11902,1,1
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.039795,0.13147,0.16882,1,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0060595,0.13071,0.18321,1,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0019819,0.13047,0.12564,1,1
2,GO DNA REPLICATION INITIATION,0.0027747,0.13034,0.12515,1,1
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.035336,0.13028,0.12554,1,1
2,GO IMPORT INTO CELL,0.00025617,0.12911,0.15167,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0029256,0.12906,0.15119,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.001235,0.12859,0.14052,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0013443,0.12852,0.12146,1,1
2,GO RNA 5 END PROCESSING,0.0016347,0.12803,0.20822,1,1
2,GO HEME METABOLIC PROCESS,0.028852,0.12782,0.14261,1,1
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0042095,0.12776,0.18875,1,1
2,GO COPPER ION HOMEOSTASIS,0.043444,0.12748,0.10537,1,1
2,GO PROTEIN HETEROOLIGOMERIZATION,0.00159,0.12746,0.13155,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0025617,0.12705,0.16466,1,1
2,GO TRANSEPITHELIAL TRANSPORT,0.0028872,0.12673,0.13665,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,0.000662,0.12654,0.12694,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.01829,0.12652,0.13493,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.017506,0.12644,0.11081,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0058389,0.12629,0.13073,1,1
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.001422,0.12593,0.13192,1,1
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0049019,0.12556,0.13926,1,1
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00014599,0.12556,0.16328,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00020504,0.12531,0.14041,1,1
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.015501,0.12505,0.12645,1,1
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.014332,0.12434,0.14802,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0005133,0.12415,0.13715,1,1
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.062114,0.12355,0.106,1,1
2,GO AXON EXTENSION,0.008211,0.12322,0.13802,1,1
2,GO HYPOTONIC RESPONSE,0.028264,0.12272,0.13127,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00034485,0.1227,0.13968,1,1
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0037498,0.12238,0.15426,1,1
2,GO FOREBRAIN CELL MIGRATION,0.0083098,0.12237,0.14453,1,1
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.015501,0.12106,0.21298,1,1
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0080166,0.12022,0.16303,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.016752,0.11989,0.14062,1,1
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.002702,0.11968,0.12524,1,1
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.01251,0.11879,0.12066,1,1
2,GO ALDEHYDE CATABOLIC PROCESS,0.014332,0.11864,0.094376,1,1
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.02915,0.11793,0.15558,1,1
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0050904,0.11789,0.16175,1,1
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.032938,0.11765,0.11957,1,1
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.00055343,0.11617,0.11588,1,1
2,GO MRNA METHYLATION,0.01016,0.11601,0.16515,1,1
2,GO REGULATION OF AXONOGENESIS,0.017125,0.1153,0.1331,1,1
2,GO PROTEIN TARGETING,0.00013016,0.11516,0.12305,1,1
2,GO PYRUVATE METABOLIC PROCESS,0.014332,0.11502,0.10345,1,1
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.050154,0.11469,0.08844,1,1
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.049212,0.11332,0.10998,1,1
2,GO PEPTIDE METABOLIC PROCESS,0.00086244,0.11258,0.11838,1,1
2,GO RRNA METHYLATION,0.0089251,0.11233,0.17455,1,1
2,GO CELLULAR RESPONSE TO HEAT,0.0014624,0.11207,0.10983,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.056652,0.11206,0.089232,1,1
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.015501,0.11198,0.11348,1,1
2,GO MRNA METABOLIC PROCESS,0.00083767,0.11129,0.1039,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.05063,0.10928,0.085819,1,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.047372,0.10838,0.10907,1,1
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.00061456,0.1082,0.10966,1,1
2,GO DEVELOPMENTAL CELL GROWTH,0.018091,0.10802,0.10393,1,1
2,GO NEUROMUSCULAR PROCESS,0.0094686,0.10706,0.1284,1,1
2,GO AMINO ACID TRANSPORT,0.00020178,0.10689,0.15658,1,1
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.017315,0.10552,0.1254,1,1
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.001071,0.10534,0.13249,1,1
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.043866,0.10479,0.11672,1,1
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0019285,0.10458,0.11645,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0050904,0.10338,0.11241,1,1
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.057179,0.10222,0.079646,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.011544,0.10186,0.1032,1,1
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0076401,0.10112,0.1214,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.001704,0.10107,0.14112,1,1
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.00030928,0.10011,0.10379,1,1
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0090315,0.099828,0.086748,1,1
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0039481,0.099347,0.12326,1,1
2,GO TRNA 5 END PROCESSING,0.0025617,0.099102,0.16351,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0023637,0.09899,0.11549,1,1
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.014658,0.098576,0.10373,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.001235,0.096822,0.12739,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.010645,0.096013,0.12306,1,1
2,GO RESPONSE TO NITRIC OXIDE,0.010041,0.095731,0.087258,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.0010113,0.095097,0.089787,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,6.0079e-05,0.094692,0.13696,1,1
2,GO CARBOHYDRATE PHOSPHORYLATION,0.022686,0.094554,0.12347,1,1
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.010279,0.094137,0.13578,1,1
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0025617,0.094002,0.10309,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.01829,0.093897,0.10655,1,1
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.0044864,0.093412,0.15276,1,1
2,GO MIRNA METABOLIC PROCESS,0.016205,0.092975,0.099197,1,1
2,GO COCHLEA DEVELOPMENT,0.040187,0.092968,0.097606,1,1
2,GO DENDRITE DEVELOPMENT,0.055093,0.092096,0.097644,1,1
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0094686,0.091975,0.085293,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0062108,0.091787,0.086803,1,1
2,GO CARDIAC CONDUCTION,0.03006,0.091616,0.10899,1,1
2,GO CELLULAR RESPONSE TO PH,0.028556,0.089654,0.086785,1,1
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0067673,0.088888,0.14808,1,1
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.009139,0.088621,0.10931,1,1
2,GO ATP METABOLIC PROCESS,0.00072342,0.08862,0.10352,1,1
2,GO CELL RECOGNITION,0.0048405,0.088376,0.1049,1,1
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.011151,0.088318,0.1166,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0088198,0.087987,0.11219,1,1
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.011544,0.087903,0.13115,1,1
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.02915,0.087572,0.1105,1,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.055609,0.087268,0.072541,1,1
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.056652,0.087028,0.083585,1,1
2,GO REGULATION OF MRNA PROCESSING,0.043025,0.086797,0.068425,1,1
2,GO SNRNA PROCESSING,0.047827,0.085568,0.085866,1,1
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.020166,0.084128,0.12746,1,1
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0030436,0.083811,0.09318,1,1
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.043444,0.083387,0.07961,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.0052854,0.082565,0.10093,1,1
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.0020367,0.08019,0.10105,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0087156,0.080009,0.088786,1,1
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.0090315,0.079687,0.10643,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.010279,0.077634,0.10855,1,1
2,GO PROTEIN NEDDYLATION,0.024173,0.076908,0.090326,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0021215,0.074556,0.11519,1,1
2,GO PHOSPHATE ION TRANSPORT,0.041383,0.073634,0.072994,1,1
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0014022,0.07192,0.11766,1,1
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.017699,0.071919,0.092564,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.022928,0.069693,0.076584,1,1
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.01829,0.068501,0.069755,1,1
2,GO REGULATION OF METAL ION TRANSPORT,0.056128,0.06738,0.071653,1,1
2,GO PROTEIN TETRAMERIZATION,0.0045438,0.067255,0.098046,1,1
2,GO REGULATION OF CELL SIZE,0.053071,0.066272,0.087243,1,1
2,GO SKELETAL MUSCLE CONTRACTION,0.026561,0.065419,0.12879,1,1
2,GO MRNA PROCESSING,0.028852,0.064901,0.069323,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.046921,0.063684,0.072094,1,1
2,GO REGULATION OF PROTEIN TARGETING,0.022209,0.062082,0.087333,1,1
2,GO RNA CAPPING,0.010522,0.058538,0.082266,1,1
2,GO RESPONSE TO HEAT,0.025743,0.054667,0.07904,1,1
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.016386,0.050861,0.078086,1,1
2,GO PROTEIN HOMOOLIGOMERIZATION,0.019104,0.045772,0.074334,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,2.1234e-05,1.049,0.94726,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,1.5014e-05,0.88439,0.8484,1,1
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,4.2444e-07,0.7549,0.84069,1,1
3,GO HISTAMINE SECRETION,7.4854e-10,0.68516,0.6429,1,1
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00042128,0.67745,0.49261,1,1
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.1588e-05,0.66462,0.75274,1,1
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,3.7282e-08,0.63417,0.66156,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.9309e-10,0.62784,0.58289,1,1
3,GO TOLERANCE INDUCTION,2.2505e-06,0.62759,0.52604,1,1
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,1.6514e-08,0.61034,0.54492,1,1
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,1.069e-09,0.60984,0.57463,1,1
3,GO HISTAMINE TRANSPORT,1.9905e-10,0.59743,0.60076,1,1
3,GO RESPONSE TO TYPE I INTERFERON,4.1552e-07,0.59233,0.5188,1,1
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,3.357e-07,0.57263,0.52751,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00098255,0.558,0.40109,1,1
3,GO DETECTION OF OTHER ORGANISM,1.7154e-07,0.55236,0.52498,1,1
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,6.5837e-06,0.54528,0.41352,1,1
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,3.3435e-06,0.54141,0.5254,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,5.2445e-07,0.53695,0.49695,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,9.819e-05,0.53469,0.47162,1,1
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.3196e-05,0.52869,0.43891,1,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.8161e-07,0.51833,0.49374,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00016901,0.51777,0.41288,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,3.7605e-06,0.51533,0.50213,1,1
3,GO REGULATION OF MICROVILLUS ORGANIZATION,1.7706e-05,0.51365,0.43494,1,1
3,GO NEGATIVE REGULATION OF ANOIKIS,2.2397e-08,0.51046,0.60356,1,1
3,GO MUCUS SECRETION,3.9613e-05,0.50716,0.48205,1,1
3,GO O GLYCAN PROCESSING,1.3376e-10,0.50623,0.49179,1,1
3,GO REGULATION OF PLATELET AGGREGATION,9.2321e-08,0.50519,0.49581,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00081356,0.50369,0.49591,1,1
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00010323,0.50341,0.41339,1,1
3,GO RENAL ABSORPTION,2.0776e-06,0.50196,0.46797,1,1
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0039481,0.49425,0.29509,1,1
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,7.8976e-09,0.48917,0.48949,1,1
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,1.8793e-06,0.48623,0.43498,1,1
3,GO T CELL MEDIATED CYTOTOXICITY,1.5576e-05,0.47838,0.42708,1,1
3,GO DOPAMINE BIOSYNTHETIC PROCESS,1.5037e-07,0.47832,0.55729,1,1
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,1.5052e-06,0.47809,0.51218,1,1
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.0004e-06,0.47458,0.47119,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,3.3435e-06,0.47135,0.4555,1,1
3,GO RESPONSE TO INTERFERON BETA,7.5001e-05,0.46907,0.42064,1,1
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.1535e-07,0.46827,0.56686,1,1
3,GO REGULATION OF PLATELET ACTIVATION,1.7534e-07,0.46464,0.4173,1,1
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,9.2321e-08,0.45931,0.43359,1,1
3,GO IMMUNOLOGICAL MEMORY PROCESS,1.0791e-07,0.45912,0.42231,1,1
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,5.6487e-06,0.45849,0.41819,1,1
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.6994e-06,0.45844,0.37123,1,1
3,GO POSITIVE REGULATION OF CELL MATURATION,2.3274e-07,0.4578,0.4091,1,1
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,5.4184e-05,0.452,0.43642,1,1
3,GO SPHINGOMYELIN METABOLIC PROCESS,2.7e-09,0.45055,0.42708,1,1
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.00015331,0.44722,0.3753,1,1
3,GO NEURONAL ACTION POTENTIAL,3.1004e-08,0.44608,0.4594,1,1
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.00037835,0.44479,0.3697,1,1
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,1.6062e-07,0.44338,0.50991,1,1
3,GO LIPOXYGENASE PATHWAY,7.0072e-05,0.44305,0.40623,1,1
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.5052e-06,0.44298,0.39981,1,1
3,GO TOXIN METABOLIC PROCESS,1.0161e-09,0.44203,0.4758,1,1
3,GO GERMINAL CENTER FORMATION,9.404e-07,0.44155,0.44167,1,1
3,GO HEPATOCYTE APOPTOTIC PROCESS,2.7452e-06,0.43898,0.45964,1,1
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,3.247e-08,0.43884,0.44731,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,4.8198e-07,0.43703,0.41707,1,1
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.8318e-07,0.43498,0.50449,1,1
3,GO DENDRITIC CELL DIFFERENTIATION,2.8001e-06,0.43354,0.3791,1,1
3,GO REGULATION OF VASCULOGENESIS,2.8271e-07,0.43219,0.43127,1,1
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,7.6446e-07,0.42971,0.40084,1,1
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0005056,0.42888,0.37369,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,5.8262e-07,0.42706,0.40658,1,1
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,2.5868e-06,0.42587,0.47906,1,1
3,GO REGULATION OF WATER LOSS VIA SKIN,1.0094e-07,0.42191,0.43246,1,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.7385e-05,0.42053,0.39234,1,1
3,GO RESPONSE TO IMMOBILIZATION STRESS,2.6981e-08,0.4202,0.40587,1,1
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,6.1119e-05,0.41728,0.37311,1,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,1.0212e-06,0.41716,0.40244,1,1
3,GO RESPONSE TO INTERFERON ALPHA,0.0014624,0.41694,0.34875,1,1
3,GO RESPONSE TO PAIN,1.3419e-09,0.41661,0.42497,1,1
3,GO LABYRINTHINE LAYER MORPHOGENESIS,2.6914e-06,0.41645,0.44717,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,5.0563e-05,0.41587,0.35925,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,2.6352e-05,0.41571,0.348,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.6158e-05,0.41475,0.35937,1,1
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.188e-08,0.41355,0.49177,1,1
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,5.9498e-07,0.41272,0.46165,1,1
3,GO DNA DEAMINATION,7.5001e-05,0.4127,0.3653,1,1
3,GO RESPONSE TO MAGNESIUM ION,6.6066e-07,0.41075,0.43186,1,1
3,GO INTESTINAL ABSORPTION,2.3467e-08,0.40957,0.46589,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,2.3239e-05,0.40829,0.34787,1,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,2.0429e-07,0.40823,0.36664,1,1
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,9.086e-06,0.4073,0.37936,1,1
3,GO REGULATION OF ANOIKIS,4.4787e-08,0.40653,0.45717,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,5.2344e-05,0.40647,0.37569,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,2.0478e-05,0.40606,0.35906,1,1
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,1.7534e-07,0.40522,0.4342,1,1
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,1.9044e-05,0.40418,0.38382,1,1
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.0756e-05,0.4041,0.42006,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,3.0156e-07,0.40195,0.36733,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,5.3562e-07,0.3985,0.35187,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.2057e-05,0.39697,0.32163,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0002117,0.39679,0.36973,1,1
3,GO TYPE B PANCREATIC CELL PROLIFERATION,4.8416e-06,0.39509,0.42255,1,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,1.9175e-06,0.39486,0.45014,1,1
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,5.6085e-05,0.39423,0.37633,1,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,6.1119e-05,0.394,0.2984,1,1
3,GO ANTIBACTERIAL HUMORAL RESPONSE,2.5934e-07,0.39295,0.33905,1,1
3,GO GALACTOSE METABOLIC PROCESS,2.4528e-05,0.39257,0.3475,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,2.6828e-05,0.39191,0.37609,1,1
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,4.4807e-06,0.39149,0.37632,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00014839,0.39102,0.40271,1,1
3,GO MEMBRANE LIPID CATABOLIC PROCESS,2.0879e-07,0.39074,0.37405,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.971e-06,0.39047,0.43079,1,1
3,GO CELLULAR DEFENSE RESPONSE,1.6418e-07,0.39039,0.31907,1,1
3,GO ADHESION OF SYMBIONT TO HOST,1.155e-06,0.39039,0.43875,1,1
3,GO MICROVILLUS ORGANIZATION,1.6654e-06,0.38967,0.37536,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,1.3196e-05,0.38907,0.35831,1,1
3,GO FRUCTOSE METABOLIC PROCESS,0.0022095,0.38836,0.34315,1,1
3,GO REGULATORY T CELL DIFFERENTIATION,7.6446e-07,0.38699,0.36198,1,1
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,4.3997e-05,0.38594,0.39625,1,1
3,GO ALPHA BETA T CELL PROLIFERATION,1.4163e-06,0.38496,0.34387,1,1
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00053704,0.38446,0.329,1,1
3,GO VITAMIN D METABOLIC PROCESS,1.2792e-06,0.38247,0.36403,1,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.5865e-05,0.38246,0.31887,1,1
3,GO RESPONSE TO COLD,2.5223e-10,0.38225,0.37821,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,6.8888e-05,0.38139,0.32262,1,1
3,GO GLYCOLIPID CATABOLIC PROCESS,1.2027e-05,0.38098,0.41403,1,1
3,GO DENDRITIC CELL APOPTOTIC PROCESS,3.9613e-05,0.37918,0.36227,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.0169e-05,0.37742,0.36895,1,1
3,GO REGULATION OF TISSUE REMODELING,3.9941e-08,0.37545,0.33997,1,1
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00024045,0.3744,0.34288,1,1
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,2.0429e-07,0.37407,0.42902,1,1
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00095459,0.37395,0.31225,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,4.0657e-06,0.37294,0.48898,1,1
3,GO PROTEIN O LINKED GLYCOSYLATION,4.1403e-10,0.37203,0.36378,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,1.8419e-06,0.37072,0.45327,1,1
3,GO RESPONSE TO DIETARY EXCESS,7.5451e-08,0.36936,0.39988,1,1
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.00010497,0.36886,0.3181,1,1
3,GO EOSINOPHIL MIGRATION,1.6158e-05,0.36854,0.36349,1,1
3,GO MATURE B CELL DIFFERENTIATION,3.6924e-05,0.36841,0.3152,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,1.9044e-05,0.36841,0.32832,1,1
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00029052,0.36704,0.36935,1,1
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,1.2027e-05,0.3667,0.38355,1,1
3,GO IMMUNOGLOBULIN SECRETION,4.9361e-06,0.3645,0.31072,1,1
3,GO REVERSE CHOLESTEROL TRANSPORT,0.00022208,0.36424,0.38892,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,4.3997e-05,0.36397,0.33643,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,1.3056e-06,0.36368,0.38324,1,1
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,5.8856e-08,0.36363,0.33456,1,1
3,GO EOSINOPHIL CHEMOTAXIS,7.5217e-06,0.36235,0.38618,1,1
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,6.1583e-08,0.36215,0.38815,1,1
3,GO CELLULAR RESPONSE TO COPPER ION,0.0066039,0.35875,0.34673,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.4592e-06,0.35651,0.32249,1,1
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,2.0853e-05,0.35522,0.38947,1,1
3,GO REGULATION OF BONE REMODELING,2.6362e-08,0.35326,0.3617,1,1
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,2.4371e-06,0.35304,0.42498,1,1
3,GO SUPEROXIDE ANION GENERATION,9.6129e-06,0.35289,0.31851,1,1
3,GO ACTIN FILAMENT NETWORK FORMATION,0.00031414,0.35279,0.31758,1,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,1.8363e-05,0.35267,0.32352,1,1
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.046031,0.35188,0.18157,1,1
3,GO LIPID TRANSLOCATION,1.7721e-08,0.35187,0.34136,1,1
3,GO AMMONIUM ION METABOLIC PROCESS,3.8118e-09,0.35133,0.43818,1,1
3,GO KERATAN SULFATE CATABOLIC PROCESS,6.4341e-05,0.35062,0.33189,1,1
3,GO NEUROTRANSMITTER METABOLIC PROCESS,8.6579e-07,0.34987,0.31354,1,1
3,GO RELAXATION OF CARDIAC MUSCLE,4.3946e-06,0.34816,0.34981,1,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,9.0235e-07,0.34708,0.2971,1,1
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0046018,0.34673,0.2624,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,5.0323e-06,0.34656,0.357,1,1
3,GO PROTEIN DEGLYCOSYLATION,2.4371e-06,0.34623,0.29999,1,1
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.00030928,0.34515,0.2949,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,9.5999e-07,0.34453,0.38305,1,1
3,GO RESPONSE TO EPINEPHRINE,7.9617e-06,0.34407,0.39324,1,1
3,GO B CELL APOPTOTIC PROCESS,1.9014e-08,0.34355,0.36811,1,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,9.086e-06,0.34296,0.28366,1,1
3,GO CORTICOSTEROID HORMONE SECRETION,7.6283e-05,0.3421,0.31827,1,1
3,GO CORNIFICATION,8.5867e-06,0.34118,0.31106,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,1.7385e-05,0.34085,0.31803,1,1
3,GO MYELIN MAINTENANCE,3.094e-05,0.34076,0.38285,1,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,1.7706e-05,0.33971,0.34835,1,1
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,3.9102e-06,0.33967,0.40037,1,1
3,GO CERAMIDE CATABOLIC PROCESS,6.6578e-05,0.33902,0.34421,1,1
3,GO MEMBRANE RAFT ORGANIZATION,0.00061456,0.33836,0.3102,1,1
3,GO GAP JUNCTION ASSEMBLY,0.0001803,0.33673,0.29726,1,1
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,1.3878e-06,0.33615,0.28195,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.2139e-09,0.33441,0.37601,1,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,9.2321e-08,0.3341,0.3079,1,1
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.719e-07,0.33403,0.30917,1,1
3,GO ZYMOGEN ACTIVATION,1.3196e-05,0.33357,0.33459,1,1
3,GO TISSUE REMODELING,6.6066e-07,0.3331,0.28378,1,1
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,1.3468e-07,0.33281,0.34768,1,1
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,3.8246e-05,0.33263,0.30128,1,1
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.1165e-05,0.33047,0.3491,1,1
3,GO AMINE BIOSYNTHETIC PROCESS,1.9064e-09,0.33027,0.36656,1,1
3,GO POSITIVE REGULATION OF WOUND HEALING,1.0791e-07,0.33,0.35456,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0024281,0.32977,0.24238,1,1
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,7.8911e-05,0.32949,0.35259,1,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,1.0756e-05,0.32887,0.34674,1,1
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00017457,0.32878,0.35354,1,1
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00013673,0.32864,0.26281,1,1
3,GO INTERLEUKIN 10 PRODUCTION,6.8396e-06,0.32822,0.27209,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,5.7582e-06,0.32799,0.30147,1,1
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.064e-06,0.32649,0.33803,1,1
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00016629,0.32595,0.33769,1,1
3,GO RESPONSE TO INTERFERON GAMMA,1.0557e-05,0.32557,0.31556,1,1
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,1.0861e-06,0.32489,0.29687,1,1
3,GO CELLULAR RESPONSE TO INTERFERON BETA,8.1138e-06,0.32484,0.33018,1,1
3,GO KERATINIZATION,1.4454e-06,0.32446,0.30176,1,1
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00020504,0.32333,0.34569,1,1
3,GO BONE RESORPTION,7.892e-08,0.32301,0.30957,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0012886,0.32295,0.24725,1,1
3,GO RESPONSE TO NITROSATIVE STRESS,6.1119e-05,0.3226,0.28448,1,1
3,GO RESPONSE TO MUSCLE STRETCH,2.1196e-06,0.32171,0.40633,1,1
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00047589,0.3217,0.30373,1,1
3,GO BILE ACID AND BILE SALT TRANSPORT,0.00013016,0.32146,0.36001,1,1
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0001179,0.32131,0.24583,1,1
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.0395e-05,0.32112,0.30561,1,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,7.8911e-05,0.32085,0.34186,1,1
3,GO OPTIC NERVE DEVELOPMENT,2.3661e-05,0.32013,0.33534,1,1
3,GO MITOCHONDRIAL DEPOLARIZATION,1.4334e-08,0.31967,0.3296,1,1
3,GO KERATINOCYTE DEVELOPMENT,0.00029052,0.31885,0.34544,1,1
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,7.6657e-06,0.31802,0.33169,1,1
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,1.5674e-06,0.31777,0.28786,1,1
3,GO REGULATION OF NEURON MATURATION,7.3803e-06,0.31607,0.28705,1,1
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.5372e-07,0.31565,0.32256,1,1
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.0026663,0.31521,0.22735,1,1
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,6.2175e-05,0.31451,0.29536,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0062108,0.31436,0.24232,1,1
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.6321e-06,0.31387,0.28512,1,1
3,GO BEHAVIORAL RESPONSE TO PAIN,0.00011406,0.31385,0.31058,1,1
3,GO MAST CELL ACTIVATION,3.4296e-07,0.31332,0.3119,1,1
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00025215,0.3126,0.30568,1,1
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.4972e-05,0.31213,0.24302,1,1
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.4305e-07,0.31181,0.28493,1,1
3,GO RESPONSE TO WATER,2.3891e-06,0.31157,0.32443,1,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00013232,0.31117,0.28447,1,1
3,GO GLIAL CELL FATE COMMITMENT,0.0067673,0.31072,0.29051,1,1
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0025277,0.31046,0.25317,1,1
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00030449,0.31011,0.38482,1,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.014823,0.31004,0.22115,1,1
3,GO MAGNESIUM ION TRANSPORT,1.5372e-07,0.30951,0.322,1,1
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,2.4091e-05,0.30871,0.258,1,1
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,2.9332e-05,0.3085,0.30322,1,1
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00017176,0.30752,0.30383,1,1
3,GO MAST CELL MEDIATED IMMUNITY,7.105e-06,0.30743,0.28303,1,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,5.5412e-06,0.30723,0.27769,1,1
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,3.1479e-07,0.30722,0.31451,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,1.8032e-05,0.30689,0.26626,1,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,1.734e-06,0.30686,0.34773,1,1
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.2057e-05,0.30632,0.28417,1,1
3,GO DETERMINATION OF ADULT LIFESPAN,4.0657e-06,0.30606,0.29804,1,1
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,3.2784e-06,0.3046,0.26084,1,1
3,GO RESPONSE TO INTERLEUKIN 18,0.0012886,0.30439,0.31594,1,1
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,4.0657e-06,0.30399,0.31638,1,1
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,1.2733e-08,0.30384,0.31291,1,1
3,GO BONE REMODELING,3.2162e-07,0.30355,0.31041,1,1
3,GO REGULATION OF B CELL PROLIFERATION,2.7078e-07,0.30335,0.29718,1,1
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00053704,0.30211,0.31216,1,1
3,GO RESPONSE TO COPPER ION,3.3214e-05,0.30199,0.36097,1,1
3,GO N GLYCAN PROCESSING,4.7172e-05,0.30191,0.32526,1,1
3,GO NEGATIVE REGULATION OF COAGULATION,0.00067188,0.30189,0.24884,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.4972e-05,0.30163,0.2455,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,5.0323e-06,0.30158,0.29691,1,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,2.011e-05,0.30157,0.3028,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,2.0478e-05,0.30142,0.24341,1,1
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,4.1456e-06,0.30061,0.28845,1,1
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0020646,0.30022,0.27657,1,1
3,GO HOMOTYPIC CELL CELL ADHESION,8.8389e-07,0.30011,0.30385,1,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,1.5014e-05,0.29989,0.24414,1,1
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0020929,0.29969,0.27131,1,1
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0016575,0.29968,0.20985,1,1
3,GO LEYDIG CELL DIFFERENTIATION,0.00013899,0.29821,0.3497,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.8924e-05,0.29813,0.26367,1,1
3,GO DETECTION OF BIOTIC STIMULUS,0.00013232,0.2979,0.28544,1,1
3,GO ANOIKIS,1.471e-07,0.29781,0.34798,1,1
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,8.4805e-07,0.29766,0.32758,1,1
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00030928,0.29748,0.2172,1,1
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,2.8305e-05,0.2973,0.28513,1,1
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0001179,0.29723,0.26625,1,1
3,GO NEGATIVE REGULATION OF BONE REMODELING,3.2146e-06,0.29715,0.387,1,1
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.2253e-05,0.29714,0.28628,1,1
3,GO PLASMA MEMBRANE FUSION,6.8888e-05,0.29683,0.29465,1,1
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,5.9056e-05,0.29656,0.31383,1,1
3,GO MICROVILLUS ASSEMBLY,0.0010865,0.29644,0.25662,1,1
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0066039,0.29638,0.23693,1,1
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.4334e-08,0.29586,0.2919,1,1
3,GO ENDOTHELIAL CELL CHEMOTAXIS,5.2303e-06,0.295,0.35129,1,1
3,GO MACROPHAGE CYTOKINE PRODUCTION,4.4771e-05,0.295,0.35955,1,1
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,2.188e-08,0.29485,0.33328,1,1
3,GO REGULATION OF CELL KILLING,8.7502e-06,0.29472,0.26822,1,1
3,GO KERATAN SULFATE METABOLIC PROCESS,1.9563e-06,0.29444,0.28303,1,1
3,GO INTERLEUKIN 12 PRODUCTION,1.1316e-06,0.29402,0.27754,1,1
3,GO ACTIN FILAMENT SEVERING,0.00080175,0.294,0.26977,1,1
3,GO STEROID HORMONE SECRETION,0.00011218,0.29341,0.26583,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.4409e-05,0.29309,0.24805,1,1
3,GO INDOLALKYLAMINE METABOLIC PROCESS,5.9498e-07,0.29309,0.36987,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00040857,0.29272,0.2446,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,6.0079e-05,0.29265,0.2562,1,1
3,GO T CELL EXTRAVASATION,0.0038478,0.29263,0.25681,1,1
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,8.8796e-05,0.29254,0.27791,1,1
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,1.7071e-05,0.29238,0.29115,1,1
3,GO B CELL PROLIFERATION,1.6654e-06,0.2916,0.2478,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.6782e-07,0.29131,0.33684,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00062378,0.29098,0.22826,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,7.6283e-05,0.29094,0.28944,1,1
3,GO SEQUESTERING OF ACTIN MONOMERS,0.0037016,0.29091,0.22746,1,1
3,GO CATECHOLAMINE UPTAKE,6.2175e-05,0.29035,0.30171,1,1
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.011678,0.28977,0.22095,1,1
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,1.5052e-06,0.28975,0.26839,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00014129,0.28975,0.31368,1,1
3,GO APICAL JUNCTION ASSEMBLY,5.3562e-07,0.28975,0.28498,1,1
3,GO ADRENAL GLAND DEVELOPMENT,1.4472e-05,0.28903,0.32768,1,1
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,1.6654e-06,0.28878,0.42121,1,1
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,7.333e-07,0.28843,0.31636,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,9.5999e-07,0.28836,0.27969,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,1.1165e-05,0.28814,0.25289,1,1
3,GO LUNG ALVEOLUS DEVELOPMENT,5.8262e-07,0.28778,0.28423,1,1
3,GO OSTEOBLAST PROLIFERATION,4.3236e-05,0.2872,0.27044,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00018323,0.28713,0.27331,1,1
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0075485,0.28687,0.24621,1,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.8793e-06,0.28679,0.25402,1,1
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,1.8419e-06,0.28667,0.34152,1,1
3,GO REGULATION OF INTEGRIN ACTIVATION,3.9941e-08,0.28651,0.34173,1,1
3,GO OLIGODENDROCYTE DEVELOPMENT,4.3946e-06,0.2865,0.2564,1,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,1.2534e-06,0.28608,0.2862,1,1
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0020646,0.286,0.26041,1,1
3,GO REGULATION OF DENDRITE EXTENSION,2.5884e-05,0.28585,0.31127,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00037835,0.28584,0.23911,1,1
3,GO REGULATION OF EXOSOMAL SECRETION,2.4305e-07,0.28567,0.30512,1,1
3,GO NOTCH RECEPTOR PROCESSING,0.00048316,0.28516,0.30013,1,1
3,GO VASODILATION,2.5868e-06,0.28473,0.2908,1,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00055343,0.2847,0.2464,1,1
3,GO FOAM CELL DIFFERENTIATION,1.9563e-06,0.2846,0.31627,1,1
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.01829,0.28432,0.22303,1,1
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.3693e-05,0.28426,0.27292,1,1
3,GO PHAGOLYSOSOME ASSEMBLY,8.9166e-06,0.28423,0.33951,1,1
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0044298,0.28355,0.22528,1,1
3,GO BLOOD VESSEL REMODELING,5.4184e-05,0.28331,0.2478,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,3.6162e-06,0.28295,0.25414,1,1
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.00012186,0.28208,0.23976,1,1
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.3878e-06,0.28201,0.35875,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00012594,0.28159,0.22989,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,8.2543e-08,0.28144,0.26386,1,1
3,GO SENSORY PERCEPTION OF SMELL,3.357e-07,0.28135,0.27789,1,1
3,GO RESPONSE TO ACIDIC PH,0.00014599,0.28063,0.28592,1,1
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,2.913e-06,0.28026,0.26508,1,1
3,GO STEROID ESTERIFICATION,7.3739e-05,0.28021,0.41053,1,1
3,GO DOPAMINE TRANSPORT,1.1588e-05,0.2799,0.35477,1,1
3,GO RESPONSE TO INTERLEUKIN 15,0.00014839,0.27988,0.25065,1,1
3,GO REGULATION OF RESPIRATORY BURST,8.1361e-07,0.27987,0.32087,1,1
3,GO REGULATION OF VIRAL LIFE CYCLE,6.4592e-06,0.27981,0.26885,1,1
3,GO REGULATION OF ICOSANOID SECRETION,3.5606e-08,0.2798,0.2957,1,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,2.011e-05,0.27978,0.2248,1,1
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0005133,0.27972,0.24796,1,1
3,GO RESPONSE TO LITHIUM ION,7.4873e-07,0.27969,0.35018,1,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,3.9872e-06,0.27951,0.29484,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0001803,0.27921,0.21472,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,1.9175e-06,0.27885,0.2717,1,1
3,GO TRANSPOSITION,1.9749e-05,0.27882,0.32132,1,1
3,GO REGULATION OF ACROSOME REACTION,0.00045468,0.2788,0.23381,1,1
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,1.2534e-06,0.2784,0.27668,1,1
3,GO LUNG CELL DIFFERENTIATION,9.6562e-05,0.27784,0.33389,1,1
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00075607,0.2778,0.22514,1,1
3,GO STEROL HOMEOSTASIS,3.5022e-05,0.2777,0.2208,1,1
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00098255,0.27765,0.23258,1,1
3,GO ACUTE INFLAMMATORY RESPONSE,7.0337e-07,0.27753,0.273,1,1
3,GO HYALURONAN BIOSYNTHETIC PROCESS,9.086e-06,0.27704,0.26274,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,3.3435e-06,0.27692,0.2976,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0013255,0.27691,0.21852,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,3.1494e-05,0.27673,0.25801,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,6.337e-06,0.27668,0.27389,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,6.7724e-05,0.27648,0.2572,1,1
3,GO REGULATION OF COAGULATION,3.6924e-05,0.27645,0.27035,1,1
3,GO INTERLEUKIN 8 PRODUCTION,4.5558e-05,0.27639,0.23506,1,1
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00010852,0.27637,0.24619,1,1
3,GO REGULATION OF MYOBLAST FUSION,1.0361e-05,0.27622,0.30985,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,9.1829e-05,0.27587,0.24215,1,1
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0057669,0.27575,0.19513,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,7.3803e-06,0.27562,0.31661,1,1
3,GO REGULATION OF ORGANIC ACID TRANSPORT,4.31e-06,0.27561,0.23043,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00011033,0.27539,0.22913,1,1
3,GO T CELL MEDIATED IMMUNITY,3.758e-05,0.27532,0.25463,1,1
3,GO CELL KILLING,2.206e-06,0.27522,0.24025,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,2.4091e-05,0.27518,0.22463,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,4.0657e-06,0.27492,0.28511,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0020929,0.27486,0.31911,1,1
3,GO HYPOTHALAMUS DEVELOPMENT,3.8924e-05,0.27423,0.2531,1,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00054518,0.27319,0.22083,1,1
3,GO FUCOSE METABOLIC PROCESS,0.00020504,0.27294,0.23731,1,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,1.0756e-05,0.27258,0.24315,1,1
3,GO EPITHELIAL CELL CELL ADHESION,0.0092477,0.27254,0.22381,1,1
3,GO DETECTION OF CALCIUM ION,9.4341e-06,0.2725,0.34875,1,1
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0031247,0.27239,0.21012,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,1.9393e-05,0.27163,0.238,1,1
3,GO EPITHELIAL CELL MORPHOGENESIS,0.00019229,0.27152,0.33291,1,1
3,GO PROTEIN DEMANNOSYLATION,2.0364e-06,0.27142,0.30334,1,1
3,GO GLYCOSYLATION,7.3476e-09,0.27123,0.26095,1,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,1.7071e-05,0.27111,0.26392,1,1
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.00039622,0.2711,0.27985,1,1
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.0169e-05,0.27098,0.36629,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0053519,0.27043,0.21114,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,1.155e-06,0.27007,0.31105,1,1
3,GO POSITIVE REGULATION OF HEART RATE,7.105e-06,0.26971,0.28859,1,1
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00030928,0.26968,0.24363,1,1
3,GO DEFENSE RESPONSE TO VIRUS,3.094e-05,0.26953,0.23571,1,1
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0042636,0.26904,0.21303,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.0395e-05,0.26904,0.26012,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,2.2015e-05,0.26839,0.23987,1,1
3,GO RESPONSE TO FORSKOLIN,0.0042095,0.26836,0.22368,1,1
3,GO REGULATION OF B CELL ACTIVATION,1.4454e-06,0.2676,0.23201,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00031907,0.26757,0.26684,1,1
3,GO REGULATION OF MAST CELL ACTIVATION,3.2631e-05,0.2674,0.25178,1,1
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,5.2445e-07,0.26718,0.273,1,1
3,GO ANTIMICROBIAL HUMORAL RESPONSE,4.9228e-07,0.26697,0.22933,1,1
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.0021215,0.26666,0.27554,1,1
3,GO VITAMIN D BIOSYNTHETIC PROCESS,4.3236e-05,0.26631,0.31302,1,1
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,8.0256e-05,0.26598,0.34765,1,1
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00010852,0.26579,0.22981,1,1
3,GO DOPAMINE METABOLIC PROCESS,1.6654e-06,0.26561,0.29844,1,1
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,2.4091e-05,0.26547,0.26349,1,1
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,4.2487e-05,0.26544,0.27135,1,1
3,GO VIRAL GENOME REPLICATION,1.9044e-05,0.2654,0.22989,1,1
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.8793e-06,0.26509,0.25828,1,1
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,7.9617e-06,0.26505,0.29558,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.0557e-05,0.26453,0.20942,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00029511,0.26421,0.25891,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.2482e-05,0.26416,0.28293,1,1
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00030928,0.26394,0.24613,1,1
3,GO RESPONSE TO STEROL DEPLETION,6.2046e-07,0.26383,0.31659,1,1
3,GO ENTRY INTO HOST,0.00015583,0.26338,0.22693,1,1
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,8.4424e-05,0.26324,0.32242,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.000662,0.26244,0.23791,1,1
3,GO DIOL METABOLIC PROCESS,2.6386e-06,0.26165,0.28131,1,1
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.0958e-05,0.26149,0.27208,1,1
3,GO CHEMOKINE PRODUCTION,0.00011406,0.26147,0.21954,1,1
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,3.6162e-06,0.26137,0.2374,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,1.9749e-05,0.26136,0.2739,1,1
3,GO REGULATION OF CELL PROJECTION SIZE,0.000286,0.26109,0.26502,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,6.9711e-06,0.26078,0.26858,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,9.3381e-05,0.26031,0.24551,1,1
3,GO RESPIRATORY BURST,7.3739e-05,0.26025,0.24381,1,1
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,8.3013e-05,0.26007,0.28203,1,1
3,GO DORSAL AORTA DEVELOPMENT,0.0016122,0.26004,0.22171,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.011151,0.25973,0.21562,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,5.7051e-07,0.25918,0.24251,1,1
3,GO EMBRYONIC PLACENTA DEVELOPMENT,2.4091e-05,0.25901,0.22301,1,1
3,GO B CELL MEDIATED IMMUNITY,2.7804e-05,0.25879,0.26237,1,1
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,3.6162e-06,0.25874,0.31739,1,1
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,2.206e-06,0.25857,0.22416,1,1
3,GO B CELL HOMEOSTASIS,2.9859e-05,0.25829,0.22813,1,1
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,3.3806e-05,0.2582,0.24594,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00039018,0.25771,0.26087,1,1
3,GO REGULATION OF PROTEIN GLYCOSYLATION,3.3806e-05,0.25757,0.31819,1,1
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0047198,0.25718,0.16792,1,1
3,GO THYMOCYTE APOPTOTIC PROCESS,0.001955,0.25716,0.19593,1,1
3,GO INNATE IMMUNE RESPONSE,3.6877e-06,0.25679,0.21914,1,1
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,8.2686e-06,0.25657,0.22497,1,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,6.7461e-07,0.25641,0.23572,1,1
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,1.2253e-05,0.25623,0.22648,1,1
3,GO POSITIVE REGULATION OF COAGULATION,0.00036124,0.2562,0.2427,1,1
3,GO INTERLEUKIN 13 PRODUCTION,0.021509,0.25578,0.18804,1,1
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,5.7059e-05,0.25577,0.25815,1,1
3,GO LEUKOTRIENE METABOLIC PROCESS,0.00013899,0.25547,0.22109,1,1
3,GO REGULATION OF CELL CELL ADHESION,6.7724e-05,0.25547,0.19194,1,1
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00012388,0.25501,0.25986,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,3.5646e-05,0.25471,0.32801,1,1
3,GO PEPTIDYL ASPARAGINE MODIFICATION,3.2631e-05,0.25451,0.21439,1,1
3,GO INTERLEUKIN 6 PRODUCTION,3.152e-06,0.25434,0.21638,1,1
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,2.9332e-05,0.25413,0.30933,1,1
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00012388,0.25408,0.23384,1,1
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0073682,0.25372,0.21842,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.2534e-06,0.25358,0.25103,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION,3.8924e-05,0.2535,0.21191,1,1
3,GO MYOBLAST FUSION,3.3214e-05,0.25335,0.26277,1,1
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.5359e-06,0.25324,0.26456,1,1
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0048405,0.25302,0.19566,1,1
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00032408,0.25225,0.20823,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,4.4771e-05,0.25213,0.24175,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0085105,0.2518,0.14415,1,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00024045,0.25162,0.18027,1,1
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2954e-05,0.25155,0.21421,1,1
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,3.9822e-07,0.25144,0.25793,1,1
3,GO PROGRAMMED NECROTIC CELL DEATH,2.342e-06,0.25141,0.24642,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00033955,0.25136,0.20148,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,1.3442e-05,0.25136,0.23135,1,1
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0022701,0.25136,0.21567,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,4.1456e-06,0.25126,0.22647,1,1
3,GO RESPONSE TO TUMOR CELL,0.00028155,0.25121,0.27844,1,1
3,GO LIPOSACCHARIDE METABOLIC PROCESS,7.4873e-07,0.25095,0.23508,1,1
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,9.6129e-06,0.2509,0.23618,1,1
3,GO AMYLOID FIBRIL FORMATION,0.00048316,0.25084,0.29434,1,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,1.4741e-05,0.25075,0.23688,1,1
3,GO POSITIVE REGULATION OF FERTILIZATION,0.0011836,0.25075,0.21484,1,1
3,GO PHAGOSOME ACIDIFICATION,1.3174e-07,0.25057,0.26624,1,1
3,GO REGULATION OF DOPAMINE SECRETION,0.00013232,0.25055,0.36228,1,1
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,7.8911e-05,0.25045,0.26871,1,1
3,GO HAIR CELL DIFFERENTIATION,8.1623e-05,0.2504,0.20769,1,1
3,GO RESPONSE TO GONADOTROPIN,4.8839e-05,0.24998,0.20835,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00010673,0.24987,0.27316,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00013899,0.24954,0.20818,1,1
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,1.7706e-05,0.2495,0.24651,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.5865e-05,0.24944,0.24247,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00053704,0.24944,0.26158,1,1
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,8.1623e-05,0.24941,0.23501,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.024428,0.2494,0.23887,1,1
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0046604,0.24914,0.17879,1,1
3,GO TRANSMISSION OF NERVE IMPULSE,1.2253e-05,0.24874,0.26877,1,1
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.057711,0.24868,0.2783,1,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.00015583,0.24856,0.27893,1,1
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,1.155e-06,0.24844,0.28124,1,1
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0054192,0.24832,0.22233,1,1
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,9.4959e-05,0.24815,0.21802,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.7385e-05,0.24808,0.20947,1,1
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.063258,0.24761,0.16996,1,1
3,GO SPHINGOLIPID METABOLIC PROCESS,3.0295e-08,0.24745,0.23688,1,1
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.029754,0.24741,0.20429,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0085105,0.24646,0.22042,1,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,3.0905e-06,0.24637,0.22728,1,1
3,GO REGULATION OF RECEPTOR CLUSTERING,0.0059116,0.24628,0.25373,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.1274e-05,0.24606,0.19896,1,1
3,GO INTERLEUKIN 5 PRODUCTION,0.031311,0.24602,0.17881,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0011021,0.24583,0.22234,1,1
3,GO REGULATION OF TRANSPOSITION,0.00011596,0.24581,0.31686,1,1
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,8.4424e-05,0.24579,0.21343,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00010497,0.24573,0.2613,1,1
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00011596,0.24512,0.22192,1,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00033955,0.24511,0.26476,1,1
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.9941e-08,0.24502,0.30204,1,1
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.0094686,0.24489,0.14903,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.021053,0.24488,0.14723,1,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.7605e-06,0.24487,0.20852,1,1
3,GO ETHER METABOLIC PROCESS,8.4262e-06,0.24466,0.23615,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,7.3803e-06,0.24427,0.26567,1,1
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00076726,0.24421,0.26313,1,1
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,1.1375e-05,0.24395,0.22713,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.00080175,0.24391,0.19863,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0005211,0.24362,0.26633,1,1
3,GO RESPONSE TO INTERLEUKIN 2,1.5865e-05,0.24361,0.23882,1,1
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00026858,0.24329,0.20589,1,1
3,GO ADAPTIVE IMMUNE RESPONSE,2.5424e-05,0.24322,0.23324,1,1
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0034243,0.24312,0.202,1,1
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,1.0557e-05,0.24279,0.2197,1,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,7.8911e-05,0.24276,0.19494,1,1
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,6.0079e-05,0.24258,0.27502,1,1
3,GO RESPONSE TO PROTOZOAN,0.00040235,0.24256,0.20731,1,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.1361e-07,0.24249,0.24819,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00076726,0.24212,0.20162,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00054518,0.2419,0.28227,1,1
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00022208,0.24168,0.21401,1,1
3,GO CERAMIDE METABOLIC PROCESS,4.8198e-07,0.24168,0.22569,1,1
3,GO DEFENSE RESPONSE TO BACTERIUM,4.1552e-07,0.24129,0.22591,1,1
3,GO REGULATION OF RECEPTOR BINDING,0.0099244,0.24126,0.19736,1,1
3,GO RESPONSE TO REDOX STATE,0.00073415,0.24099,0.21469,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00099681,0.24062,0.19893,1,1
3,GO CERAMIDE BIOSYNTHETIC PROCESS,5.9498e-07,0.24045,0.23021,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,1.1806e-05,0.24039,0.23053,1,1
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.00031907,0.24031,0.2104,1,1
3,GO RESPONSE TO THYROID HORMONE,0.0023321,0.24025,0.22888,1,1
3,GO NUCLEOTIDE SALVAGE,0.0050904,0.23993,0.16568,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00074504,0.23986,0.20164,1,1
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00029511,0.23978,0.23813,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0022701,0.23973,0.20385,1,1
3,GO TYPE 2 IMMUNE RESPONSE,0.0013443,0.23972,0.25946,1,1
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.002631,0.23964,0.19833,1,1
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,7.4873e-07,0.23938,0.24555,1,1
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,2.5868e-06,0.23907,0.21568,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.3056e-06,0.23899,0.24376,1,1
3,GO LEUKOCYTE PROLIFERATION,2.3661e-05,0.23888,0.19964,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00086244,0.2388,0.19515,1,1
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00040857,0.23848,0.20915,1,1
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,6.4592e-06,0.23836,0.22349,1,1
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.00014129,0.23836,0.2467,1,1
3,GO AMYLOID BETA CLEARANCE,0.0011836,0.23834,0.18197,1,1
3,GO LEUKOCYTE CELL CELL ADHESION,0.00025617,0.23832,0.17073,1,1
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.342e-06,0.23829,0.22751,1,1
3,GO T CELL PROLIFERATION,8.5858e-05,0.23811,0.19412,1,1
3,GO TYPE I INTERFERON PRODUCTION,2.7804e-05,0.23802,0.20589,1,1
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.001071,0.23776,0.27854,1,1
3,GO ZYMOGEN INHIBITION,0.00032408,0.23737,0.24101,1,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,4.9694e-05,0.2373,0.21172,1,1
3,GO SMOOTH MUSCLE CELL MIGRATION,0.00029052,0.23726,0.22772,1,1
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,8.5867e-06,0.23708,0.25625,1,1
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.00027716,0.23689,0.18945,1,1
3,GO RESPONSE TO MINERALOCORTICOID,0.00026858,0.23686,0.19676,1,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.5022e-05,0.23684,0.20176,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00029052,0.23664,0.18616,1,1
3,GO CELL CELL JUNCTION ASSEMBLY,3.2146e-06,0.23655,0.21893,1,1
3,GO MYELOID LEUKOCYTE ACTIVATION,1.7693e-06,0.23651,0.22354,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0016806,0.23617,0.32721,1,1
3,GO INTERLEUKIN 1 PRODUCTION,0.00063314,0.23616,0.19057,1,1
3,GO GASTRULATION WITH MOUTH FORMING SECOND,3.0395e-05,0.23606,0.26295,1,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0005211,0.2359,0.18889,1,1
3,GO MOVEMENT IN HOST ENVIRONMENT,9.6562e-05,0.23586,0.2065,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00024819,0.23584,0.17376,1,1
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,6.7105e-06,0.23577,0.21915,1,1
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0011341,0.23522,0.22982,1,1
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,6.4341e-05,0.23518,0.25087,1,1
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,1.0958e-05,0.23495,0.22328,1,1
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,3.2894e-09,0.23488,0.2535,1,1
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,3.5022e-05,0.23433,0.26092,1,1
3,GO WATER HOMEOSTASIS,1.1316e-06,0.23429,0.25954,1,1
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,6.3249e-05,0.23428,0.20076,1,1
3,GO REGULATION OF NECROTIC CELL DEATH,3.8347e-06,0.23423,0.24707,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0054872,0.23421,0.14508,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,7.3803e-06,0.23419,0.23422,1,1
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.00080175,0.23407,0.24898,1,1
3,GO MEMBRANE LIPID METABOLIC PROCESS,1.9465e-08,0.23402,0.23958,1,1
3,GO AMINO SUGAR CATABOLIC PROCESS,6.1119e-05,0.23401,0.22774,1,1
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.033948,0.23398,0.17099,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00033955,0.23385,0.18926,1,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.0004e-06,0.23348,0.23013,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00026024,0.23307,0.25537,1,1
3,GO LEUKOCYTE MEDIATED IMMUNITY,1.9175e-06,0.23276,0.2251,1,1
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.00017457,0.2327,0.22336,1,1
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0022701,0.23251,0.17138,1,1
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0039481,0.23227,0.24943,1,1
3,GO RESPONSE TO VIRUS,3.6924e-05,0.23198,0.20285,1,1
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,3.1004e-08,0.23186,0.24211,1,1
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.1806e-05,0.23184,0.23861,1,1
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00049053,0.23183,0.20906,1,1
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,6.4592e-06,0.23153,0.19625,1,1
3,GO PHOSPHOLIPID TRANSPORT,1.5037e-07,0.23133,0.24994,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.0361e-05,0.23095,0.22136,1,1
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,5.5127e-05,0.23093,0.32169,1,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.5558e-05,0.23079,0.18662,1,1
3,GO HEART TRABECULA FORMATION,0.0024281,0.23071,0.23586,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,1.1165e-05,0.23062,0.242,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00026024,0.23062,0.20604,1,1
3,GO KERATINOCYTE DIFFERENTIATION,2.6914e-06,0.23039,0.23749,1,1
3,GO DIGESTIVE SYSTEM PROCESS,2.2958e-06,0.23038,0.22065,1,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.00076726,0.23022,0.25651,1,1
3,GO LYTIC VACUOLE ORGANIZATION,3.4553e-09,0.23016,0.27709,1,1
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,3.8161e-07,0.23007,0.26833,1,1
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0023637,0.22982,0.24209,1,1
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0047198,0.2296,0.29559,1,1
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.034636,0.22948,0.28892,1,1
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0001803,0.22946,0.25092,1,1
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.8793e-06,0.22903,0.22475,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,2.913e-06,0.22898,0.23997,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00010852,0.22894,0.20088,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,8.3013e-05,0.22881,0.27936,1,1
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.010895,0.22864,0.21329,1,1
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,9.6129e-06,0.22864,0.23939,1,1
3,GO STEROID METABOLIC PROCESS,9.404e-07,0.22852,0.22288,1,1
3,GO REGULATION OF HEART RATE,5.6487e-06,0.22849,0.21882,1,1
3,GO MEMBRANE DEPOLARIZATION,4.4807e-06,0.22843,0.24352,1,1
3,GO RESPONSE TO CORTICOSTERONE,0.00070238,0.22817,0.21117,1,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,2.5868e-06,0.22802,0.2016,1,1
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,8.8282e-08,0.22778,0.22878,1,1
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.00015331,0.22767,0.18593,1,1
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0013255,0.22756,0.18414,1,1
3,GO BARBED END ACTIN FILAMENT CAPPING,0.0021505,0.2275,0.25308,1,1
3,GO FUCOSYLATION,0.00016629,0.22743,0.19901,1,1
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,5.2445e-07,0.22727,0.21512,1,1
3,GO EPITHELIAL CELL FATE COMMITMENT,0.014494,0.22714,0.1694,1,1
3,GO CYTOKINE METABOLIC PROCESS,2.011e-05,0.22661,0.22591,1,1
3,GO RESPONSE TO INSECTICIDE,0.0025277,0.22659,0.25077,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,7.7166e-08,0.22634,0.23562,1,1
3,GO REGULATION OF PROSTAGLANDIN SECRETION,2.4371e-06,0.2262,0.25744,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00084997,0.22591,0.15646,1,1
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00014129,0.22584,0.27104,1,1
3,GO LIPID LOCALIZATION,4.4285e-07,0.22575,0.21084,1,1
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0020367,0.22549,0.16176,1,1
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00037257,0.22505,0.19479,1,1
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,1.8723e-07,0.22493,0.24429,1,1
3,GO REGULATION OF WOUND HEALING,6.9711e-06,0.22466,0.25698,1,1
3,GO IMMUNE EFFECTOR PROCESS,4.4807e-06,0.22446,0.21305,1,1
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00042777,0.22445,0.23852,1,1
3,GO PLATELET DEGRANULATION,9.3381e-05,0.22443,0.24482,1,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,8.5858e-05,0.22439,0.22256,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0001803,0.22436,0.18377,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,1.9175e-06,0.22435,0.21917,1,1
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.00061456,0.22411,0.25674,1,1
3,GO RESPONSE TO GROWTH HORMONE,7.2414e-06,0.22411,0.27133,1,1
3,GO REGULATION OF FATTY ACID TRANSPORT,2.4861e-06,0.22409,0.26441,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.4409e-05,0.22382,0.219,1,1
3,GO REGULATION OF MEMBRANE REPOLARIZATION,4.8839e-05,0.22363,0.22695,1,1
3,GO RESPONSE TO CAFFEINE,0.00091404,0.22357,0.17298,1,1
3,GO OLIGOPEPTIDE TRANSPORT,0.0027381,0.22351,0.19619,1,1
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.007921,0.22303,0.22892,1,1
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,5.3562e-07,0.22297,0.20633,1,1
3,GO HUMORAL IMMUNE RESPONSE,2.7452e-06,0.22296,0.21912,1,1
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.0044864,0.22277,0.26423,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.8305e-05,0.22263,0.2121,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00010323,0.22261,0.27332,1,1
3,GO NECROTIC CELL DEATH,1.9175e-06,0.2226,0.24329,1,1
3,GO POSITIVE REGULATION OF HEART CONTRACTION,1.3325e-06,0.2226,0.26819,1,1
3,GO PROTEIN HYDROXYLATION,0.001568,0.22257,0.21446,1,1
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.6877e-06,0.22207,0.21847,1,1
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,5.6487e-06,0.22194,0.1965,1,1
3,GO ALANINE TRANSPORT,0.0019819,0.22166,0.18479,1,1
3,GO CYTOPLASM ORGANIZATION,0.00046165,0.22164,0.22002,1,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,2.206e-06,0.22159,0.21911,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00020178,0.22149,0.30217,1,1
3,GO VASCULAR WOUND HEALING,0.00016361,0.22131,0.29661,1,1
3,GO LEUKOCYTE MIGRATION,7.5217e-06,0.22121,0.20746,1,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,5.8856e-08,0.2211,0.24094,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00019541,0.22106,0.21008,1,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00023294,0.22095,0.25277,1,1
3,GO LINOLEIC ACID METABOLIC PROCESS,0.0016806,0.22095,0.21277,1,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,2.6828e-05,0.22092,0.20817,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.0019023,0.22088,0.16636,1,1
3,GO PLATELET ACTIVATION,0.00011406,0.22078,0.19797,1,1
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00013232,0.2207,0.24058,1,1
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.004156,0.22051,0.17448,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00019541,0.22047,0.26851,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.8814e-05,0.22043,0.23798,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.3468e-07,0.2201,0.27824,1,1
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0059116,0.22005,0.21434,1,1
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00024045,0.21991,0.20062,1,1
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.000286,0.21971,0.22649,1,1
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,3.2631e-05,0.21934,0.22268,1,1
3,GO DIOL BIOSYNTHETIC PROCESS,8.1138e-06,0.21928,0.28255,1,1
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00013673,0.21883,0.22247,1,1
3,GO INTERFERON ALPHA PRODUCTION,5.8698e-06,0.21882,0.24911,1,1
3,GO PROTEIN TARGETING TO LYSOSOME,0.00044103,0.21872,0.26155,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0014624,0.21857,0.18582,1,1
3,GO ICOSANOID METABOLIC PROCESS,9.2585e-06,0.21835,0.2503,1,1
3,GO DEFENSE RESPONSE,2.342e-06,0.21824,0.19904,1,1
3,GO REGULATION OF ACTION POTENTIAL,0.00033955,0.21818,0.21286,1,1
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00019541,0.21816,0.20376,1,1
3,GO MANNOSYLATION,1.3325e-06,0.21807,0.24139,1,1
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00013673,0.21807,0.22837,1,1
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00055343,0.21798,0.22871,1,1
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.2143e-08,0.2179,0.23821,1,1
3,GO POLYSACCHARIDE METABOLIC PROCESS,5.2445e-07,0.21786,0.21451,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00024045,0.21778,0.21432,1,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00029976,0.21778,0.1816,1,1
3,GO INTEGRIN ACTIVATION,3.4098e-06,0.21744,0.264,1,1
3,GO REGULATION OF POSITIVE CHEMOTAXIS,3.5022e-05,0.21738,0.23843,1,1
3,GO LEUKOCYTE CHEMOTAXIS,2.7804e-05,0.21726,0.18397,1,1
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00017741,0.2172,0.27659,1,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,1.3948e-05,0.21702,0.25921,1,1
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,2.0853e-05,0.21693,0.21793,1,1
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,4.2487e-05,0.21671,0.2406,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,5.8698e-06,0.21665,0.24926,1,1
3,GO PROTEIN O LINKED MANNOSYLATION,0.0005056,0.21659,0.21041,1,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00012594,0.21652,0.17176,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0024941,0.2165,0.16698,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,3.6877e-06,0.21642,0.19893,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0001862,0.21642,0.1997,1,1
3,GO REGULATION OF PEPTIDASE ACTIVITY,4.5684e-06,0.2163,0.21686,1,1
3,GO STEROL METABOLIC PROCESS,1.5052e-06,0.21609,0.20957,1,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00037257,0.21607,0.15105,1,1
3,GO PLATELET AGGREGATION,6.8888e-05,0.21562,0.23952,1,1
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.7999e-05,0.21509,0.20525,1,1
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0042095,0.21508,0.18899,1,1
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.012227,0.21505,0.23151,1,1
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00095459,0.21504,0.197,1,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,1.5865e-05,0.21503,0.2099,1,1
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.001483,0.21498,0.24247,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.00012594,0.21492,0.20919,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,3.758e-05,0.21488,0.20251,1,1
3,GO COPPER ION TRANSPORT,0.00032916,0.21481,0.21742,1,1
3,GO RESPONSE TO INTERLEUKIN 6,6.3249e-05,0.21474,0.2121,1,1
3,GO ENERGY HOMEOSTASIS,8.7316e-05,0.21453,0.22124,1,1
3,GO DISACCHARIDE METABOLIC PROCESS,4.8839e-05,0.21426,0.29481,1,1
3,GO LIVER MORPHOGENESIS,2.0478e-05,0.21418,0.33244,1,1
3,GO CYTOKINE PRODUCTION,4.1751e-05,0.21392,0.187,1,1
3,GO SKIN DEVELOPMENT,4.7999e-05,0.21356,0.18914,1,1
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.001955,0.21335,0.23552,1,1
3,GO EPIDERMIS DEVELOPMENT,3.1494e-05,0.21324,0.18705,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00023294,0.21283,0.16027,1,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,2.206e-06,0.21274,0.25746,1,1
3,GO REGULATION OF AMINO ACID TRANSPORT,0.00055343,0.21274,0.2025,1,1
3,GO SECRETION BY TISSUE,0.00023294,0.21272,0.19649,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.6828e-05,0.21254,0.23949,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,3.5646e-05,0.21241,0.24932,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00049053,0.21233,0.15274,1,1
3,GO GOLGI TO ENDOSOME TRANSPORT,6.545e-05,0.21208,0.21337,1,1
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,3.758e-05,0.21206,0.22336,1,1
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00026438,0.21185,0.25524,1,1
3,GO SNARE COMPLEX ASSEMBLY,0.00044103,0.21175,0.20269,1,1
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,1.0169e-05,0.21171,0.24954,1,1
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0071918,0.2116,0.22945,1,1
3,GO NUCLEOTIDE TRANSPORT,2.0364e-06,0.21146,0.19951,1,1
3,GO HETEROTYPIC CELL CELL ADHESION,0.0043737,0.21111,0.16922,1,1
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,3.5038e-07,0.21108,0.21407,1,1
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,5.332e-06,0.21094,0.21666,1,1
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,3.4409e-05,0.21081,0.22966,1,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,6.6578e-05,0.21074,0.19341,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,4.7488e-06,0.21057,0.22777,1,1
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,5.4701e-07,0.21051,0.21124,1,1
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,1.5576e-05,0.2104,0.29516,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00010323,0.2104,0.21108,1,1
3,GO CELL CHEMOTAXIS,3.094e-05,0.21032,0.18851,1,1
3,GO GRANULOCYTE CHEMOTAXIS,0.00014362,0.21023,0.16292,1,1
3,GO MECHANORECEPTOR DIFFERENTIATION,8.7502e-06,0.21012,0.20697,1,1
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.2057e-05,0.21006,0.21215,1,1
3,GO B CELL ACTIVATION,2.1621e-05,0.20995,0.17732,1,1
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00073415,0.2096,0.18805,1,1
3,GO BILE ACID METABOLIC PROCESS,1.7071e-05,0.2095,0.23172,1,1
3,GO ENDOCRINE PROCESS,1.3948e-05,0.20938,0.20344,1,1
3,GO CELL CELL ADHESION,0.00040235,0.20934,0.15687,1,1
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,2.9332e-05,0.20906,0.28081,1,1
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00013899,0.2088,0.19778,1,1
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,3.8246e-05,0.20865,0.27316,1,1
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,5.7582e-06,0.20811,0.20355,1,1
3,GO CELLULAR RESPONSE TO FATTY ACID,0.00027284,0.2081,0.20053,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0030436,0.20796,0.17694,1,1
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0093576,0.2079,0.16527,1,1
3,GO CARBOHYDRATE TRANSPORT,2.0429e-07,0.2079,0.19868,1,1
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00059648,0.20786,0.18195,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00010852,0.20781,0.18253,1,1
3,GO RESPONSE TO INACTIVITY,0.0026663,0.20771,0.22619,1,1
3,GO AMELOGENESIS,0.01585,0.20765,0.17926,1,1
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00021857,0.20765,0.20188,1,1
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00063314,0.20755,0.20741,1,1
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0049019,0.20741,0.17763,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0016575,0.20739,0.23504,1,1
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,9.2585e-06,0.20729,0.20902,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,9.2321e-08,0.20728,0.21505,1,1
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00069207,0.2071,0.20482,1,1
3,GO SPHINGOID METABOLIC PROCESS,7.8911e-05,0.20706,0.24222,1,1
3,GO STEROL TRANSPORT,8.7316e-05,0.20696,0.19743,1,1
3,GO PROSTAGLANDIN TRANSPORT,0.0005133,0.20692,0.19806,1,1
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0051547,0.20687,0.13402,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,8.8796e-05,0.20663,0.20676,1,1
3,GO POSITIVE REGULATION OF ANION TRANSPORT,1.6158e-05,0.20658,0.20611,1,1
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00012594,0.2065,0.19999,1,1
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,9.6562e-05,0.206,0.25475,1,1
3,GO SIGNAL PEPTIDE PROCESSING,5.9834e-06,0.20591,0.27617,1,1
3,GO NEGATIVE REGULATION OF LIPID STORAGE,4.0314e-05,0.20585,0.2372,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,1.6761e-05,0.20585,0.20322,1,1
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00018923,0.20573,0.17401,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0050904,0.20563,0.16729,1,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00091404,0.20561,0.1979,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.0005056,0.20529,0.20486,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.002631,0.20529,0.18995,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.00052901,0.20515,0.15462,1,1
3,GO TRANSCYTOSIS,0.00099681,0.20512,0.17304,1,1
3,GO NERVE DEVELOPMENT,0.0005211,0.2051,0.21458,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00012186,0.20509,0.20472,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.4472e-05,0.20502,0.1923,1,1
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00019541,0.20488,0.30284,1,1
3,GO SKELETAL MUSCLE ADAPTATION,0.00084997,0.20485,0.19882,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00043435,0.20471,0.17377,1,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.3196e-05,0.20464,0.20592,1,1
3,GO EXTRACELLULAR VESICLE BIOGENESIS,1.6994e-06,0.20456,0.23889,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0024609,0.20454,0.1475,1,1
3,GO RESPONSE TO MECHANICAL STIMULUS,2.342e-06,0.20439,0.22244,1,1
3,GO STEROID BIOSYNTHETIC PROCESS,2.856e-06,0.20434,0.19387,1,1
3,GO CELLULAR RESPONSE TO STEROL,3.8246e-05,0.20432,0.22692,1,1
3,GO RESPONSE TO METAL ION,2.2286e-07,0.2042,0.18903,1,1
3,GO ORGANELLE MEMBRANE FUSION,2.0853e-05,0.20415,0.18346,1,1
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0013826,0.20407,0.19096,1,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,5.1304e-06,0.20398,0.2041,1,1
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.032607,0.20387,0.16486,1,1
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,4.2444e-07,0.20384,0.21736,1,1
3,GO AMINOGLYCAN METABOLIC PROCESS,9.6562e-05,0.20378,0.18918,1,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,9.8716e-08,0.2037,0.19276,1,1
3,GO ACROSOME REACTION,0.0058389,0.20346,0.1438,1,1
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0038977,0.20323,0.15626,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,3.0395e-05,0.20312,0.19518,1,1
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,4.5684e-06,0.20291,0.20643,1,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.0302e-06,0.20267,0.20016,1,1
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,4.6359e-05,0.20261,0.21263,1,1
3,GO ACTION POTENTIAL,1.2716e-05,0.20257,0.19794,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.8049e-05,0.20196,0.19491,1,1
3,GO LYMPHOCYTE HOMEOSTASIS,0.00025617,0.20194,0.15117,1,1
3,GO CELL CELL JUNCTION ORGANIZATION,0.00013451,0.20189,0.19125,1,1
3,GO MEMBRANE FUSION,6.2169e-06,0.2018,0.18614,1,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.5022e-05,0.20174,0.18218,1,1
3,GO DIET INDUCED THERMOGENESIS,3.094e-05,0.20151,0.22877,1,1
3,GO PURINE NUCLEOTIDE TRANSPORT,1.0169e-05,0.20126,0.19691,1,1
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0078263,0.20095,0.17046,1,1
3,GO AMYLOID BETA FORMATION,0.00090088,0.20092,0.19761,1,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.00044103,0.20087,0.22459,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.023919,0.20077,0.12386,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.000662,0.20065,0.20774,1,1
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0020929,0.20058,0.16646,1,1
3,GO GLOMERULUS DEVELOPMENT,0.002702,0.20057,0.19317,1,1
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,9.2585e-06,0.20044,0.19126,1,1
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0011341,0.2002,0.35572,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00068191,0.20013,0.15274,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,9.4959e-05,0.20011,0.19914,1,1
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.0429e-07,0.2,0.23379,1,1
3,GO RESPONSE TO BIOTIC STIMULUS,1.5865e-05,0.1999,0.17622,1,1
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.0048405,0.19946,0.24259,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0026663,0.19943,0.18436,1,1
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,3.9613e-05,0.19934,0.18194,1,1
3,GO REGULATION OF RESPONSE TO FOOD,0.0095807,0.19933,0.11661,1,1
3,GO REGULATION OF CELL ADHESION,0.00048316,0.19931,0.16568,1,1
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0056958,0.19918,0.13345,1,1
3,GO MONOCYTE CHEMOTAXIS,0.0023637,0.19904,0.15874,1,1
3,GO RESPONSE TO FATTY ACID,0.00088789,0.19885,0.15428,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0012527,0.19882,0.21206,1,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00029976,0.19879,0.15571,1,1
3,GO DIGESTION,6.337e-06,0.19854,0.21568,1,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,1.2482e-05,0.19844,0.18223,1,1
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0104,0.19834,0.13089,1,1
3,GO METHIONINE METABOLIC PROCESS,0.000662,0.19833,0.17708,1,1
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.00020835,0.19825,0.22705,1,1
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.2954e-05,0.19806,0.20998,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.00042777,0.19786,0.17764,1,1
3,GO PROTEIN N LINKED GLYCOSYLATION,3.0905e-06,0.19766,0.21146,1,1
3,GO ALPHA BETA T CELL ACTIVATION,0.00013899,0.19759,0.17782,1,1
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.024687,0.19743,0.13265,1,1
3,GO RESPONSE TO XENOBIOTIC STIMULUS,8.1623e-05,0.19732,0.1779,1,1
3,GO REGULATION OF MUSCLE ADAPTATION,5.9056e-05,0.1972,0.18999,1,1
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,2.0478e-05,0.19692,0.20483,1,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.0005211,0.19691,0.18027,1,1
3,GO INTERFERON BETA PRODUCTION,0.0027747,0.19663,0.15633,1,1
3,GO ENDOCARDIUM DEVELOPMENT,0.00071283,0.19653,0.23907,1,1
3,GO VACUOLAR ACIDIFICATION,5.4356e-06,0.19597,0.22926,1,1
3,GO RESPONSE TO CYTOKINE,3.8924e-05,0.19587,0.17235,1,1
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00036124,0.19548,0.17131,1,1
3,GO AMINE METABOLIC PROCESS,9.2321e-08,0.19535,0.19154,1,1
3,GO REGULATION OF BLOOD PRESSURE,1.2027e-05,0.19533,0.16881,1,1
3,GO REGULATION OF CELL ACTIVATION,0.00024819,0.19527,0.15066,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.015674,0.19524,0.14036,1,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.3948e-05,0.19524,0.20641,1,1
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0018764,0.19514,0.20562,1,1
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0038478,0.19508,0.18505,1,1
3,GO T CELL ACTIVATION,0.00021857,0.19506,0.15813,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0052854,0.19493,0.19525,1,1
3,GO REGULATION OF SYMBIOTIC PROCESS,7.2497e-05,0.19479,0.18833,1,1
3,GO ACTIVATION OF IMMUNE RESPONSE,5.3256e-05,0.19477,0.15858,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,4.9694e-05,0.19436,0.23174,1,1
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0018508,0.19431,0.23261,1,1
3,GO MYELOID LEUKOCYTE MIGRATION,1.9393e-05,0.19416,0.18649,1,1
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0094686,0.19406,0.12482,1,1
3,GO SODIUM ION HOMEOSTASIS,0.00012594,0.19396,0.16949,1,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0005789,0.19395,0.17403,1,1
3,GO GLYCOPROTEIN METABOLIC PROCESS,2.913e-06,0.19381,0.19487,1,1
3,GO INOSITOL METABOLIC PROCESS,0.00034485,0.19368,0.20199,1,1
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.062114,0.19364,0.12211,1,1
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,3.3806e-05,0.1936,0.20518,1,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,2.856e-06,0.19355,0.16868,1,1
3,GO RESPONSE TO BACTERIUM,3.628e-05,0.1935,0.17022,1,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0032928,0.19343,0.16207,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0002443,0.19321,0.14,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,1.1086e-06,0.1932,0.17558,1,1
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0011341,0.19312,0.16885,1,1
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00011218,0.19312,0.21186,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.00069207,0.19306,0.18667,1,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,5.3256e-05,0.19304,0.16317,1,1
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00053704,0.19299,0.19293,1,1
3,GO REGULATION OF FERTILIZATION,4.8839e-05,0.19289,0.19279,1,1
3,GO MEMBRANE FISSION,0.014823,0.19288,0.15449,1,1
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.024173,0.1928,0.1731,1,1
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00049802,0.19268,0.18749,1,1
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010522,0.19265,0.15956,1,1
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.0024941,0.19264,0.16967,1,1
3,GO MULTICELLULAR ORGANISM AGING,4.1751e-05,0.19253,0.18054,1,1
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0039992,0.19246,0.13375,1,1
3,GO LUNG EPITHELIUM DEVELOPMENT,0.00061456,0.1922,0.22364,1,1
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.004964,0.19219,0.20574,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,1.6654e-06,0.19194,0.19169,1,1
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0013069,0.1918,0.17489,1,1
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0047198,0.19168,0.15753,1,1
3,GO GRANULOCYTE MIGRATION,6.2175e-05,0.19144,0.1836,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.001118,0.19133,0.20176,1,1
3,GO LIPOPROTEIN METABOLIC PROCESS,7.4873e-07,0.19117,0.21411,1,1
3,GO RESPONSE TO AMPHETAMINE,0.006444,0.19113,0.17468,1,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00092737,0.19112,0.14912,1,1
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.011678,0.19098,0.15516,1,1
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.011022,0.19069,0.14712,1,1
3,GO RESPONSE TO PH,0.00010673,0.19056,0.19561,1,1
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,9.4959e-05,0.19046,0.20989,1,1
3,GO PHAGOSOME MATURATION,1.3948e-05,0.19041,0.21927,1,1
3,GO POSITIVE REGULATION OF CHEMOTAXIS,2.3239e-05,0.19014,0.19635,1,1
3,GO MUSCLE ADAPTATION,2.4972e-05,0.1901,0.19191,1,1
3,GO RENAL SYSTEM PROCESS,0.00032408,0.18978,0.17703,1,1
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0017277,0.18975,0.18242,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00037257,0.1897,0.14792,1,1
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0011021,0.18947,0.20099,1,1
3,GO CELLULAR GLUCAN METABOLIC PROCESS,1.5576e-05,0.18917,0.18639,1,1
3,GO SECONDARY METABOLIC PROCESS,0.00018923,0.18913,0.21497,1,1
3,GO VIRAL LIFE CYCLE,0.00019857,0.189,0.15533,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0058389,0.18894,0.15519,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.00096848,0.1889,0.17452,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,9.1829e-05,0.18889,0.2102,1,1
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.022209,0.18845,0.12622,1,1
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,6.5837e-06,0.18828,0.18412,1,1
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.0053519,0.18828,0.13344,1,1
3,GO LEUKOCYTE HOMEOSTASIS,0.0037016,0.1882,0.12691,1,1
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0019023,0.18782,0.1973,1,1
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.00035024,0.18764,0.16574,1,1
3,GO SENSORY PERCEPTION OF TASTE,1.4741e-05,0.18718,0.17237,1,1
3,GO REGULATION OF ANION TRANSPORT,3.8924e-05,0.18702,0.17076,1,1
3,GO AMINE TRANSPORT,9.3381e-05,0.18672,0.23631,1,1
3,GO CELL ACTIVATION,4.4771e-05,0.18648,0.17137,1,1
3,GO RESPONSE TO ISCHEMIA,9.3381e-05,0.18636,0.18934,1,1
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.00044781,0.18604,0.23668,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.9711e-06,0.18597,0.18215,1,1
3,GO CHOLESTEROL STORAGE,0.001568,0.18594,0.20478,1,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0037985,0.18521,0.15517,1,1
3,GO RESPONSE TO CADMIUM ION,0.00099681,0.18519,0.19176,1,1
3,GO TRANSFERRIN TRANSPORT,2.4837e-07,0.18509,0.23032,1,1
3,GO ENDOTHELIUM DEVELOPMENT,0.0037985,0.18503,0.14976,1,1
3,GO NEUTROPHIL MIGRATION,6.8888e-05,0.18495,0.1708,1,1
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00015838,0.18495,0.18411,1,1
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.00011986,0.18451,0.20504,1,1
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0022701,0.18441,0.17779,1,1
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,3.2631e-05,0.18439,0.22773,1,1
3,GO REGULATION OF BODY FLUID LEVELS,0.00015331,0.1843,0.16154,1,1
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.006444,0.1843,0.14548,1,1
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,2.2958e-06,0.18426,0.17953,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.001568,0.18425,0.19555,1,1
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,7.3739e-05,0.18423,0.17964,1,1
3,GO CYTOKINE SECRETION,7.3803e-06,0.1842,0.21149,1,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0029256,0.18417,0.18792,1,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,1.4741e-05,0.18414,0.16463,1,1
3,GO REGULATION OF B CELL DIFFERENTIATION,0.0048405,0.18408,0.1449,1,1
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00060545,0.18399,0.16869,1,1
3,GO INFLAMMATORY RESPONSE,9.2585e-06,0.18397,0.19074,1,1
3,GO REGULATION OF LYSOSOMAL LUMEN PH,3.2057e-05,0.18388,0.24491,1,1
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,7.0337e-07,0.18385,0.17239,1,1
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.016568,0.18381,0.13055,1,1
3,GO PARENTAL BEHAVIOR,0.065005,0.18376,0.13513,1,1
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00030449,0.18369,0.15393,1,1
3,GO MUSCLE HYPERTROPHY,8.7502e-06,0.18363,0.20521,1,1
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.0076401,0.18352,0.19198,1,1
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.0042095,0.18335,0.14343,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00081356,0.18331,0.1684,1,1
3,GO PEPTIDE SECRETION,3.0811e-07,0.18328,0.19138,1,1
3,GO GDP METABOLIC PROCESS,0.0038478,0.18322,0.20328,1,1
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.00091404,0.18318,0.15594,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00022565,0.18314,0.16168,1,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,9.9844e-05,0.18308,0.1716,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.004964,0.18305,0.16994,1,1
3,GO MYOTUBE DIFFERENTIATION,3.8924e-05,0.18293,0.19232,1,1
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.00040235,0.18246,0.24389,1,1
3,GO B CELL DIFFERENTIATION,4.4771e-05,0.18241,0.16172,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.001483,0.18236,0.23059,1,1
3,GO REGULATION OF RESPONSE TO WOUNDING,6.0079e-05,0.18217,0.2129,1,1
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.0060595,0.18202,0.16709,1,1
3,GO RESPONSE TO NUTRIENT,0.00080175,0.18194,0.1487,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0016347,0.18187,0.16573,1,1
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0056958,0.18185,0.20535,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00063314,0.18181,0.18463,1,1
3,GO INTERACTION WITH HOST,0.00033432,0.18178,0.16307,1,1
3,GO EXOCYTOSIS,1.9175e-06,0.18176,0.18792,1,1
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,8.0256e-05,0.18163,0.19362,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.6994e-06,0.18153,0.19194,1,1
3,GO FATTY ACID CATABOLIC PROCESS,9.819e-05,0.18127,0.16468,1,1
3,GO LIPID EXPORT FROM CELL,0.00059648,0.18115,0.17806,1,1
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,4.8839e-05,0.18108,0.16859,1,1
3,GO T CELL MIGRATION,0.0063654,0.18091,0.14157,1,1
3,GO PROTEIN AUTOPROCESSING,3.8246e-05,0.18081,0.19361,1,1
3,GO ACTIVATED T CELL PROLIFERATION,0.00060545,0.18035,0.17372,1,1
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00029511,0.18029,0.12982,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00010673,0.18016,0.1613,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0030038,0.18008,0.16575,1,1
3,GO TISSUE HOMEOSTASIS,3.9613e-05,0.18001,0.16332,1,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0083098,0.17994,0.14114,1,1
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,4.7172e-05,0.17988,0.16287,1,1
3,GO ADIPOSE TISSUE DEVELOPMENT,0.00010497,0.17966,0.19009,1,1
3,GO PROSTAGLANDIN SECRETION,0.0019285,0.1794,0.16605,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001483,0.17914,0.15557,1,1
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00024045,0.17913,0.2671,1,1
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,6.8396e-06,0.17908,0.1632,1,1
3,GO CD40 SIGNALING PATHWAY,0.001442,0.17905,0.15556,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.00033955,0.17904,0.16829,1,1
3,GO REGULATION OF PEPTIDE SECRETION,2.7078e-07,0.179,0.18622,1,1
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00087508,0.17875,0.16702,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.6657e-06,0.17873,0.23192,1,1
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,9.9844e-05,0.17853,0.19714,1,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,4.0314e-05,0.17849,0.17701,1,1
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.00040235,0.17844,0.16237,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.064e-06,0.17844,0.19552,1,1
3,GO RESPONSE TO PEPTIDOGLYCAN,0.00020178,0.17839,0.19218,1,1
3,GO POSITIVE REGULATION OF SECRETION,7.333e-07,0.1783,0.17977,1,1
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,7.3739e-05,0.17818,0.16077,1,1
3,GO FLUID TRANSPORT,0.00024045,0.17801,0.18616,1,1
3,GO LYMPHOCYTE MIGRATION,0.00041488,0.178,0.14983,1,1
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,2.913e-06,0.17798,0.20342,1,1
3,GO REGULATION OF DEFENSE RESPONSE,7.6657e-06,0.17764,0.17459,1,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0021215,0.17754,0.19249,1,1
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0005618,0.17695,0.18623,1,1
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0018764,0.1769,0.19319,1,1
3,GO LIPID STORAGE,6.4341e-05,0.17672,0.19211,1,1
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.0018508,0.17656,0.17061,1,1
3,GO NEURON MATURATION,0.0016122,0.17649,0.17456,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00010852,0.17648,0.24263,1,1
3,GO LYMPHOCYTE ACTIVATION,0.00046165,0.1764,0.13424,1,1
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0024609,0.17612,0.19209,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0065235,0.17606,0.20557,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0058389,0.17605,0.13825,1,1
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00017176,0.17602,0.17206,1,1
3,GO PARAXIAL MESODERM DEVELOPMENT,0.049212,0.176,0.12422,1,1
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,8.8796e-05,0.17584,0.19383,1,1
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0013633,0.17582,0.14769,1,1
3,GO POSITIVE CHEMOTAXIS,0.00040235,0.17572,0.17342,1,1
3,GO MAINTENANCE OF CELL POLARITY,0.034984,0.17534,0.14359,1,1
3,GO REGULATION OF ISOTYPE SWITCHING,0.0010558,0.1753,0.17553,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.010895,0.17508,0.15516,1,1
3,GO NATURAL KILLER CELL ACTIVATION,0.00075607,0.17506,0.15468,1,1
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0011503,0.175,0.18745,1,1
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.00071283,0.17494,0.18002,1,1
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0005618,0.17492,0.17465,1,1
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.016752,0.17486,0.11566,1,1
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00065224,0.17458,0.1653,1,1
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0017517,0.17447,0.17331,1,1
3,GO INTERLEUKIN 4 PRODUCTION,0.0087156,0.17447,0.15546,1,1
3,GO PIGMENT ACCUMULATION,0.056128,0.17441,0.12633,1,1
3,GO GLIAL CELL APOPTOTIC PROCESS,0.0017277,0.17441,0.25552,1,1
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.1552e-07,0.17428,0.21946,1,1
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0027747,0.17392,0.1601,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.006444,0.17389,0.12973,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00092737,0.17376,0.192,1,1
3,GO KETONE BIOSYNTHETIC PROCESS,0.00044103,0.17364,0.20221,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0029645,0.17363,0.16627,1,1
3,GO AUTOPHAGY OF NUCLEUS,0.0016122,0.17358,0.14977,1,1
3,GO PH REDUCTION,2.8001e-06,0.17342,0.18304,1,1
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.015159,0.17324,0.11496,1,1
3,GO UBIQUINONE METABOLIC PROCESS,0.00015331,0.17317,0.17864,1,1
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.0013443,0.17313,0.1455,1,1
3,GO ENERGY RESERVE METABOLIC PROCESS,0.00013016,0.17299,0.16046,1,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00011218,0.17296,0.20745,1,1
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0015038,0.17288,0.15566,1,1
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.0030839,0.1727,0.1672,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,7.2497e-05,0.17267,0.16039,1,1
3,GO PROTEIN DESTABILIZATION,4.1026e-05,0.17266,0.16844,1,1
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00011406,0.17264,0.17605,1,1
3,GO REGULATION OF CARDIAC CONDUCTION,5.4184e-05,0.1723,0.18653,1,1
3,GO TERPENOID METABOLIC PROCESS,0.0030436,0.1723,0.14515,1,1
3,GO PROTEIN PROCESSING,1.5674e-06,0.17209,0.20392,1,1
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.022446,0.17177,0.16543,1,1
3,GO BASIC AMINO ACID TRANSPORT,0.066192,0.17176,0.14186,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,1.9175e-06,0.17157,0.16627,1,1
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,3.6162e-06,0.1714,0.16968,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.001235,0.17137,0.14144,1,1
3,GO RESPONSE TO STEROL,0.00020504,0.17137,0.19252,1,1
3,GO PROTEIN TARGETING TO VACUOLE,0.00088789,0.17135,0.16562,1,1
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0051547,0.17131,0.16726,1,1
3,GO DETECTION OF STIMULUS,9.404e-07,0.17117,0.15161,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION,0.00028155,0.17103,0.1601,1,1
3,GO CELLULAR RESPONSE TO DSRNA,0.0013443,0.17099,0.16559,1,1
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.010645,0.17099,0.15959,1,1
3,GO OUTER DYNEIN ARM ASSEMBLY,0.063258,0.1709,0.10473,1,1
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,2.5868e-06,0.17058,0.19013,1,1
3,GO RESPONSE TO FUNGUS,2.9332e-05,0.17039,0.17133,1,1
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.011151,0.17038,0.19478,1,1
3,GO COAGULATION,0.00092737,0.17037,0.15215,1,1
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0065235,0.17033,0.18328,1,1
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00010497,0.17022,0.19003,1,1
3,GO WOUND HEALING,0.0015463,0.17012,0.15537,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00090088,0.1701,0.13727,1,1
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.0005133,0.17003,0.1721,1,1
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0005133,0.16998,0.16159,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE,1.6457e-05,0.16994,0.18276,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,6.3249e-05,0.16984,0.14589,1,1
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.001483,0.16981,0.15149,1,1
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00014599,0.16964,0.16652,1,1
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.038637,0.16962,0.11945,1,1
3,GO BICARBONATE TRANSPORT,0.00016901,0.16952,0.2059,1,1
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.00068191,0.1695,0.1792,1,1
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0057669,0.16949,0.15244,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.003607,0.16947,0.12458,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.002702,0.16914,0.19784,1,1
3,GO RESPONSE TO INSULIN,2.8305e-05,0.16912,0.14665,1,1
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,6.545e-05,0.16907,0.20407,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.001483,0.16892,0.16542,1,1
3,GO PIGMENTATION,0.00021511,0.1689,0.13951,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.018693,0.16869,0.11389,1,1
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.0016122,0.16865,0.15702,1,1
3,GO NEUTROPHIL CHEMOTAXIS,0.00032916,0.16859,0.14053,1,1
3,GO GLAND DEVELOPMENT,0.00095459,0.16814,0.12908,1,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,1.536e-06,0.16809,0.17854,1,1
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.015674,0.16804,0.14289,1,1
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,3.0395e-05,0.16785,0.184,1,1
3,GO REGULATION OF SODIUM ION TRANSPORT,0.0002117,0.16771,0.17661,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00095459,0.16769,0.17401,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.00076726,0.16759,0.15315,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.018898,0.16756,0.14534,1,1
3,GO PROTEIN ADP RIBOSYLATION,0.0022396,0.16748,0.1549,1,1
3,GO INSULIN SECRETION,7.2414e-06,0.16739,0.18429,1,1
3,GO VESICLE TARGETING,0.0019023,0.16726,0.13016,1,1
3,GO COPULATION,0.0063654,0.16725,0.15964,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0024609,0.16709,0.15244,1,1
3,GO SUPEROXIDE METABOLIC PROCESS,0.00024819,0.16709,0.17404,1,1
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0032928,0.16707,0.18766,1,1
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0039481,0.16706,0.18712,1,1
3,GO RESPONSE TO CALCIUM ION,4.2487e-05,0.16704,0.17084,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,9.795e-06,0.16702,0.19711,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0022095,0.16677,0.16225,1,1
3,GO VESICLE ORGANIZATION,7.8911e-05,0.16665,0.14348,1,1
3,GO EPITHELIAL CELL DEVELOPMENT,0.0018764,0.16633,0.1526,1,1
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,4.6202e-07,0.16624,0.17932,1,1
3,GO CELLULAR RESPONSE TO CALCIUM ION,3.5646e-05,0.16615,0.20292,1,1
3,GO ORGANIC ANION TRANSPORT,2.6914e-06,0.16605,0.16144,1,1
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0095807,0.16601,0.1587,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,8.7502e-06,0.16593,0.17441,1,1
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,4.4771e-05,0.16591,0.21621,1,1
3,GO LEUKOCYTE DIFFERENTIATION,0.0002443,0.16574,0.13705,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.018898,0.16573,0.12512,1,1
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00039622,0.16571,0.18498,1,1
3,GO LIPID METABOLIC PROCESS,5.6487e-06,0.16551,0.15602,1,1
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.018091,0.16549,0.10706,1,1
3,GO DNA DEMETHYLATION,0.0080166,0.16548,0.13396,1,1
3,GO COPPER ION HOMEOSTASIS,0.00072342,0.16539,0.17905,1,1
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00023667,0.16538,0.15655,1,1
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.015159,0.16531,0.14456,1,1
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.0015038,0.16527,0.17967,1,1
3,GO INTERFERON GAMMA PRODUCTION,0.0071918,0.16503,0.12361,1,1
3,GO CARNITINE METABOLIC PROCESS,0.013856,0.16498,0.15397,1,1
3,GO LIPID HOMEOSTASIS,0.00013899,0.16497,0.16504,1,1
3,GO RESPONSE TO INORGANIC SUBSTANCE,1.1789e-06,0.16496,0.15895,1,1
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.012087,0.16487,0.15035,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.002702,0.16485,0.17888,1,1
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0045438,0.1648,0.12016,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,3.3806e-05,0.16469,0.26859,1,1
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0022396,0.16466,0.16148,1,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,2.2015e-05,0.16455,0.18179,1,1
3,GO LIPID OXIDATION,0.00025215,0.16448,0.1545,1,1
3,GO SECRETION,1.6654e-06,0.16441,0.16465,1,1
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0020367,0.1643,0.11879,1,1
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00018323,0.16429,0.17311,1,1
3,GO REGULATION OF CELLULAR PH,2.9514e-07,0.16428,0.1765,1,1
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00053704,0.16428,0.14369,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00083767,0.16419,0.15167,1,1
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,7.2497e-05,0.16412,0.16228,1,1
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.0034692,0.16408,0.14007,1,1
3,GO CATECHOLAMINE SECRETION,0.00055343,0.16393,0.26029,1,1
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.00067188,0.16382,0.16244,1,1
3,GO SPERM CAPACITATION,0.00081356,0.16375,0.17234,1,1
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00013451,0.16375,0.15131,1,1
3,GO ALCOHOL METABOLIC PROCESS,8.0256e-05,0.16374,0.15512,1,1
3,GO RESPONSE TO IRON ION,0.00024045,0.16372,0.19431,1,1
3,GO ACUTE PHASE RESPONSE,9.9844e-05,0.16358,0.19772,1,1
3,GO REGULATION OF ENDOCRINE PROCESS,1.5576e-05,0.16344,0.22561,1,1
3,GO LOCOMOTOR RHYTHM,0.014013,0.16329,0.14049,1,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00018923,0.16324,0.1697,1,1
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0044298,0.16321,0.16257,1,1
3,GO MACROPHAGE DIFFERENTIATION,0.018091,0.1632,0.12469,1,1
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,3.2784e-06,0.16315,0.18708,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00026438,0.16307,0.15772,1,1
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.004156,0.16294,0.2179,1,1
3,GO RESPONSE TO WOUNDING,0.0022095,0.1629,0.1471,1,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,8.4424e-05,0.16282,0.15497,1,1
3,GO TISSUE MIGRATION,0.0044298,0.16269,0.14267,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0024609,0.16268,0.12915,1,1
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.00027284,0.16242,0.13312,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,6.7724e-05,0.16241,0.22572,1,1
3,GO CELLULAR RESPONSE TO KETONE,0.0076401,0.16228,0.11981,1,1
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.001568,0.16227,0.17598,1,1
3,GO ANION TRANSPORT,3.4098e-06,0.16223,0.15091,1,1
3,GO ENDOTHELIAL CELL MIGRATION,0.0040509,0.16217,0.15023,1,1
3,GO SEQUESTERING OF TRIGLYCERIDE,0.017125,0.16207,0.14781,1,1
3,GO GLUCOSE METABOLIC PROCESS,6.8885e-07,0.16201,0.18137,1,1
3,GO REGULATION OF IMMUNE RESPONSE,9.1829e-05,0.162,0.15949,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0069343,0.16172,0.13525,1,1
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0002443,0.16162,0.21634,1,1
3,GO DEVELOPMENTAL INDUCTION,0.0027747,0.16152,0.15462,1,1
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00019541,0.16137,0.1717,1,1
3,GO RESPONSE TO PROGESTERONE,0.0029256,0.16114,0.16179,1,1
3,GO CHEMICAL HOMEOSTASIS,4.31e-06,0.16105,0.14743,1,1
3,GO INTRACELLULAR STEROL TRANSPORT,0.00067188,0.16103,0.22562,1,1
3,GO RESPONSE TO AMINE,0.035336,0.16099,0.10246,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.011022,0.16094,0.15061,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,7.6283e-05,0.16093,0.20084,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.001442,0.16086,0.1524,1,1
3,GO T CELL DIFFERENTIATION,0.00068191,0.16085,0.12683,1,1
3,GO LYSOSOME LOCALIZATION,0.00017457,0.16084,0.16584,1,1
3,GO PROTEIN MANNOSYLATION,0.00024045,0.16075,0.19012,1,1
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.025475,0.16028,0.10378,1,1
3,GO CELLULAR RESPONSE TO VIRUS,0.001704,0.16011,0.14354,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,1.536e-06,0.16006,0.177,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00049053,0.16002,0.17249,1,1
3,GO REGULATION OF PH,9.6538e-08,0.15978,0.18163,1,1
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.00012594,0.15964,0.23168,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00091404,0.15953,0.14754,1,1
3,GO GANGLIOSIDE METABOLIC PROCESS,0.043025,0.15943,0.11937,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.060988,0.15942,0.13461,1,1
3,GO GLIAL CELL DEVELOPMENT,0.0013069,0.15929,0.15788,1,1
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00053704,0.159,0.19696,1,1
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,4.3997e-05,0.15898,0.18269,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,1.3948e-05,0.15884,0.17708,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0094686,0.15883,0.12675,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0057669,0.15881,0.16508,1,1
3,GO REGULATION OF HORMONE SECRETION,1.7071e-05,0.15866,0.16564,1,1
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00068191,0.15848,0.18106,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.6158e-05,0.15842,0.17781,1,1
3,GO CARBOHYDRATE HOMEOSTASIS,1.5674e-06,0.15823,0.17197,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,6.1119e-05,0.15822,0.16246,1,1
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,1.7385e-05,0.15812,0.22521,1,1
3,GO CRANIAL NERVE DEVELOPMENT,0.0037985,0.15811,0.17633,1,1
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,3.5022e-05,0.15792,0.16088,1,1
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0060595,0.15789,0.14694,1,1
3,GO BIOLOGICAL ADHESION,0.0032928,0.15781,0.13211,1,1
3,GO T CELL CYTOKINE PRODUCTION,0.0053519,0.15756,0.14954,1,1
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00016361,0.15752,0.1585,1,1
3,GO MACROMOLECULE DEPALMITOYLATION,0.0033361,0.15738,0.15063,1,1
3,GO ENDOCRINE HORMONE SECRETION,6.4341e-05,0.15733,0.18873,1,1
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00020835,0.1573,0.19741,1,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.00029052,0.15709,0.14645,1,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.011411,0.15701,0.13963,1,1
3,GO ADAPTIVE THERMOGENESIS,9.404e-07,0.15689,0.18011,1,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.0002443,0.15664,0.15475,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,7.3803e-06,0.1565,0.15649,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.001071,0.15637,0.17138,1,1
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0071918,0.15631,0.19419,1,1
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00027284,0.15615,0.15185,1,1
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0021798,0.15609,0.14278,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00029976,0.15588,0.18409,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0019023,0.15575,0.15921,1,1
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,1.1588e-05,0.1557,0.16174,1,1
3,GO STRIATED MUSCLE ADAPTATION,0.00022565,0.15569,0.19909,1,1
3,GO MYELIN ASSEMBLY,0.0016575,0.1554,0.21727,1,1
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.00049053,0.15486,0.17065,1,1
3,GO GAMMA DELTA T CELL ACTIVATION,0.010645,0.15486,0.19092,1,1
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.01251,0.15466,0.15751,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.056128,0.15462,0.1531,1,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0062877,0.15455,0.15232,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0038478,0.15451,0.16958,1,1
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00037257,0.15431,0.15962,1,1
3,GO NEPHRON DEVELOPMENT,0.018693,0.15414,0.11477,1,1
3,GO STRIATED MUSCLE CONTRACTION,0.0007901,0.1541,0.13531,1,1
3,GO RENAL TUBULE DEVELOPMENT,0.01585,0.15407,0.11671,1,1
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,6.3249e-05,0.154,0.14327,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00068191,0.15395,0.15114,1,1
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00010673,0.15393,0.18138,1,1
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0032078,0.15392,0.17176,1,1
3,GO DRUG METABOLIC PROCESS,0.00024819,0.15381,0.22315,1,1
3,GO ER OVERLOAD RESPONSE,0.0062877,0.15373,0.1704,1,1
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0005789,0.15372,0.17905,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.010041,0.15345,0.12761,1,1
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0084096,0.15345,0.13724,1,1
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0056958,0.15334,0.1342,1,1
3,GO DETECTION OF MECHANICAL STIMULUS,0.010522,0.1533,0.15347,1,1
3,GO PHAGOCYTOSIS,0.0025961,0.15311,0.14029,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.001422,0.15304,0.13957,1,1
3,GO REGULATION OF CELL MATRIX ADHESION,0.0022095,0.15285,0.18522,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0058389,0.15284,0.14039,1,1
3,GO ION TRANSPORT,8.4262e-06,0.15277,0.14063,1,1
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,1.4163e-06,0.15274,0.18058,1,1
3,GO DETOXIFICATION,0.017125,0.15264,0.11225,1,1
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0058389,0.15263,0.1858,1,1
3,GO STEROID CATABOLIC PROCESS,0.0021505,0.15242,0.22449,1,1
3,GO FATTY ACID BIOSYNTHETIC PROCESS,6.545e-05,0.15242,0.17325,1,1
3,GO IMMUNOGLOBULIN PRODUCTION,0.00032408,0.15237,0.13109,1,1
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.016568,0.15234,0.2038,1,1
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,1.1588e-05,0.15233,0.14797,1,1
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00059648,0.15223,0.22322,1,1
3,GO POSITIVE REGULATION OF HORMONE SECRETION,9.9803e-06,0.15222,0.1805,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00011596,0.15198,0.19447,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.026561,0.15168,0.11118,1,1
3,GO REGULATION OF TUBE SIZE,0.00026858,0.15156,0.13587,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0032501,0.15152,0.13258,1,1
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0029645,0.15152,0.18939,1,1
3,GO SEQUESTERING OF CALCIUM ION,0.0031247,0.15128,0.12145,1,1
3,GO RESPONSE TO INTERLEUKIN 1,0.00026438,0.15113,0.12358,1,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.001704,0.15092,0.14458,1,1
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.05357,0.15087,0.081158,1,1
3,GO INORGANIC ANION TRANSPORT,1.5865e-05,0.15068,0.14389,1,1
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.057179,0.15059,0.14674,1,1
3,GO LIPID CATABOLIC PROCESS,1.8032e-05,0.15055,0.16524,1,1
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0046604,0.15041,0.14987,1,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0010259,0.15041,0.1605,1,1
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.0087156,0.1504,0.16311,1,1
3,GO PLASMA MEMBRANE ORGANIZATION,0.00015583,0.15036,0.19043,1,1
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.057179,0.15035,0.10431,1,1
3,GO REGULATION OF LIPID TRANSPORT,0.00037257,0.1503,0.16037,1,1
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0005211,0.15003,0.17289,1,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.012087,0.15001,0.11552,1,1
3,GO REGULATION OF HORMONE LEVELS,1.6994e-06,0.14998,0.17432,1,1
3,GO MONONUCLEAR CELL MIGRATION,0.0046018,0.14987,0.13196,1,1
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.0043184,0.1498,0.15646,1,1
3,GO GPI ANCHOR METABOLIC PROCESS,3.6162e-06,0.14955,0.22748,1,1
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0025617,0.14948,0.15538,1,1
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00010673,0.14939,0.14996,1,1
3,GO T CELL APOPTOTIC PROCESS,0.012798,0.14922,0.11976,1,1
3,GO METAL ION HOMEOSTASIS,8.0256e-05,0.14919,0.12526,1,1
3,GO SYNCYTIUM FORMATION,0.0005056,0.14897,0.19486,1,1
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0080166,0.14891,0.13996,1,1
3,GO CHLORIDE ION HOMEOSTASIS,0.043866,0.14886,0.11798,1,1
3,GO FATTY ACID METABOLIC PROCESS,2.4972e-05,0.14877,0.16499,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,6.1119e-05,0.14874,0.15368,1,1
3,GO PEROXISOMAL TRANSPORT,0.00029511,0.14869,0.1487,1,1
3,GO BROWN FAT CELL DIFFERENTIATION,0.00012594,0.14865,0.19594,1,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0017517,0.14862,0.11898,1,1
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00095459,0.1484,0.11707,1,1
3,GO RETINOL METABOLIC PROCESS,0.0011836,0.14826,0.21046,1,1
3,GO REGULATION OF HEMOPOIESIS,0.0010558,0.14819,0.12014,1,1
3,GO ENGULFMENT OF APOPTOTIC CELL,0.0018256,0.14814,0.18617,1,1
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00096848,0.14808,0.1431,1,1
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,9.03e-05,0.14798,0.18264,1,1
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,2.2416e-05,0.14794,0.13864,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.001071,0.14792,0.11104,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION,9.819e-05,0.14784,0.1557,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0028118,0.14777,0.16806,1,1
3,GO POTASSIUM ION HOMEOSTASIS,0.014172,0.14774,0.11576,1,1
3,GO PLACENTA DEVELOPMENT,0.020605,0.14766,0.10811,1,1
3,GO RECEPTOR CATABOLIC PROCESS,0.017506,0.1476,0.12043,1,1
3,GO T CELL LINEAGE COMMITMENT,0.0019285,0.14754,0.15102,1,1
3,GO ZINC ION TRANSPORT,0.0020929,0.14725,0.12806,1,1
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00068191,0.1472,0.13774,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,1.5865e-05,0.14717,0.16844,1,1
3,GO RESPONSE TO ANGIOTENSIN,0.016386,0.14714,0.14,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.01995,0.14685,0.25878,1,1
3,GO REGULATION OF APPETITE,0.0089251,0.14676,0.099572,1,1
3,GO FATTY ACID BETA OXIDATION,0.011151,0.14672,0.10992,1,1
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.0095807,0.14669,0.20353,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00026858,0.14669,0.17411,1,1
3,GO ESTROUS CYCLE,0.045591,0.14667,0.15131,1,1
3,GO CELLULAR RESPONSE TO STARVATION,3.5461e-06,0.14663,0.16775,1,1
3,GO MANGANESE ION TRANSPORT,0.0013443,0.14652,0.14733,1,1
3,GO XENOBIOTIC TRANSPORT,0.0032501,0.14611,0.15852,1,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,9.9803e-06,0.14575,0.17835,1,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0014022,0.14572,0.13979,1,1
3,GO FAT CELL DIFFERENTIATION,0.00034485,0.14555,0.16382,1,1
3,GO HEART TRABECULA MORPHOGENESIS,0.0071051,0.14548,0.14165,1,1
3,GO EPITHELIUM DEVELOPMENT,0.00073415,0.14546,0.12641,1,1
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.00014129,0.14537,0.17123,1,1
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0028492,0.14536,0.16158,1,1
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0043184,0.14528,0.18299,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0028872,0.14524,0.1464,1,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,1.9393e-05,0.14516,0.13947,1,1
3,GO PROTEIN KINASE B SIGNALING,0.0042095,0.1451,0.12181,1,1
3,GO CELLULAR RESPONSE TO ALKALOID,6.6578e-05,0.14509,0.17218,1,1
3,GO VACUOLE ORGANIZATION,1.0424e-06,0.145,0.17753,1,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.000286,0.14476,0.1441,1,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00019229,0.14473,0.14284,1,1
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.017699,0.14465,0.13001,1,1
3,GO REGULATION OF CHEMOTAXIS,0.00072342,0.14455,0.14077,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.027686,0.14441,0.11255,1,1
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0033799,0.14441,0.13646,1,1
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,3.9613e-05,0.14389,0.15325,1,1
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0011021,0.14379,0.13098,1,1
3,GO HEPARIN METABOLIC PROCESS,0.064418,0.14371,0.12223,1,1
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00076726,0.14361,0.13179,1,1
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00094089,0.14357,0.15729,1,1
3,GO REGULATION OF SECRETION,5.5412e-06,0.14318,0.15342,1,1
3,GO ION HOMEOSTASIS,3.6924e-05,0.143,0.12939,1,1
3,GO ATP BIOSYNTHETIC PROCESS,0.037882,0.14283,0.12618,1,1
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.001568,0.14277,0.11232,1,1
3,GO GLUCOSE IMPORT,0.001422,0.14274,0.12185,1,1
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0059852,0.14273,0.1314,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,2.4091e-05,0.14265,0.15227,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.029754,0.14261,0.14313,1,1
3,GO REGULATION OF GLUCONEOGENESIS,2.8305e-05,0.14233,0.17483,1,1
3,GO REGULATION OF LIPID STORAGE,0.00092737,0.14222,0.15261,1,1
3,GO VESICLE BUDDING FROM MEMBRANE,0.0012886,0.14216,0.1256,1,1
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.00013232,0.14202,0.19106,1,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0030839,0.14184,0.11046,1,1
3,GO GOLGI VESICLE BUDDING,0.00041488,0.14182,0.12949,1,1
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.027973,0.14172,0.1228,1,1
3,GO GLIAL CELL ACTIVATION,0.0092477,0.14159,0.14023,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.003607,0.14155,0.13626,1,1
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.027686,0.14142,0.12299,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0007786,0.14134,0.14149,1,1
3,GO GLUTAMATE METABOLIC PROCESS,0.0013069,0.14129,0.12922,1,1
3,GO ORGANELLE FUSION,5.6085e-05,0.14122,0.15033,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00038422,0.14098,0.15939,1,1
3,GO FATTY ACID TRANSPORT,0.00044103,0.14091,0.14462,1,1
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.043866,0.1408,0.13906,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.007921,0.14077,0.11513,1,1
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0030038,0.14057,0.14474,1,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0015463,0.1405,0.13203,1,1
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0083098,0.14045,0.12725,1,1
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.00099681,0.14044,0.1266,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0002117,0.14035,0.16076,1,1
3,GO ACTIN NUCLEATION,0.00075607,0.14018,0.15611,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0005056,0.14001,0.13764,1,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0011836,0.13994,0.11872,1,1
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.016752,0.13989,0.11096,1,1
3,GO RESPONSE TO OSMOTIC STRESS,0.00090088,0.13973,0.13035,1,1
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.002631,0.13966,0.1541,1,1
3,GO IRON ION TRANSPORT,5.2303e-06,0.13963,0.17175,1,1
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0104,0.13915,0.14177,1,1
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.001776,0.13902,0.1355,1,1
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.9393e-05,0.13882,0.15576,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00040235,0.13867,0.16374,1,1
3,GO TEMPERATURE HOMEOSTASIS,1.7071e-05,0.13854,0.16088,1,1
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.0087156,0.13852,0.17567,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00057029,0.13845,0.16783,1,1
3,GO NEGATIVE T CELL SELECTION,0.022686,0.13845,0.13543,1,1
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0058389,0.13843,0.14557,1,1
3,GO MACROPHAGE ACTIVATION,3.6924e-05,0.1384,0.21067,1,1
3,GO RESPONSE TO DSRNA,0.001235,0.13813,0.13166,1,1
3,GO REGULATION OF PROTEOLYSIS,0.00011596,0.1381,0.14292,1,1
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00022565,0.13801,0.12456,1,1
3,GO PROTEIN PALMITOYLATION,0.020605,0.13796,0.12475,1,1
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.00062378,0.13795,0.13366,1,1
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.023173,0.13782,0.094217,1,1
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0016575,0.1378,0.15559,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.027401,0.13755,0.14988,1,1
3,GO MEMBRANE REPOLARIZATION,0.001568,0.13738,0.18003,1,1
3,GO LIPID DROPLET ORGANIZATION,5.7059e-05,0.13731,0.20798,1,1
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0067673,0.13716,0.11937,1,1
3,GO CHOLESTEROL EFFLUX,0.0046018,0.13704,0.13487,1,1
3,GO MONOVALENT INORGANIC CATION TRANSPORT,7.6657e-06,0.13698,0.16103,1,1
3,GO CARBOHYDRATE METABOLIC PROCESS,5.0323e-06,0.1369,0.15065,1,1
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.026013,0.13689,0.13364,1,1
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.000286,0.13684,0.1815,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,1.4472e-05,0.13678,0.13782,1,1
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.0034243,0.13648,0.11626,1,1
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0012705,0.13624,0.15822,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0029645,0.13623,0.11548,1,1
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.00053704,0.13622,0.17768,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.058787,0.13621,0.11529,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,0.0010408,0.1362,0.11537,1,1
3,GO SODIUM ION TRANSPORT,9.6129e-06,0.1361,0.17138,1,1
3,GO LIPID IMPORT INTO CELL,0.016752,0.13571,0.14949,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00029976,0.1357,0.13127,1,1
3,GO SECONDARY PALATE DEVELOPMENT,0.012087,0.13561,0.14778,1,1
3,GO REGULATION OF GLUCOSE IMPORT,0.0012005,0.13556,0.12396,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.0014624,0.13548,0.11318,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.018693,0.13527,0.11704,1,1
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.023668,0.13522,0.16116,1,1
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0026663,0.13518,0.17382,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0003557,0.13516,0.15215,1,1
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00011218,0.13481,0.20946,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0028118,0.1348,0.11697,1,1
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00015583,0.13465,0.14459,1,1
3,GO POSITIVE T CELL SELECTION,0.0027381,0.13463,0.13077,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.030994,0.13443,0.11806,1,1
3,GO MUSCLE CELL DEVELOPMENT,0.0007901,0.13439,0.13836,1,1
3,GO RESPONSE TO DRUG,0.00060545,0.13435,0.1334,1,1
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.01995,0.13426,0.15962,1,1
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.00016361,0.13421,0.15102,1,1
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,2.2824e-05,0.13408,0.17867,1,1
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,5.4356e-06,0.13402,0.15976,1,1
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00033432,0.13392,0.14488,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00013232,0.13387,0.13092,1,1
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00041488,0.13337,0.12112,1,1
3,GO REGULATION OF MAP KINASE ACTIVITY,0.00044103,0.1332,0.14932,1,1
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,7.2497e-05,0.13303,0.18343,1,1
3,GO ION TRANSMEMBRANE TRANSPORT,4.7999e-05,0.13299,0.13028,1,1
3,GO CALCIUM ION IMPORT,0.003166,0.13299,0.11237,1,1
3,GO EXOCYTIC PROCESS,0.00068191,0.13291,0.17639,1,1
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0092477,0.13256,0.11667,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,1.2482e-05,0.13241,0.14153,1,1
3,GO RESPONSE TO STARVATION,1.3196e-05,0.13229,0.15444,1,1
3,GO RIG I SIGNALING PATHWAY,0.036048,0.13228,0.087743,1,1
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0050904,0.13218,0.15269,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0084096,0.13196,0.12327,1,1
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.010769,0.13187,0.12512,1,1
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0078263,0.13175,0.12295,1,1
3,GO COPII COATED VESICLE BUDDING,0.0016347,0.13161,0.11384,1,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00013451,0.13131,0.13995,1,1
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0024941,0.1311,0.15393,1,1
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00040235,0.13104,0.16274,1,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.002702,0.13095,0.11278,1,1
3,GO NEUROINFLAMMATORY RESPONSE,0.004964,0.13091,0.13238,1,1
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.0001803,0.13076,0.12765,1,1
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.023419,0.13059,0.12151,1,1
3,GO APOPTOTIC SIGNALING PATHWAY,7.1274e-05,0.13051,0.13503,1,1
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00086244,0.13047,0.11036,1,1
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.018898,0.13035,0.16047,1,1
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0071918,0.13033,0.1324,1,1
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.00014839,0.13026,0.16317,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0073682,0.12991,0.12346,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.00029511,0.12948,0.13541,1,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0010259,0.12935,0.11532,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0020367,0.12934,0.17533,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,0.00080175,0.12929,0.111,1,1
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0073682,0.12926,0.1247,1,1
3,GO TRANSMEMBRANE TRANSPORT,1.2716e-05,0.12906,0.13006,1,1
3,GO HOMEOSTATIC PROCESS,6.7724e-05,0.12895,0.11764,1,1
3,GO DRUG CATABOLIC PROCESS,0.0075485,0.12894,0.17418,1,1
3,GO CATION TRANSMEMBRANE TRANSPORT,0.00023667,0.12875,0.12155,1,1
3,GO MEMBRANE ORGANIZATION,0.00044781,0.12871,0.11164,1,1
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0005211,0.12865,0.13023,1,1
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0094686,0.12864,0.12659,1,1
3,GO NEUROTRANSMITTER REUPTAKE,0.050154,0.12846,0.12406,1,1
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.025475,0.12784,0.18655,1,1
3,GO SULFUR COMPOUND TRANSPORT,0.0005789,0.1278,0.1393,1,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0045438,0.12779,0.1109,1,1
3,GO REGULATION OF PROTEIN DEACETYLATION,0.0024281,0.12769,0.13425,1,1
3,GO RELAXATION OF MUSCLE,0.0057669,0.12766,0.15157,1,1
3,GO REGULATION OF PROTEIN MATURATION,0.025743,0.12753,0.10489,1,1
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.03006,0.12753,0.10751,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00036124,0.12733,0.12336,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.017699,0.12728,0.15572,1,1
3,GO PIGMENT GRANULE LOCALIZATION,0.0033361,0.12727,0.1356,1,1
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0088198,0.1271,0.12487,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056255,0.12658,0.13453,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,2.2015e-05,0.12657,0.13374,1,1
3,GO SERTOLI CELL DIFFERENTIATION,0.022209,0.12655,0.16972,1,1
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.034636,0.12653,0.1308,1,1
3,GO T CELL SELECTION,0.00055343,0.12647,0.13403,1,1
3,GO MYELOID CELL DIFFERENTIATION,0.0012177,0.12619,0.12048,1,1
3,GO SINGLE FERTILIZATION,0.0031247,0.12592,0.089409,1,1
3,GO RESPONSE TO DEXAMETHASONE,0.0051547,0.12591,0.12942,1,1
3,GO MUSCLE SYSTEM PROCESS,0.0025961,0.12578,0.10501,1,1
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0025961,0.12574,0.13172,1,1
3,GO RESPONSE TO KETONE,0.0034692,0.1256,0.11871,1,1
3,GO MESONEPHROS DEVELOPMENT,0.0046604,0.12534,0.1365,1,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00016098,0.12508,0.13434,1,1
3,GO CALCIUM MEDIATED SIGNALING,4.1026e-05,0.12504,0.11505,1,1
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.01499,0.12496,0.1113,1,1
3,GO RESPONSE TO STEROID HORMONE,0.0045438,0.12486,0.11214,1,1
3,GO CELLULAR ION HOMEOSTASIS,0.00011406,0.12473,0.1156,1,1
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.0072795,0.12473,0.14853,1,1
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00012594,0.12472,0.14434,1,1
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,4.6359e-05,0.12461,0.13686,1,1
3,GO TUMOR NECROSIS FACTOR SECRETION,0.015159,0.12461,0.10837,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,2.3661e-05,0.12447,0.13467,1,1
3,GO REGULATION OF JUN KINASE ACTIVITY,0.0066851,0.12442,0.12483,1,1
3,GO REGULATION OF HISTONE DEACETYLATION,0.0015463,0.12441,0.1683,1,1
3,GO RESPONSE TO LIPID,0.0017277,0.12429,0.11881,1,1
3,GO PROTON TRANSMEMBRANE TRANSPORT,1.1375e-05,0.12408,0.15073,1,1
3,GO EATING BEHAVIOR,0.00039018,0.12395,0.16231,1,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00010673,0.1239,0.13578,1,1
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.03006,0.12385,0.11845,1,1
3,GO RESPONSE TO TESTOSTERONE,0.0042636,0.12384,0.14799,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0059852,0.12381,0.15868,1,1
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.014332,0.12371,0.097449,1,1
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0016806,0.12369,0.15572,1,1
3,GO ZINC ION HOMEOSTASIS,0.017315,0.12355,0.19005,1,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,2.3239e-05,0.12353,0.1421,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.013546,0.12346,0.093317,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.8347e-06,0.12331,0.152,1,1
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0030436,0.12328,0.15948,1,1
3,GO REGULATION OF LIPID LOCALIZATION,0.0005056,0.12327,0.14469,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0005211,0.12325,0.12709,1,1
3,GO PROTEIN MATURATION,8.2686e-06,0.1231,0.15855,1,1
3,GO RESPONSE TO PEPTIDE HORMONE,0.000662,0.12275,0.11372,1,1
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.011022,0.12273,0.17354,1,1
3,GO FEAR RESPONSE,0.022446,0.12266,0.094398,1,1
3,GO REGULATION OF TOR SIGNALING,0.00029052,0.12258,0.12419,1,1
3,GO AUTOPHAGOSOME MATURATION,0.00090088,0.12255,0.1537,1,1
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0015463,0.12245,0.17029,1,1
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0010113,0.12235,0.11853,1,1
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.011813,0.12214,0.10843,1,1
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.017506,0.12213,0.10743,1,1
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00098255,0.12194,0.119,1,1
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00046872,0.12183,0.12207,1,1
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0070192,0.12183,0.13012,1,1
3,GO POSITIVE REGULATION OF SIGNALING,0.00020504,0.12175,0.11884,1,1
3,GO POSITIVE REGULATION OF TRANSPORT,0.00031414,0.12154,0.11401,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0023957,0.12151,0.13352,1,1
3,GO NIK NF KAPPAB SIGNALING,0.0017517,0.12141,0.10832,1,1
3,GO CARDIAC CELL DEVELOPMENT,0.0035605,0.12116,0.12485,1,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.065596,0.1211,0.12411,1,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.027118,0.12105,0.15791,1,1
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0022095,0.12097,0.12341,1,1
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.036772,0.12096,0.12898,1,1
3,GO ACTIVATION OF MAPK ACTIVITY,0.0002443,0.12079,0.15377,1,1
3,GO AMINE CATABOLIC PROCESS,0.0045438,0.12078,0.17187,1,1
3,GO CELLULAR RESPONSE TO LIPID,0.0062108,0.12062,0.10802,1,1
3,GO REGULATION OF PEPTIDE TRANSPORT,6.337e-06,0.12056,0.13607,1,1
3,GO FC RECEPTOR SIGNALING PATHWAY,0.0023009,0.12024,0.1103,1,1
3,GO RESPONSE TO TOXIC SUBSTANCE,0.00031414,0.12022,0.13534,1,1
3,GO EXECUTION PHASE OF APOPTOSIS,2.4861e-06,0.12017,0.1389,1,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.00096848,0.12015,0.12904,1,1
3,GO HEXOSE CATABOLIC PROCESS,0.053071,0.12005,0.11315,1,1
3,GO PEROXISOME ORGANIZATION,0.0005133,0.12004,0.13754,1,1
3,GO RESPONSE TO HORMONE,0.0013826,0.12002,0.11279,1,1
3,GO AGING,0.00024819,0.11959,0.12307,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.0022396,0.11945,0.11919,1,1
3,GO STEROL BIOSYNTHETIC PROCESS,0.0014624,0.11915,0.13781,1,1
3,GO OXIDATION REDUCTION PROCESS,0.00011033,0.11899,0.12922,1,1
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.000662,0.11895,0.14412,1,1
3,GO RESPONSE TO CORTICOSTEROID,0.012653,0.11876,0.11168,1,1
3,GO ACID SECRETION,0.001118,0.11872,0.12795,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0041031,0.11861,0.12749,1,1
3,GO CIRCADIAN RHYTHM,0.00029052,0.11847,0.12433,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0062108,0.11805,0.13451,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0021798,0.118,0.14137,1,1
3,GO REPLICATIVE SENESCENCE,0.049681,0.11795,0.1403,1,1
3,GO POSITIVE REGULATION OF MYELINATION,0.00053704,0.1179,0.14839,1,1
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0022701,0.11774,0.12345,1,1
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0017277,0.11768,0.13816,1,1
3,GO PROTEOLYSIS,0.00014362,0.11756,0.11703,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0020092,0.11737,0.12601,1,1
3,GO ENDOSOME ORGANIZATION,0.00047589,0.11727,0.13697,1,1
3,GO PIGMENT GRANULE ORGANIZATION,0.023668,0.11674,0.10219,1,1
3,GO ANION TRANSMEMBRANE TRANSPORT,8.3013e-05,0.11674,0.13082,1,1
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.00012186,0.11667,0.11841,1,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0016122,0.11662,0.11558,1,1
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00022565,0.1166,0.1506,1,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,7.5001e-05,0.11643,0.15291,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0001803,0.11628,0.14373,1,1
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0065235,0.11624,0.14118,1,1
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0002443,0.11618,0.12447,1,1
3,GO MYELOID CELL HOMEOSTASIS,0.0073682,0.1161,0.11809,1,1
3,GO TRANSITION METAL ION TRANSPORT,7.5217e-06,0.11592,0.15319,1,1
3,GO POLYOL CATABOLIC PROCESS,0.0023957,0.11585,0.1407,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00032408,0.11557,0.1476,1,1
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0012527,0.11546,0.13162,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0024281,0.11542,0.14688,1,1
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.006444,0.11539,0.13111,1,1
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.02915,0.11536,0.090557,1,1
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.014332,0.11507,0.16857,1,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.062684,0.11489,0.093469,1,1
3,GO RESPONSE TO OXYGEN LEVELS,0.0014624,0.1148,0.11672,1,1
3,GO REGULATION OF STEROL TRANSPORT,0.028264,0.11472,0.10093,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00026438,0.11434,0.11781,1,1
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.011678,0.1142,0.13187,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.8032e-05,0.11391,0.14345,1,1
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00054518,0.11369,0.15185,1,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,2.3239e-05,0.11366,0.14125,1,1
3,GO SARCOMERE ORGANIZATION,0.021973,0.11354,0.11676,1,1
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.055609,0.11353,0.13517,1,1
3,GO FATTY ACYL COA METABOLIC PROCESS,0.0015249,0.11323,0.17475,1,1
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0067673,0.11304,0.11563,1,1
3,GO POLYOL BIOSYNTHETIC PROCESS,0.00010152,0.11246,0.15448,1,1
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.011813,0.11233,0.095979,1,1
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,9.9844e-05,0.1123,0.14923,1,1
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.00099681,0.11215,0.10983,1,1
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0018764,0.11215,0.13336,1,1
3,GO KERATINOCYTE MIGRATION,0.0062877,0.11214,0.12233,1,1
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.039795,0.11183,0.13967,1,1
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.02128,0.11182,0.12316,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.0024281,0.11177,0.11847,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.8032e-05,0.11163,0.14187,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0047798,0.11155,0.12728,1,1
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.019735,0.11154,0.11121,1,1
3,GO REGULATION OF BONE DEVELOPMENT,0.051595,0.11133,0.10215,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00018323,0.11128,0.12025,1,1
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0022095,0.11098,0.18954,1,1
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0011836,0.11096,0.1065,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.001071,0.11052,0.18471,1,1
3,GO POSITIVE REGULATION OF CELL DEATH,0.0035605,0.11007,0.10602,1,1
3,GO REGULATION OF RECEPTOR RECYCLING,0.02128,0.10976,0.11854,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0032501,0.10974,0.09969,1,1
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0035605,0.10968,0.11099,1,1
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0096941,0.10944,0.10587,1,1
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.013243,0.10931,0.096007,1,1
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0054192,0.10894,0.13706,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0028118,0.10881,0.12091,1,1
3,GO RESPONSE TO ACID CHEMICAL,0.0014022,0.10864,0.11783,1,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0071051,0.10844,0.10419,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00024045,0.10842,0.11311,1,1
3,GO THYMIC T CELL SELECTION,0.013243,0.10839,0.1072,1,1
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.039406,0.10832,0.071626,1,1
3,GO LIPID MODIFICATION,0.00042777,0.10826,0.1291,1,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.0027381,0.10774,0.10529,1,1
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.040981,0.1074,0.12013,1,1
3,GO RESPONSE TO OXIDATIVE STRESS,0.00084997,0.10709,0.11713,1,1
3,GO DENDRITE EXTENSION,0.0037985,0.10656,0.20058,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00040235,0.10654,0.13084,1,1
3,GO TRANSITION METAL ION HOMEOSTASIS,0.00073415,0.10647,0.13479,1,1
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.031311,0.10641,0.096006,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00029511,0.10633,0.12675,1,1
3,GO POSITIVE REGULATION OF CELL GROWTH,0.0075485,0.1062,0.095838,1,1
3,GO REGULATION OF MACROPHAGE MIGRATION,0.0022095,0.10599,0.12838,1,1
3,GO TRANSLESION SYNTHESIS,0.002702,0.10583,0.1019,1,1
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0018764,0.10574,0.11527,1,1
3,GO SENSORY PERCEPTION,0.0001862,0.10571,0.11048,1,1
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0087156,0.10524,0.10496,1,1
3,GO REGULATION OF MAPK CASCADE,0.0030839,0.10518,0.12021,1,1
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.004964,0.10372,0.10903,1,1
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0023637,0.10355,0.11304,1,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.003607,0.1034,0.10805,1,1
3,GO PROTEIN AUTOUBIQUITINATION,0.00046872,0.10296,0.11196,1,1
3,GO AUTOPHAGOSOME ORGANIZATION,0.00036124,0.10296,0.14103,1,1
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.044722,0.10281,0.098119,1,1
3,GO RESPONSE TO ACTIVITY,0.0066039,0.1025,0.11323,1,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0092477,0.10231,0.090436,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.026013,0.10229,0.08834,1,1
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00088789,0.10188,0.1228,1,1
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.048285,0.10184,0.14697,1,1
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.031311,0.10158,0.1202,1,1
3,GO SELECTIVE AUTOPHAGY,0.0010408,0.10154,0.1318,1,1
3,GO ANIMAL ORGAN MATURATION,0.007921,0.10141,0.15378,1,1
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.021053,0.10101,0.1954,1,1
3,GO ORGANIC ACID CATABOLIC PROCESS,0.0071051,0.10098,0.099051,1,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00062378,0.10093,0.10903,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0037985,0.10088,0.1146,1,1
3,GO GOLGI ORGANIZATION,6.545e-05,0.10023,0.13308,1,1
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0054192,0.10007,0.13486,1,1
3,GO REGULATION OF AUTOPHAGY,0.00032916,0.10002,0.11213,1,1
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00082553,0.099304,0.11177,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00044781,0.099,0.13344,1,1
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.043025,0.098433,0.12089,1,1
3,GO SKELETAL MUSCLE CONTRACTION,0.020828,0.098125,0.11076,1,1
3,GO POLYOL METABOLIC PROCESS,0.0045438,0.098028,0.095621,1,1
3,GO NADP METABOLIC PROCESS,0.02945,0.097976,0.13548,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.016568,0.097722,0.12452,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.019104,0.097673,0.091066,1,1
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.020828,0.097595,0.082879,1,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.00034485,0.097586,0.11471,1,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0073682,0.09747,0.093927,1,1
3,GO RECEPTOR RECYCLING,0.017506,0.097405,0.11432,1,1
3,GO VIRAL RELEASE FROM HOST CELL,0.008211,0.097386,0.112,1,1
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0038478,0.096588,0.1139,1,1
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00040857,0.09651,0.13231,1,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00080175,0.096127,0.10066,1,1
3,GO POSITIVE THYMIC T CELL SELECTION,0.015159,0.096126,0.14851,1,1
3,GO REGULATION OF CELL DEATH,0.0043184,0.095849,0.093068,1,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.0037985,0.09558,0.1195,1,1
3,GO DETECTION OF ABIOTIC STIMULUS,0.017506,0.095556,0.088478,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.001483,0.095357,0.094422,1,1
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.0023009,0.095213,0.11864,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0104,0.09521,0.12934,1,1
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.022928,0.09521,0.11087,1,1
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.01128,0.095151,0.12616,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.00088789,0.094033,0.10633,1,1
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0090315,0.093817,0.13625,1,1
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.026838,0.093801,0.13118,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00095459,0.093727,0.12302,1,1
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0002443,0.093243,0.13615,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.001568,0.093043,0.1041,1,1
3,GO GOLGI RIBBON FORMATION,0.02945,0.093012,0.12489,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,0.0062108,0.092898,0.15182,1,1
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.042197,0.092666,0.076038,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0075485,0.092155,0.10098,1,1
3,GO APOPTOTIC PROCESS,0.0017517,0.092064,0.097801,1,1
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00019229,0.091879,0.11447,1,1
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.00031414,0.091419,0.17347,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.051595,0.091361,0.11476,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00073415,0.091243,0.10836,1,1
3,GO REGULATION OF RESPONSE TO STRESS,0.0010113,0.091232,0.10644,1,1
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.03006,0.090909,0.10477,1,1
3,GO MAINTENANCE OF LOCATION,0.0048405,0.090904,0.10087,1,1
3,GO SPLEEN DEVELOPMENT,0.042609,0.090874,0.085295,1,1
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0030436,0.090499,0.098399,1,1
3,GO ANIMAL ORGAN REGENERATION,0.01585,0.089937,0.10169,1,1
3,GO CELL CELL RECOGNITION,0.0014624,0.089924,0.12978,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.027118,0.089912,0.12124,1,1
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.001118,0.089672,0.1174,1,1
3,GO RESPONSE TO OXYGEN RADICAL,0.026013,0.089541,0.1104,1,1
3,GO RETINA HOMEOSTASIS,0.036048,0.089328,0.055531,1,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,6.2175e-05,0.088972,0.11842,1,1
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.023173,0.088655,0.12039,1,1
3,GO MUSCLE CELL PROLIFERATION,0.062684,0.08851,0.08344,1,1
3,GO TOR SIGNALING,0.00067188,0.088346,0.099767,1,1
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.040981,0.088223,0.12142,1,1
3,GO SYMBIOTIC PROCESS,0.011949,0.088046,0.074996,1,1
3,GO NEGATIVE REGULATION OF CELL DEATH,0.010769,0.08803,0.083592,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00068191,0.087934,0.11444,1,1
3,GO REGULATION OF VACUOLE ORGANIZATION,0.016938,0.086613,0.10425,1,1
3,GO RESPONSE TO ETHER,0.058247,0.086206,0.081711,1,1
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.052083,0.086109,0.065194,1,1
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0098086,0.086002,0.1147,1,1
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.0095807,0.084979,0.11524,1,1
3,GO DNA CATABOLIC PROCESS,0.0018508,0.084736,0.099849,1,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.00086244,0.084307,0.11281,1,1
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.054582,0.083924,0.090005,1,1
3,GO HORMONE BIOSYNTHETIC PROCESS,0.052575,0.083696,0.10513,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.03068,0.083211,0.089824,1,1
3,GO EXCRETION,0.018898,0.083187,0.10454,1,1
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.040981,0.082688,0.084147,1,1
3,GO MAINTENANCE OF LOCATION IN CELL,0.0037016,0.082447,0.10108,1,1
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.0042636,0.082353,0.11787,1,1
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.024687,0.082084,0.15109,1,1
3,GO RESPONSE TO ABIOTIC STIMULUS,0.0017517,0.081784,0.092886,1,1
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.020166,0.081601,0.090773,1,1
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.024428,0.081179,0.10046,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.056652,0.079616,0.088124,1,1
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.033608,0.078684,0.073832,1,1
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0088198,0.077918,0.083638,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0040509,0.077781,0.094762,1,1
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.027401,0.076837,0.094936,1,1
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.01585,0.076788,0.083897,1,1
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0033361,0.076295,0.097967,1,1
3,GO ORGANELLE DISASSEMBLY,0.0012005,0.075735,0.10697,1,1
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0037016,0.075371,0.096981,1,1
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0024281,0.075295,0.088381,1,1
3,GO ATP METABOLIC PROCESS,0.0069343,0.075158,0.080847,1,1
3,GO POSTREPLICATION REPAIR,0.056652,0.075111,0.057833,1,1
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0033799,0.074942,0.1165,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.02915,0.074884,0.11845,1,1
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.015674,0.07454,0.12083,1,1
3,GO AUTOPHAGY OF MITOCHONDRION,0.0024281,0.074343,0.1158,1,1
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.035336,0.073527,0.079616,1,1
3,GO REGULATION OF MITOPHAGY,0.03902,0.073461,0.10751,1,1
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.056652,0.073271,0.079445,1,1
3,GO REGULATION OF NUCLEASE ACTIVITY,0.041383,0.072655,0.079172,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.036048,0.071257,0.084856,1,1
3,GO CELLULAR IRON ION HOMEOSTASIS,0.044292,0.070676,0.09033,1,1
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.002631,0.068053,0.12299,1,1
3,GO REGULATION OF PROTEIN STABILITY,0.0030839,0.067299,0.08853,1,1
3,GO PROTEIN POLYUBIQUITINATION,0.0025961,0.067258,0.085994,1,1
3,GO FERTILIZATION,0.015159,0.065647,0.065574,1,1
3,GO MITOPHAGY,0.027118,0.065616,0.10635,1,1
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.041383,0.064412,0.072124,1,1
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.0033799,0.063322,0.10036,1,1
3,GO GOLGI VESICLE TRANSPORT,0.017506,0.063202,0.081963,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.042197,0.062703,0.10453,1,1
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.02945,0.062554,0.10211,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.034636,0.061607,0.073983,1,1
3,GO REGULATION OF CATABOLIC PROCESS,0.03006,0.055986,0.063688,1,1
3,GO THIOESTER METABOLIC PROCESS,0.0065235,0.048182,0.11458,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.026838,0.04687,0.072831,1,1
3,GO MACROAUTOPHAGY,0.0029256,0.042349,0.091596,1,1
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.031953,0.04179,0.063338,1,1
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.013243,0.20147,0.18596,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.016386,0.18082,0.1434,1,1
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.027973,0.16095,0.081438,1,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.057711,0.15341,0.1093,1,1
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.033948,0.14948,0.081229,1,1
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.043866,0.10291,0.074179,1,1
5,GO REGULATION OF SYNAPSE MATURATION,1.2058e-07,0.70198,0.5774,1,1
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,5.3747e-08,0.67842,0.66523,1,1
5,GO ANATOMICAL STRUCTURE REGRESSION,8.1138e-06,0.6459,0.45322,1,1
5,GO SYNAPSE MATURATION,1.0212e-06,0.6354,0.518,1,1
5,GO VOCALIZATION BEHAVIOR,6.3569e-09,0.63364,0.64593,1,1
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.971e-06,0.62635,0.56414,1,1
5,GO COMMISSURAL NEURON AXON GUIDANCE,2.6981e-08,0.62528,0.60866,1,1
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,3.4796e-08,0.60796,0.66669,1,1
5,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,7.7166e-08,0.58956,0.57668,1,1
5,GO PREPULSE INHIBITION,2.538e-07,0.58051,0.53619,1,1
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,1.1316e-06,0.57101,0.56265,1,1
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.3082e-09,0.56851,0.56969,1,1
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,1.3948e-05,0.56806,0.53206,1,1
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,1.1858e-08,0.56405,0.56599,1,1
5,GO SYNAPTIC MEMBRANE ADHESION,8.4805e-07,0.56033,0.47871,1,1
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,2.0398e-08,0.55601,0.53564,1,1
5,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,1.0161e-09,0.53392,0.57644,1,1
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,6.8885e-07,0.53305,0.5268,1,1
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,1.0781e-08,0.52165,0.50528,1,1
5,GO NEURONAL ION CHANNEL CLUSTERING,7.7166e-08,0.51595,0.52027,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,3.0811e-07,0.51515,0.4007,1,1
5,GO CARDIAC VENTRICLE FORMATION,5.1351e-07,0.5108,0.49726,1,1
5,GO POSTSYNAPSE ASSEMBLY,3.5606e-08,0.50113,0.52192,1,1
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,8.2543e-08,0.497,0.5087,1,1
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,5.9834e-06,0.49639,0.42927,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,1.9175e-06,0.49484,0.49743,1,1
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,8.2543e-08,0.49396,0.45716,1,1
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,2.6914e-06,0.4909,0.52184,1,1
5,GO NEURON CELL CELL ADHESION,9.8716e-08,0.48843,0.56227,1,1
5,GO FACIAL NERVE MORPHOGENESIS,1.8701e-05,0.48339,0.4248,1,1
5,GO RETINAL ROD CELL DIFFERENTIATION,5.4356e-06,0.48124,0.3906,1,1
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,8.6579e-07,0.47137,0.41774,1,1
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,2.4837e-07,0.46326,0.49962,1,1
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,3.8246e-05,0.45933,0.42296,1,1
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,5.0278e-07,0.45731,0.50785,1,1
5,GO SYNAPTIC VESICLE CLUSTERING,1.0424e-06,0.45711,0.54092,1,1
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,6.4434e-08,0.45616,0.42463,1,1
5,GO LIMB BUD FORMATION,4.9361e-06,0.45585,0.43239,1,1
5,GO NOSE DEVELOPMENT,5.2538e-08,0.45493,0.51699,1,1
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,9.4959e-05,0.4536,0.412,1,1
5,GO POSITIVE REGULATION OF NEURON MIGRATION,1.0958e-05,0.45133,0.40631,1,1
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,1.5277e-10,0.44781,0.45624,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.8673e-09,0.44439,0.41393,1,1
5,GO SOMATIC STEM CELL DIVISION,1.0958e-05,0.43758,0.41332,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,2.5359e-06,0.43565,0.4902,1,1
5,GO MALE SEX DETERMINATION,5.3747e-08,0.43412,0.409,1,1
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,2.1624e-06,0.43402,0.34848,1,1
5,GO SPINAL CORD PATTERNING,2.634e-09,0.43202,0.48458,1,1
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,3.9613e-05,0.43125,0.3666,1,1
5,GO REGULATION OF NEURON MIGRATION,1.4677e-08,0.43076,0.42084,1,1
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,1.0212e-06,0.4291,0.36555,1,1
5,GO CARDIAC CHAMBER FORMATION,9.7998e-07,0.42609,0.4351,1,1
5,GO THALAMUS DEVELOPMENT,2.6362e-08,0.42602,0.42686,1,1
5,GO FORELIMB MORPHOGENESIS,1.1579e-08,0.4252,0.39041,1,1
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.6761e-05,0.42307,0.36207,1,1
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,2.65e-07,0.42234,0.44347,1,1
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,3.9035e-08,0.42079,0.36377,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,1.5674e-06,0.42024,0.40335,1,1
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00011218,0.41959,0.31953,1,1
5,GO CELL PROLIFERATION IN HINDBRAIN,1.0004e-06,0.41933,0.36996,1,1
5,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,1.2604e-07,0.41896,0.4837,1,1
5,GO MICROTUBULE DEPOLYMERIZATION,1.8793e-06,0.41616,0.33508,1,1
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,3.1479e-07,0.41415,0.42599,1,1
5,GO REGULATION OF NEUROBLAST PROLIFERATION,1.1858e-08,0.41163,0.39283,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,4.5558e-05,0.41128,0.40868,1,1
5,GO CEREBELLAR CORTEX MORPHOGENESIS,5.3617e-10,0.41125,0.37833,1,1
5,GO NEURON FATE SPECIFICATION,5.3747e-08,0.41018,0.49006,1,1
5,GO INNER DYNEIN ARM ASSEMBLY,8.5858e-05,0.41001,0.41457,1,1
5,GO OTIC VESICLE DEVELOPMENT,9.4341e-06,0.40728,0.37008,1,1
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,4.8198e-07,0.40717,0.43223,1,1
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,3.1479e-07,0.40511,0.37623,1,1
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,1.6158e-05,0.40426,0.37318,1,1
5,GO HISTONE H3 K9 DEMETHYLATION,2.8262e-08,0.40341,0.37681,1,1
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.0017e-09,0.4032,0.44928,1,1
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,4.0678e-07,0.40253,0.38637,1,1
5,GO INNERVATION,5.4356e-06,0.40244,0.46223,1,1
5,GO CELL DIFFERENTIATION IN HINDBRAIN,5.9116e-09,0.40055,0.38455,1,1
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,7.5001e-05,0.39807,0.3636,1,1
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,5.1351e-07,0.39722,0.40078,1,1
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,2.0776e-06,0.39564,0.40351,1,1
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,7.8911e-05,0.39458,0.3447,1,1
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,4.31e-06,0.394,0.3252,1,1
5,GO REGULATION OF RECEPTOR CLUSTERING,0.00013673,0.39197,0.34367,1,1
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,4.2444e-07,0.39185,0.40106,1,1
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,1.9136e-07,0.38949,0.35679,1,1
5,GO PROSTATE GLAND MORPHOGENESIS,0.00047589,0.38861,0.32219,1,1
5,GO MICROTUBULE ANCHORING AT CENTROSOME,9.3415e-09,0.38858,0.36812,1,1
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,2.5359e-06,0.388,0.39027,1,1
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0001803,0.38785,0.33976,1,1
5,GO CRANIAL NERVE MORPHOGENESIS,4.4807e-06,0.38759,0.3406,1,1
5,GO HEART VALVE FORMATION,2.6386e-06,0.38702,0.46307,1,1
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,4.3997e-05,0.38428,0.38162,1,1
5,GO ACROSOME ASSEMBLY,1.5027e-08,0.38359,0.35484,1,1
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,3.152e-06,0.38286,0.35646,1,1
5,GO RESPONSE TO ACETYLCHOLINE,3.4796e-08,0.38083,0.39164,1,1
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.2958e-06,0.38057,0.41452,1,1
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,1.5293e-05,0.38029,0.31087,1,1
5,GO PARENTAL BEHAVIOR,1.8363e-05,0.37753,0.42789,1,1
5,GO NEURON FATE COMMITMENT,6.5906e-08,0.37658,0.39136,1,1
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,1.6994e-06,0.3753,0.48998,1,1
5,GO TONGUE MORPHOGENESIS,2.1234e-05,0.37502,0.38662,1,1
5,GO CRANIAL NERVE DEVELOPMENT,2.1624e-06,0.37464,0.31616,1,1
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0021215,0.37389,0.2779,1,1
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.00014129,0.37223,0.29001,1,1
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,1.7154e-07,0.37147,0.3442,1,1
5,GO CENTRIOLE CENTRIOLE COHESION,1.725e-09,0.3694,0.38992,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,4.1751e-05,0.36895,0.33593,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,1.1086e-06,0.36809,0.36745,1,1
5,GO CEREBELLAR CORTEX FORMATION,5.9116e-09,0.36773,0.36883,1,1
5,GO CORONARY VASCULATURE MORPHOGENESIS,4.2487e-05,0.36752,0.3422,1,1
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,3.9822e-07,0.36539,0.41412,1,1
5,GO NERVE DEVELOPMENT,7.333e-07,0.3651,0.35218,1,1
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,1.0791e-07,0.36463,0.4168,1,1
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,5.1351e-07,0.36338,0.32738,1,1
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0010408,0.3607,0.31734,1,1
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,1.4472e-05,0.36047,0.3274,1,1
5,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00091404,0.36004,0.3489,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,8.3066e-07,0.35788,0.38465,1,1
5,GO HISTONE H3 K36 METHYLATION,7.8778e-10,0.35622,0.38381,1,1
5,GO SYNAPTIC VESICLE DOCKING,0.00091404,0.35618,0.31304,1,1
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.00054518,0.35582,0.28128,1,1
5,GO ATRIAL SEPTUM MORPHOGENESIS,1.7706e-05,0.3548,0.3905,1,1
5,GO TONGUE DEVELOPMENT,1.5014e-05,0.35436,0.33152,1,1
5,GO DIVALENT METAL ION EXPORT,3.2146e-06,0.35423,0.38268,1,1
5,GO HISTONE H3 K9 METHYLATION,4.7501e-09,0.3533,0.33368,1,1
5,GO MAST CELL MIGRATION,0.00015838,0.35311,0.38489,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS,7.1274e-05,0.35025,0.35729,1,1
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,7.5217e-06,0.34939,0.29605,1,1
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,9.404e-07,0.34932,0.33219,1,1
5,GO LONG TERM SYNAPTIC DEPRESSION,1.2604e-07,0.34921,0.36825,1,1
5,GO HISTONE H3 K27 METHYLATION,6.4699e-07,0.34892,0.27534,1,1
5,GO PROTEIN LOCALIZATION TO AXON,8.3013e-05,0.34852,0.3955,1,1
5,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,2.8262e-08,0.34784,0.40658,1,1
5,GO TELENCEPHALON GLIAL CELL MIGRATION,3.7605e-06,0.34687,0.30785,1,1
5,GO FOREBRAIN REGIONALIZATION,8.4415e-08,0.34644,0.41171,1,1
5,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.015501,0.34548,0.1893,1,1
5,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.9558e-07,0.34499,0.35436,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,4.3355e-07,0.34487,0.42736,1,1
5,GO SPINAL CORD DEVELOPMENT,6.6581e-11,0.34477,0.37199,1,1
5,GO EMBRYONIC BRAIN DEVELOPMENT,3.4098e-06,0.34472,0.25387,1,1
5,GO SEX DETERMINATION,1.8318e-07,0.34425,0.32353,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0093576,0.34412,0.24271,1,1
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,6.2175e-05,0.34409,0.30254,1,1
5,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,5.6245e-08,0.34093,0.33106,1,1
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,3.6162e-06,0.34028,0.30483,1,1
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,8.6579e-07,0.34006,0.33793,1,1
5,GO RESPONSE TO AUDITORY STIMULUS,1.7385e-05,0.33994,0.39004,1,1
5,GO MECHANOSENSORY BEHAVIOR,0.0013633,0.33992,0.37824,1,1
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,6.8885e-07,0.33965,0.40118,1,1
5,GO RECEPTOR CLUSTERING,2.7668e-07,0.33857,0.30652,1,1
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0003557,0.33816,0.30029,1,1
5,GO ATRIAL SEPTUM DEVELOPMENT,3.1494e-05,0.33788,0.31003,1,1
5,GO NEURON CELLULAR HOMEOSTASIS,9.1829e-05,0.33747,0.29559,1,1
5,GO ECTODERMAL PLACODE DEVELOPMENT,2.0776e-06,0.33643,0.40408,1,1
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.00010497,0.33635,0.31994,1,1
5,GO CARDIAC MYOFIBRIL ASSEMBLY,1.6457e-05,0.33562,0.28292,1,1
5,GO SYNAPTIC VESICLE MATURATION,0.00015083,0.33518,0.35477,1,1
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,5.8262e-07,0.33498,0.34047,1,1
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.00020178,0.33492,0.2664,1,1
5,GO REGULATION OF SYNAPSE ASSEMBLY,3.4773e-06,0.3346,0.28421,1,1
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.001568,0.33392,0.35193,1,1
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,5.1356e-08,0.33365,0.3169,1,1
5,GO RESPONSE TO L GLUTAMATE,2.8814e-05,0.33364,0.32598,1,1
5,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.00065224,0.33263,0.27594,1,1
5,GO BRAIN MORPHOGENESIS,1.6514e-08,0.33209,0.32096,1,1
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,2.7668e-07,0.33156,0.30948,1,1
5,GO CEREBELLAR CORTEX DEVELOPMENT,6.586e-10,0.33139,0.35559,1,1
5,GO NEGATIVE REGULATION OF AXONOGENESIS,2.011e-05,0.32998,0.27665,1,1
5,GO LEFT RIGHT AXIS SPECIFICATION,6.4341e-05,0.32961,0.29537,1,1
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,1.7693e-06,0.32926,0.30082,1,1
5,GO NUCLEAR MIGRATION,2.7668e-07,0.32895,0.32585,1,1
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,4.2784e-08,0.32876,0.33932,1,1
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00029511,0.32875,0.2672,1,1
5,GO STARTLE RESPONSE,8.5867e-06,0.32843,0.35474,1,1
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,8.1138e-06,0.3282,0.34682,1,1
5,GO ACTIN FILAMENT BASED TRANSPORT,2.3784e-07,0.32757,0.34358,1,1
5,GO NEURON PROJECTION GUIDANCE,5.8856e-08,0.32725,0.31696,1,1
5,GO ASTRAL MICROTUBULE ORGANIZATION,4.4749e-10,0.32723,0.37866,1,1
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,4.8198e-07,0.3263,0.3236,1,1
5,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,6.0565e-09,0.32489,0.29411,1,1
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,7.105e-06,0.32483,0.35901,1,1
5,GO NEURON PROJECTION ARBORIZATION,7.333e-07,0.32457,0.35071,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,4.0314e-05,0.32439,0.28555,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,7.8911e-05,0.3236,0.31523,1,1
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,1.5372e-07,0.3228,0.30919,1,1
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,1.734e-06,0.32273,0.29957,1,1
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.00010152,0.32205,0.29222,1,1
5,GO CELL JUNCTION MAINTENANCE,1.5037e-07,0.32197,0.35252,1,1
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.3599e-06,0.32168,0.31875,1,1
5,GO NOREPINEPHRINE SECRETION,1.1165e-05,0.32118,0.32006,1,1
5,GO TELENCEPHALON REGIONALIZATION,1.3693e-05,0.32081,0.37468,1,1
5,GO NEUROBLAST PROLIFERATION,1.3671e-08,0.32031,0.33712,1,1
5,GO NUCLEUS LOCALIZATION,3.1479e-07,0.31934,0.30731,1,1
5,GO GANGLION DEVELOPMENT,0.00015583,0.31919,0.3286,1,1
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,4.719e-07,0.31903,0.30661,1,1
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.00039622,0.31805,0.27719,1,1
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00021857,0.31805,0.27673,1,1
5,GO ESTROUS CYCLE,2.3239e-05,0.3179,0.27135,1,1
5,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00013232,0.31754,0.29676,1,1
5,GO CELL DIFFERENTIATION IN SPINAL CORD,2.7676e-09,0.31744,0.35054,1,1
5,GO NEURON MIGRATION,6.3569e-09,0.31715,0.35493,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.4285e-07,0.31688,0.34296,1,1
5,GO MYELIN MAINTENANCE,0.0014022,0.31622,0.27738,1,1
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,6.5837e-06,0.31591,0.32848,1,1
5,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,2.3891e-06,0.31582,0.32277,1,1
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.00011406,0.31572,0.28023,1,1
5,GO METENCEPHALON DEVELOPMENT,1.1533e-09,0.31458,0.33858,1,1
5,GO DORSAL SPINAL CORD DEVELOPMENT,3.5794e-07,0.31441,0.37845,1,1
5,GO MRNA SPLICE SITE SELECTION,3.5427e-10,0.31428,0.36948,1,1
5,GO INHIBITORY SYNAPSE ASSEMBLY,1.5014e-05,0.3141,0.39487,1,1
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.00090088,0.314,0.23147,1,1
5,GO COCHLEA MORPHOGENESIS,2.5424e-05,0.31396,0.30522,1,1
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,5.4184e-05,0.31394,0.33,1,1
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,7.6283e-05,0.31312,0.28783,1,1
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00027716,0.31298,0.27779,1,1
5,GO NEURAL TUBE PATTERNING,5.1356e-08,0.3128,0.29194,1,1
5,GO REGULATION OF HISTONE H3 K9 METHYLATION,3.055e-09,0.31244,0.32803,1,1
5,GO NEURON RECOGNITION,1.2482e-05,0.31064,0.30197,1,1
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,2.0364e-06,0.31051,0.41721,1,1
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0048405,0.30992,0.29411,1,1
5,GO CELL FATE SPECIFICATION,1.1579e-08,0.30964,0.31123,1,1
5,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,7.2497e-05,0.3096,0.30191,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,8.7316e-05,0.3087,0.27108,1,1
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,2.3467e-08,0.30857,0.30513,1,1
5,GO DENDRITIC SPINE MORPHOGENESIS,2.0879e-07,0.30831,0.32458,1,1
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,2.2697e-09,0.30754,0.31449,1,1
5,GO DORSAL VENTRAL AXIS SPECIFICATION,3.8246e-05,0.30749,0.30578,1,1
5,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,8.7502e-06,0.30697,0.31999,1,1
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.4409e-05,0.30596,0.34865,1,1
5,GO AXONAL FASCICULATION,0.00038422,0.3059,0.27616,1,1
5,GO REGULATION OF AXONOGENESIS,2.1338e-07,0.30589,0.30259,1,1
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,6.895e-08,0.30564,0.34422,1,1
5,GO NON MOTILE CILIUM ASSEMBLY,6.3359e-07,0.30491,0.26684,1,1
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,2.4972e-05,0.30487,0.2818,1,1
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,2.3467e-08,0.30478,0.32357,1,1
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.0001179,0.30459,0.28551,1,1
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,1.1282e-07,0.30407,0.36022,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,1.9558e-07,0.30404,0.28556,1,1
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,4.4807e-06,0.30401,0.30952,1,1
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,5.2538e-08,0.30361,0.31566,1,1
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,9.5999e-07,0.30306,0.322,1,1
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,4.5684e-06,0.30291,0.24642,1,1
5,GO HISTONE H3 K9 MODIFICATION,3.6293e-09,0.30284,0.30251,1,1
5,GO HIPPO SIGNALING,2.0478e-05,0.30267,0.27655,1,1
5,GO PROTEIN DEMETHYLATION,8.6937e-09,0.30205,0.30505,1,1
5,GO REGULATION OF DENDRITE MORPHOGENESIS,1.0036e-08,0.30166,0.31322,1,1
5,GO OLIGODENDROCYTE DEVELOPMENT,2.7312e-05,0.30104,0.23962,1,1
5,GO METANEPHROS MORPHOGENESIS,7.7586e-05,0.30083,0.25709,1,1
5,GO THYROID GLAND DEVELOPMENT,1.6654e-06,0.30078,0.30346,1,1
5,GO POSTSYNAPSE ORGANIZATION,7.5266e-09,0.3006,0.33732,1,1
5,GO EMBRYONIC BODY MORPHOGENESIS,5.0323e-06,0.30032,0.31824,1,1
5,GO CELL PROLIFERATION IN FOREBRAIN,1.9044e-05,0.2999,0.28403,1,1
5,GO CELLULAR COMPONENT MAINTENANCE,8.2543e-08,0.2998,0.28885,1,1
5,GO PROTEIN LOCALIZATION TO CILIUM,3.4796e-08,0.29967,0.31032,1,1
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,9.6562e-05,0.29962,0.28952,1,1
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,3.9035e-08,0.29932,0.31666,1,1
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,9.6562e-05,0.29883,0.34419,1,1
5,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,1.6782e-07,0.29848,0.28358,1,1
5,GO DENTATE GYRUS DEVELOPMENT,0.00019541,0.29809,0.36341,1,1
5,GO EPITHELIAL CELL MATURATION,3.5461e-06,0.29774,0.29839,1,1
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00011218,0.29719,0.28841,1,1
5,GO PHOTORECEPTOR CELL MAINTENANCE,3.247e-08,0.29698,0.27879,1,1
5,GO SIALYLATION,4.3997e-05,0.29622,0.31484,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00037257,0.29557,0.22055,1,1
5,GO HINDBRAIN DEVELOPMENT,1.069e-09,0.29544,0.29742,1,1
5,GO RESPONSE TO POTASSIUM ION,4.3236e-05,0.2954,0.32159,1,1
5,GO AXON DEVELOPMENT,1.0791e-07,0.29538,0.28371,1,1
5,GO REGULATION OF CILIUM ASSEMBLY,1.2733e-08,0.29535,0.27764,1,1
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0071051,0.29534,0.29065,1,1
5,GO EXCITATORY SYNAPSE ASSEMBLY,2.3891e-06,0.29525,0.37346,1,1
5,GO COLLECTING DUCT DEVELOPMENT,6.8396e-06,0.29472,0.37369,1,1
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,2.913e-06,0.29461,0.25389,1,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,5.2538e-08,0.29433,0.25967,1,1
5,GO DENDRITE MORPHOGENESIS,1.3039e-08,0.29355,0.31995,1,1
5,GO SYNAPSE ORGANIZATION,9.4407e-08,0.29326,0.2898,1,1
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,4.3774e-08,0.29284,0.28788,1,1
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,1.7154e-07,0.29245,0.30605,1,1
5,GO MYOBLAST MIGRATION,0.0065235,0.29233,0.21996,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0002117,0.29192,0.318,1,1
5,GO SPERMATID NUCLEUS DIFFERENTIATION,3.1004e-08,0.29189,0.29006,1,1
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,6.2993e-08,0.29175,0.2948,1,1
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,1.2032e-06,0.29154,0.2411,1,1
5,GO URETER DEVELOPMENT,0.00048316,0.29148,0.35015,1,1
5,GO NEURON MATURATION,2.538e-07,0.29096,0.28949,1,1
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.001422,0.29089,0.29713,1,1
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,6.2175e-05,0.29078,0.26258,1,1
5,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,1.5994e-06,0.29039,0.28872,1,1
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,1.3325e-06,0.29028,0.30955,1,1
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,1.0861e-06,0.29018,0.37621,1,1
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,7.1274e-05,0.29001,0.24175,1,1
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00049802,0.28996,0.35476,1,1
5,GO SYNAPSE ASSEMBLY,2.5934e-07,0.28992,0.30785,1,1
5,GO PRESYNAPSE ORGANIZATION,7.5217e-06,0.2898,0.28374,1,1
5,GO INTRACILIARY TRANSPORT,1.3769e-07,0.28939,0.31926,1,1
5,GO VENTRAL SPINAL CORD DEVELOPMENT,1.4677e-08,0.28875,0.31176,1,1
5,GO LEARNING,5.1356e-08,0.28868,0.28993,1,1
5,GO CHLORIDE ION HOMEOSTASIS,0.00016901,0.28859,0.2775,1,1
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,8.2864e-09,0.28848,0.3449,1,1
5,GO REGULATION OF CENTRIOLE REPLICATION,1.3878e-06,0.28786,0.28493,1,1
5,GO POST ANAL TAIL MORPHOGENESIS,6.7105e-06,0.28776,0.27104,1,1
5,GO AXONEME ASSEMBLY,3.0811e-07,0.28709,0.33481,1,1
5,GO NEPHRON TUBULE FORMATION,8.1623e-05,0.28706,0.29228,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0003557,0.28702,0.2616,1,1
5,GO ADULT HEART DEVELOPMENT,0.00036686,0.28653,0.235,1,1
5,GO PENILE ERECTION,0.00039622,0.28632,0.26081,1,1
5,GO RETINA LAYER FORMATION,0.00014839,0.28625,0.31194,1,1
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,4.31e-06,0.2861,0.30175,1,1
5,GO SEROTONIN TRANSPORT,0.0010259,0.28593,0.22565,1,1
5,GO NEURAL CREST FORMATION,0.00031414,0.28547,0.26257,1,1
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,5.2344e-05,0.28461,0.27596,1,1
5,GO OUTER DYNEIN ARM ASSEMBLY,7.6283e-05,0.28447,0.32725,1,1
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.01016,0.28415,0.22865,1,1
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,1.9989e-07,0.28393,0.2679,1,1
5,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,1.1858e-08,0.28373,0.30298,1,1
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0021798,0.28342,0.27922,1,1
5,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0044864,0.28281,0.24526,1,1
5,GO PROTEIN LOCALIZATION TO SYNAPSE,1.9563e-06,0.28267,0.29486,1,1
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.0023637,0.28189,0.29508,1,1
5,GO MICROTUBULE ANCHORING,5.1351e-07,0.28084,0.2577,1,1
5,GO POTASSIUM ION HOMEOSTASIS,7.0337e-07,0.27996,0.29052,1,1
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,9.7991e-09,0.27992,0.31555,1,1
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,7.0017e-09,0.27977,0.30585,1,1
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00026438,0.27957,0.26139,1,1
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,5.4356e-06,0.27938,0.28464,1,1
5,GO RESPONSE TO VITAMIN A,0.00035024,0.27936,0.23363,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,1.7385e-05,0.2792,0.32555,1,1
5,GO ACTIN CROSSLINK FORMATION,2.8271e-07,0.27842,0.35384,1,1
5,GO RETROGRADE AXONAL TRANSPORT,1.3878e-06,0.27771,0.30504,1,1
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,8.5858e-05,0.27721,0.27052,1,1
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,5.0323e-06,0.27714,0.25041,1,1
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.00094089,0.27697,0.18325,1,1
5,GO NEGATIVE REGULATION OF TORC1 SIGNALING,1.536e-06,0.27589,0.33461,1,1
5,GO PANCREAS DEVELOPMENT,1.9558e-07,0.27574,0.30638,1,1
5,GO POSITIVE REGULATION OF AXONOGENESIS,1.1316e-06,0.27529,0.29182,1,1
5,GO MICROTUBULE BUNDLE FORMATION,1.9014e-08,0.27525,0.29584,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,1.0361e-05,0.27505,0.22107,1,1
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.044292,0.27471,0.18222,1,1
5,GO RESPONSE TO ELECTRICAL STIMULUS,2.0853e-05,0.27464,0.25998,1,1
5,GO DENDRITIC SPINE DEVELOPMENT,7.5451e-08,0.27458,0.29499,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,2.1624e-06,0.27451,0.30092,1,1
5,GO RESPONSE TO NICOTINE,9.4407e-08,0.27401,0.30638,1,1
5,GO INTRACILIARY RETROGRADE TRANSPORT,4.0657e-06,0.27391,0.34288,1,1
5,GO TUBE FORMATION,3.5038e-07,0.27322,0.22845,1,1
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.4837e-07,0.27295,0.27346,1,1
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00019229,0.27258,0.2376,1,1
5,GO MESENCHYMAL CELL PROLIFERATION,0.00038422,0.27244,0.25134,1,1
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.00019229,0.27238,0.21794,1,1
5,GO PROTEIN POLYGLUTAMYLATION,9.0235e-07,0.27222,0.29375,1,1
5,GO ADULT BEHAVIOR,2.0881e-08,0.27218,0.30588,1,1
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,2.9078e-09,0.27215,0.29627,1,1
5,GO REGULATION OF EXTENT OF CELL GROWTH,5.5864e-07,0.27206,0.29152,1,1
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,1.5994e-06,0.27155,0.22311,1,1
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,5.9116e-09,0.27093,0.29483,1,1
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0010558,0.27091,0.21596,1,1
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,2.0478e-05,0.27019,0.24344,1,1
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,1.7693e-06,0.27011,0.24767,1,1
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,4.6578e-06,0.26983,0.29676,1,1
5,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,1.475e-06,0.26977,0.2459,1,1
5,GO REGULATION OF HIPPO SIGNALING,0.001704,0.26957,0.22085,1,1
5,GO NEPHRON MORPHOGENESIS,3.3214e-05,0.26921,0.20947,1,1
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,4.1815e-08,0.26917,0.30725,1,1
5,GO REGULATION OF STEM CELL PROLIFERATION,1.5713e-07,0.26882,0.27186,1,1
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,2.4528e-05,0.26788,0.25521,1,1
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.00015331,0.26781,0.20648,1,1
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,3.1479e-07,0.26773,0.29236,1,1
5,GO CARDIAC ATRIUM DEVELOPMENT,1.9749e-05,0.26764,0.26172,1,1
5,GO REGULATION OF SYNAPTIC PLASTICITY,1.734e-06,0.26746,0.26622,1,1
5,GO CELL PART MORPHOGENESIS,4.9069e-08,0.26739,0.27364,1,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,1.2792e-06,0.26732,0.29736,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00022208,0.26723,0.22041,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,5.9056e-05,0.26709,0.26933,1,1
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,3.3228e-08,0.26707,0.25075,1,1
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,2.0879e-07,0.26699,0.31595,1,1
5,GO REGULATION OF COLLATERAL SPROUTING,0.00035024,0.26653,0.28539,1,1
5,GO NEURAL PRECURSOR CELL PROLIFERATION,3.2094e-09,0.26614,0.27858,1,1
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0071051,0.26604,0.17607,1,1
5,GO ENDOCARDIUM DEVELOPMENT,7.8911e-05,0.26588,0.24831,1,1
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,4.7999e-05,0.26543,0.26536,1,1
5,GO REGULATION OF DENDRITE DEVELOPMENT,2.0398e-08,0.26526,0.28718,1,1
5,GO DENDRITE SELF AVOIDANCE,0.00098255,0.26465,0.22548,1,1
5,GO HISTONE H3 K9 TRIMETHYLATION,9.1205e-09,0.26437,0.29243,1,1
5,GO NEGATIVE REGULATION OF AXON EXTENSION,7.8124e-06,0.26437,0.28092,1,1
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,1.3999e-08,0.26426,0.29844,1,1
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,5.4967e-09,0.26412,0.30185,1,1
5,GO MITOCHONDRION DISTRIBUTION,3.2146e-06,0.26404,0.25603,1,1
5,GO DIENCEPHALON DEVELOPMENT,7.9617e-06,0.26387,0.26233,1,1
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,6.7411e-08,0.26335,0.28472,1,1
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,2.1234e-05,0.26306,0.29019,1,1
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,7.2414e-06,0.26305,0.29231,1,1
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0424e-06,0.26302,0.30324,1,1
5,GO REGULATION OF NEURON DIFFERENTIATION,6.5906e-08,0.26278,0.25458,1,1
5,GO APPENDAGE MORPHOGENESIS,6.6066e-07,0.26275,0.2575,1,1
5,GO HINDBRAIN MORPHOGENESIS,1.3039e-08,0.26262,0.27215,1,1
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,4.1751e-05,0.2624,0.2478,1,1
5,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,2.1624e-06,0.2624,0.27621,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00032916,0.26199,0.21431,1,1
5,GO REGULATION OF CYCLASE ACTIVITY,5.9834e-06,0.26148,0.24994,1,1
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,1.3196e-05,0.26131,0.23498,1,1
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,6.3359e-07,0.26117,0.24274,1,1
5,GO APICAL PROTEIN LOCALIZATION,1.3878e-06,0.26077,0.30876,1,1
5,GO MICROTUBULE POLYMERIZATION,9.9803e-06,0.26037,0.23441,1,1
5,GO OVARIAN FOLLICLE DEVELOPMENT,3.0156e-07,0.26027,0.29746,1,1
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,3.0905e-06,0.26009,0.25472,1,1
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,9.3381e-05,0.2599,0.23566,1,1
5,GO HINDLIMB MORPHOGENESIS,0.00040235,0.25974,0.22629,1,1
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,1.064e-06,0.25952,0.25894,1,1
5,GO SYNAPTIC SIGNALING,1.5713e-07,0.25905,0.26413,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.5994e-06,0.25864,0.26801,1,1
5,GO GENETIC IMPRINTING,3.152e-06,0.25863,0.25362,1,1
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.000662,0.25849,0.22457,1,1
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,8.0712e-08,0.25845,0.29547,1,1
5,GO SMOOTHENED SIGNALING PATHWAY,1.5753e-08,0.25801,0.25433,1,1
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.00021857,0.25795,0.25199,1,1
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,7.2129e-08,0.25758,0.25323,1,1
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,1.4207e-05,0.25675,0.2807,1,1
5,GO FOREBRAIN CELL MIGRATION,2.8001e-06,0.25571,0.26354,1,1
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,8.6579e-07,0.25559,0.2476,1,1
5,GO REGULATION OF MICROTUBULE BINDING,0.00030928,0.25548,0.25085,1,1
5,GO LOCALIZATION WITHIN MEMBRANE,3.9102e-06,0.25523,0.23021,1,1
5,GO CILIUM ORGANIZATION,2.3853e-09,0.25494,0.26285,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,1.5865e-05,0.25489,0.22142,1,1
5,GO EMBRYONIC DIGIT MORPHOGENESIS,1.3693e-05,0.25423,0.21155,1,1
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,2.3891e-06,0.25403,0.24039,1,1
5,GO PROTEIN LOCALIZATION TO KINETOCHORE,9.086e-06,0.25394,0.23728,1,1
5,GO NOREPINEPHRINE TRANSPORT,9.3381e-05,0.25389,0.27306,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,2.2775e-07,0.25381,0.23077,1,1
5,GO DENDRITE DEVELOPMENT,1.3999e-08,0.2538,0.28751,1,1
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,2.9859e-05,0.25377,0.27488,1,1
5,GO NEURON PROJECTION ORGANIZATION,1.1086e-06,0.25363,0.27884,1,1
5,GO EPITHELIAL CELL MORPHOGENESIS,0.0069343,0.25352,0.24214,1,1
5,GO MESONEPHROS DEVELOPMENT,0.00044781,0.25349,0.19151,1,1
5,GO HISTONE H2A MONOUBIQUITINATION,3.7195e-09,0.25347,0.28253,1,1
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.00054518,0.25329,0.29453,1,1
5,GO POSITIVE REGULATION OF AXON EXTENSION,1.2482e-05,0.25297,0.25862,1,1
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0018006,0.25288,0.20498,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,5.2303e-06,0.25272,0.25487,1,1
5,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.025743,0.25262,0.21652,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,5.4356e-06,0.25223,0.23723,1,1
5,GO RESPONSE TO LEUCINE,0.00015583,0.25204,0.26885,1,1
5,GO REPLICATION FORK PROCESSING,3.2057e-05,0.25183,0.23849,1,1
5,GO IRON COORDINATION ENTITY TRANSPORT,4.0314e-05,0.25181,0.2557,1,1
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,1.0361e-05,0.25179,0.27155,1,1
5,GO CELLULAR RESPONSE TO VITAMIN D,0.00055343,0.25174,0.24879,1,1
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0011021,0.2516,0.24646,1,1
5,GO FOREBRAIN DEVELOPMENT,3.7195e-09,0.25158,0.26785,1,1
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.971e-06,0.25151,0.20984,1,1
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0016122,0.25144,0.24762,1,1
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00012804,0.25139,0.31522,1,1
5,GO PROTEIN PALMITOYLATION,1.6994e-06,0.25128,0.2674,1,1
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,1.1307e-08,0.25113,0.30138,1,1
5,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0028118,0.25105,0.24803,1,1
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,3.4003e-08,0.25086,0.22483,1,1
5,GO HISTONE H4 DEACETYLATION,0.0001179,0.25073,0.20035,1,1
5,GO PEPTIDYL LYSINE TRIMETHYLATION,3.2162e-07,0.25052,0.22808,1,1
5,GO INNER EAR MORPHOGENESIS,1.9175e-06,0.25051,0.25584,1,1
5,GO NEURAL TUBE DEVELOPMENT,9.0235e-07,0.25045,0.21897,1,1
5,GO SEROTONIN SECRETION,0.002702,0.25017,0.24211,1,1
5,GO VENTRICULAR SYSTEM DEVELOPMENT,3.6293e-09,0.25014,0.29765,1,1
5,GO DIGESTIVE TRACT MORPHOGENESIS,3.2057e-05,0.25011,0.24029,1,1
5,GO KINETOCHORE ORGANIZATION,0.00014362,0.24982,0.2309,1,1
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.0018256,0.24952,0.2262,1,1
5,GO BASIC AMINO ACID TRANSPORT,0.022209,0.24935,0.14443,1,1
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,1.6062e-07,0.24922,0.28187,1,1
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,1.9926e-08,0.24914,0.27796,1,1
5,GO COCHLEA DEVELOPMENT,9.2321e-08,0.24896,0.31911,1,1
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.00018923,0.24892,0.18693,1,1
5,GO CELLULAR COMPONENT MORPHOGENESIS,6.1583e-08,0.24888,0.25919,1,1
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,1.1086e-06,0.24881,0.29958,1,1
5,GO STEM CELL DIVISION,0.00058763,0.24876,0.20412,1,1
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,2.1196e-06,0.2487,0.24526,1,1
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.00020178,0.24835,0.29337,1,1
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,5.3747e-08,0.2482,0.23878,1,1
5,GO SPERM AXONEME ASSEMBLY,2.3661e-05,0.24816,0.25201,1,1
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.021973,0.24767,0.21184,1,1
5,GO STEM CELL PROLIFERATION,1.3325e-06,0.24742,0.23315,1,1
5,GO NEURON DIFFERENTIATION,1.8142e-08,0.24719,0.25076,1,1
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.00021857,0.24709,0.20664,1,1
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,3.7356e-07,0.24667,0.25633,1,1
5,GO SYNAPTIC VESICLE EXOCYTOSIS,1.2716e-05,0.24637,0.27782,1,1
5,GO NEUROTRANSMITTER SECRETION,6.9711e-06,0.24635,0.27753,1,1
5,GO SOMITE DEVELOPMENT,1.3878e-06,0.2462,0.22685,1,1
5,GO COLLATERAL SPROUTING,7.2497e-05,0.24606,0.27187,1,1
5,GO G0 TO G1 TRANSITION,1.4471e-09,0.24595,0.27865,1,1
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.011949,0.2458,0.22259,1,1
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.0045438,0.245,0.25606,1,1
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0005211,0.24482,0.19715,1,1
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,5.8049e-05,0.24474,0.24648,1,1
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00025617,0.24431,0.20407,1,1
5,GO NEURON DEVELOPMENT,4.9069e-08,0.24426,0.2491,1,1
5,GO UTERUS DEVELOPMENT,0.00040857,0.24404,0.2355,1,1
5,GO KIDNEY MORPHOGENESIS,9.6129e-06,0.24388,0.2231,1,1
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,1.6062e-07,0.24388,0.24976,1,1
5,GO LATERAL VENTRICLE DEVELOPMENT,0.00013451,0.24372,0.28641,1,1
5,GO EPITHELIAL CELL FATE COMMITMENT,0.00049053,0.24356,0.34112,1,1
5,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,4.9624e-10,0.24353,0.28888,1,1
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,1.1316e-06,0.24309,0.22803,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,7.2497e-05,0.24264,0.25894,1,1
5,GO DOSAGE COMPENSATION,1.9563e-06,0.24256,0.23525,1,1
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,2.8305e-05,0.24219,0.26986,1,1
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,4.1456e-06,0.24191,0.26109,1,1
5,GO BONE MORPHOGENESIS,0.0040509,0.24189,0.16491,1,1
5,GO DORSAL VENTRAL PATTERN FORMATION,5.9116e-09,0.24172,0.29008,1,1
5,GO CONVERGENT EXTENSION,0.0005789,0.24166,0.20666,1,1
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00028155,0.24153,0.21954,1,1
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.064418,0.24141,0.24126,1,1
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,3.3435e-06,0.24074,0.26473,1,1
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,1.1789e-06,0.24074,0.24712,1,1
5,GO STRIATUM DEVELOPMENT,5.3256e-05,0.2405,0.25746,1,1
5,GO MOTILE CILIUM ASSEMBLY,0.00049802,0.24039,0.27865,1,1
5,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,1.4741e-05,0.24038,0.2322,1,1
5,GO EMBRYONIC ORGAN MORPHOGENESIS,2.4837e-07,0.24032,0.23188,1,1
5,GO PEPTIDYL LYSINE DIMETHYLATION,8.8389e-07,0.24028,0.23781,1,1
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,5.9056e-05,0.24024,0.22669,1,1
5,GO ENERGY HOMEOSTASIS,0.0007786,0.24013,0.1991,1,1
5,GO CORPUS CALLOSUM DEVELOPMENT,0.00013899,0.23994,0.29023,1,1
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,3.357e-07,0.2399,0.24881,1,1
5,GO SKELETAL SYSTEM MORPHOGENESIS,1.0361e-05,0.23978,0.19905,1,1
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.00026438,0.23969,0.20982,1,1
5,GO LONG TERM SYNAPTIC POTENTIATION,2.011e-05,0.23936,0.24619,1,1
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.00024045,0.2393,0.2482,1,1
5,GO NEGATIVE REGULATION OF DNA REPLICATION,4.3236e-05,0.23921,0.21468,1,1
5,GO REPRODUCTIVE BEHAVIOR,9.404e-07,0.23864,0.26906,1,1
5,GO POSITIVE REGULATION OF HISTONE METHYLATION,1.1307e-08,0.23862,0.25759,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,2.7312e-05,0.23848,0.2284,1,1
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.00013899,0.23843,0.30377,1,1
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.003607,0.23821,0.21245,1,1
5,GO SEGMENTATION,1.9393e-05,0.23816,0.19465,1,1
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,3.9102e-06,0.23809,0.26263,1,1
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.017699,0.23804,0.20471,1,1
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00083767,0.23791,0.24146,1,1
5,GO CARDIAC ATRIUM MORPHOGENESIS,3.0395e-05,0.23787,0.27523,1,1
5,GO MITOTIC RECOMBINATION,0.00091404,0.23786,0.20387,1,1
5,GO SULFATION,0.00015838,0.23737,0.2156,1,1
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.00023667,0.23719,0.21785,1,1
5,GO CENTRIOLE ASSEMBLY,4.4285e-07,0.23668,0.27393,1,1
5,GO MICROTUBULE BASED MOVEMENT,1.1307e-08,0.23662,0.23067,1,1
5,GO MECHANORECEPTOR DIFFERENTIATION,2.4528e-05,0.23655,0.26765,1,1
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0027381,0.23652,0.23096,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,8.6328e-08,0.23608,0.24476,1,1
5,GO EPITHELIAL TUBE FORMATION,8.3066e-07,0.23602,0.21531,1,1
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,2.4091e-05,0.23582,0.2377,1,1
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,2.1621e-05,0.23556,0.21034,1,1
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.4472e-05,0.2355,0.22311,1,1
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,1.8701e-05,0.23523,0.18363,1,1
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,1.2954e-05,0.23522,0.21562,1,1
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0007901,0.23517,0.28045,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,7.1274e-05,0.23517,0.2081,1,1
5,GO REGULATION OF DEVELOPMENTAL GROWTH,6.2046e-07,0.23514,0.20815,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00016361,0.23507,0.2301,1,1
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,3.152e-06,0.23489,0.2799,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,3.0905e-06,0.23486,0.29504,1,1
5,GO REGULATION OF CHROMATIN BINDING,5.1351e-07,0.23483,0.28996,1,1
5,GO INOSITOL METABOLIC PROCESS,0.00026024,0.23482,0.23041,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,1.3325e-06,0.2348,0.22655,1,1
5,GO EPITHELIAL TUBE MORPHOGENESIS,2.6352e-05,0.23469,0.1824,1,1
5,GO REGULATION OF TUBULIN DEACETYLATION,0.000286,0.2346,0.25546,1,1
5,GO LOCOMOTORY BEHAVIOR,6.4699e-07,0.23413,0.2687,1,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,1.2058e-07,0.23391,0.22877,1,1
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,8.1361e-07,0.23389,0.24064,1,1
5,GO ORGANIC CATION TRANSPORT,0.00015083,0.23366,0.20247,1,1
5,GO NEUROGENESIS,4.3774e-08,0.2335,0.23474,1,1
5,GO TRANSPORT ALONG MICROTUBULE,4.2784e-08,0.23317,0.21975,1,1
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0007786,0.23313,0.22516,1,1
5,GO EXPLORATION BEHAVIOR,0.0068504,0.23303,0.192,1,1
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,7.333e-07,0.23292,0.26521,1,1
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,2.9332e-05,0.23289,0.24346,1,1
5,GO MITOTIC SISTER CHROMATID COHESION,7.1274e-05,0.23278,0.22304,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.3239e-05,0.23259,0.24363,1,1
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,2.6914e-06,0.2324,0.22656,1,1
5,GO POSITIVE REGULATION OF DNA REPAIR,1.9014e-08,0.23227,0.22629,1,1
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.00080175,0.23226,0.20058,1,1
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,1.3351e-08,0.23201,0.23608,1,1
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,1.1588e-05,0.23173,0.26721,1,1
5,GO HIPPOCAMPUS DEVELOPMENT,1.1789e-06,0.23172,0.23845,1,1
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,2.2958e-06,0.23171,0.21462,1,1
5,GO APPENDAGE DEVELOPMENT,1.8419e-06,0.23164,0.22551,1,1
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00015838,0.23154,0.23137,1,1
5,GO NEURON PROJECTION EXTENSION,1.734e-06,0.23137,0.25702,1,1
5,GO REGULATION OF RECEPTOR INTERNALIZATION,9.2321e-08,0.23116,0.24349,1,1
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.014658,0.23101,0.1785,1,1
5,GO ERYTHROCYTE MATURATION,3.5646e-05,0.23082,0.20629,1,1
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00011033,0.23073,0.19159,1,1
5,GO FAT CELL PROLIFERATION,0.012653,0.23063,0.17745,1,1
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00045468,0.23043,0.30153,1,1
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.0169e-05,0.23042,0.2733,1,1
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,2.7614e-08,0.22951,0.24491,1,1
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.033608,0.2295,0.21137,1,1
5,GO MIDGUT DEVELOPMENT,0.0071051,0.22945,0.20492,1,1
5,GO EMBRYONIC HEMOPOIESIS,5.7582e-06,0.22943,0.27343,1,1
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,1.4163e-06,0.22938,0.21544,1,1
5,GO REGULATION OF GLIAL CELL PROLIFERATION,6.8888e-05,0.22914,0.23911,1,1
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,5.0563e-05,0.22905,0.21643,1,1
5,GO NEURAL NUCLEUS DEVELOPMENT,1.155e-06,0.22904,0.27887,1,1
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,1.6158e-05,0.22903,0.26731,1,1
5,GO FUCOSYLATION,0.001955,0.22888,0.17993,1,1
5,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,1.7706e-05,0.22874,0.23825,1,1
5,GO HISTONE H4 K16 ACETYLATION,6.337e-06,0.22863,0.20679,1,1
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,1.1588e-05,0.22823,0.23928,1,1
5,GO MICROTUBULE BASED TRANSPORT,7.5451e-08,0.22808,0.22357,1,1
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.00031907,0.228,0.20142,1,1
5,GO RENAL VESICLE DEVELOPMENT,0.0012177,0.22782,0.21953,1,1
5,GO EMBRYONIC ORGAN DEVELOPMENT,1.1316e-06,0.22743,0.20492,1,1
5,GO MUSCLE FIBER DEVELOPMENT,2.4091e-05,0.22723,0.2184,1,1
5,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.001704,0.2272,0.19577,1,1
5,GO PALLIUM DEVELOPMENT,2.9602e-08,0.22667,0.24685,1,1
5,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.001442,0.22652,0.18381,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0033361,0.2265,0.22406,1,1
5,GO REGULATION OF APPETITE,1.8032e-05,0.22634,0.19045,1,1
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,4.0868e-08,0.2263,0.2561,1,1
5,GO CEREBRAL CORTEX DEVELOPMENT,3.2094e-09,0.22623,0.27755,1,1
5,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,2.0776e-06,0.22621,0.22056,1,1
5,GO TRACHEA DEVELOPMENT,0.0066039,0.22615,0.19651,1,1
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,1.4334e-08,0.22606,0.20305,1,1
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00035024,0.22596,0.24835,1,1
5,GO HEAD DEVELOPMENT,5.4967e-09,0.22588,0.23929,1,1
5,GO SYNAPTIC VESICLE LOCALIZATION,2.5884e-05,0.22576,0.25726,1,1
5,GO SECONDARY PALATE DEVELOPMENT,0.00020835,0.22575,0.25925,1,1
5,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.00034485,0.22563,0.19071,1,1
5,GO LUNG CELL DIFFERENTIATION,0.001483,0.22529,0.27176,1,1
5,GO EMBRYONIC EYE MORPHOGENESIS,2.5884e-05,0.22494,0.24818,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00086244,0.22484,0.24558,1,1
5,GO SEX DIFFERENTIATION,7.0337e-07,0.22433,0.18768,1,1
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.00046872,0.22417,0.1827,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,7.8124e-06,0.22415,0.30142,1,1
5,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.0032078,0.22409,0.20812,1,1
5,GO KINETOCHORE ASSEMBLY,0.0010259,0.22395,0.19739,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0022396,0.22389,0.1665,1,1
5,GO TELENCEPHALON DEVELOPMENT,1.5753e-08,0.22359,0.25667,1,1
5,GO MAINTENANCE OF ORGANELLE LOCATION,1.5293e-05,0.22347,0.2202,1,1
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0058389,0.2234,0.1804,1,1
5,GO L GLUTAMATE IMPORT,0.0038977,0.22336,0.15948,1,1
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,9.086e-06,0.22326,0.20773,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.0068504,0.22323,0.17546,1,1
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.004964,0.223,0.16228,1,1
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,1.4741e-05,0.22262,0.21783,1,1
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,2.5934e-07,0.22257,0.1956,1,1
5,GO REGULATION OF HEAT GENERATION,6.3249e-05,0.22256,0.27411,1,1
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0005789,0.22233,0.23347,1,1
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.00042777,0.22162,0.26743,1,1
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,2.206e-06,0.2215,0.23774,1,1
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,1.1588e-05,0.22139,0.24906,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING,5.4701e-07,0.22124,0.22452,1,1
5,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0018256,0.2211,0.28067,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0013826,0.22107,0.22147,1,1
5,GO REGULATION OF HISTONE METHYLATION,3.7195e-09,0.22103,0.24867,1,1
5,GO MYOTUBE CELL DEVELOPMENT,1.3196e-05,0.22103,0.23253,1,1
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.00059648,0.22098,0.24524,1,1
5,GO GENITALIA MORPHOGENESIS,0.009139,0.22028,0.2701,1,1
5,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.6457e-05,0.22004,0.19181,1,1
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.030994,0.21997,0.16613,1,1
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,7.0337e-07,0.21976,0.23164,1,1
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,9.819e-05,0.21941,0.24781,1,1
5,GO SUBSTANTIA NIGRA DEVELOPMENT,3.8347e-06,0.21924,0.21435,1,1
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.1456e-06,0.21909,0.22833,1,1
5,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0032928,0.21891,0.18181,1,1
5,GO DETECTION OF MECHANICAL STIMULUS,0.00013232,0.21854,0.23391,1,1
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,1.2886e-07,0.21839,0.2067,1,1
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,5.2445e-07,0.21829,0.22652,1,1
5,GO DNA DOUBLE STRAND BREAK PROCESSING,0.00012594,0.21826,0.22011,1,1
5,GO EAR MORPHOGENESIS,9.6129e-06,0.21813,0.21761,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00017176,0.21809,0.21255,1,1
5,GO HISTONE H2A UBIQUITINATION,5.6245e-08,0.21808,0.24026,1,1
5,GO SENSORY SYSTEM DEVELOPMENT,1.6418e-07,0.2178,0.21416,1,1
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,8.7502e-06,0.21775,0.23758,1,1
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,2.3661e-05,0.21755,0.22655,1,1
5,GO PRO B CELL DIFFERENTIATION,0.00016361,0.21731,0.26129,1,1
5,GO GLIAL CELL PROLIFERATION,0.00095459,0.21724,0.18005,1,1
5,GO REGULATION OF CELL DEVELOPMENT,2.538e-07,0.2171,0.21228,1,1
5,GO ENDOCRINE PANCREAS DEVELOPMENT,1.6158e-05,0.21706,0.23768,1,1
5,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,1.8594e-09,0.21694,0.25133,1,1
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,2.1196e-06,0.2168,0.27026,1,1
5,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,4.6359e-05,0.21673,0.26717,1,1
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.020385,0.21667,0.14063,1,1
5,GO LACTATE METABOLIC PROCESS,0.001568,0.21645,0.17144,1,1
5,GO MITOTIC G2 M TRANSITION CHECKPOINT,4.0657e-06,0.21635,0.21724,1,1
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,1.8135e-09,0.21624,0.27082,1,1
5,GO NON RECOMBINATIONAL REPAIR,4.0314e-05,0.21604,0.16718,1,1
5,GO PEPTIDYL LYSINE METHYLATION,3.7195e-09,0.21588,0.24909,1,1
5,GO CAMERA TYPE EYE DEVELOPMENT,3.0156e-07,0.21583,0.2168,1,1
5,GO SPERMATID DIFFERENTIATION,2.9602e-08,0.21567,0.21246,1,1
5,GO CELL MORPHOGENESIS,7.1819e-07,0.21561,0.21769,1,1
5,GO REGULATION OF ORGANELLE ASSEMBLY,6.2993e-08,0.21555,0.2013,1,1
5,GO HISTONE H4 K5 ACETYLATION,8.5867e-06,0.2153,0.20374,1,1
5,GO SYNAPTIC TRANSMISSION GABAERGIC,0.00019229,0.21527,0.2015,1,1
5,GO ECTODERM DEVELOPMENT,1.0361e-05,0.21525,0.19341,1,1
5,GO SINGLE STRAND BREAK REPAIR,4.7172e-05,0.21523,0.21156,1,1
5,GO MITOTIC CHROMOSOME CONDENSATION,4.1751e-05,0.215,0.25062,1,1
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,6.7105e-06,0.21488,0.24081,1,1
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00030449,0.21483,0.33675,1,1
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,2.856e-06,0.21445,0.22155,1,1
5,GO TUBULIN DEACETYLATION,0.00020504,0.21402,0.23817,1,1
5,GO MATING BEHAVIOR,3.1494e-05,0.21394,0.2372,1,1
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,4.1552e-07,0.21383,0.22263,1,1
5,GO SUBPALLIUM DEVELOPMENT,0.0041031,0.21364,0.21496,1,1
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.00053704,0.21353,0.23151,1,1
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,3.9613e-05,0.21346,0.22055,1,1
5,GO CENTROMERE COMPLEX ASSEMBLY,0.00074504,0.21339,0.19463,1,1
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.013394,0.21333,0.15579,1,1
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,4.31e-06,0.21327,0.20641,1,1
5,GO MITOTIC SPINDLE ORGANIZATION,4.9694e-05,0.21319,0.18087,1,1
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,3.4296e-07,0.21311,0.22862,1,1
5,GO SENSORY ORGAN MORPHOGENESIS,1.4454e-06,0.21306,0.20646,1,1
5,GO REGULATION OF CHROMATIN ASSEMBLY,7.4873e-07,0.21306,0.23931,1,1
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,7.4873e-07,0.21297,0.21567,1,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.002631,0.21288,0.24517,1,1
5,GO STRESS GRANULE ASSEMBLY,0.00016629,0.21284,0.19608,1,1
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,8.7502e-06,0.21266,0.2419,1,1
5,GO CELL PROJECTION ORGANIZATION,4.0868e-08,0.21258,0.21923,1,1
5,GO EYE MORPHOGENESIS,9.5999e-07,0.21258,0.21472,1,1
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,2.2824e-05,0.21245,0.21002,1,1
5,GO DEVELOPMENTAL CELL GROWTH,3.4098e-06,0.21241,0.22595,1,1
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,9.5999e-07,0.21188,0.21532,1,1
5,GO OVULATION CYCLE PROCESS,6.7724e-05,0.21182,0.19659,1,1
5,GO REGULATION OF MICROTUBULE BASED PROCESS,1.8723e-07,0.2117,0.21557,1,1
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.00092737,0.21136,0.19483,1,1
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00044781,0.21125,0.16575,1,1
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,8.4262e-06,0.21118,0.19941,1,1
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.00030449,0.21096,0.20361,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,7.6657e-06,0.21095,0.25961,1,1
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0059852,0.21095,0.17852,1,1
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00010673,0.21088,0.2318,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1.2143e-08,0.21078,0.19811,1,1
5,GO CELLULAR RESPONSE TO VITAMIN,0.0023637,0.21073,0.20583,1,1
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,8.3013e-05,0.21028,0.22249,1,1
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.00071283,0.21016,0.18279,1,1
5,GO LYSINE METABOLIC PROCESS,0.019312,0.21014,0.15967,1,1
5,GO LONG TERM MEMORY,0.00046872,0.20997,0.20743,1,1
5,GO EMBRYONIC MORPHOGENESIS,1.0361e-05,0.20973,0.1761,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.00060545,0.2097,0.20753,1,1
5,GO MEMBRANE DISASSEMBLY,0.0077327,0.2095,0.17201,1,1
5,GO ENAMEL MINERALIZATION,0.03068,0.20933,0.17904,1,1
5,GO REGULATION OF CELL MORPHOGENESIS,2.1624e-06,0.20915,0.2142,1,1
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,1.0861e-06,0.20915,0.21195,1,1
5,GO CELL JUNCTION ORGANIZATION,2.6914e-06,0.20911,0.21497,1,1
5,GO REGULATION OF GONAD DEVELOPMENT,0.00028155,0.2088,0.21665,1,1
5,GO OPTIC NERVE DEVELOPMENT,0.0010259,0.20863,0.29865,1,1
5,GO CHROMATIN SILENCING AT TELOMERE,9.404e-07,0.2085,0.22267,1,1
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.00026438,0.20814,0.23587,1,1
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,4.2271e-06,0.20792,0.20109,1,1
5,GO MALE SEX DIFFERENTIATION,3.2631e-05,0.2078,0.16724,1,1
5,GO FEMALE SEX DIFFERENTIATION,3.2784e-06,0.20771,0.20629,1,1
5,GO GAMETE GENERATION,1.1533e-09,0.20767,0.20649,1,1
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0013826,0.20748,0.19078,1,1
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.01849,0.20744,0.19798,1,1
5,GO CELL PROJECTION ASSEMBLY,2.1807e-07,0.20708,0.19475,1,1
5,GO BEHAVIOR,2.2775e-07,0.20683,0.2303,1,1
5,GO WHITE FAT CELL DIFFERENTIATION,3.5022e-05,0.20682,0.22712,1,1
5,GO REGULATION OF GLUTAMATE SECRETION,0.0043184,0.20678,0.23814,1,1
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.024428,0.2067,0.18542,1,1
5,GO MITOCHONDRION LOCALIZATION,5.0323e-06,0.20657,0.20997,1,1
5,GO NEUROTRANSMITTER TRANSPORT,1.8032e-05,0.20644,0.25655,1,1
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.012798,0.2063,0.1422,1,1
5,GO RESPONSE TO FOOD,1.2027e-05,0.20615,0.19041,1,1
5,GO V D J RECOMBINATION,2.9859e-05,0.20606,0.28287,1,1
5,GO HISTONE H3 K4 METHYLATION,4.0033e-09,0.20604,0.255,1,1
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,1.7071e-05,0.20597,0.23421,1,1
5,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.0007786,0.20578,0.22114,1,1
5,GO NEURAL CREST CELL DIFFERENTIATION,0.0005056,0.20572,0.1959,1,1
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0023321,0.20556,0.16248,1,1
5,GO G2 DNA DAMAGE CHECKPOINT,4.7488e-06,0.20544,0.22234,1,1
5,GO LATERAL MESODERM DEVELOPMENT,0.0054872,0.20531,0.21826,1,1
5,GO CELLULAR RESPONSE TO STEROL,0.00013232,0.20522,0.21847,1,1
5,GO RESPONSE TO STEROL,0.00055343,0.20499,0.18281,1,1
5,GO MEMBRANE HYPERPOLARIZATION,0.00049053,0.20499,0.25337,1,1
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.019104,0.20479,0.22996,1,1
5,GO PROTEIN ACYLATION,6.0565e-09,0.20472,0.20302,1,1
5,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.016027,0.20464,0.1511,1,1
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,6.2169e-06,0.20454,0.20208,1,1
5,GO NEURAL CREST CELL MIGRATION,0.00044781,0.20448,0.24421,1,1
5,GO OLIGODENDROCYTE DIFFERENTIATION,2.6914e-06,0.20441,0.23732,1,1
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,5.8262e-07,0.20438,0.22208,1,1
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,2.206e-06,0.20431,0.25008,1,1
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,1.9393e-05,0.20424,0.20595,1,1
5,GO SCHWANN CELL DIFFERENTIATION,6.4341e-05,0.20416,0.2061,1,1
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0053519,0.20395,0.21597,1,1
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.0053519,0.20383,0.18814,1,1
5,GO PRESYNAPTIC ENDOCYTOSIS,6.0991e-06,0.20375,0.24153,1,1
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0002117,0.20373,0.18334,1,1
5,GO RESPONSE TO NERVE GROWTH FACTOR,5.8698e-06,0.2037,0.22266,1,1
5,GO REGULATION OF TORC1 SIGNALING,9.8716e-08,0.20337,0.25495,1,1
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,3.8983e-07,0.20325,0.20202,1,1
5,GO POLYOL CATABOLIC PROCESS,0.00049802,0.20311,0.16056,1,1
5,GO CAMERA TYPE EYE MORPHOGENESIS,5.4701e-07,0.20303,0.22563,1,1
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00029976,0.20302,0.27484,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,4.3946e-06,0.20284,0.23289,1,1
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,4.6202e-07,0.20277,0.2186,1,1
5,GO PATTERN SPECIFICATION PROCESS,4.6881e-08,0.20271,0.22742,1,1
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.040981,0.20268,0.12839,1,1
5,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.00010673,0.20262,0.2074,1,1
5,GO CHONDROCYTE PROLIFERATION,0.017125,0.2026,0.16826,1,1
5,GO HOMOLOGOUS CHROMOSOME SEGREGATION,6.2175e-05,0.2026,0.20157,1,1
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.9859e-05,0.20245,0.19935,1,1
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,6.7105e-06,0.20229,0.24307,1,1
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,6.3569e-09,0.20215,0.19767,1,1
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,8.8282e-08,0.20214,0.22195,1,1
5,GO SCHWANN CELL DEVELOPMENT,0.00012594,0.20211,0.21769,1,1
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,2.206e-06,0.20207,0.2239,1,1
5,GO RECOMBINATIONAL REPAIR,1.7071e-05,0.20206,0.19177,1,1
5,GO DOPAMINE TRANSPORT,0.0024941,0.2018,0.27663,1,1
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00026438,0.20169,0.20873,1,1
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,6.895e-08,0.20166,0.22381,1,1
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.00023667,0.20162,0.16627,1,1
5,GO MEMBRANE DOCKING,7.4873e-07,0.20157,0.18907,1,1
5,GO PROTEIN LOCALIZATION TO CHROMATIN,7.5217e-06,0.20153,0.19321,1,1
5,GO HETEROCHROMATIN ORGANIZATION,2.206e-06,0.20148,0.20085,1,1
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0010408,0.20143,0.16059,1,1
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,6.895e-08,0.20139,0.21746,1,1
5,GO SKIN EPIDERMIS DEVELOPMENT,0.00040857,0.20132,0.16525,1,1
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0066851,0.20118,0.19464,1,1
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00020835,0.20115,0.21675,1,1
5,GO NEGATIVE CHEMOTAXIS,0.010041,0.20109,0.20821,1,1
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.0038478,0.20096,0.16043,1,1
5,GO ENDOCRINE SYSTEM DEVELOPMENT,8.7502e-06,0.20091,0.22525,1,1
5,GO CELLULAR RESPONSE TO X RAY,0.0005789,0.2008,0.14855,1,1
5,GO AXON EXTENSION,1.9563e-06,0.2007,0.2666,1,1
5,GO OVULATION CYCLE,9.03e-05,0.20068,0.1889,1,1
5,GO LYMPH VESSEL DEVELOPMENT,0.048285,0.20045,0.134,1,1
5,GO P BODY ASSEMBLY,5.8262e-07,0.20045,0.21676,1,1
5,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.0071918,0.20043,0.15454,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,9.9803e-06,0.20031,0.18178,1,1
5,GO SENSORY ORGAN DEVELOPMENT,1.5713e-07,0.19981,0.21787,1,1
5,GO MALE GAMETE GENERATION,1.3761e-09,0.19979,0.20354,1,1
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0054872,0.19964,0.18009,1,1
5,GO VENTRICULAR SEPTUM DEVELOPMENT,0.00088789,0.19953,0.17228,1,1
5,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.00040235,0.19939,0.19628,1,1
5,GO COGNITION,1.5674e-06,0.19925,0.20671,1,1
5,GO DERMATAN SULFATE METABOLIC PROCESS,0.05063,0.1991,0.16245,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,1.1588e-05,0.1991,0.18976,1,1
5,GO POST EMBRYONIC DEVELOPMENT,3.1494e-05,0.19908,0.20047,1,1
5,GO FEAR RESPONSE,0.00052901,0.19891,0.17167,1,1
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00032916,0.19881,0.19821,1,1
5,GO MALE MEIOTIC NUCLEAR DIVISION,8.4424e-05,0.19881,0.22063,1,1
5,GO ATP DEPENDENT CHROMATIN REMODELING,3.0302e-06,0.19875,0.21244,1,1
5,GO HEART FORMATION,0.0025277,0.19856,0.19973,1,1
5,GO MOLTING CYCLE,0.00014839,0.19851,0.1628,1,1
5,GO ENDOTHELIAL CELL DEVELOPMENT,0.0081133,0.19832,0.14905,1,1
5,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.0013826,0.19816,0.24501,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0074579,0.19815,0.16033,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,3.8347e-06,0.19807,0.2076,1,1
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,3.0395e-05,0.19805,0.21955,1,1
5,GO CENTROSOME DUPLICATION,1.9563e-06,0.19775,0.23552,1,1
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.9465e-08,0.19766,0.23639,1,1
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,6.0079e-05,0.19738,0.21366,1,1
5,GO NEUROMUSCULAR PROCESS,4.31e-06,0.19735,0.22652,1,1
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,3.0395e-05,0.19732,0.22874,1,1
5,GO REGULATION OF RESPONSE TO FOOD,0.00017176,0.19726,0.18914,1,1
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,6.3249e-05,0.19693,0.23736,1,1
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,1.9393e-05,0.19684,0.18944,1,1
5,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0049019,0.19683,0.17973,1,1
5,GO POSITIVE REGULATION OF RNA SPLICING,2.5424e-05,0.19632,0.17778,1,1
5,GO HISTONE H3 K14 ACETYLATION,1.3599e-06,0.19607,0.20385,1,1
5,GO REGULATION OF CELL CYCLE ARREST,4.4787e-08,0.19594,0.20408,1,1
5,GO DIGESTIVE SYSTEM DEVELOPMENT,2.2015e-05,0.19583,0.20649,1,1
5,GO AXIS ELONGATION,0.0028492,0.19582,0.18449,1,1
5,GO NEURAL TUBE FORMATION,5.0323e-06,0.19582,0.19964,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,4.9361e-06,0.19578,0.17957,1,1
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,3.3435e-06,0.19576,0.21993,1,1
5,GO ADIPOSE TISSUE DEVELOPMENT,0.00013673,0.1957,0.19532,1,1
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,3.4098e-06,0.19566,0.17434,1,1
5,GO MICROTUBULE BASED PROCESS,7.71e-09,0.19551,0.21841,1,1
5,GO GERM CELL DEVELOPMENT,2.1595e-09,0.19546,0.22254,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.020385,0.19537,0.14185,1,1
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.00058763,0.19522,0.20779,1,1
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,9.7998e-07,0.19494,0.2052,1,1
5,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.0018764,0.19493,0.18281,1,1
5,GO MICROTUBULE NUCLEATION,0.00036124,0.19483,0.19656,1,1
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0067673,0.19483,0.2026,1,1
5,GO RESPONSE TO BMP,0.0011341,0.1948,0.16577,1,1
5,GO ENSHEATHMENT OF NEURONS,3.0395e-05,0.19475,0.17967,1,1
5,GO PROTEIN DEPOLYMERIZATION,4.6359e-05,0.19453,0.18715,1,1
5,GO PROSTATE GLAND GROWTH,0.016205,0.19442,0.19518,1,1
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,4.6202e-07,0.19404,0.21066,1,1
5,GO REGULATION OF CILIUM MOVEMENT,4.1456e-06,0.19403,0.22918,1,1
5,GO GLIAL CELL DEVELOPMENT,0.00042777,0.19389,0.16891,1,1
5,GO REGULATION OF CELL SIZE,2.5359e-06,0.19366,0.21862,1,1
5,GO ASSOCIATIVE LEARNING,1.9044e-05,0.1936,0.19458,1,1
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0002443,0.19359,0.21037,1,1
5,GO DNA REPLICATION CHECKPOINT,1.5293e-05,0.19334,0.21523,1,1
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.00039622,0.19333,0.13846,1,1
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,1.3693e-05,0.19331,0.18332,1,1
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0019023,0.19328,0.1607,1,1
5,GO PROTEIN ACETYLATION,2.188e-08,0.1932,0.19277,1,1
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.00011406,0.19319,0.18795,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00096848,0.19311,0.19014,1,1
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,2.4972e-05,0.19303,0.22511,1,1
5,GO REGULATION OF MRNA PROCESSING,3.247e-08,0.19294,0.21943,1,1
5,GO REGIONALIZATION,2.5934e-07,0.19286,0.22054,1,1
5,GO MAMMARY GLAND DEVELOPMENT,0.0012527,0.19279,0.15072,1,1
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,7.6283e-05,0.19273,0.20369,1,1
5,GO PEPTIDE HORMONE SECRETION,9.7998e-07,0.19263,0.21695,1,1
5,GO SOMITOGENESIS,6.6578e-05,0.19262,0.17357,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.00038422,0.1924,0.16879,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,2.011e-05,0.19239,0.19874,1,1
5,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.00049053,0.19238,0.19704,1,1
5,GO CELL FATE COMMITMENT,1.7154e-07,0.19235,0.21244,1,1
5,GO SMOOTH MUSCLE CONTRACTION,0.0028492,0.19224,0.12985,1,1
5,GO DEMETHYLATION,3.3228e-08,0.19222,0.20357,1,1
5,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,2.3239e-05,0.19196,0.19722,1,1
5,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0013633,0.19187,0.1687,1,1
5,GO AXONAL TRANSPORT,2.3661e-05,0.19187,0.20956,1,1
5,GO ADHERENS JUNCTION ASSEMBLY,0.0023321,0.19183,0.19844,1,1
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,2.8814e-05,0.19152,0.16934,1,1
5,GO HISTONE METHYLATION,8.9047e-09,0.19146,0.24056,1,1
5,GO SYNAPTIC VESICLE RECYCLING,9.795e-06,0.19137,0.23034,1,1
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,4.3082e-09,0.19106,0.23056,1,1
5,GO NUCLEOSOME ASSEMBLY,1.2027e-05,0.19076,0.21613,1,1
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.010279,0.19055,0.15281,1,1
5,GO NEGATIVE REGULATION OF DNA REPAIR,0.000662,0.1905,0.14219,1,1
5,GO DEVELOPMENTAL GROWTH,5.5412e-06,0.19048,0.18311,1,1
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.00016361,0.19038,0.20417,1,1
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0024281,0.19033,0.17217,1,1
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00014129,0.19027,0.1679,1,1
5,GO REGULATION OF DNA REPAIR,1.7534e-07,0.19023,0.19339,1,1
5,GO GLAND DEVELOPMENT,0.00012594,0.1902,0.15444,1,1
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,1.996e-06,0.1902,0.17626,1,1
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.001568,0.19014,0.20429,1,1
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0137,0.19008,0.20801,1,1
5,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0027381,0.19005,0.1615,1,1
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0032501,0.19,0.17597,1,1
5,GO MAINTENANCE OF CELL NUMBER,4.9694e-05,0.18996,0.15444,1,1
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,1.3039e-08,0.18992,0.20017,1,1
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,6.8888e-05,0.18981,0.17856,1,1
5,GO TISSUE MORPHOGENESIS,0.0005056,0.18979,0.13259,1,1
5,GO SPECIFICATION OF SYMMETRY,4.0678e-07,0.1897,0.18719,1,1
5,GO RENAL TUBULE DEVELOPMENT,0.0023009,0.18961,0.15699,1,1
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,3.9822e-07,0.18928,0.17192,1,1
5,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,1.9044e-05,0.18898,0.19096,1,1
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0005056,0.1889,0.20482,1,1
5,GO DNA RECOMBINATION,6.8888e-05,0.1889,0.15966,1,1
5,GO RETINOIC ACID METABOLIC PROCESS,0.0007786,0.18881,0.2423,1,1
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.011678,0.18878,0.18675,1,1
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0061347,0.18859,0.16618,1,1
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.00069207,0.18853,0.18779,1,1
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00061456,0.18852,0.21076,1,1
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00011986,0.18844,0.19575,1,1
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,1.9393e-05,0.18842,0.20104,1,1
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.0023009,0.18833,0.20665,1,1
5,GO FILOPODIUM ASSEMBLY,0.00099681,0.1883,0.18396,1,1
5,GO REGULATION OF SISTER CHROMATID COHESION,2.3891e-06,0.18821,0.24215,1,1
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00012388,0.18816,0.16477,1,1
5,GO HORMONE MEDIATED SIGNALING PATHWAY,2.2015e-05,0.18814,0.1591,1,1
5,GO FUCOSE METABOLIC PROCESS,0.0022396,0.18812,0.17846,1,1
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,4.5239e-09,0.18801,0.19117,1,1
5,GO CHROMATIN SILENCING,9.1205e-09,0.18793,0.22773,1,1
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0095807,0.18785,0.15671,1,1
5,GO RESPONSE TO UV B,0.031311,0.18784,0.15334,1,1
5,GO ANIMAL ORGAN MORPHOGENESIS,5.6085e-05,0.1876,0.15837,1,1
5,GO DNA PACKAGING,1.9175e-06,0.18747,0.19979,1,1
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,1.5372e-07,0.18735,0.21301,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,2.4861e-06,0.18729,0.21031,1,1
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.00041488,0.18727,0.15784,1,1
5,GO REGULATION OF HISTONE PHOSPHORYLATION,0.00091404,0.18717,0.16076,1,1
5,GO SERTOLI CELL DEVELOPMENT,0.0019819,0.18697,0.20237,1,1
5,GO EPIDERMIS MORPHOGENESIS,0.037509,0.18686,0.12631,1,1
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,2.0364e-06,0.18679,0.1983,1,1
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0038977,0.18667,0.12405,1,1
5,GO SEXUAL REPRODUCTION,2.4452e-09,0.18665,0.19398,1,1
5,GO REGULATION OF CIRCADIAN RHYTHM,1.0279e-08,0.18664,0.22687,1,1
5,GO EMBRYONIC PATTERN SPECIFICATION,2.2824e-05,0.18637,0.19822,1,1
5,GO DNA REPLICATION,4.31e-06,0.18637,0.19337,1,1
5,GO HISTONE H3 K4 TRIMETHYLATION,0.00019229,0.18636,0.18619,1,1
5,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.043444,0.18623,0.15862,1,1
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,2.2015e-05,0.18618,0.21905,1,1
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.001442,0.18601,0.19711,1,1
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00032916,0.18593,0.18995,1,1
5,GO GLAND MORPHOGENESIS,0.016938,0.18584,0.1482,1,1
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.00039622,0.18578,0.26139,1,1
5,GO CARDIAC SEPTUM MORPHOGENESIS,0.0027381,0.18544,0.1993,1,1
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0033361,0.18539,0.19164,1,1
5,GO HISTONE H4 ACETYLATION,2.9514e-07,0.18509,0.20107,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0028118,0.18501,0.14407,1,1
5,GO LYMPH VESSEL MORPHOGENESIS,0.012227,0.18489,0.16138,1,1
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,8.5867e-06,0.18482,0.17776,1,1
5,GO CARDIAC VENTRICLE MORPHOGENESIS,0.00032408,0.18471,0.16921,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.044722,0.18464,0.16239,1,1
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.00049053,0.18459,0.22167,1,1
5,GO REGULATION OF NEURON MATURATION,0.0060595,0.1844,0.17909,1,1
5,GO MULTICELLULAR ORGANISM GROWTH,1.8053e-06,0.18432,0.19004,1,1
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00041488,0.18397,0.24205,1,1
5,GO MEIOTIC CHROMOSOME SEGREGATION,5.0563e-05,0.18392,0.1899,1,1
5,GO REGULATION OF AXON GUIDANCE,0.00015583,0.1839,0.23753,1,1
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00082553,0.18378,0.17827,1,1
5,GO REGULATION OF TRANSPOSITION,0.0046018,0.18375,0.20243,1,1
5,GO EPITHELIAL CELL DEVELOPMENT,0.00059648,0.18362,0.16784,1,1
5,GO SPINDLE ORGANIZATION,1.7071e-05,0.18359,0.18178,1,1
5,GO REGULATION OF JUN KINASE ACTIVITY,0.00026024,0.18358,0.15123,1,1
5,GO CELL JUNCTION ASSEMBLY,0.00017457,0.18354,0.18101,1,1
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.00030928,0.1835,0.14232,1,1
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.013394,0.18344,0.13935,1,1
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,1.1806e-05,0.18286,0.20795,1,1
5,GO HISTONE DEACETYLATION,2.1234e-05,0.18275,0.1858,1,1
5,GO PEPTIDYL LYSINE ACETYLATION,2.0398e-08,0.18275,0.19957,1,1
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,3.3806e-05,0.18268,0.15832,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00042777,0.18266,0.19677,1,1
5,GO REGULATION OF CELL DIVISION,4.0657e-06,0.18265,0.17487,1,1
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00017741,0.18263,0.26253,1,1
5,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.00034485,0.18249,0.16725,1,1
5,GO CHROMOSOME LOCALIZATION,0.00019541,0.18234,0.14678,1,1
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,8.3013e-05,0.18212,0.17368,1,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00014362,0.18196,0.26098,1,1
5,GO EMBRYO DEVELOPMENT,2.0364e-06,0.18182,0.16731,1,1
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,7.2414e-06,0.18181,0.22205,1,1
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.00073415,0.18165,0.23149,1,1
5,GO REGULATION OF FATTY ACID OXIDATION,0.0020367,0.18158,0.16842,1,1
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00029052,0.18153,0.21118,1,1
5,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00065224,0.18149,0.15046,1,1
5,GO NEURON PROJECTION REGENERATION,0.0005618,0.18144,0.19849,1,1
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,4.1456e-06,0.18138,0.21121,1,1
5,GO REGULATION OF ANIMAL ORGAN FORMATION,0.0054192,0.18134,0.17548,1,1
5,GO REGULATION OF PROTEIN DEACETYLATION,0.0001862,0.18129,0.17095,1,1
5,GO GLIAL CELL DIFFERENTIATION,4.0314e-05,0.18123,0.18823,1,1
5,GO ACTIVATION OF GTPASE ACTIVITY,5.5127e-05,0.18114,0.16502,1,1
5,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,2.8886e-07,0.1811,0.20379,1,1
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.00032916,0.18085,0.14399,1,1
5,GO CENTROSOME SEPARATION,0.0005618,0.18074,0.17226,1,1
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0059116,0.18067,0.14013,1,1
5,GO LIMBIC SYSTEM DEVELOPMENT,5.4356e-06,0.18065,0.20469,1,1
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,1.5604e-09,0.1803,0.23475,1,1
5,GO HISTONE H3 DEACETYLATION,2.2958e-06,0.1802,0.22413,1,1
5,GO EXTRACELLULAR TRANSPORT,0.0003557,0.18003,0.22326,1,1
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,1.5052e-06,0.17995,0.20961,1,1
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0001862,0.17994,0.1596,1,1
5,GO ACROSOME REACTION,0.00027284,0.17987,0.21459,1,1
5,GO REGULATION OF SPINDLE ASSEMBLY,0.0035146,0.1797,0.13556,1,1
5,GO MOTOR NEURON AXON GUIDANCE,0.0092477,0.17961,0.15623,1,1
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,1.8032e-05,0.17957,0.22338,1,1
5,GO POSITIVE REGULATION OF CELL MATURATION,0.048285,0.17952,0.14417,1,1
5,GO REGULATION OF MEMBRANE POTENTIAL,5.1446e-05,0.17941,0.19224,1,1
5,GO REGULATION OF CELL DIFFERENTIATION,1.3196e-05,0.17931,0.15677,1,1
5,GO SPERM MOTILITY,2.0879e-07,0.17923,0.21316,1,1
5,GO PERICARDIUM DEVELOPMENT,0.024947,0.17909,0.15624,1,1
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.00091404,0.17907,0.18721,1,1
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,4.0657e-06,0.17899,0.20934,1,1
5,GO RESPIRATORY SYSTEM DEVELOPMENT,0.001442,0.17873,0.1674,1,1
5,GO MONOAMINE TRANSPORT,6.6578e-05,0.17869,0.27727,1,1
5,GO MRNA EXPORT FROM NUCLEUS,0.00048316,0.1785,0.14055,1,1
5,GO PROTEIN KINASE C SIGNALING,0.00095459,0.17844,0.21396,1,1
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,2.011e-05,0.17829,0.17454,1,1
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.00015331,0.17821,0.20372,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.036772,0.17816,0.13622,1,1
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,4.9069e-08,0.17785,0.17486,1,1
5,GO CHROMATIN DISASSEMBLY,0.00019229,0.17776,0.19464,1,1
5,GO RESPONSE TO COCAINE,1.8701e-05,0.17761,0.23486,1,1
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,3.4098e-06,0.1776,0.17959,1,1
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.9563e-06,0.17751,0.21,1,1
5,GO FERTILIZATION,5.2445e-07,0.17743,0.17484,1,1
5,GO MITRAL VALVE DEVELOPMENT,0.0025277,0.17723,0.20003,1,1
5,GO MISMATCH REPAIR,1.996e-06,0.177,0.19921,1,1
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,1.5865e-05,0.17699,0.1838,1,1
5,GO REPRODUCTION,6.7461e-07,0.17687,0.15893,1,1
5,GO REGULATION OF DNA RECOMBINATION,0.00047589,0.17676,0.14954,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00088789,0.17671,0.19283,1,1
5,GO ADULT LOCOMOTORY BEHAVIOR,0.0001862,0.17666,0.19885,1,1
5,GO ODONTOGENESIS,0.024428,0.17664,0.13253,1,1
5,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0010865,0.17663,0.14538,1,1
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0002117,0.17659,0.16045,1,1
5,GO RESPONSE TO DOPAMINE,8.1138e-06,0.17641,0.19974,1,1
5,GO REGULATION OF GLUCOSE IMPORT,0.00022927,0.1763,0.16949,1,1
5,GO MATING,3.758e-05,0.1761,0.18504,1,1
5,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00010673,0.17602,0.17866,1,1
5,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,2.2416e-05,0.17599,0.19301,1,1
5,GO REGULATION OF HORMONE SECRETION,1.5293e-05,0.17593,0.18082,1,1
5,GO MULTICELLULAR ORGANISM REPRODUCTION,1.3351e-08,0.17585,0.17948,1,1
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.00055343,0.17575,0.22556,1,1
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.00025617,0.17566,0.14313,1,1
5,GO PROTEIN AUTO ADP RIBOSYLATION,0.0059116,0.17561,0.20866,1,1
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.015159,0.17557,0.14545,1,1
5,GO DOUBLE STRAND BREAK REPAIR,3.5022e-05,0.17555,0.17157,1,1
5,GO LABYRINTHINE LAYER DEVELOPMENT,0.007921,0.17549,0.16654,1,1
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,8.4424e-05,0.17544,0.16528,1,1
5,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00071283,0.17541,0.26045,1,1
5,GO DEFINITIVE HEMOPOIESIS,0.001235,0.17535,0.20794,1,1
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00045468,0.17531,0.18186,1,1
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00012594,0.17507,0.29868,1,1
5,GO PROSTATIC BUD FORMATION,0.028556,0.17501,0.22086,1,1
5,GO LIPID TRANSLOCATION,0.0023637,0.17498,0.18496,1,1
5,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,1.4741e-05,0.17492,0.16686,1,1
5,GO HEART VALVE DEVELOPMENT,0.0062108,0.17476,0.15486,1,1
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00059648,0.17454,0.14958,1,1
5,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0017517,0.1745,0.17514,1,1
5,GO HAIR CELL DIFFERENTIATION,0.001704,0.1744,0.23212,1,1
5,GO REGULATION OF FILOPODIUM ASSEMBLY,0.0020646,0.17436,0.18809,1,1
5,GO LEFT RIGHT PATTERN FORMATION,0.00081356,0.17431,0.20342,1,1
5,GO REGULATION OF VASCULAR PERMEABILITY,0.010522,0.17425,0.12802,1,1
5,GO EAR DEVELOPMENT,4.9361e-06,0.17424,0.21939,1,1
5,GO AXIS SPECIFICATION,1.1588e-05,0.17407,0.19586,1,1
5,GO AXO DENDRITIC TRANSPORT,3.628e-05,0.17402,0.19642,1,1
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,6.4592e-06,0.17379,0.20479,1,1
5,GO NUCLEOSOME ORGANIZATION,4.6578e-06,0.17378,0.19357,1,1
5,GO INTRACELLULAR MRNA LOCALIZATION,0.0037498,0.17362,0.15542,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0027747,0.1734,0.15772,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00087508,0.17333,0.12866,1,1
5,GO MEIOSIS I CELL CYCLE PROCESS,2.1234e-05,0.17333,0.19032,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00012388,0.17299,0.14402,1,1
5,GO REGULATION OF MRNA POLYADENYLATION,1.1588e-05,0.17298,0.19348,1,1
5,GO REGULATION OF LYASE ACTIVITY,0.00016098,0.1729,0.19286,1,1
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,2.4528e-05,0.17281,0.17431,1,1
5,GO CILIUM MOVEMENT,4.5233e-07,0.17276,0.22429,1,1
5,GO REGULATION OF INSULIN SECRETION,4.4807e-06,0.17265,0.20693,1,1
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,3.5022e-05,0.1726,0.19445,1,1
5,GO REGULATION OF SPINDLE CHECKPOINT,8.5858e-05,0.1725,0.22431,1,1
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.00098255,0.17246,0.14438,1,1
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0010259,0.17242,0.2428,1,1
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,3.3806e-05,0.17239,0.15833,1,1
5,GO RECEPTOR INTERNALIZATION,0.00064263,0.17219,0.14376,1,1
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0047198,0.17219,0.14648,1,1
5,GO GROOMING BEHAVIOR,0.0027381,0.17191,0.19986,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00015838,0.17188,0.23723,1,1
5,GO ARTERY MORPHOGENESIS,0.057179,0.17188,0.10118,1,1
5,GO TRANSMISSION OF NERVE IMPULSE,0.00037257,0.17172,0.22609,1,1
5,GO MESENCHYME DEVELOPMENT,0.001704,0.17155,0.14644,1,1
5,GO PROTEIN AUTOUBIQUITINATION,3.2631e-05,0.17151,0.15615,1,1
5,GO HEART MORPHOGENESIS,8.0256e-05,0.17141,0.17896,1,1
5,GO RENAL FILTRATION,0.01499,0.1714,0.27126,1,1
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.2344e-05,0.17119,0.16586,1,1
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.0001862,0.17112,0.1479,1,1
5,GO CELL CELL SIGNALING,3.4773e-06,0.17094,0.1692,1,1
5,GO GDP METABOLIC PROCESS,0.0012005,0.17082,0.21988,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,8.2686e-06,0.17077,0.15264,1,1
5,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0063654,0.17068,0.15611,1,1
5,GO INTRA S DNA DAMAGE CHECKPOINT,0.00033955,0.17068,0.1827,1,1
5,GO EXOCRINE SYSTEM DEVELOPMENT,0.0089251,0.17063,0.17875,1,1
5,GO CARDIAC VENTRICLE DEVELOPMENT,0.0007901,0.17059,0.14543,1,1
5,GO CEREBRAL CORTEX CELL MIGRATION,3.758e-05,0.17057,0.23805,1,1
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00021511,0.1703,0.1482,1,1
5,GO REGULATION OF CHROMOSOME SEGREGATION,7.2497e-05,0.17011,0.1794,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00042128,0.1701,0.12975,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.010895,0.16994,0.17651,1,1
5,GO CYTOKINESIS,1.2954e-05,0.16993,0.16265,1,1
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.0011668,0.16942,0.21035,1,1
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.0044864,0.16921,0.16681,1,1
5,GO SINGLE FERTILIZATION,1.3325e-06,0.16914,0.17078,1,1
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,1.1282e-07,0.16913,0.20491,1,1
5,GO PROSTATE GLAND DEVELOPMENT,0.023173,0.16908,0.13262,1,1
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,2.2416e-05,0.16903,0.17069,1,1
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.060988,0.16896,0.13024,1,1
5,GO THYMUS DEVELOPMENT,1.155e-06,0.16893,0.22401,1,1
5,GO PROTEIN METHYLATION,3.7282e-08,0.16879,0.21731,1,1
5,GO CARDIAC CHAMBER DEVELOPMENT,0.004156,0.16865,0.13207,1,1
5,GO FOREGUT MORPHOGENESIS,0.00036686,0.16862,0.22326,1,1
5,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,1.536e-06,0.16848,0.21891,1,1
5,GO DNA INTEGRITY CHECKPOINT,8.4805e-07,0.16837,0.19311,1,1
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,3.8983e-07,0.16827,0.19306,1,1
5,GO HISTONE UBIQUITINATION,1.5052e-06,0.16801,0.17759,1,1
5,GO UROGENITAL SYSTEM DEVELOPMENT,0.0044864,0.16792,0.12856,1,1
5,GO REGULATION OF WNT SIGNALING PATHWAY,0.00032408,0.16791,0.13872,1,1
5,GO HISTONE EXCHANGE,0.00084997,0.16789,0.15823,1,1
5,GO NEGATIVE REGULATION OF TOR SIGNALING,5.2303e-06,0.16787,0.20655,1,1
5,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.0035605,0.16785,0.16929,1,1
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,4.0678e-07,0.16782,0.1899,1,1
5,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.00029976,0.16781,0.18727,1,1
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.016752,0.16761,0.13319,1,1
5,GO ADHERENS JUNCTION ORGANIZATION,0.00071283,0.16758,0.19885,1,1
5,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0073682,0.16741,0.19163,1,1
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0023637,0.16737,0.15799,1,1
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,1.0004e-06,0.16736,0.18571,1,1
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00016629,0.16718,0.15504,1,1
5,GO SPERM CAPACITATION,0.0020092,0.1671,0.16659,1,1
5,GO REGULATION OF PHOSPHATASE ACTIVITY,8.3066e-07,0.16709,0.18599,1,1
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00073415,0.16708,0.18033,1,1
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00088789,0.16702,0.12741,1,1
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0024941,0.16695,0.16236,1,1
5,GO CELL CYCLE ARREST,5.2303e-06,0.16668,0.16175,1,1
5,GO DNA CONFORMATION CHANGE,1.0958e-05,0.16667,0.17888,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,6.4434e-08,0.16656,0.22166,1,1
5,GO CELL CELL SIGNALING BY WNT,0.0001179,0.16645,0.14462,1,1
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0010865,0.1663,0.13312,1,1
5,GO MULTI ORGANISM PROCESS,2.3784e-07,0.16618,0.16092,1,1
5,GO CANONICAL WNT SIGNALING PATHWAY,0.000662,0.16604,0.13606,1,1
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,5.4356e-06,0.166,0.19443,1,1
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,4.31e-06,0.16579,0.19453,1,1
5,GO GLIOGENESIS,5.5127e-05,0.16577,0.17237,1,1
5,GO CHROMATIN REMODELING AT CENTROMERE,0.0033361,0.16575,0.17475,1,1
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.011151,0.16568,0.16255,1,1
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00044781,0.16561,0.18986,1,1
5,GO LUNG MORPHOGENESIS,0.017699,0.16541,0.1378,1,1
5,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0007901,0.16522,0.16671,1,1
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.006444,0.16519,0.1369,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00048316,0.16518,0.15826,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0021798,0.16501,0.2169,1,1
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.0557e-05,0.16499,0.21818,1,1
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0031247,0.16488,0.12389,1,1
5,GO REGULATION OF SYSTEM PROCESS,6.2175e-05,0.1648,0.16812,1,1
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.00020504,0.16477,0.18974,1,1
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0069343,0.16476,0.12846,1,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.00020835,0.16475,0.18157,1,1
5,GO SISTER CHROMATID COHESION,9.6129e-06,0.1645,0.19852,1,1
5,GO PROTEIN TARGETING TO VACUOLE,0.058787,0.16449,0.1029,1,1
5,GO HEAT GENERATION,0.00039018,0.16445,0.19413,1,1
5,GO MEMORY,1.9393e-05,0.16445,0.19727,1,1
5,GO DEVELOPMENTAL INDUCTION,0.001776,0.16438,0.17272,1,1
5,GO CARDIAC SEPTUM DEVELOPMENT,0.0034243,0.16433,0.16402,1,1
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0017277,0.16429,0.14472,1,1
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0022396,0.1641,0.17854,1,1
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.00018323,0.16406,0.1811,1,1
5,GO ENDOTHELIUM DEVELOPMENT,0.0028492,0.16405,0.16027,1,1
5,GO COVALENT CHROMATIN MODIFICATION,8.2903e-10,0.16398,0.21554,1,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.012087,0.16385,0.15125,1,1
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.049681,0.16369,0.15618,1,1
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0007786,0.16362,0.19506,1,1
5,GO HORMONE TRANSPORT,2.2416e-05,0.16358,0.17549,1,1
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00012594,0.16357,0.14337,1,1
5,GO REGULATION OF HEART MORPHOGENESIS,0.0066039,0.16351,0.17727,1,1
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0051547,0.16347,0.19605,1,1
5,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,7.1274e-05,0.16344,0.14961,1,1
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00036124,0.1634,0.14685,1,1
5,GO CATECHOLAMINE SECRETION,0.00017457,0.16336,0.3108,1,1
5,GO OOGENESIS,1.3174e-07,0.16323,0.20389,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0011021,0.1632,0.19303,1,1
5,GO POTASSIUM ION TRANSPORT,1.7706e-05,0.16311,0.20936,1,1
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0005618,0.16308,0.1739,1,1
5,GO REGULATION OF DNA REPLICATION,8.5867e-06,0.16298,0.1734,1,1
5,GO REGULATION OF CHROMATIN ORGANIZATION,1.2143e-08,0.16295,0.19746,1,1
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,3.628e-05,0.16292,0.16752,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0013069,0.1629,0.16567,1,1
5,GO REGULATION OF GTPASE ACTIVITY,0.00019229,0.16289,0.14356,1,1
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.051595,0.16272,0.13811,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,7.8124e-06,0.16271,0.16113,1,1
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00010673,0.16264,0.18918,1,1
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.034636,0.16245,0.14836,1,1
5,GO DNA DEPENDENT DNA REPLICATION,1.0756e-05,0.16236,0.18984,1,1
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0020367,0.16234,0.12168,1,1
5,GO DEVELOPMENTAL MATURATION,1.6994e-06,0.16218,0.19087,1,1
5,GO CYTOSKELETON ORGANIZATION,4.5684e-06,0.16215,0.16351,1,1
5,GO REGULATION OF EXOCYTOSIS,5.0563e-05,0.16214,0.18304,1,1
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,5.1304e-06,0.16214,0.15831,1,1
5,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0023637,0.16188,0.17974,1,1
5,GO ACTIVATION OF JNKK ACTIVITY,0.006444,0.16186,0.1611,1,1
5,GO MRNA PROCESSING,0.00014362,0.16178,0.1446,1,1
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.00033955,0.16178,0.14855,1,1
5,GO GLIAL CELL MIGRATION,0.049681,0.16173,0.10677,1,1
5,GO REGULATION OF MYELINATION,0.00049053,0.16154,0.16175,1,1
5,GO HISTONE DEUBIQUITINATION,9.9844e-05,0.16141,0.18271,1,1
5,GO REGULATION OF HELICASE ACTIVITY,0.0017517,0.16122,0.17488,1,1
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.0023957,0.16114,0.14827,1,1
5,GO REGULATION OF CYTOKINESIS,4.3946e-06,0.16107,0.19664,1,1
5,GO TOOTH MINERALIZATION,0.0096941,0.16099,0.19897,1,1
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.009139,0.16095,0.21235,1,1
5,GO LENS FIBER CELL DIFFERENTIATION,0.003607,0.16073,0.16132,1,1
5,GO POSITIVE REGULATION OF MRNA PROCESSING,7.1274e-05,0.16062,0.16597,1,1
5,GO CHROMATIN ORGANIZATION,1.5217e-09,0.1606,0.21485,1,1
5,GO POSITIVE REGULATION OF CELL DIVISION,3.8246e-05,0.16046,0.18619,1,1
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0065235,0.16035,0.18548,1,1
5,GO GOLGI LOCALIZATION,0.013093,0.16031,0.097091,1,1
5,GO TORC1 SIGNALING,1.6994e-06,0.16026,0.21252,1,1
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00015583,0.16007,0.16593,1,1
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.00049802,0.16001,0.14853,1,1
5,GO ORGANELLE LOCALIZATION,8.4262e-06,0.15989,0.14638,1,1
5,GO CALCINEURIN MEDIATED SIGNALING,3.5646e-05,0.15979,0.20383,1,1
5,GO REGULATION OF HISTONE MODIFICATION,9.4407e-08,0.15975,0.18864,1,1
5,GO CHROMATIN REMODELING,8.1361e-07,0.15973,0.19674,1,1
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00068191,0.15973,0.18313,1,1
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.000662,0.15968,0.16248,1,1
5,GO GAMMA DELTA T CELL ACTIVATION,0.03068,0.15968,0.17165,1,1
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.001776,0.15944,0.14278,1,1
5,GO SKELETAL SYSTEM DEVELOPMENT,0.0012705,0.15939,0.12426,1,1
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.6158e-05,0.15936,0.17828,1,1
5,GO NUCLEAR CHROMOSOME SEGREGATION,6.5837e-06,0.15925,0.1765,1,1
5,GO INTERSTRAND CROSS LINK REPAIR,7.5217e-06,0.15917,0.19745,1,1
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.00061456,0.15915,0.17341,1,1
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,1.0004e-06,0.15915,0.17444,1,1
5,GO ESTABLISHMENT OF CELL POLARITY,1.4207e-05,0.15896,0.17746,1,1
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.011813,0.15884,0.13634,1,1
5,GO MIDBRAIN DEVELOPMENT,1.1375e-05,0.15877,0.15879,1,1
5,GO HISTONE H3 K9 ACETYLATION,2.8305e-05,0.15845,0.18358,1,1
5,GO EMBRYONIC AXIS SPECIFICATION,3.7605e-06,0.15834,0.2275,1,1
5,GO TUBE MORPHOGENESIS,0.0061347,0.15811,0.11855,1,1
5,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,5.7582e-06,0.15795,0.18354,1,1
5,GO MESENCHYMAL CELL DIFFERENTIATION,0.0037498,0.15793,0.14438,1,1
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0023009,0.15771,0.13564,1,1
5,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0050904,0.15769,0.13812,1,1
5,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.00017741,0.15726,0.18376,1,1
5,GO MEIOTIC SPINDLE ORGANIZATION,0.00011406,0.1571,0.21099,1,1
5,GO NERVOUS SYSTEM PROCESS,2.5359e-06,0.15703,0.16994,1,1
5,GO CHROMOSOME SEGREGATION,1.0958e-05,0.157,0.17685,1,1
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.012087,0.15695,0.20139,1,1
5,GO REGULATION OF CHROMOSOME ORGANIZATION,2.2958e-06,0.15685,0.16202,1,1
5,GO REGULATION OF MITOPHAGY,0.00074504,0.15675,0.15496,1,1
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00054518,0.15673,0.19458,1,1
5,GO POSITIVE REGULATION OF HEAT GENERATION,0.0023321,0.15673,0.23615,1,1
5,GO MUSCLE ORGAN MORPHOGENESIS,0.0016122,0.15663,0.14144,1,1
5,GO MEMBRANE BIOGENESIS,0.0011836,0.15655,0.21419,1,1
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.00011986,0.1565,0.15762,1,1
5,GO CELL CYCLE CHECKPOINT,5.1351e-07,0.15649,0.19361,1,1
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0070192,0.15649,0.19071,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0031247,0.15643,0.15347,1,1
5,GO REGULATION OF MEMBRANE PERMEABILITY,3.9613e-05,0.15637,0.15304,1,1
5,GO MITOTIC CYTOKINESIS,0.0019285,0.15632,0.11902,1,1
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,5.2344e-05,0.15627,0.17212,1,1
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.00029976,0.15624,0.13823,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00021857,0.15623,0.17181,1,1
5,GO GROWTH,4.8839e-05,0.15622,0.14361,1,1
5,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,2.0853e-05,0.15619,0.21174,1,1
5,GO SPINDLE LOCALIZATION,0.00041488,0.15598,0.15385,1,1
5,GO RNA POLYADENYLATION,0.0051547,0.15598,0.12526,1,1
5,GO REGULATION OF HAIR CYCLE,0.0018006,0.15588,0.15416,1,1
5,GO REGULATION OF RNA SPLICING,2.5756e-08,0.15584,0.20427,1,1
5,GO DNA GEOMETRIC CHANGE,0.00020178,0.15581,0.15875,1,1
5,GO VASCULOGENESIS,0.0095807,0.15569,0.16084,1,1
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0010408,0.15563,0.16187,1,1
5,GO SECRETORY GRANULE ORGANIZATION,0.0012705,0.15539,0.16319,1,1
5,GO MITOTIC SPINDLE ASSEMBLY,0.00065224,0.15513,0.15162,1,1
5,GO EPITHELIUM DEVELOPMENT,0.0020929,0.15512,0.1209,1,1
5,GO REGULATION OF SPINDLE ORGANIZATION,0.0011836,0.15507,0.14073,1,1
5,GO REGULATION OF CELL CYCLE CHECKPOINT,4.4771e-05,0.15502,0.20221,1,1
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.022209,0.15495,0.15981,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.015501,0.15479,0.14591,1,1
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.00033432,0.15478,0.18391,1,1
5,GO OUTFLOW TRACT MORPHOGENESIS,0.011813,0.15475,0.16321,1,1
5,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00037257,0.15446,0.16316,1,1
5,GO FOCAL ADHESION ASSEMBLY,0.01585,0.15445,0.12486,1,1
5,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0075485,0.15444,0.22403,1,1
5,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0018006,0.15444,0.16929,1,1
5,GO TRANSPOSITION,0.003607,0.15437,0.199,1,1
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,2.8305e-05,0.15418,0.19072,1,1
5,GO NEURON APOPTOTIC PROCESS,9.6129e-06,0.15417,0.15708,1,1
5,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0058389,0.15396,0.14345,1,1
5,GO DNA REPAIR,4.6359e-05,0.15393,0.14777,1,1
5,GO AORTA MORPHOGENESIS,0.065005,0.15386,0.12265,1,1
5,GO INSULIN SECRETION,7.3803e-06,0.15384,0.20549,1,1
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.011949,0.15383,0.14445,1,1
5,GO DETECTION OF VISIBLE LIGHT,8.5867e-06,0.15376,0.13336,1,1
5,GO REGULATION OF ACTION POTENTIAL,0.0063654,0.15373,0.1622,1,1
5,GO CIRCADIAN RHYTHM,1.1789e-06,0.15365,0.17559,1,1
5,GO GMP METABOLIC PROCESS,0.0023321,0.15356,0.15178,1,1
5,GO CELL VOLUME HOMEOSTASIS,0.0012177,0.15354,0.14936,1,1
5,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,5.4184e-05,0.15347,0.20756,1,1
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0085105,0.15345,0.14561,1,1
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.031631,0.15338,0.1328,1,1
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,3.3214e-05,0.15318,0.16635,1,1
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0024941,0.15314,0.12275,1,1
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0096941,0.15312,0.14409,1,1
5,GO LACTATION,0.010769,0.15304,0.12279,1,1
5,GO REPLACEMENT OSSIFICATION,0.025743,0.15299,0.1291,1,1
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0017517,0.15291,0.13438,1,1
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.00057029,0.15283,0.18279,1,1
5,GO REGULATION OF CENTROSOME CYCLE,1.9393e-05,0.15269,0.19043,1,1
5,GO REGULATION OF MRNA 3 END PROCESSING,0.0001179,0.15262,0.16541,1,1
5,GO TELOMERE CAPPING,0.00021511,0.15262,0.14695,1,1
5,GO EXIT FROM MITOSIS,0.0010259,0.15247,0.14255,1,1
5,GO METAPHASE PLATE CONGRESSION,0.00083767,0.15239,0.13117,1,1
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0063654,0.15234,0.18082,1,1
5,GO TUBE DEVELOPMENT,0.0047798,0.15231,0.119,1,1
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0046604,0.15217,0.13483,1,1
5,GO MITOTIC CELL CYCLE CHECKPOINT,2.3274e-07,0.15211,0.19588,1,1
5,GO SODIUM ION TRANSPORT,0.00044103,0.15205,0.14738,1,1
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,4.3997e-05,0.15203,0.17774,1,1
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0088198,0.152,0.15777,1,1
5,GO DNA STRAND ELONGATION,0.00032916,0.15183,0.17989,1,1
5,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.001235,0.15182,0.17713,1,1
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.0104,0.15181,0.20219,1,1
5,GO NEUROTRANSMITTER UPTAKE,0.0037016,0.15179,0.15715,1,1
5,GO CHONDROCYTE DEVELOPMENT,0.0058389,0.15176,0.17582,1,1
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0024609,0.15173,0.20104,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0034243,0.15151,0.14905,1,1
5,GO HISTONE H2A ACETYLATION,4.3997e-05,0.15132,0.18369,1,1
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0052854,0.15099,0.18503,1,1
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.00099681,0.15098,0.15224,1,1
5,GO RNA SPLICING,0.00012594,0.15064,0.14162,1,1
5,GO UV PROTECTION,0.0062877,0.15059,0.17367,1,1
5,GO REGULATION OF DNA BINDING,2.7452e-06,0.15047,0.16172,1,1
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0032078,0.15045,0.12151,1,1
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.051595,0.15039,0.098108,1,1
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0045438,0.15034,0.15924,1,1
5,GO CELL CYCLE PROCESS,5.8698e-06,0.15033,0.14944,1,1
5,GO EATING BEHAVIOR,0.00014839,0.15033,0.16742,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.022928,0.15022,0.11849,1,1
5,GO SISTER CHROMATID SEGREGATION,7.5001e-05,0.15008,0.16542,1,1
5,GO REGULATION OF SODIUM ION TRANSPORT,0.00094089,0.14994,0.15557,1,1
5,GO REGULATION OF CELLULAR COMPONENT SIZE,6.7724e-05,0.14994,0.15868,1,1
5,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0005133,0.14994,0.18613,1,1
5,GO POLYSACCHARIDE METABOLIC PROCESS,0.0035146,0.14983,0.12012,1,1
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0034692,0.14982,0.13618,1,1
5,GO VESICLE DOCKING,0.0025961,0.14971,0.13859,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0071051,0.14963,0.12509,1,1
5,GO FEEDING BEHAVIOR,0.00010673,0.14961,0.18348,1,1
5,GO CELL CYCLE G2 M PHASE TRANSITION,0.00033955,0.14951,0.12846,1,1
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.046474,0.14938,0.086321,1,1
5,GO GOLGI RIBBON FORMATION,0.00038422,0.14934,0.19975,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.015501,0.14926,0.15596,1,1
5,GO CELLULAR RESPONSE TO UV,5.4184e-05,0.14922,0.15652,1,1
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,2.3239e-05,0.1492,0.14556,1,1
5,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0063654,0.14919,0.12726,1,1
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0056255,0.14896,0.13336,1,1
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.00015583,0.14892,0.14545,1,1
5,GO JNK CASCADE,0.004156,0.1489,0.10636,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.035691,0.14885,0.11413,1,1
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,9.3381e-05,0.14882,0.18602,1,1
5,GO POSITIVE REGULATION OF DNA REPLICATION,4.1026e-05,0.14864,0.1585,1,1
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.0002443,0.14856,0.15305,1,1
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0053519,0.14854,0.22134,1,1
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.0030839,0.1485,0.14989,1,1
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,2.4305e-07,0.14847,0.16507,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,3.4296e-07,0.14844,0.16581,1,1
5,GO SIGNAL RELEASE,2.9859e-05,0.14842,0.16115,1,1
5,GO ORGANELLE ASSEMBLY,3.8983e-07,0.14841,0.16044,1,1
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,6.3249e-05,0.1484,0.1783,1,1
5,GO MRNA METHYLATION,0.0034243,0.14836,0.1575,1,1
5,GO REGULATION OF CELL CYCLE PROCESS,4.1456e-06,0.14816,0.14881,1,1
5,GO CHROMOSOME ORGANIZATION,8.8282e-08,0.1481,0.18081,1,1
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00014129,0.14796,0.15193,1,1
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,1.2886e-07,0.14787,0.16212,1,1
5,GO REGULATION OF FEEDING BEHAVIOR,0.0018508,0.14778,0.17477,1,1
5,GO ORGANELLE FISSION,1.0958e-05,0.14765,0.15304,1,1
5,GO VISUAL BEHAVIOR,0.00023667,0.14761,0.15094,1,1
5,GO RRNA CATABOLIC PROCESS,0.0052854,0.14759,0.14088,1,1
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00011406,0.14741,0.16329,1,1
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,2.1621e-05,0.14739,0.15714,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.032278,0.14734,0.16874,1,1
5,GO RHYTHMIC PROCESS,3.5038e-07,0.14729,0.18144,1,1
5,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0054192,0.14722,0.15987,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0039481,0.14716,0.13606,1,1
5,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.00017176,0.14712,0.1773,1,1
5,GO CELL CELL JUNCTION ORGANIZATION,0.0085105,0.14702,0.1415,1,1
5,GO CLATHRIN COAT ASSEMBLY,0.03902,0.14699,0.12373,1,1
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.00084997,0.14696,0.13639,1,1
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.0051547,0.14695,0.14792,1,1
5,GO REGULATION OF POTASSIUM ION TRANSPORT,4.7999e-05,0.14685,0.18175,1,1
5,GO ROOF OF MOUTH DEVELOPMENT,0.00018923,0.14684,0.18601,1,1
5,GO HEART DEVELOPMENT,0.00029511,0.14678,0.14447,1,1
5,GO MEIOTIC CELL CYCLE,3.0302e-06,0.14675,0.17874,1,1
5,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,4.4771e-05,0.14666,0.1797,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,3.628e-05,0.14655,0.15137,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.00062378,0.14648,0.1765,1,1
5,GO ANIMAL ORGAN MATURATION,0.00026438,0.14648,0.19729,1,1
5,GO CHROMOSOME CONDENSATION,0.00046872,0.14639,0.16931,1,1
5,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,6.337e-06,0.14634,0.16345,1,1
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0061347,0.14634,0.14155,1,1
5,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0035146,0.14599,0.14622,1,1
5,GO CELLULAR RESPONSE TO LIGHT STIMULUS,1.0557e-05,0.14591,0.14073,1,1
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,5.5127e-05,0.14579,0.17119,1,1
5,GO ANOIKIS,0.0099244,0.14577,0.15518,1,1
5,GO CELLULAR RESPONSE TO NUTRIENT,0.0066039,0.14574,0.17004,1,1
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.00022208,0.14547,0.17732,1,1
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.00067188,0.14547,0.15501,1,1
5,GO BONE DEVELOPMENT,0.011813,0.14511,0.11454,1,1
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.05063,0.14502,0.10047,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0027747,0.14494,0.14388,1,1
5,GO CELL DIVISION,5.2303e-06,0.14466,0.16305,1,1
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0089251,0.14463,0.12373,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0018764,0.14459,0.15267,1,1
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00086244,0.14456,0.13582,1,1
5,GO SENSORY PERCEPTION OF PAIN,0.00072342,0.14449,0.14159,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE,7.6657e-06,0.14427,0.13956,1,1
5,GO REGULATION OF FIBROBLAST MIGRATION,0.011544,0.14408,0.12559,1,1
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0024281,0.14401,0.18408,1,1
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0075485,0.14395,0.11447,1,1
5,GO LIPID PHOSPHORYLATION,1.2954e-05,0.14395,0.17064,1,1
5,GO NEGATIVE REGULATION OF CELL AGING,0.033271,0.14381,0.12502,1,1
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,9.9803e-06,0.1436,0.15381,1,1
5,GO CARDIAC MUSCLE CELL PROLIFERATION,0.024428,0.14348,0.10877,1,1
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,1.9044e-05,0.14344,0.15553,1,1
5,GO HOMOLOGOUS RECOMBINATION,0.0015463,0.14337,0.171,1,1
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0015038,0.14337,0.1434,1,1
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.036772,0.14328,0.11962,1,1
5,GO REGULATION OF SENSORY PERCEPTION,0.00071283,0.14325,0.13398,1,1
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.01128,0.14306,0.12354,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0047198,0.14301,0.18847,1,1
5,GO REGULATION OF HISTONE DEACETYLATION,0.0095807,0.14294,0.13598,1,1
5,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.040187,0.14288,0.18714,1,1
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.004156,0.14285,0.16198,1,1
5,GO REGULATION OF HORMONE LEVELS,0.00071283,0.14276,0.12761,1,1
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.0046604,0.14268,0.077702,1,1
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0020092,0.14268,0.17282,1,1
5,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.001955,0.14267,0.15414,1,1
5,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,3.2057e-05,0.14266,0.15402,1,1
5,GO MAMMARY GLAND MORPHOGENESIS,0.021973,0.14256,0.13976,1,1
5,GO REGULATION OF MITOCHONDRIAL FISSION,0.0137,0.14231,0.10393,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0005618,0.1423,0.13627,1,1
5,GO MITOTIC NUCLEAR DIVISION,7.5001e-05,0.14208,0.15715,1,1
5,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.00017457,0.14192,0.1454,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0044298,0.1419,0.13988,1,1
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0016806,0.14187,0.1807,1,1
5,GO MRNA TRANSPORT,0.00053704,0.14179,0.12962,1,1
5,GO RNA EXPORT FROM NUCLEUS,0.0071918,0.14173,0.11101,1,1
5,GO INTRACELLULAR LIPID TRANSPORT,0.020828,0.14171,0.12356,1,1
5,GO MUSCLE CELL DIFFERENTIATION,0.0012527,0.14171,0.12866,1,1
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00044781,0.14169,0.1445,1,1
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0020367,0.14153,0.13407,1,1
5,GO REGULATION OF CELL CYCLE,8.1361e-07,0.1414,0.1502,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00025215,0.1414,0.15115,1,1
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00068191,0.14104,0.17567,1,1
5,GO HYPEROSMOTIC RESPONSE,0.00016098,0.14103,0.18789,1,1
5,GO DNA METHYLATION OR DEMETHYLATION,4.2487e-05,0.14094,0.13643,1,1
5,GO VIRAL RNA GENOME REPLICATION,0.014172,0.14089,0.11245,1,1
5,GO HISTONE PHOSPHORYLATION,0.00086244,0.14069,0.13566,1,1
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0030436,0.14066,0.13417,1,1
5,GO ACTIN FILAMENT BASED PROCESS,0.0040509,0.14064,0.1196,1,1
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00064263,0.14057,0.12687,1,1
5,GO MRNA 3 END PROCESSING,0.00048316,0.14051,0.14446,1,1
5,GO NUCLEAR EXPORT,0.0033361,0.1405,0.11437,1,1
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,1.5865e-05,0.14048,0.14864,1,1
5,GO REGULATION OF CHROMOSOME SEPARATION,0.0011341,0.14042,0.1566,1,1
5,GO NEGATIVE REGULATION OF RNA SPLICING,1.1806e-05,0.14042,0.16754,1,1
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,8.9166e-06,0.14037,0.14866,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.033271,0.14035,0.11469,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.019104,0.14029,0.13925,1,1
5,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00011596,0.14026,0.1356,1,1
5,GO CHROMOSOME SEPARATION,0.00052901,0.14024,0.16835,1,1
5,GO RNA DESTABILIZATION,0.0005056,0.14017,0.15745,1,1
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.010769,0.14004,0.10154,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.001422,0.13995,0.19765,1,1
5,GO RESPONSE TO GROWTH FACTOR,0.0058389,0.13994,0.10944,1,1
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.000662,0.13992,0.20584,1,1
5,GO CELL CYCLE DNA REPLICATION,4.2487e-05,0.13992,0.18743,1,1
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0024281,0.13988,0.1646,1,1
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00011033,0.13964,0.14623,1,1
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.016938,0.13953,0.10179,1,1
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.0012886,0.13952,0.12424,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,1.734e-06,0.13948,0.15946,1,1
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,1.3056e-06,0.13928,0.1782,1,1
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.00073415,0.1392,0.19702,1,1
5,GO PEPTIDYL SERINE MODIFICATION,8.4424e-05,0.1388,0.13934,1,1
5,GO SPINDLE ASSEMBLY,0.00012804,0.13877,0.15869,1,1
5,GO MYELIN ASSEMBLY,0.024947,0.13855,0.1537,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00014839,0.13831,0.14874,1,1
5,GO RENAL WATER HOMEOSTASIS,0.00084997,0.1382,0.21075,1,1
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0055559,0.13818,0.13538,1,1
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.043866,0.1381,0.085183,1,1
5,GO NEGATIVE REGULATION OF NEURON DEATH,8.8796e-05,0.13774,0.14447,1,1
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.038258,0.13768,0.17367,1,1
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.00036124,0.13764,0.16623,1,1
5,GO MUSCLE TISSUE DEVELOPMENT,0.00065224,0.13743,0.11927,1,1
5,GO MITOCHONDRIAL GENOME MAINTENANCE,0.00092737,0.13733,0.15468,1,1
5,GO RENAL SYSTEM PROCESS,0.0025961,0.13725,0.16092,1,1
5,GO PROTEIN DEPHOSPHORYLATION,2.011e-05,0.13721,0.13727,1,1
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0062108,0.13719,0.11284,1,1
5,GO DETECTION OF LIGHT STIMULUS,8.5858e-05,0.13703,0.10807,1,1
5,GO LIPOPROTEIN METABOLIC PROCESS,0.0047798,0.13682,0.10066,1,1
5,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0024281,0.13667,0.11675,1,1
5,GO POSITIVE REGULATION OF GROWTH,3.1494e-05,0.13662,0.15873,1,1
5,GO UV DAMAGE EXCISION REPAIR,0.0015463,0.13661,0.15728,1,1
5,GO CORONARY VASCULATURE DEVELOPMENT,0.024947,0.1366,0.14197,1,1
5,GO FEMALE GAMETE GENERATION,1.475e-06,0.13655,0.162,1,1
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00074504,0.13655,0.10887,1,1
5,GO DENDRITIC SPINE MAINTENANCE,0.0028492,0.13651,0.20877,1,1
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.02174,0.13622,0.16753,1,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0037016,0.13617,0.1497,1,1
5,GO PROTEIN LOCALIZATION TO NUCLEUS,0.010279,0.13612,0.096388,1,1
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,1.5293e-05,0.13588,0.15362,1,1
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0028118,0.13584,0.14117,1,1
5,GO EPITHELIAL CELL PROLIFERATION,0.016568,0.13583,0.10993,1,1
5,GO HISTONE H3 ACETYLATION,6.2169e-06,0.13583,0.16143,1,1
5,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,8.1138e-06,0.13582,0.1647,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.00017176,0.13579,0.1218,1,1
5,GO LENS FIBER CELL DEVELOPMENT,0.013856,0.13568,0.16939,1,1
5,GO REGULATION OF TELOMERE CAPPING,0.0095807,0.13562,0.11966,1,1
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.011411,0.13559,0.12644,1,1
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.028264,0.13559,0.11463,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0018764,0.13555,0.1371,1,1
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0013633,0.13553,0.082309,1,1
5,GO FAT CELL DIFFERENTIATION,0.009139,0.13544,0.1152,1,1
5,GO ONE CARBON METABOLIC PROCESS,0.033608,0.13527,0.097964,1,1
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00015838,0.13521,0.15418,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.026013,0.13521,0.10846,1,1
5,GO ENDOCYTIC RECYCLING,0.0062877,0.13517,0.12448,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00092737,0.13509,0.12389,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE,4.9228e-07,0.13509,0.15502,1,1
5,GO DNA LIGATION,0.040187,0.13505,0.098703,1,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00036686,0.13491,0.10873,1,1
5,GO PEPTIDYL LYSINE MODIFICATION,4.7963e-08,0.13484,0.18071,1,1
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.057711,0.13477,0.088322,1,1
5,GO REGULATION OF DEPHOSPHORYLATION,2.0364e-06,0.13476,0.16678,1,1
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00046165,0.13466,0.21821,1,1
5,GO POSITIVE REGULATION OF HEART GROWTH,0.035691,0.13461,0.10393,1,1
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00034485,0.13457,0.13467,1,1
5,GO GOLGI ORGANIZATION,0.0098086,0.13453,0.091104,1,1
5,GO NUCLEUS ORGANIZATION,0.001483,0.13435,0.11481,1,1
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.016752,0.13434,0.10832,1,1
5,GO SODIUM ION HOMEOSTASIS,0.00068191,0.13428,0.16576,1,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0098086,0.13424,0.13296,1,1
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,1.0958e-05,0.13418,0.14481,1,1
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.010279,0.13415,0.097215,1,1
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0085105,0.13413,0.11861,1,1
5,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.000286,0.13413,0.11877,1,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00024819,0.1341,0.11234,1,1
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.023419,0.13407,0.094952,1,1
5,GO REGULATION OF GROWTH,0.00013451,0.13405,0.13315,1,1
5,GO MEIOTIC CELL CYCLE PROCESS,2.1234e-05,0.13403,0.1685,1,1
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.024947,0.13402,0.15918,1,1
5,GO CELL CYCLE,3.152e-06,0.134,0.14633,1,1
5,GO PEPTIDYL AMINO ACID MODIFICATION,0.00019229,0.13393,0.11537,1,1
5,GO RESPIRATORY SYSTEM PROCESS,0.0075485,0.13381,0.14265,1,1
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.039406,0.13365,0.082387,1,1
5,GO MITOTIC G1 S TRANSITION CHECKPOINT,1.3442e-05,0.1336,0.18754,1,1
5,GO NUCLEOTIDE PHOSPHORYLATION,0.010041,0.13356,0.10821,1,1
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00033432,0.13354,0.11066,1,1
5,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,3.628e-05,0.13341,0.13391,1,1
5,GO OOCYTE DIFFERENTIATION,0.015329,0.13332,0.10779,1,1
5,GO MULTICELLULAR ORGANISM AGING,0.0075485,0.13331,0.12031,1,1
5,GO REGULATION OF VASOCONSTRICTION,0.001422,0.13316,0.14794,1,1
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.036048,0.13306,0.10465,1,1
5,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.00037257,0.13305,0.14256,1,1
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.001568,0.13302,0.15053,1,1
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0050269,0.13298,0.092276,1,1
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.001235,0.13296,0.13317,1,1
5,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.058247,0.13292,0.13478,1,1
5,GO ERYTHROCYTE DEVELOPMENT,0.022209,0.13291,0.10945,1,1
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.0021215,0.13286,0.14946,1,1
5,GO ASYMMETRIC CELL DIVISION,0.011411,0.13276,0.17164,1,1
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0035605,0.13262,0.10795,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0011021,0.13239,0.1546,1,1
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0060595,0.13232,0.10113,1,1
5,GO DETECTION OF ABIOTIC STIMULUS,4.3946e-06,0.13212,0.16945,1,1
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.00049802,0.13208,0.14545,1,1
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0051547,0.132,0.11561,1,1
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00023667,0.132,0.13268,1,1
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.02521,0.13199,0.13903,1,1
5,GO ERROR PRONE TRANSLESION SYNTHESIS,1.0361e-05,0.1319,0.18014,1,1
5,GO REGULATION OF CENTROSOME DUPLICATION,0.00020504,0.13179,0.18054,1,1
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0016806,0.13172,0.16608,1,1
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00088789,0.1315,0.11548,1,1
5,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0030839,0.13145,0.12813,1,1
5,GO CELLULAR RESPONSE TO STARVATION,0.00042128,0.13144,0.13516,1,1
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0075485,0.13142,0.10971,1,1
5,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00028155,0.13135,0.12011,1,1
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.00018923,0.13133,0.14231,1,1
5,GO POSITIVE REGULATION OF JNK CASCADE,0.017506,0.13128,0.10451,1,1
5,GO ENDOSOME TO LYSOSOME TRANSPORT,8.0256e-05,0.13113,0.14305,1,1
5,GO VESICLE LOCALIZATION,0.001118,0.13109,0.11623,1,1
5,GO REGULATION OF STEM CELL DIVISION,0.018693,0.13108,0.13237,1,1
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0027747,0.13084,0.128,1,1
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0054192,0.13077,0.10278,1,1
5,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0076401,0.13069,0.12425,1,1
5,GO PROTEIN MONOUBIQUITINATION,0.00027716,0.13059,0.14042,1,1
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0072795,0.13025,0.10684,1,1
5,GO LYSOSOMAL TRANSPORT,0.0060595,0.13019,0.1164,1,1
5,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00016361,0.13006,0.16589,1,1
5,GO APOPTOTIC DNA FRAGMENTATION,5.3256e-05,0.12999,0.139,1,1
5,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0059116,0.12994,0.13939,1,1
5,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.0991e-06,0.12989,0.14684,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0039481,0.12987,0.10523,1,1
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.001118,0.12986,0.11408,1,1
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00159,0.1298,0.10698,1,1
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.00025617,0.12955,0.13814,1,1
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,1.5027e-08,0.12945,0.18415,1,1
5,GO DEPHOSPHORYLATION,2.9859e-05,0.12935,0.13347,1,1
5,GO NEGATIVE REGULATION OF SIGNALING,0.0015038,0.12931,0.10836,1,1
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.03006,0.12919,0.1335,1,1
5,GO REGULATION OF ORGANELLE ORGANIZATION,7.7586e-05,0.12915,0.12749,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0043184,0.12914,0.12534,1,1
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0044298,0.12902,0.17966,1,1
5,GO ACTIN FILAMENT ORGANIZATION,0.021053,0.12891,0.10363,1,1
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,7.7586e-05,0.12888,0.17188,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00012388,0.12886,0.14878,1,1
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.01829,0.1288,0.10919,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,5.8049e-05,0.12873,0.13454,1,1
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.037139,0.12872,0.10772,1,1
5,GO MITOTIC CELL CYCLE,0.00015838,0.12865,0.13121,1,1
5,GO MUSCLE CELL DEVELOPMENT,0.011411,0.12855,0.10595,1,1
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.01995,0.12849,0.10635,1,1
5,GO OXIDATIVE DEMETHYLATION,0.0061347,0.12848,0.09826,1,1
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.004156,0.12844,0.16816,1,1
5,GO CELL MATURATION,1.2482e-05,0.12833,0.16692,1,1
5,GO RESPONSE TO LIGHT STIMULUS,8.7502e-06,0.12832,0.13756,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.00024819,0.12817,0.11343,1,1
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00023667,0.12797,0.10796,1,1
5,GO MUSCLE ORGAN DEVELOPMENT,0.00026858,0.12728,0.12986,1,1
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.008211,0.12724,0.096437,1,1
5,GO REGULATION OF CELLULAR LOCALIZATION,0.0003557,0.12709,0.1173,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00040857,0.12701,0.1261,1,1
5,GO REGULATION OF PHOSPHORYLATION,0.0039992,0.12676,0.09948,1,1
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.00067188,0.12665,0.18123,1,1
5,GO RESPONSE TO AMINO ACID STARVATION,0.00099681,0.12662,0.15003,1,1
5,GO REGULATION OF MITOTIC CELL CYCLE,5.8049e-05,0.12651,0.12713,1,1
5,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.0021505,0.12637,0.11758,1,1
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00029976,0.12637,0.16221,1,1
5,GO PROTEIN AUTOPHOSPHORYLATION,0.0059852,0.12636,0.11379,1,1
5,GO ACTIVATION OF JUN KINASE ACTIVITY,0.001776,0.12627,0.14228,1,1
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.033608,0.12626,0.1265,1,1
5,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00033955,0.1262,0.11948,1,1
5,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00039018,0.12609,0.15942,1,1
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.027401,0.12602,0.11502,1,1
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.064418,0.12598,0.097353,1,1
5,GO POSITIVE REGULATION OF MITOPHAGY,0.0075485,0.12566,0.12846,1,1
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0043184,0.12547,0.14024,1,1
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,3.4773e-06,0.12546,0.13714,1,1
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.014332,0.12544,0.10328,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00032408,0.12538,0.13668,1,1
5,GO CARDIAC CONDUCTION,0.0013255,0.12512,0.18118,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.0032928,0.12507,0.11014,1,1
5,GO DNA METABOLIC PROCESS,7.8911e-05,0.125,0.12744,1,1
5,GO PROTEOGLYCAN METABOLIC PROCESS,0.010041,0.1249,0.12871,1,1
5,GO CELL CYCLE PHASE TRANSITION,0.00059648,0.1249,0.11611,1,1
5,GO REGULATION OF PROTEIN SUMOYLATION,0.00013899,0.12489,0.15734,1,1
5,GO ENERGY RESERVE METABOLIC PROCESS,0.0013069,0.1246,0.13556,1,1
5,GO BROWN FAT CELL DIFFERENTIATION,0.0061347,0.12457,0.15717,1,1
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.010041,0.12442,0.095044,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00099681,0.1244,0.14812,1,1
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.001422,0.12439,0.15867,1,1
5,GO RESPONSE TO UV,4.3997e-05,0.12429,0.14895,1,1
5,GO METANEPHROS DEVELOPMENT,0.017894,0.12426,0.12543,1,1
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0024609,0.12423,0.1481,1,1
5,GO REGULATION OF CELL MATURATION,0.0090315,0.12423,0.097742,1,1
5,GO CALCIUM ION IMPORT,0.011678,0.12422,0.1184,1,1
5,GO REGULATION OF GLIOGENESIS,3.4409e-05,0.12413,0.18092,1,1
5,GO NUCLEAR TRANSPORT,0.0024609,0.12412,0.11003,1,1
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,9.3381e-05,0.12384,0.1302,1,1
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.027686,0.12373,0.12299,1,1
5,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0074579,0.12363,0.12844,1,1
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0093576,0.12359,0.13909,1,1
5,GO REGULATION OF MRNA METABOLIC PROCESS,0.0020092,0.12358,0.10709,1,1
5,GO OOCYTE MATURATION,0.045591,0.12338,0.12323,1,1
5,GO GLUCOSE IMPORT,0.0013069,0.12334,0.13057,1,1
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.058787,0.12326,0.10449,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.017315,0.12323,0.087267,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.024947,0.12295,0.12007,1,1
5,GO MACROMOLECULE DEACYLATION,5.5127e-05,0.12294,0.15826,1,1
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.031631,0.1227,0.12277,1,1
5,GO POSITIVE REGULATION OF TOR SIGNALING,3.5646e-05,0.12258,0.17266,1,1
5,GO HISTONE MONOUBIQUITINATION,3.8246e-05,0.1225,0.16547,1,1
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,1.0361e-05,0.12237,0.14567,1,1
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.01585,0.12232,0.14722,1,1
5,GO ADAPTATION OF SIGNALING PATHWAY,0.043444,0.1222,0.099134,1,1
5,GO PROTEIN K48 LINKED UBIQUITINATION,0.016386,0.1222,0.097374,1,1
5,GO PIRNA METABOLIC PROCESS,0.022446,0.12219,0.11149,1,1
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.037882,0.12213,0.080494,1,1
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0025617,0.12209,0.13255,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0025277,0.1219,0.10886,1,1
5,GO NEGATIVE REGULATION OF CELL GROWTH,0.0033799,0.12179,0.11159,1,1
5,GO CHEMOSENSORY BEHAVIOR,0.013394,0.12162,0.12083,1,1
5,GO METHYLATION,0.00015083,0.12157,0.13526,1,1
5,GO NUCLEOTIDE EXCISION REPAIR,0.024428,0.12145,0.077807,1,1
5,GO POSTREPLICATION REPAIR,0.0029256,0.12143,0.095583,1,1
5,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.040981,0.12119,0.13244,1,1
5,GO EXCRETION,0.0030436,0.12091,0.13649,1,1
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,2.7312e-05,0.12084,0.18198,1,1
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.02915,0.12071,0.07405,1,1
5,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.046031,0.1207,0.10621,1,1
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.01128,0.12061,0.098432,1,1
5,GO PLACENTA DEVELOPMENT,0.022928,0.12058,0.10984,1,1
5,GO IMPORT INTO CELL,0.0052854,0.12054,0.13099,1,1
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.013394,0.12051,0.091879,1,1
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0037498,0.12047,0.10918,1,1
5,GO DNA REPLICATION INITIATION,0.00044103,0.12045,0.16709,1,1
5,GO CARBOHYDRATE PHOSPHORYLATION,0.013394,0.12009,0.13309,1,1
5,GO NEURON DEATH,0.00017741,0.12004,0.13289,1,1
5,GO PROTEIN SUMOYLATION,4.6359e-05,0.11999,0.15244,1,1
5,GO CHLORIDE TRANSPORT,0.00090088,0.11979,0.13433,1,1
5,GO RESPONSE TO IRON ION,0.019104,0.11975,0.13282,1,1
5,GO PROTEIN INSERTION INTO MEMBRANE,0.0024941,0.11969,0.10578,1,1
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.00080175,0.11968,0.11673,1,1
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0056958,0.11967,0.0965,1,1
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.013546,0.11958,0.10616,1,1
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0099244,0.11944,0.098114,1,1
5,GO CYTOSOLIC TRANSPORT,0.0033799,0.11937,0.11672,1,1
5,GO POSITIVE REGULATION OF SIGNALING,0.0074579,0.11936,0.092192,1,1
5,GO REGULATION OF TOR SIGNALING,6.3249e-05,0.11923,0.15649,1,1
5,GO IMPORT INTO NUCLEUS,0.0062877,0.1191,0.097311,1,1
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.0089251,0.11887,0.093689,1,1
5,GO ESCRT COMPLEX DISASSEMBLY,0.02174,0.11883,0.12046,1,1
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,3.6924e-05,0.11872,0.13892,1,1
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0080166,0.11856,0.090859,1,1
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.001442,0.11854,0.1382,1,1
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.028556,0.11844,0.097418,1,1
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.038637,0.11842,0.13814,1,1
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00013899,0.1183,0.15621,1,1
5,GO NEGATIVE REGULATION OF BINDING,0.0003557,0.11825,0.12792,1,1
5,GO ENDOSOMAL TRANSPORT,0.0067673,0.11788,0.097287,1,1
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.051595,0.11783,0.098054,1,1
5,GO REGULATION OF PROTEIN ACETYLATION,3.4773e-06,0.11777,0.16294,1,1
5,GO NCRNA TRANSCRIPTION,0.01499,0.11776,0.086061,1,1
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.022686,0.11761,0.11479,1,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.031631,0.11739,0.078499,1,1
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.00021857,0.11734,0.11808,1,1
5,GO PEPTIDYL CYSTEINE MODIFICATION,0.00096848,0.1173,0.1328,1,1
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.00018323,0.11717,0.12401,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION,0.0005618,0.1171,0.11284,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0098086,0.11707,0.13779,1,1
5,GO ORGAN GROWTH,0.0057669,0.11699,0.10705,1,1
5,GO HEART PROCESS,0.0098086,0.11654,0.12142,1,1
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.03429,0.11639,0.069236,1,1
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.030368,0.11625,0.10477,1,1
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.045155,0.11608,0.085076,1,1
5,GO ACTIVATION OF MAPK ACTIVITY,0.022209,0.11601,0.088336,1,1
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.011022,0.11599,0.096914,1,1
5,GO REGULATION OF SECRETION,0.00032916,0.11578,0.12944,1,1
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.021053,0.11559,0.085157,1,1
5,GO ESTABLISHMENT OF RNA LOCALIZATION,0.016752,0.11557,0.092161,1,1
5,GO CARDIAC CELL DEVELOPMENT,0.013093,0.11549,0.11302,1,1
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.047372,0.11532,0.10598,1,1
5,GO PROTEIN POLYUBIQUITINATION,0.0067673,0.1153,0.089374,1,1
5,GO REGULATION OF DNA METABOLIC PROCESS,5.7059e-05,0.1153,0.13129,1,1
5,GO INTERMEDIATE FILAMENT BASED PROCESS,0.035336,0.11521,0.10704,1,1
5,GO PHOTOPERIODISM,4.7172e-05,0.11506,0.18326,1,1
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.023419,0.11493,0.10338,1,1
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0010113,0.11492,0.14563,1,1
5,GO REGULATION OF TRANSPORT,0.00083767,0.11491,0.10971,1,1
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.036409,0.11466,0.12267,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0018006,0.11457,0.14821,1,1
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.0057669,0.11447,0.10852,1,1
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0040509,0.11446,0.10656,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.0005133,0.1142,0.13515,1,1
5,GO RESPONSE TO CARBOHYDRATE,0.0056255,0.11416,0.10115,1,1
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.049681,0.11414,0.081708,1,1
5,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00059648,0.11403,0.16353,1,1
5,GO RESPONSE TO MONOSACCHARIDE,0.0023321,0.11399,0.11286,1,1
5,GO ACTIN FILAMENT BASED MOVEMENT,0.016386,0.11394,0.11571,1,1
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.01128,0.11393,0.091381,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0039481,0.11392,0.10378,1,1
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0075485,0.11378,0.15624,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.058247,0.11373,0.15027,1,1
5,GO REGULATION OF CELL AGING,0.015674,0.11369,0.11471,1,1
5,GO DNA DEALKYLATION,0.0038977,0.11351,0.13352,1,1
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.015329,0.1134,0.13117,1,1
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.00064263,0.11336,0.14632,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0020929,0.1131,0.10296,1,1
5,GO STRESS FIBER ASSEMBLY,0.032938,0.11309,0.11416,1,1
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.055609,0.11301,0.071859,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION,0.0059116,0.11296,0.12239,1,1
5,GO POSITIVE REGULATION OF CELL GROWTH,0.00070238,0.11295,0.13707,1,1
5,GO INTRACELLULAR PROTEIN TRANSPORT,0.01829,0.11291,0.06799,1,1
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.0071918,0.11283,0.11173,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,8.1623e-05,0.11273,0.16558,1,1
5,GO SNRNA TRANSCRIPTION,0.0047798,0.11273,0.095586,1,1
5,GO RETINA HOMEOSTASIS,0.00019541,0.11265,0.1291,1,1
5,GO SKELETAL MUSCLE ADAPTATION,0.029754,0.11264,0.134,1,1
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.001568,0.11242,0.10111,1,1
5,GO GANGLIOSIDE METABOLIC PROCESS,0.03006,0.1124,0.12893,1,1
5,GO PEPTIDE SECRETION,0.0025277,0.11227,0.1119,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0025961,0.1121,0.13432,1,1
5,GO T CELL DIFFERENTIATION IN THYMUS,0.0041031,0.11204,0.12115,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.024947,0.11202,0.12288,1,1
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00049053,0.11198,0.12296,1,1
5,GO ANATOMICAL STRUCTURE MATURATION,2.2824e-05,0.11194,0.15514,1,1
5,GO MESODERM DEVELOPMENT,0.0034692,0.1119,0.10825,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.016752,0.11178,0.11411,1,1
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.041789,0.11174,0.10509,1,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011151,0.11171,0.10066,1,1
5,GO PROTEIN LOCALIZATION TO MEMBRANE,6.8888e-05,0.1116,0.09997,1,1
5,GO RNA 3 END PROCESSING,0.036409,0.11157,0.084678,1,1
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0016806,0.11153,0.12157,1,1
5,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.0958e-05,0.11146,0.13935,1,1
5,GO PIGMENTATION,0.023173,0.11132,0.091464,1,1
5,GO CELL MOTILITY,0.017506,0.11109,0.098995,1,1
5,GO RNA DECAPPING,0.035336,0.11106,0.08999,1,1
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.016938,0.11102,0.14903,1,1
5,GO STRIATED MUSCLE CELL PROLIFERATION,0.0080166,0.111,0.11574,1,1
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.026838,0.11095,0.085109,1,1
5,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.049212,0.11094,0.13995,1,1
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.053071,0.11087,0.076535,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.019735,0.11077,0.097833,1,1
5,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00090088,0.11054,0.13474,1,1
5,GO RNA LOCALIZATION,0.025475,0.11054,0.082261,1,1
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00159,0.11052,0.10458,1,1
5,GO DNA METHYLATION,0.0005211,0.11049,0.13332,1,1
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00041488,0.1104,0.14019,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.017506,0.11028,0.28002,1,1
5,GO REGULATION OF TRANSFERASE ACTIVITY,0.0039481,0.11026,0.098311,1,1
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.041383,0.1102,0.11991,1,1
5,GO RESPONSE TO RADIATION,0.00016629,0.11014,0.11378,1,1
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.011813,0.11001,0.098046,1,1
5,GO CARBOHYDRATE HOMEOSTASIS,0.0030839,0.10996,0.11486,1,1
5,GO DNA CATABOLIC PROCESS,8.5858e-05,0.10991,0.13305,1,1
5,GO MUSCLE STRUCTURE DEVELOPMENT,0.0021798,0.10991,0.11418,1,1
5,GO PSEUDOPODIUM ORGANIZATION,0.023173,0.10983,0.19173,1,1
5,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0084096,0.1097,0.17356,1,1
5,GO ACTIVATION OF MAPKK ACTIVITY,0.016027,0.10954,0.12449,1,1
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00098255,0.10949,0.13842,1,1
5,GO SECOND MESSENGER MEDIATED SIGNALING,0.0010113,0.10947,0.11914,1,1
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.0066039,0.10943,0.14784,1,1
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0037985,0.10936,0.17043,1,1
5,GO MITOCHONDRIAL FISSION,0.044722,0.10914,0.075803,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0012705,0.10909,0.12162,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0056255,0.10891,0.096006,1,1
5,GO REGULATION OF BINDING,0.0025617,0.10889,0.10696,1,1
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0022396,0.10885,0.14303,1,1
5,GO STEM CELL DIFFERENTIATION,0.001955,0.10878,0.10586,1,1
5,GO RESPONSE TO STARVATION,0.00061456,0.1085,0.13057,1,1
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.017315,0.1085,0.092673,1,1
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0023009,0.10835,0.12707,1,1
5,GO SENSORY PERCEPTION,0.00014599,0.10835,0.12452,1,1
5,GO POSITIVE REGULATION OF NEURON DEATH,0.011949,0.10826,0.10946,1,1
5,GO ANIMAL ORGAN FORMATION,0.0047798,0.10805,0.14596,1,1
5,GO REGULATION OF NUCLEAR DIVISION,8.3013e-05,0.10805,0.13679,1,1
5,GO REGULATION OF BLOOD CIRCULATION,0.0055559,0.108,0.1311,1,1
5,GO DNA DEMETHYLATION,0.0024941,0.10777,0.15238,1,1
5,GO REGULATION OF PEPTIDE SECRETION,0.0032501,0.10763,0.10918,1,1
5,GO SKIN DEVELOPMENT,0.033271,0.1075,0.098407,1,1
5,GO INTRACELLULAR TRANSPORT,0.0070192,0.10746,0.079682,1,1
5,GO CARDIOCYTE DIFFERENTIATION,0.049212,0.10726,0.084482,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,6.1119e-05,0.10722,0.22081,1,1
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00015083,0.10712,0.12735,1,1
5,GO VACUOLAR TRANSPORT,0.014013,0.10708,0.095466,1,1
5,GO ION TRANSMEMBRANE TRANSPORT,0.0019819,0.10704,0.11377,1,1
5,GO NOTCH SIGNALING PATHWAY,0.0063654,0.10693,0.12176,1,1
5,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0084096,0.10689,0.092563,1,1
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.016938,0.10686,0.099412,1,1
5,GO PROTEIN HOMOOLIGOMERIZATION,0.002631,0.10673,0.097254,1,1
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00063314,0.10673,0.11222,1,1
5,GO REGULATION OF ATP METABOLIC PROCESS,0.0066851,0.1067,0.10518,1,1
5,GO MULTICELLULAR ORGANISMAL SIGNALING,0.00041488,0.10649,0.18999,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.014172,0.10635,0.093254,1,1
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.023668,0.10592,0.090917,1,1
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.0037985,0.10591,0.11517,1,1
5,GO RESPONSE TO AXON INJURY,0.0090315,0.10582,0.12848,1,1
5,GO TAXIS,0.0016122,0.10577,0.13068,1,1
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0075485,0.10574,0.080121,1,1
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.020166,0.10567,0.090079,1,1
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0030038,0.10561,0.098939,1,1
5,GO REGULATION OF PROTEIN POLYMERIZATION,0.0013255,0.10558,0.12903,1,1
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0098086,0.10547,0.090999,1,1
5,GO REGULATION OF HYDROLASE ACTIVITY,0.042197,0.10535,0.077342,1,1
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.0137,0.10533,0.11309,1,1
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.00075607,0.10532,0.14188,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0019285,0.10502,0.10229,1,1
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.004156,0.105,0.10495,1,1
5,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.0081133,0.10498,0.096002,1,1
5,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,1.2954e-05,0.10497,0.15559,1,1
5,GO MYOBLAST DIFFERENTIATION,0.031953,0.10497,0.085652,1,1
5,GO REGULATION OF ENDOCYTOSIS,0.018693,0.10483,0.09899,1,1
5,GO PIGMENT GRANULE LOCALIZATION,0.043866,0.10483,0.11003,1,1
5,GO CELL CELL ADHESION,0.056652,0.10476,0.088565,1,1
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0019285,0.10473,0.1166,1,1
5,GO RECEPTOR METABOLIC PROCESS,0.0055559,0.1047,0.11015,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0034243,0.10464,0.14331,1,1
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.046031,0.10461,0.089028,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0012705,0.10459,0.10883,1,1
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0066851,0.10453,0.10603,1,1
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.037509,0.10445,0.11895,1,1
5,GO MITOTIC CELL CYCLE ARREST,0.010895,0.10441,0.1566,1,1
5,GO LIPID DROPLET ORGANIZATION,0.0034692,0.10425,0.13531,1,1
5,GO PEPTIDYL THREONINE MODIFICATION,0.00015838,0.10418,0.13852,1,1
5,GO RESPONSE TO SALT STRESS,0.028264,0.10414,0.10911,1,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.028264,0.10402,0.073443,1,1
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0018764,0.10402,0.10646,1,1
5,GO CELLULAR RESPONSE TO RADIATION,0.00034485,0.10392,0.10535,1,1
5,GO PROTEIN ADP RIBOSYLATION,0.01849,0.10382,0.1214,1,1
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.013546,0.10341,0.081052,1,1
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.03006,0.10298,0.082682,1,1
5,GO CELL GROWTH,0.00025215,0.10288,0.13782,1,1
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.035691,0.10277,0.076928,1,1
5,GO TOR SIGNALING,0.00020835,0.10254,0.13193,1,1
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.038637,0.10243,0.19687,1,1
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.006444,0.10226,0.10095,1,1
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.002631,0.10224,0.10711,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE,0.012367,0.10219,0.094519,1,1
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0019023,0.10213,0.11305,1,1
5,GO BIOLOGICAL ADHESION,0.055093,0.10194,0.090275,1,1
5,GO CAMP METABOLIC PROCESS,0.035691,0.10172,0.13506,1,1
5,GO BILE ACID BIOSYNTHETIC PROCESS,0.02174,0.10168,0.10739,1,1
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.012227,0.10162,0.071416,1,1
5,GO DNA MODIFICATION,0.00033432,0.10158,0.10842,1,1
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.028852,0.10155,0.1082,1,1
5,GO RESPONSE TO ACID CHEMICAL,0.008211,0.10135,0.1006,1,1
5,GO EXOCYTIC PROCESS,0.056128,0.10133,0.10568,1,1
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0054872,0.10127,0.11355,1,1
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0098086,0.10109,0.088332,1,1
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.026286,0.10088,0.078704,1,1
5,GO MITOTIC METAPHASE PLATE CONGRESSION,0.0083098,0.10087,0.093921,1,1
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.030994,0.10069,0.075262,1,1
5,GO EPIDERMIS DEVELOPMENT,0.028556,0.10056,0.09669,1,1
5,GO NUCLEAR ENVELOPE ORGANIZATION,0.018693,0.10038,0.098471,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.001118,0.10034,0.11656,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.018091,0.1003,0.12416,1,1
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.049681,0.10025,0.10389,1,1
5,GO EXECUTION PHASE OF APOPTOSIS,0.0013255,0.10018,0.10966,1,1
5,GO PROTEIN CATABOLIC PROCESS,0.034984,0.10017,0.069402,1,1
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0089251,0.099601,0.097017,1,1
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.027401,0.099509,0.15453,1,1
5,GO REGULATION OF HISTONE UBIQUITINATION,0.018091,0.099436,0.094595,1,1
5,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0039481,0.099341,0.078383,1,1
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0062877,0.099119,0.1217,1,1
5,GO RESPONSE TO X RAY,0.062114,0.098972,0.07558,1,1
5,GO REGULATION OF CELL SHAPE,0.019523,0.098572,0.11362,1,1
5,GO CIRCULATORY SYSTEM PROCESS,0.020385,0.098539,0.095576,1,1
5,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0086125,0.098269,0.082165,1,1
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0012886,0.098145,0.1118,1,1
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.019104,0.097889,0.11668,1,1
5,GO CHONDROCYTE DIFFERENTIATION,0.042197,0.097725,0.10105,1,1
5,GO METAL ION TRANSPORT,0.0021798,0.097647,0.11007,1,1
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.013546,0.097627,0.12832,1,1
5,GO RESPONSE TO ETHER,0.058247,0.097386,0.095959,1,1
5,GO HOMEOSTATIC PROCESS,0.01995,0.097271,0.072422,1,1
5,GO PHOTOTRANSDUCTION,0.0033799,0.097126,0.069932,1,1
5,GO REGULATION OF TELOMERE MAINTENANCE,0.051111,0.097062,0.082316,1,1
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0088198,0.097047,0.093432,1,1
5,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.034984,0.096986,0.091257,1,1
5,GO ACTIN CYTOSKELETON REORGANIZATION,0.018091,0.09697,0.10269,1,1
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0067673,0.096927,0.11002,1,1
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0084096,0.096794,0.12133,1,1
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0028118,0.096635,0.094029,1,1
5,GO REGULATION OF PEPTIDE TRANSPORT,0.00091404,0.096226,0.10591,1,1
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0038478,0.096037,0.16998,1,1
5,GO CATION TRANSPORT,0.0021798,0.095985,0.11169,1,1
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0010113,0.09598,0.1015,1,1
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0038977,0.095956,0.11101,1,1
5,GO LIPID MODIFICATION,0.018898,0.095799,0.089226,1,1
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0031247,0.095685,0.12725,1,1
5,GO REGULATION OF CELL POPULATION PROLIFERATION,0.027401,0.095525,0.08338,1,1
5,GO BILE ACID METABOLIC PROCESS,0.022209,0.094945,0.11046,1,1
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.001955,0.094796,0.097021,1,1
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00022565,0.094628,0.11807,1,1
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.038258,0.094297,0.10845,1,1
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.012087,0.0942,0.096911,1,1
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.011151,0.094133,0.099443,1,1
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00070238,0.094066,0.10674,1,1
5,GO NEGATIVE REGULATION OF BEHAVIOR,0.058787,0.093867,0.11392,1,1
5,GO POLYOL METABOLIC PROCESS,0.057179,0.093645,0.083815,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.046921,0.093592,0.10163,1,1
5,GO POSITIVE REGULATION OF BINDING,0.0081133,0.093569,0.091686,1,1
5,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.01499,0.093295,0.077321,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.003607,0.093245,0.098105,1,1
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.063258,0.093187,0.076201,1,1
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.063258,0.093076,0.099062,1,1
5,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.003166,0.092997,0.12079,1,1
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.063836,0.092977,0.069769,1,1
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.009139,0.092956,0.10483,1,1
5,GO SPINDLE MIDZONE ASSEMBLY,0.0096941,0.092904,0.14629,1,1
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.032607,0.092877,0.076717,1,1
5,GO SENSORY PERCEPTION OF SMELL,0.0080166,0.092794,0.097099,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.023668,0.092758,0.092376,1,1
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.039406,0.092699,0.098501,1,1
5,GO REGULATION OF ION TRANSPORT,0.003607,0.092528,0.11531,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.0019819,0.092379,0.095515,1,1
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.05063,0.092153,0.093441,1,1
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0042636,0.092139,0.10262,1,1
5,GO ENDOCRINE HORMONE SECRETION,0.056652,0.091962,0.074417,1,1
5,GO THYROID HORMONE METABOLIC PROCESS,0.034636,0.091961,0.15308,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0013255,0.091929,0.10785,1,1
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.036409,0.091444,0.068804,1,1
5,GO CELLULAR RESPONSE TO ALCOHOL,0.010041,0.091439,0.1179,1,1
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.027973,0.091429,0.093318,1,1
5,GO CATION TRANSMEMBRANE TRANSPORT,0.0020929,0.091398,0.11671,1,1
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.024428,0.091296,0.086237,1,1
5,GO CELL RECOGNITION,0.0059852,0.09125,0.12037,1,1
5,GO ERROR FREE TRANSLESION SYNTHESIS,0.029754,0.091024,0.07767,1,1
5,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.016386,0.090862,0.079182,1,1
5,GO BASE EXCISION REPAIR,0.0024281,0.090806,0.10592,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0086125,0.090607,0.10122,1,1
5,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.015501,0.090458,0.13244,1,1
5,GO IMPORT ACROSS PLASMA MEMBRANE,0.025475,0.090293,0.10997,1,1
5,GO MUSCLE SYSTEM PROCESS,0.064418,0.089861,0.076333,1,1
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.00026858,0.089758,0.13443,1,1
5,GO POSITIVE REGULATION OF TRANSPORT,0.013093,0.089699,0.088121,1,1
5,GO MRNA METABOLIC PROCESS,0.01499,0.089444,0.079491,1,1
5,GO RESPONSE TO ESTRADIOL,0.0083098,0.089237,0.11179,1,1
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.016752,0.089207,0.11018,1,1
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.041383,0.089052,0.073167,1,1
5,GO REGULATION OF METAL ION TRANSPORT,0.02128,0.088795,0.083624,1,1
5,GO GENE SILENCING,0.00016098,0.088763,0.12574,1,1
5,GO ADAPTIVE THERMOGENESIS,0.046031,0.088711,0.078962,1,1
5,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0016347,0.088481,0.13099,1,1
5,GO PROTEIN K63 LINKED UBIQUITINATION,0.031953,0.08844,0.07864,1,1
5,GO REGULATION OF ORGAN GROWTH,0.01849,0.088073,0.09639,1,1
5,GO RESPONSE TO PROSTAGLANDIN E,0.024428,0.087813,0.11341,1,1
5,GO NEGATIVE REGULATION OF GROWTH,0.025743,0.087387,0.091028,1,1
5,GO PROTEIN POLYMERIZATION,0.0025277,0.086967,0.11652,1,1
5,GO RESPONSE TO ACTIVITY,0.011813,0.086834,0.097147,1,1
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.01849,0.086808,0.13443,1,1
5,GO RESPONSE TO INSULIN,0.027118,0.08656,0.085629,1,1
5,GO TRANSCRIPTION BY RNA POLYMERASE III,0.03902,0.086545,0.068885,1,1
5,GO CONNECTIVE TISSUE DEVELOPMENT,0.033948,0.086533,0.091425,1,1
5,GO CHEMICAL HOMEOSTASIS,0.03429,0.086488,0.07538,1,1
5,GO RESPONSE TO ABIOTIC STIMULUS,0.029754,0.086473,0.06846,1,1
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.021509,0.086446,0.079213,1,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00046872,0.086424,0.13096,1,1
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0038977,0.086303,0.087945,1,1
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.046921,0.086025,0.07911,1,1
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0022396,0.085745,0.11832,1,1
5,GO TRANSLESION SYNTHESIS,0.0098086,0.085744,0.094159,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.031953,0.085708,0.10528,1,1
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0098086,0.085662,0.10355,1,1
5,GO INORGANIC ANION TRANSPORT,0.015159,0.085655,0.088628,1,1
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0014624,0.085307,0.11671,1,1
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.007921,0.08529,0.10974,1,1
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.020605,0.08484,0.10409,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0050269,0.084817,0.11195,1,1
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.037882,0.084644,0.076496,1,1
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0070192,0.084535,0.10284,1,1
5,GO POSITIVE REGULATION OF GLIOGENESIS,0.0019819,0.08427,0.14692,1,1
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.011544,0.084098,0.1057,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0054192,0.084086,0.089448,1,1
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.02915,0.083732,0.10003,1,1
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.012798,0.083566,0.12534,1,1
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.060432,0.083003,0.080081,1,1
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.015674,0.082947,0.095211,1,1
5,GO ION TRANSPORT,0.0062877,0.082862,0.0966,1,1
5,GO ANION TRANSMEMBRANE TRANSPORT,0.010279,0.082702,0.094322,1,1
5,GO SERTOLI CELL DIFFERENTIATION,0.024947,0.082688,0.13102,1,1
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0071051,0.082651,0.092107,1,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.044292,0.082495,0.11244,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.059879,0.082447,0.07439,1,1
5,GO TISSUE HOMEOSTASIS,0.058247,0.082301,0.073629,1,1
5,GO POSITIVE REGULATION OF SECRETION,0.0137,0.081645,0.09256,1,1
5,GO MEMBRANE ORGANIZATION,0.016205,0.081227,0.086257,1,1
5,GO CELLULAR HYPEROSMOTIC RESPONSE,0.05357,0.081054,0.10793,1,1
5,GO SPLEEN DEVELOPMENT,0.035336,0.080767,0.096212,1,1
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.034984,0.080078,0.078034,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.027686,0.08007,0.078155,1,1
5,GO TRANSMEMBRANE TRANSPORT,0.01585,0.079807,0.082496,1,1
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.035691,0.07979,0.10465,1,1
5,GO CARBOHYDRATE CATABOLIC PROCESS,0.063836,0.079764,0.07141,1,1
5,GO RESPONSE TO PEPTIDE HORMONE,0.052575,0.07933,0.073973,1,1
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0066851,0.078636,0.11119,1,1
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0092477,0.078613,0.11195,1,1
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.045155,0.078382,0.095577,1,1
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.051111,0.0783,0.070582,1,1
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.053071,0.078184,0.11012,1,1
5,GO POSITIVE REGULATION OF CELL DEATH,0.051111,0.078133,0.075731,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.034636,0.077823,0.061359,1,1
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0077327,0.077566,0.096545,1,1
5,GO APOPTOTIC PROCESS,0.047827,0.077379,0.066525,1,1
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.020385,0.077378,0.068415,1,1
5,GO MUSCLE CONTRACTION,0.060988,0.07728,0.077488,1,1
5,GO DNA BIOSYNTHETIC PROCESS,0.037882,0.076991,0.065345,1,1
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.046031,0.076985,0.10389,1,1
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.01585,0.076907,0.097406,1,1
5,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.020166,0.076822,0.074984,1,1
5,GO PROTEIN STABILIZATION,0.058787,0.076424,0.064629,1,1
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.040981,0.07596,0.076149,1,1
5,GO CELLULAR RESPONSE TO PH,0.059879,0.075902,0.07083,1,1
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.016205,0.075848,0.082763,1,1
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.003166,0.075741,0.093263,1,1
5,GO REGULATION OF ACTIN FILAMENT LENGTH,0.057711,0.075473,0.081328,1,1
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0032078,0.075359,0.13257,1,1
5,GO TELOMERE ORGANIZATION,0.047372,0.075168,0.081593,1,1
5,GO RESPONSE TO NITROGEN COMPOUND,0.034984,0.075097,0.072075,1,1
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.026013,0.074991,0.077723,1,1
5,GO REGULATION OF MACROAUTOPHAGY,0.0066851,0.07486,0.088631,1,1
5,GO REGULATION OF REPRODUCTIVE PROCESS,0.036772,0.074532,0.070243,1,1
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.007921,0.074379,0.087354,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0019819,0.074313,0.096212,1,1
5,GO ESTABLISHMENT OF TISSUE POLARITY,0.026013,0.074101,0.083912,1,1
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.054074,0.073081,0.077095,1,1
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.062684,0.072952,0.066931,1,1
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.003607,0.072143,0.097026,1,1
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.012653,0.07207,0.087874,1,1
5,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.020385,0.072066,0.13877,1,1
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.020605,0.071816,0.069272,1,1
5,GO CELL CYCLE G1 S PHASE TRANSITION,0.0070192,0.07137,0.10049,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.062114,0.071349,0.10358,1,1
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.02128,0.071192,0.066623,1,1
5,GO TRACHEA MORPHOGENESIS,0.029754,0.07101,0.13709,1,1
5,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0024941,0.070904,0.10245,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0099244,0.070124,0.10029,1,1
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.047827,0.06968,0.069783,1,1
5,GO TEMPERATURE HOMEOSTASIS,0.023419,0.06932,0.08849,1,1
5,GO MITOPHAGY,0.01016,0.069168,0.10821,1,1
5,GO NON CANONICAL WNT SIGNALING PATHWAY,0.01995,0.069164,0.085809,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.037139,0.069047,0.082186,1,1
5,GO REGULATION OF AUTOPHAGY,0.031311,0.069025,0.071899,1,1
5,GO CELLULAR HOMEOSTASIS,0.058247,0.068759,0.058848,1,1
5,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.05357,0.067291,0.069871,1,1
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.055093,0.067055,0.067886,1,1
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.065596,0.066907,0.061443,1,1
5,GO CELLULAR SENESCENCE,0.02128,0.066533,0.096828,1,1
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.056128,0.06638,0.1361,1,1
5,GO DETECTION OF STIMULUS,0.013546,0.066235,0.074098,1,1
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.034636,0.0659,0.079067,1,1
5,GO RESPONSE TO PEPTIDE,0.059879,0.064685,0.072297,1,1
5,GO REGULATION OF PROTEIN TARGETING,0.047827,0.063876,0.076307,1,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.049681,0.063672,0.065427,1,1
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.048285,0.063033,0.077906,1,1
5,GO MACROAUTOPHAGY,0.028264,0.062892,0.071647,1,1
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.055609,0.06279,0.061763,1,1
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.031311,0.061415,0.072002,1,1
5,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.038258,0.06027,0.075115,1,1
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.061549,0.059644,0.095782,1,1
5,GO NEGATIVE REGULATION OF SECRETION,0.02174,0.059507,0.080627,1,1
5,GO REGULATION OF ATPASE ACTIVITY,0.018693,0.059181,0.073405,1,1
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.052575,0.05651,0.073699,1,1
5,GO BLASTOCYST DEVELOPMENT,0.035336,0.054638,0.059753,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.037509,0.054249,0.075465,1,1
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.055609,0.047725,0.075749,1,1
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.020166,0.040679,0.081091,1,1
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.03006,0.037347,0.083869,1,1
